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Abstract 
Athletes and practitioners are continually looking for new strategies that 
could minimise the negative effects of exercise-induced muscle damage 
(EIMD) and hasten the recovery process. One strategy that has shown 
promise in recent years is the use of functional foods rich in phytonutrients. A 
functional food that has attracted a lot of attention recently, although primarily 
for its performance enhancing effects, is beetroot (Beta Vulgaris L.).In 
addition to displaying a range of physiological effects that may benefit 
athletic performance, beetroot also exhibits antioxidant (AOX) and anti-
inflammatory effects, both of which could be of benefit for reducing 
secondary damage and enhancing exercise recovery. Nonetheless, the 
effect of beetroot on exercise recovery is yet to be systematically 
investigated in the literature. Thus, the overarching aim of this thesis was to 
test the efficacy of beetroot supplementation, in the form of beetroot juice 
(BTJ), as a recovery intervention following strenuous exercise.  
The series of investigations that set out to address this aim have led to many 
novel and interesting findings. To start with, study 1 was the first to show that 
a commercially available BTJ is a rich source of phytonutrients and therefore 
possesses a high AOX capacity in comparison to several other fruit and 
vegetable juices. Secondly, and perhaps the most novel finding in this thesis, 
was that BTJ showed promise as an efficacious recovery intervention 
following some bouts of muscle-damaging exercise. Although not a 
consistent finding throughout this thesis, BTJ was able to improve the 
recovery of dynamic muscle function and reduce muscle pain after eccentric-
heavy exercise. Another important finding was that BTJ, despite being rich in 
AOXs, did not adversely affect the acute adaptive response to exercise, as 
measured by the repeated bout effect (RBE). In contrast to the findings in the 
earlier studies, however, BTJ was not found to be beneficial for recovery 
after long distance running. Importantly, the final study in this thesis provided 
the first evidence that BTJ is more beneficial than sodium nitrate (SN) for 
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enhancing some aspects of recovery. This study highlighted the importance 
of the phytonuteints in BTJ other than nitrate on recovery after exercise. In 
summary, the collective findings of this thesis provide new information on the 
potential application of a phytonutient rich functional food, in BTJ, for 
recovery from strenuous athletic performance. 
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RPE Rate of perceived exertion 
RSE Repeated sprint exercise 
RST Repeated sprint test 
RST1 Repeated sprint test 1 
RST2 Repeated sprint test 2 
RT Retention time 
SERCA Sarcoplasmic Ca2+ ATPase 
SD SD 
SN Sodium nitrate 
SSC Stretch-shortening cycle 
SR Sarcoplasmic reticulum  
TAS Total antioxidant status 
TBARS Thiobarbituric acid reactive species  
TEAC Trolox equivalent antioxidant capacity  
TGF-β1 Transforming growth factor beta 1 
TNF-α Tumour necrosis factor alpha 
VAS Visual analogue scale 
VCAM-1 Vascular cell adhesion protein 1 
VEGF Vascular endothelial growth factor 
VO2max Maximal volume of oxygen uptake 
8-OHdG 8-Hydroxyl-2′-Deoxyguanosine 
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1.1 Introduction  
It is now well-established that exercise, particularly if highly strenuous for the 
individual, can result in ultrastructure damage to skeletal muscle fibres (i.e., 
myofibrils) and components of the extracellular matrix (ECM) (i.e., desmin 
and dystrophin) (Beaton, Tarnopolsky, & Phillips, 2002; Friden & Lieber, 
2001; Friden, Sjostrom, & Ekblom, 1981, 1983; Hoppeler, 1986; Stupka, 
Tarnopolsky, Yardley, & Phillips, 2001). The consequences of such damage 
have also been well described in the literature, and include transient 
increases in biomarkers of inflammation and oxidative stress (Andersson et 
al., 2010a; Andersson, Karlsen, Blomhoff, Raastad, & Kadi, 2010b; Close 
Ashton, McArdle, & Maclaren, 2005; Pizza, Peterson, Baas, & Koh, 2005), 
muscle soreness (Paulsen et al., 2010; Smith, 1992), impaired range of 
movement (Howatson, Goodall, & van Someren, 2009; Warren, Lowe, & 
Armstrong, 1999) and, perhaps of most importance, marked and prolonged 
declines in muscle function (Ebbeling & Clarkson, 1989; Howatson & van 
Someren, 2008; Paulsen, Mikkelsen, Raastad, & Peake, 2012).  
 
The aforementioned symptoms of muscle damage are typically more 
pronounced after exercise that incorporates some form of eccentric 
contraction, in which a muscle is placed under tension to produce force 
(Child et al., 1999; Ebbeling & Clarkson, 1989; Paulsen et al., 2012). 
Because many sports and athletic activities, particularly those that involve 
the stretch shortening cycle (SSC), such as running, jumping, sprinting, 
change of direction and decelerating employ high force eccentric muscle 
contractions, they often result in at least some degree of muscle damage 
(Byrne, Twist, & Eston, 2004; Duffield, Cannon, & Kind, 2010; Hyldahl & 
Hubal, 2014; Warhol, Siegel, Evans, & Silverman, 1985).  
Despite extensive research efforts, the precise aetiology of muscle damage 
is not yet completely understood (Hyldahl & Hubal, 2014). However, there is 
generally an agreement that it probably occurs in two phases (Howatson & 
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van Someren, 2008; Hubal, Chen, Thompson, & Clarkson, 2008; Toumi & 
Best, 2003). Indeed, it is widely accepted that physical damage to the muscle 
ultrastructure and/or impairments in excitation-contraction (EC) coupling are 
probably the main stimuli responsible for initiating the muscle damage 
process, i.e., primary damage (Hyldah & Hubal, 2014; Proske & Morgan, 
2001; Warren, Ingalls, Lowe, & Armstrong, 2002). Such damage is then 
thought to trigger a series of biochemical changes that have the capacity to 
further harm the muscle and connective tissues, a response commonly 
referred to as secondary muscle damage (Howatson & van Someren, 2008; 
Hubal et al., 2008; McArdle et al., 1999; Sousa, Teixeira, & Soares, 2013; 
Toumi & Best 2003). The hallmarks of secondary damage are inflammation 
and oxidative stress, which typically develop in the hours and days after the 
damaging event (Nikolaidis et al., 2008; Smith, Kruger, Smith, & Hyburgh, 
2008). Although this biological response is innately a beneficial process, 
triggered to regenerate damaged tissues, somewhat paradoxically, it might 
also have deleterious effects for muscle function recovery, at least in the 
short term (Best, Fiebig, Corr, Brickson, & Ji, 1999; Lapointe, Frenette, & 
Cote, 2002; McArdle et al., 1999; Pizza et al., 2005; Toumi & Best, 2003).  
Irrespective of the mechanisms involved, muscle damage remains an 
obstinate problem for both athletes and recreational exercisers. Not only can 
the acute force loss affect subsequent performance, but the lingering effects 
of muscle soreness may heighten injury risk and negatively impact 
adherence to exercise programs (Howatson & van Someren, 2008; Smith, 
1992). Because in many sports athletes are expected to train or compete 
several times in a weekly cycle (Montgomery et al., 2008; Nédélec et al., 
2013), there is an increased need for effective recovery strategies that may 
help to reduce the magnitude of EIMD in the days after exercise.  
In the past two decades, a number of investigations have examined the 
effects of nutritional or pharmacological supplements on EIMD (see Sousa et 
al., 2013 for review). Particular interest has focused on the potential benefit 
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of oral supplements that exhibit AOX or anti-inflammatory effects (Sousa et 
al., 2013). The potential benefits of these supplements are that they 
counteract the potentially harmful effects of inflammation and oxidative stress 
(i.e., the hallmarks of secondary damage) by bolstering endogenous 
defences when they might be compromised from an exercise or non-exercise 
stressor (Paulsen et al., 2014b; Nikolaidis, Kerksick, Lamprecht, & McAnulty, 
2012a). The majority of studies in this area have focused on the effects of 
vitamin C and E, which have primarily AOX effects (Nikolaidis et al., 2012a), 
or non-steroidal anti-inflammatory drugs (NSAIDS), which have primarily 
anti-inflammatory effects (Schoenfeld, 2012). However, after extensive 
research, these supplements have been deemed largely ineffective at 
alleviating symptoms of EIMD, and if taken chronically, or in high doses, 
might actually have deleterious effects for training adaptations or 
regeneration (Bjørnsen et al., 2015; Close et al., 2006; Paulsen et al., 2014a, 
2014b). In light of these findings, many researchers have shifted their focus 
onto the effects of other AOX and anti-inflammatory interventions on EIMD, 
most notably that of functional foods (Sousa et al., 2013). These foods 
typically refer to fruits and vegetables that are not only naturally rich in anti-
inflammatory and AOX phytonutrients, but also possess additional biological 
effects that may be of benefit in minimising EIMD (Nikolaidis et al., 2012a; 
Sousa et al., 2013). To date, functional food supplements have shown more 
promise than vitamin C and E or NSAIDS for enhancing recovery after 
muscle-damaging exercise (Myburgh, 2014; Sousa et al., 2013). Indeed, 
cherry (Bell et al., 2014a; Howatson et al., 2010), blueberry (McLeay et al., 
2009) and pomegranate juice (Trombold, Barnes, Critchley, & Coyle, 2010; 
Trombold, Reinfeld, Casler, & Coyle, 2011) have all been shown to help 
alleviate some of the symptoms of EIMD.  
One of most studied functional foods in recent years, in both the clinical and 
exercise domains, has been beetroot (Beta Vulgaris L.). Indeed, there has 
been an enormous research effort over the past decade to delineate the 
physiological and biochemical effects that beetroot (and its constituents) 
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might afford, and how these effects could be exploited to improve health 
outcomes (Gilchrist et al., 2013; 2014; Joris and Mensink, 2013; Webb et al., 
2008) or exercise performance (Bailey et al., 2009; Lansley et al., 2010; 
Jones, 2014a; 2014b). There is now strong evidence that beetroot juice can 
positively influence the metabolic and vascular systems, effects that have 
been largely attributed to its high inorganic nitrate content (Jones, 2014a). 
Although less well studied, an emerging body of work has also shown that 
beetroot has AOX and anti-inflammatory properties (El Gamal et al., 2014; 
Ninfali & Angelino, 2013). These are thought to be mediated by the high 
number of phenolic and betalainic compounds in beetroot (Esatbeyoglu, 
Wagner, Schini-Kerth, & Rimbach, 2015; Ninfali & Angelino, 2013). However, 
as with the aforementioned physiological effects of beetroot, additive and 
synergistic effects with nitrate, which is found in abundance in beetroot, 
cannot be ruled out. Furthermore, nitrate, via its conversion to nitric oxide 
(NOx), has been shown to demonstrate potent anti-inflammatory effects 
independent of any interactions with phenolic compounds (Jädert et al., 2012; 
Justice et al., 2015). From an exercise perspective, while beetroot, via a juice 
beverage, has emerged as an effective and popular ergogenic aid for 
performance enhancement (Jones, 2014a; 2014b), it is yet to be explored 
whether BTJ can expedite recovery following strenuous exercise. However, 
the proposed relationship between inflammation, secondary muscle damage 
and muscle function loss (Howatson & van Someren, 2008; Pizza et al., 
2005; Toumi & Best, 2003), makes the expectation tenable that a 
phytochemical-rich BTJ has the potential to be a beneficial recovery aid after 
exercise. Thus, the overarching objective of this thesis was to investigate 
whether acute supplementation with beetroot, consumed as a juice, can 
attenuate indices of muscle damage and enhance recovery following 
different modes of strenuous exercise. Specifically, this idea was addressed 
in six experimental Chapters, which aimed to:  
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1) Establish the phytonutrient content of a commercially available BTJ, 
and the plasma bioavailability of two of its most bioactive components, 
betanin and nitrate.  
2) Examine whether supplementation with BTJ can attenuate indices of 
muscle damage following an eccentric-heavy exercise task, and 
whether these effects are dependent on the dose given. 
3) Examine the effects of BTJ supplementation on the acute adaptive 
response, i.e., the RBE to eccentric exercise. 
4) Investigate the effects of acute BTJ supplementation on indices of 
muscle damage and recovery between bouts of repeated sprint 
exercise in team-sports players.  
5) Examine the influence of BTJ on muscle damage and inflammation 
following a marathon. 
6) To compare the effects of a nitrate-matched BTJ and sodium nitrate 
(SN) drink on indices of EIMD.  
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2 Literature review 
Publication arising from this Chapter: Clifford, T., Howatson, G., West, D. J., & 
Stevenson, E. J. (2015). The potential benefits of red beetroot supplementation in 
health and disease. Nutrients, 7(4), 2801-2822. 
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2.1 Introduction  
The objective of this literature review is to highlight the research that has led 
to formulating the hypotheses to be investigated in this this thesis; whether 
BTJ is an efficacious recovery aid following strenuous exercise. The 
literature review begins by describing the aetiological mechanisms 
associated with EIMD and the deleterious consequences of these effects. 
The markers typically used to assess the presence and magnitude of EIMD 
are then discussed. This is followed by a brief discussion on the use of AOX 
and anti-inflammatory supplements to alleviate EIMD and, where relevant, 
their potential role in exercise-induced adaptation. The review finishes by 
highlighting evidence from studies showing the physiological and biological 
actions of beetroot and its constituents, and aims to provide a rationale for 
exploring its use as a nutritional intervention for exercise recovery.  
2.2 Exercise-induced muscle damage 
Typically, EIMD refers to the signs and symptoms that manifest in the days 
after unaccustomed or especially strenuous exercise; more specifically, 
either the direct changes at the local level (i.e., sarcomere disruption and EC 
coupling failure) or, perhaps more commonly, the indirect changes, such as 
muscle soreness/pain, presence of intramuscular proteins in the blood, and 
reduced muscle function (Clarkson & Hubal, 2002; Ebbeling & Clarkson, 
1989; Hyldahl & Hubal, 2014; Paulsen et al., 2012; Warren et al., 1999).  
As alluded to in the introduction, although the precise aetiology of EIMD is 
not yet fully understood, it has been proposed that it occurs in a biphasic 
manner (Howatson & van Someren, 2008; Lapointe et al., 2002). The first 
phase, typically known as the primary event, refers to the mechanical and 
metabolic damage induced during the exercise task (Howatson & van 
Someren, 2008). The second phase, typically known as secondary muscle 
damage, encompasses the ensuing biochemical changes (i.e., inflammatory 
response) in the hours and days after the primary event (Faulkner, Brooks, & 
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Opiteck, 1993; Howatson & van Someren, 2008; Lapointe et al., 2002; Smith 
et al., 2008). Figure 1 provides a general overview of the proposed 
morphological and biochemical changes associated with EIMD and attempts 
to differentiate the changes attributed to primary or secondary events. A 
more detailed discussion of the most relevant processes and the potential 
mechanisms involved is presented in the following sections.  
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Figure 1 - Overview of the alleged processes that perpetuate muscle 
damage during and after exercise. Shaded grey boxes represent primary 
events; where as white boxes represent secondary events. Pink shaded 
boxes denote the outcome of these processes. *The time course of events 
and number of days these biochemical processes and symptoms such as 
DOMS manifest for after exercise is highly dependent on the level of muscle 
damage sustained (see Paulsen et al., 2012 for a more in-depth discussion).  
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2.2.1 Primary muscle damage 
It is beyond the scope of this thesis to review all the potential mechanisms of 
how eccentric contractions might cause muscle damage; for this the reader 
is referred to previous reviews of the topic (Hyldahl & Hubal, 2014; Proske & 
Morgan, 2001; Warren et al., 2002). Rather, the aim of this section is to give 
a brief overview of the two main theories that have prevailed to help explain 
the primary event believed to initiate muscle damage.  
The first theory, known as the ‘popping sarcomere hypothesis’ was originally 
put forth by Morgan, (1990), and postulates that EIMD is caused by direct 
mechanical stretch of sarcomeres (Morgan & Proske, 2004; Proske & 
Morgan, 2001). This theory proposes that when the muscle is actively 
lengthened, the longer, weaker half-sarcomeres in myofibrils will be recruited 
first and that repetitive overstretching of these weaker half-sarcomeres (i.e., 
through repeated eccentric contractions) causes them to weaken to a point 
where actin and myosin can no longer overlap (Allen, 2001). The 
overstretched sarcomeres that fail to re-attach will be unable to contribute to 
further contractions, causing sarcomere non-uniformity and instability at 
random sections throughout the myofibre (Morgan & Allen, 1999). Because 
sarcomere lengths are non-uniformly distributed across the fibre, greater 
mechanical tension is placed on the sarcomeres adjacent to the weaker half 
sarcomeres and the passive, non-contractile structures, leading to focal 
disruption within regions of the myofibril (Morgan & Allen, 1999). The 
increasing number of disrupted sarcomeres then initiates a cascade of 
events that leads to further physical damage in the ECM and eventually a 
loss of intracellular Ca2+ homeostasis; the cellular event proposed to be 
largely responsible for the initiation and propagation of secondary muscle 
damage (Beaton et al., 2002; Gissel & Clausen, 2001; Howatson & van 
Someren, 2008).  
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An alternative theory was put forth by Warren and colleagues (2002) who 
propose that a failure of the EC coupling process is the primary event that 
initiates EIMD. The first evidence to support this theory was presented by 
Warren et al. (1993), who found that by exposing muscle fibres (from mice) 
to caffeine, thereby initiating muscle fibre contraction (by stimulating the 
release of Ca2+ from sarcoplasmic reticulum; SR), they could overcome the 
decrement in isometric muscle force induced by relatively few (<20) eccentric 
muscle contractions. This led the authors to propose that the force loss 
observed after eccentric contractions was due, in large part, to a failure in the 
EC coupling process up stream of SR Ca2+ release (Warren et al., 2002), as 
opposed to damage to contractile elements (i.e., loss of sarcomere 
homogeneity) proposed by the popping sarcomere hypothesis. However, 
Warren and colleagues (2002) do point out that the data to support the EC 
uncoupling theory has been obtained from investigations using animal 
models and, therefore, these findings may not directly translate to damage in 
human skeletal muscle.   
As proponents of the popping sarcomere hypothesis, Proske and Allen 
(2001) countered the view of Warren and colleagues, (1993) and proposed 
that failure of EC coupling is more likely to be a consequence of the 
disrupted sarcomeres induced by eccentric contractions, as opposed to the 
initiating event. Irrespective of the precise mechanisms, and their relative 
contributions, both sarcomere inhomogeneity and failure of the EC coupling 
process are observed after muscle damaging exercise and, therefore, the 
most up to date expert consensus suggests that both are likely to have a 
prominent role in the manifestation of EIMD (Hyldahl & Hubal, 2014).  
2.2.2 Metabolic damage  
It has also been suggested that EIMD can arise from metabolic (as opposed 
to mechanical) stress during exercise (Tee et al., 2007). This is based on 
studies that observed symptoms of muscle damage (increased serum CK 
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and force loss) after exercise tasks that do not require significant eccentric 
muscle contractions, i.e., cycling (Bell et al., 2014; Bell et al., 2015; Saunders 
et al., 2004). Although they were quite modest rises, Bell et al. (2015), 
observed increases in plasma CK and markers of inflammation (high 
sensitivity c-reactive protein; hs-CRP and interleukin-6; IL-6) following a bout 
of high intensity cycling exercise (109 min). The cycling protocol also 
precipitated an immediate and significant reduction in isometric strength that 
had not returned to pre-exercise levels 3 days after. The presence of muscle 
damage, despite the absence of any significant eccentric muscle 
contractions, supports the concept that metabolic factors seem to have at 
least a partial role in precipitating muscle damage following exercise.  
The primary mechanisms by which exercise-induced metabolic stress 
causes muscle damage (in the absence of significant mechanical stress) are 
not well understood and it is beyond the scope of this thesis to review them 
in detail. Instead the reader is referred to Tee et al. (2007) who provided a 
theoretical model to help explain the potential mechanisms involved. Briefly, 
in their model, Tee and colleagues (2007) postulated that during high 
intensity exercise, adenosine-triphosphate (ATP) concentrations in the 
working muscles could be reduced to a point where sarcoplasmic Ca2+ 
ATPase (SERCA) activity is inhibited, preventing the efficient re-uptake of 
Ca2+. The model goes on to propose that in such instances, a rise in free 
Ca2+ might, in turn, activate cytotoxic molecules with the potential to 
compromise the integrity of the cell and degrade structural proteins, such as 
protease enzymes (i.e., calpain) and reactive oxygen and nitrogen species 
(RONS). There are several studies that report increased RONS production 
after high intensity cycling exercise that lend some support to this hypothesis 
(Bell et al., 2014; Bell et al., 2015; Morillas-Ruiz et al., 2005; Nieman et al., 
2013). In one such study with 26 trained male cyclists, oxidative damage to 
proteins, as measured by protein carbonyls (PC), and to DNA, as measured 
by 8-Hydroxyl-2’-Deoxyguanosine (8-OHdG), was evident following 90 min of 
cycling at 70% VO2max, suggesting an excess production of potentially 
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damaging RONS (Morillas-Ruiz et al., 2005). These data also suggest that in 
exercise with both a high metabolic and mechanical stress, such as field 
based team-sports and distance running, although the principal cause of 
EIMD is still likely to be related to mechanical factors (due to the repeated 
number of eccentric muscle contractions), there is likely to be a contribution 
from or interactions with metabolic factors.  
2.3 Secondary muscle damage  
The mechanical and/or metabolic damage outlined in the previous section 
appears to initiate a series of biochemical alterations that have the capacity 
to cause further damage to the cell; a phenomenon that has been termed 
secondary muscle damage (Howatson & van Someren, 2008; Toumi & Best, 
2003). The principal initiating event in secondary damage is believed to be 
the loss of Ca2+ homeostasis resulting from sarcolemma damage and 
opening of stretch activated channels (Armstrong, Warren, & Warren, 1991; 
Butterfield, Best, & Merrick, 2006; Hyldahl & Hubal, 2014). The disturbance 
in Ca2+ homeostasis then triggers an acute phase inflammatory response to 
orchestrate the degradation and subsequent regeneration of muscle cells 
(Armstrong et al., 1991; Toumi, F'Guyer, & Best, 2006) (see overview 
presented in Figure 1). The inflammatory response is believed to be the main 
instigator of secondary damage following exercise, and as such will be 
discussed in further detail below.  
1.1.3.2 Inflammation  
Exercise-induced inflammation is primarily co-ordinated by a series of 
intracellular signalling molecules known as cytokines (Cannon & St Pierre, 
1998). Cytokines operate by binding to specific receptors on the surface 
membrane of a target cell and communicating a function (Cannon & St 
Pierre, 1998). Damaged muscle cells and other cells (i.e., leuckocytes, 
endothelial cells) synthesize a large number of inflammatory cytokines that 
are either classed as pro-inflammatory (tumour-necrosis-factor-alpha; TNF–
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α, interleukin 1-beta; IL-1β, IL-6, Interleukin-8; IL-8 and interferon-gamma; 
IFN-γ) or anti-inflammatory (interlukin-1alpha; IL-1α interlukin-4; IL-4 and 
interleukin-10; IL-10) depending on their primary biological functions in 
skeletal muscle and other cells (Calle & Fernandez, 2010; Cannon & St 
Pierre, 1998; Smith, Kruger, Smith, & Myburgh, 2008). The pro-inflammatory 
cytokines TNF-α and IL-1β play a key role in attracting immune cells to 
damaged muscle (Butterfield et al., 2006; Smith et al., 2008). More 
specifically, these cytokines stimulate adhesion molecules, initially those in 
the selectin family (E-selectin-1 and P-selectin) and then vascular cell 
adhesion protein 1 (VCAM-1) which, together, help to recruit leukocytes from 
the circulation into the affected muscle tissue in a process called diapedesis 
(Butterfield et al., 2006).  
The main leukocytes recruited by damaged muscle tissues are neutrophils, 
which infiltrate muscle tissue immediately following the incitement of muscle 
damage, and may remain elevated for up to 5 days’ post, depending on the 
intensity and duration of the exercise task (Cannon & St Pierre, 1998; 
Tidball, 2005; Toumi et al., 2006). Neutrophils are thought to be primarily 
phagocytic, serving to clear cellular debris and remove necrotic fibres, thus 
paving the way for the remodelling and regenerative process (Butterfield et 
al., 2006; Chazaud, 2016). Neutrophils fulfil their phagocytic functions by 
deploying a range of proteolytic (i.e., proteases) and cytotoxic molecules 
(i.e., RONS), especially superoxide through means of an oxidative burst 
(Butterfield et al., 2006; Kharraz, Guerra, Mann, Serrano, & Munoz-Canoves, 
2013, Musarò, 2014; Tidball 2005). Furthermore, the invading neutrophils 
secrete a host of pro-inflammatory cytokines, which attract more neutrophils 
to the affected area and thus more cytotoxic molecules, forming a positive 
feedback mechanism that magnifies the local inflammatory response 
(Butterfield et al., 2006).  
It has been proposed, albeit somewhat controversially, that while neutrophil 
mediated phagocytosis is clearly an important step in the repair process, it 
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may also exacerbate the existing damage and harm healthy cells; thus, at 
least in the early stages, phagocytosis might hamper the rate of recovery 
(Lapointe et al., 2002; Pizza, Baylies, & Mitchell, 2001; Pizza et al., 2005; 
Tidball, 2005; Toumi et al., 2006). Indeed, in the model of secondary muscle 
damage proposed by Pizza (2008), neutrophils are suggested to be the main 
molecules involved, and primarily cause further damage by inhibiting the 
growth of new myofibrils or degrading undamaged ones, due to the collective 
activities of RONS (discussed in Chapter 2.1.3.2), proteases and pro-
inflammatory cytokines. In some instances, probably depending on the 
intensity and magnitude of muscle damage sustained, these activities might 
result in a further or secondary loss in muscle function in the subsequent 
days (Howatson & van Someren, 2008; Toumi & Best, 2003), although this 
appears to be absent in many studies (Warren, Call, Farthing, & Baadom-
Piaro, 2016). Nonetheless, it has been proposed that regardless of whether 
or not a further loss in muscle function is observed, the aforementioned 
biochemical changes might still inflict local muscle damage, secondary to the 
primary physical damage, and affect the rate or extent of muscle function 
recovery in the ensuing days (Toumi & Best, 2003; Warren et al., 2016).  
There are a number of studies showing a relationship between the early 
neutrophil response and the magnitude of muscle damage after strenuous 
exercise or lengthening muscle contractions (Brickson et al., 2003; Pizza et 
al., 2001; Pizza et al., 2005). In one of these studies, Pizza et al. (2005) 
found that after a series of muscle damaging eccentric contractions, mice 
deficient in the integrin CD18 (and therefore who had a blunted capacity to 
generate neutrophils) experienced less muscle tissue damage and lower 
force deficits 3 and 7 days’ post-contractions compared to non CD18 
deficient mice. It is studies such as this, and others reporting attenuations in 
muscle damage when phagocytosis is blunted (Beaton et al., 2002; Brickson 
et al., 2003; Lapointe et al., 2002), which has led to the proposal that 
temporarily suppressing the early inflammatory response after muscle 
damaging exercise could be useful for enhancing the rate of muscle recovery 
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(Toumi & Best, 2003). On the other hand, it has also been proposed that this 
stage of inflammation is a critical step for normal muscle regeneration and, 
thus, dampening this response might disrupt muscle healing in the long-term 
(Chauzad, 2015) and/or interfere with training-induced adaptations (Bjørnsen 
et al., 2015; Paulsen et al., 2014b). The potential for these effects are 
discussed in section 2.5.   
After the invasion of neutrophils in damaged muscle tissue, there is an influx 
of macrophages, another population of phagocytic immune cells that seem to 
accumulate in response to the release of chemokines (Chazaud, 2016; 
Pizza, 2008). The role of macrophages in damaged muscle is far more 
complex than that of neutrophils though, as they appear to exhibit multiple 
functions and switch phenotypes according to their surroundings and 
presence of other cells (Musarò, 2014; Smith et al., 2008; Tidball, 2005). A 
key distinction between neutrophils and macrophages is that in addition to 
releasing cytokines and RONS that promote cell lysis, macrophages also 
produce a series of growth factors that support muscle remodelling (Tidball, 
2005). 
Whether macrophages have a degradative or beneficial role in muscle 
damage appears to depend on the functional phenotype activated (Smith et 
al., 2008). Macrophages have been classified as three distinct populations 
(ED1+, ED2+, ED3+) that are activated sequentially and play separate roles 
in the resolution of muscle damage (Butterfield et al., 2006; Musarò, 2014; 
Smith et al., 2008). The ED1+ subtypes are the first macrophages to enter 
damaged fibres (within 24 h) and appear to have mainly phagocytic functions 
(Butterfield et al., 2006). They also act as signalling molecules, attracting 
additional neutrophils and pro-inflammatory cytokines to the damaged site, 
which serves to magnify the inflammatory response (Kharraz et al., 2013). 
Thus, the ED1+ population of macrophages are believed to interact with 
neutrophils to remove cellular debris and therefore may promote muscle 
degradation (Tidball, 2005). By contrast, the ED2+ and ED3+ subtypes are 
41 
 
 
not considered to contribute to phagocytosis (Smith et al., 2008). Instead, 
ED2+ and ED3+ macrophages may play a beneficial role in muscle repair by 
secreting cytokines such as IL-6 and IL-10, chemokines such as monocyte 
chemoattractant protein-1 (MCP-1), and growth promoting factors such as 
insulin like growth factor 1 (IGF-1), transforming growth factor beta 1 (TGF-
β1), interlukin-15 (IL-15), fibroblast growth factor (FGF-2), which are 
essential for healing and myogenesis (Smith et al., 2008; Urso, 2013).  
2.1.3.2 Oxidative stress 
Under normal metabolic conditions, the biological environment of a cell is 
considered to be in a state of redox (reduction: oxidation) balance, or, in 
other words, equilibrium exists between reducing and oxidising molecules 
(antioxidants and pro-oxidants, respectively) (Kannan & Jain, 2000; Kohen & 
Nyska, 2002). Molecules capable of oxidation are known as RONS and are 
continuously generated in cellular metabolism (Kohen & Nyska, 2002). At 
these low concentrations, RONS play an important role in a diverse multitude 
of cellular and biochemical processes, including gene expression, cell 
proliferation, apoptosis and muscular contraction (Baker, Hayden, & Ghosh, 
2011; Powers, Nelson, & Hudson, 2011). However, an excess production of 
RONS, as seen with strenuous exercise (Nikolaidis et al., 2008), can cause 
an imbalance in redox homeostasis, which gives rise to the condition 
typically referred to as oxidative stress (Kohen & Nyska, 2002). This 
imbalance may overwhelm the endogenous AOX defence network leaving 
DNA, carbohydrate, protein and lipid structures susceptible to oxidation and 
functional impairments (Madamanchi, Vendrov, & Runge, 2005; Powers et 
al., 2011; Reuter, Gupta, Chaturvedi, & Aggarwal, 2010). With regards to 
exercise, these functional disruptions could have important implications for 
muscle fatigue and muscle damage and, subsequently, a significant impact 
on recovery and performance (Powers & Jackson, 2008).  
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Several investigations support the contention that exercise can shift cellular 
redox balance towards a pro-oxidant state (for the sake of clarity, this shift 
will be referred to as oxidative stress throughout this thesis). This has been 
evidenced by directly observing increased production of RONS in the 
circulation (Close et al., 2004) and muscle (McArdle et al., 1999; Zerba et al., 
1990), or through detecting oxidative damage to target molecules such as 
nucleic acids, protein and lipid structures during and following acute bouts of 
exercise (Nikolaidis et al., 2008; Nikolaidis et al., 2012b). Interestingly, 
oxidative stress is not just confined to the blood and/or skeletal muscle after 
exercise but has also been observed in several other tissues, including the 
brain, kidney, and liver, suggesting that exercise may perturb redox 
homeostasis in several cells (Nikolaidis et al., 2012b). 
The degree of oxidative stress is dependent on several factors; the duration 
(short vs. prolonged) and intensity (high vs. low) of the exercise and 
predominant mode of muscle contraction (eccentric vs. concentric) 
(Nikolaidis et al., 2008; Nikolaidis et al., 2012b). It is clear that exercise 
encompassing eccentric muscle contractions produces significantly more 
RONS than other types of muscle contractions (i.e., concentric and 
isometric), which is presumably a consequence of the greater muscle 
damage and, subsequently, greater inflammatory response imposed by 
eccentric exercise (Bloomer, 2007; Nikolaidis et al., 2008; Nikolaidis et al., 
2012b). Interestingly, oxidative stress arising from eccentric muscle 
contractions appears to be more pronounced 24–96 h following the initial 
insult (Nikolaidis et al., 2008). In contrast, after exercise that does not 
generally induce significant muscle damage, in other words, does not contain 
a significant eccentric component, the acute increase in oxidative stress has 
often returned to baseline levels ≤24 h post-exercise (Nikolaidis et al., 2008; 
Nikolaidis et al., 2012b).  
It has been suggested that following lengthening muscle contractions, an 
excess production of RONS might contribute to secondary muscle damage, 
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leading to a further loss of muscle force (Zerba et al., 1990; McArdle et al., 
1999) and an increase in muscle soreness (Lee et al., 2002). In support of 
such effects, in a study by Zerba et al. (1990), mice treated with an AOX that 
directly targets superoxide generation (polyethylene glyocl-superoxide 
dismutase) had less myofibril damage and a smaller loss of muscle force 3 
days’ post in situ lengthening contractions compared to untreated mice. 
These data suggested that excessive superoxide production resulting from 
mechanical stress is associated with secondary muscle damage and the 
magnitude of force loss. Similar findings were found in the previously 
mentioned study by Pizza et al. (2005), in which they investigated muscle 
damage, inflammation and oxidative stress in healthy mice and mice 
deficient in CD18 after in situ lengthening muscle contractions. This study 
found that inhibiting neutrophil accumulation attenuated cellular protein 
carbonyl content, a marker of oxidative stress, and that this was associated 
with reduced muscle force deficits 3 days’ post exercise. Thus, akin to the 
findings from Zerba et al. (1990), this study appears to support the concept 
that oxidant production, which is derived, in large part, from infiltrating 
neutrophils (Jackson, Vasilaki, & McArdle, 2016; Nikolaidis et al., 2008) 
contributes, at least to some extent, to the prolonged loss in muscle function 
after eccentric-heavy exercise.  
It is important to note however, that at present, most of the evidence that 
suggests a more direct relationship between oxidative stress and muscle 
function loss after exercise has been derived from animal models and, 
therefore, might not directly translate to humans. In fact, as Nikolaidis et al. 
(2008) point out, a number of studies suggest that systemic oxidative stress 
might not be directly related to EIMD in humans, as assessed by changes in 
muscle function, because the two do not appear to follow a similar time-
course in recovery from exercise. Clearly, more work is required to clarify the 
role of oxidative stress in EIMD.  
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Other degradative pathways such as the caplain or ubiquitin-proteasome 
pathway are also significantly upregulated after muscle-damaging exercise 
(Raastad et al., 2010; Zhang et al., 2008) and thus, are likely to operate 
parallel to or in conjunction with the above described inflammatory and 
oxidative stress responses in secondary muscle damage. However, it was 
not within the scope of this thesis to investigate these pathways and 
therefore a detailed overview of their potential role in secondary damage has 
not been discussed. For this, the reader is referred to previous reviews on 
the topic (Belcastro, Shewchuk, & Raj, 1998; Goll, Thompson, Li, Wei, & 
Cong, 2003).  
2.4 Markers of exercise-induced muscle damage 
A number of markers have been used to quantify the presence and 
magnitude of EIMD (Duffield et al., 2008). These markers are typically 
classified as either direct: collecting and analysing sections of muscle tissue, 
or indirect: examining changes in muscle function, muscle soreness, range of 
movement, limb girth, efflux of intramuscular proteins in the blood, 
inflammation and oxidative stress (Duffield et al., 2008; Paulsen et al., 2012). 
It is not within the scope of this thesis to describe all of these markers; this 
information is available elsewhere (Duffield et al., 2008; Paulsen et al., 
2012). Rather, the aim of this section is to provide a general overview of the 
markers that were used to quantify muscle damage throughout the course of 
this thesis.  
2.4.1 Muscle function  
Tests of muscle function that delineate the power or force generating 
capacity of skeletal muscle are widely considered the best measures for 
evaluating muscle damage following strenuous exercise (Clarkson & Hubal, 
2002; Duffield et al., 2008; Ebbeling & Clarkson, 1989; Paulsen et al., 2012; 
Warren et al., 1999). Perhaps the greatest advantage of muscle function 
tests over other markers of EIMD is that muscle function is the most relevant 
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to athletes, whose principal goal during recovery is to restore optimal 
muscular performance as quickly as possible (Byrne et al., 2004).  
Muscle function is most commonly assessed by monitoring changes in 
maximal voluntary contractile force (MVC) before and after exercise (Duffield 
et al., 2008). There are several methods by which MVC has been evaluated 
but the most common include isometric muscle force (at a fixed range of 
motion) (Wilson & Murphy, 1996) or concentric and/or eccentric muscle 
torque (between a given range of motion or at a fixed velocity) (Byrne & 
Eston, 2002; Byrne et al., 2004; Warren et al., 1999).  
Reductions in MVC are thought to give a reliable estimation of the extent of 
muscle damage induced by an exercise bout (Duffield et al., 2008; Warren et 
al., 1999). However, the magnitude of change in MVC can vary widely 
depending on the nature of the exercise task and training status of the 
individual (Sayers & Clarkson, 2001). On reviewing the literature, Paulsen et 
al. (2012) found that the largest and most prolonged reductions in MVC 
occurs after activities that encompass repetitive, high force, eccentric muscle 
contractions, particularly of isolated muscle groups. It is not uncommon for 
MVC to be reduced by 25-60% after exercise involving repetitive max 
eccentric contractions of the elbow flexors or knee extensors (King & 
Duffield, 2009; Paulsen et al., 2010), and in severe cases, force may not be 
recovered ≥7 days after the damaging insult (Paulsen et al., 2012). In 
contrast, Paulsen et al. (2012) reported that other eccentrically-biased 
exercise tasks, such as downhill running or resistance exercise tend to 
induce more modest reductions in MVC (10-40%) and are recovered to pre-
exercise values by 24-96 h post.   
Nevertheless, the use of MVC as a marker of muscle function does have its 
limitations. Because MVCs are typically performed with isolated muscle 
groups, and at low velocities, they are unlikely to give a valid reflection of the 
loss of function associated with dynamic activities (i.e., jumping, sprinting) 
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that require several muscle groups to work in concert (Byrne et al., 2004; 
Gathercole, Sporer, Stellingwerff, & Sleivert, 2015; Twist & Highton, 2013; 
Wilson & Murphy, 1996). To overcome this limitation, several studies have 
also assessed movements that can be more easily extrapolated to a sporting 
context, such as jump tests (i.e., countermovement jumps; CMJ or squat 
jumps) and max effort sprints, which can estimate power output and speed, 
respectively (Byrne et al., 2004; Gathercole et al., 2015; Twist & Highton, 
2013). It therefore seems that in order to get a more complete picture of the 
magnitude and time course of EIMD, changes in both isometric and dynamic 
movements should be evaluated. 
2.4.2 Muscle soreness  
Muscle soreness or muscle pain (used interchangeably throughout this 
thesis) is another marker frequently used to assess EIMD. In fact, a review 
by Warren et al. (1999) found that muscle soreness is more commonly used 
as a marker of EIMD than muscle function. At the time of writing, muscle 
soreness was measured in 73% of studies investigating EIMD versus 55% 
for muscle function. With regards to the time course for the development of 
muscle soreness, it is known to vary considerably between individuals. 
However, in most cases, it appears ≤24 h post exercise, not immediately 
post (hence it is often referred to as delayed onset muscle soreness; 
DOMS), and peaks between 48-72 h post-exercise (Clarkson & Hubal, 2002; 
Smith, 1992).  
Muscle soreness is frequently measured with the use of a visual analogue 
scale (VAS) (MacIntyre, Reid, & McKenzie, 1995). Typically, a VAS for 
measuring muscle soreness requires individuals to rate their perceived level 
of soreness on a scale that has some iteration of ‘no soreness’ and 
‘unbearably sore’ at opposite ends of a fixed length spectrum (Howatson et 
al., 2009; Howatson et al., 2012; Paulsen et al., 2010). Participants can rate 
their soreness either passively (sitting or standing in a relaxed position) or 
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actively (while holding a squat position, for example). The simplicity and ease 
of measurement makes the VAS method attractive for quantifying muscle 
soreness; however, its usefulness for repeated measurements across days 
has been questioned (MacIntyre et al., 1995), as participants may recall their 
previous scores and erroneously gauge their present score according to this 
response.  
Another measure commonly used to quantify muscle soreness is pressure 
pain threshold (PPT). Typically, PPT represents the first point at which the 
force or pressure applied to a muscle evokes a sensation of discomfort or 
pain (Areces et al., 2015). PPT is often measured with a flat headed 
cylindrical probe attached to a strain gauge, such as an algometer (Borsa, 
Kaiser, & Martin, 2013; Connolly, McHugh, Padilla-Zakour, Carlson, & 
Sayers, 2006; Sands, McNeal, Murray, & Stone, 2015). The probe is used to 
apply force perpendicular to the muscle belly and at a constant rate; the point 
at which discomfort is first felt is recorded as newtons or kg/force and 
represents PPT (Areces et al., 2015). Importantly, it has been shown that an 
algometer can generate valid and reliable measures of PPT when used 
across consecutive days (Areces et al., 2015; Nussbaum, & Downes, 1998). 
Furthermore, PPT seems to be sensitive to exercise-induced changes in 
muscle pain. Indeed, a number of studies have reported marked and 
prolonged reductions in PPT that can last up 72 h after muscle damaging 
exercise (Bowtell, Sumners, Dyer, Fox, & Mileva, 2011; Ceci et al., 2015; 
Close et al., 2006; Connolly et al., 2006). Perhaps its biggest advantage over 
the VAS method is that it is less subjective for the participant. Thus, PPT 
seems a useful method for monitoring muscle soreness in the days after 
muscle damaging exercise.  
It is important to note, that irrespective of how muscle soreness is measured, 
its intensity and time course does not necessarily correspond with changes 
in histological muscle damage or other indirect markers of EIMD such as 
muscle function, CK efflux (Duffield et al., 2008; Hyldahl & Hubal, 2014; 
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Nosaka, Newton, & Sacco, 2002) or inflammation (Crameri et al., 2007; 
Malm et al., 2004). Consequently, it has been suggested that quantifying 
muscle soreness is not sufficient to describe EIMD, but should be measured 
in conjunction with other aforementioned indices (Paulsen et al., 2012). 
Notwithstanding, it has been demonstrated that muscle soreness or pain 
might heighten an individual’s risk of injury due to pain-related alterations in 
movement patterns during activity (Smith, 1992), and influence the degree of 
effort (Fletcher et al., 2016). Thus, evaluating muscle soreness is still 
considered a useful tool for monitoring recovery and athlete preparedness in 
the days after exercise. 
2.4.3 Intramuscular proteins as markers of membrane damage  
Systemic concentrations of the intramuscular proteins, CK, myoglobin, 
lactate dehydrogenase (LDH) and troponin are often measured as surrogate 
markers of damage to the muscle membrane (Clarkson & Hubal, 2002). Of 
these markers, CK is the most frequently measured (Baird et al., 2012; 
Ebbeling & Clarkson, 1989). As CK was the only marker of membrane 
permeability measured as part of this thesis the other aforementioned 
markers will not be discussed.  However, it should be noted that the same 
limitations associated with CK as a marker of EIMD can also be applied to 
LDH and myoglobin.  
Normal plasma CK levels in healthy individuals are low (<175 IU∙-1) but in 
response to muscle damaging exercise can rise substantially (1000-5000 IU∙-
1), which is presumably part of the reason it is so commonly used to estimate 
the extent of muscle damage associated with a particular task (Clarkson & 
Hubal, 2002). The magnitude and time course of exercise induced CK efflux 
is highly variable (Ebbeling & Clarkson, 1989; Nosaka, Newton, & Sacco, 
2002). This is probably because it can be influenced by so many different 
variables, including an individual’s physical characteristics (training status, 
gender, genetics, fibre type distribution) and the nature of the exercise task 
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undertaken (intensity, volume, type, muscle group) (Baird et al., 2012). As 
one would probably expect, exercise that is high intensity and requires 
repetitive eccentric loading of the muscle appears to evoke the largest and 
most prolonged increases in plasma CK (Baird et al., 2012). This becomes 
even more evident when smaller muscle groups such as the elbow flexors 
are subjected to high force eccentric actions (Paulsen et al., 2010; Paulsen 
et al., 2012). For example, plasma CK activity following eccentric 
contractions with the elbow flexors has been shown to reach peak values 96 
h post, increasing to 4000–6000 IU∙-1 (Hirose et al., 2004; Paulsen et al., 
2010a). By contrast, plasma CK values following two popular experimental 
models of muscle damage: downhill running and high volume plyometric 
activity (i.e., drop jumps, CMJ) is reported to peak 24-48 h post, and evoke 
more modest increases between 300-850 IU∙-1 (Dousset et al., 2007; Duffield 
et al., 2010; Etheridge, Philp, & Watt, 2008; Howatson, Goodall & van 
Someren, 2009; Howatson et al., 2012).  
Despite its widespread measurement, CK has several limitations as a marker 
of EIMD (Clarkson & Hubal, 2002; Paulsen et al., 2012). Firstly, as with 
muscle soreness, the level of CK activity does not appear to correlate well 
with decrements in muscle function following EIMD (Warren et al., 1999). 
Additionally, the high inter-subject variability associated with CK, even 
amongst relatively heterogeneous cohorts, makes accurate interpretations 
difficult (Paulsen et al., 2012). Given these limitations, it is important that CK 
analysis is accompanied by additional measures that are felt to more 
accurately reflect the time course and magnitude of EIMD, such as muscle 
function (Paulsen et al., 2012; Warren et al., 1999). 
2.4.4 Measuring exercise-induced oxidative stress  
As described in section 2.1.3.2, exercise can induce a transient state of 
cellular oxidative stress in the days after exercise. Because oxidative stress 
may be harmful to the cell and contribute to secondary muscle damage, it is 
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become more common to employ markers of oxidative stress in EIMD 
studies. In general, oxidative stress is more often measured in blood 
samples than other biological tissues due to the comparative ease of both 
collecting the sample and performing the measurement (Margaritelis et al., 
2015). However, irrespective of the biological sample, a ‘gold standard’ 
method or single biomarker that accurately reflects the oxidative state of an 
organism or RONS production, particularly in vivo, has not been identified 
(Close et al., 2004; Powers, Smuder, Kavazis, & Hudson, 2010). In an 
attempt to overcome this, the general consensus is that oxidative stress 
should be estimated by means of presenting results from a variety of 
different methods that include both direct and indirect techniques, and 
different cellular targets such as lipids and proteins (Close et al., 2005; 
Finaud, Lac, & Filaire, 2006; Jackson, 1999; Powers et al., 2010). In view of 
this, a wide range of biomarkers have been developed and are presented in 
Table 1. The most common biomarkers measure oxidative damage to lipids, 
proteins and DNA, or levels of endogenous enzymatic AOX activity (Powers 
et al., 2010; Vassalle, Pingitore, De Giuseppe, Vigna, & Bamonti, 2014). 
Less commonly, the direct assessment of radical production has been 
employed (Powers et al., 2010). It is beyond the scope of this thesis to weigh 
up the merits of each individual biomarker, for this the reader is referred to 
Powers et al. (2010), Jackson (1999) and Finaud et al. (2006). Instead, this 
thesis will provide a brief discussion of the methods and biomarkers most 
relevant to this thesis. 
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Table 1 - Overview of common biomarkers used to assess oxidative stress 
(Grielberger, Greilberger, & Djukic, 2015; Nikolaidis et al., 2015; Powers et 
al., 2010; Vassalle et al., 2015).  
Target                                Biomarker 
Protein Protein carbonyls 
 Advanced oxidation products 
Lipids  
 
 
 
 
DNA 
F2-isoprostanes 
Malondialdehyde (MDA) 
Thiobarbituric acid reactive substances (TBARS) 
Lipid hydroperoxides (LOOH) 
Conjugated dienes 
Comet assay 
8-Hydroxyl-2′-Deoxyguanosine (8-OHdG) 
AOX capacity 
 
Trolox equivalent antioxidant capacity (TEAC) 
Ferric-ion-reducing antioxidant-power 
Assay (FRAP) 
Oxygen-radical absorbance-capacity 
Assay (ORAC) 
Endogenous AOX 
Enzymes 
Superoxide dismutase 
Glutathione peroxidase 
Glutathione reductase 
Glutathione S-transferase 
Catalase 
Free radical Electro paramagnetic resonance spectroscopy 
(EPR) 
Electron spin resonance (ESR) 
 
It is possible to estimate oxidative stress directly by employing electron spin 
resonance (ESR) or electron paramagnetic resonance (EPR) spectroscopy 
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techniques. These methods can be used to detect the presence of unpaired 
electrons, that is free radicals (FR) or RONS in a biological system, by 
measuring the energy they absorb in a magnetic field, also known as a 
resonance absorption signal (Jackson, 1999). Because of the high level of 
skill and expense associated with this measurement and difficulty applying in 
vivo, it is rarely assessed in studies investigating the relationship between 
oxidative stress and EIMD (Close et al., 2005). One of the few studies that 
was conducted by Close et al. (2004), who studied RONS production in the 
72 h after 30 min of downhill running. They found significant elevations in the 
EPR signal (+122% of baseline) 72 h after the exercise bout, and thus 
provided important evidence of direct RONS production following muscle 
damaging exercise in humans.  
It is far more common for studies assessing oxidative stress and its 
relationship to EIMD to employ indirect measures, in which oxidative stress is 
identified by measuring breakdown products of oxidatively modified 
biomolecules; normally proteins and lipids (Close et al., 2005; Nikolaids et 
al., 2015; Powers et al., 2010). In most investigations, the rate of lipid 
peroxidation in a biological sample, typically muscle or blood, will be 
measured to indicate oxidative stress (Jackson, 1999). This is due to the fact 
that lipids, more so the unsaturated than saturated lipid molecules, are 
particularly susceptible to oxidation and, as a result, generate a variety of 
oxidation products that are detectable in biological samples (Finaud et al., 
2006; Nikolaidis et al., 2008; Powers et al., 2010). Those considered primary 
breakdown products of lipid oxidation, such as hydroperoxides, have been 
measured in several EIMD studies (Bell et al., 2014; Bell et al., 2015; 
Fogarty, Hughes, Burke, Brown, & Davison, 2013) including Chapter 7, and 
with the exception of isoprostanes, are favoured over the use of most 
secondary breakdown products, such as TBARS and MDA, which are 
thought to lack specificity to lipid peroxidation (Jackson, 1999; Finaud et al., 
2006). With that said, the measurement of LOOH is not without 
disadvantages (Powers et al., 2010) and, therefore, it is presently suggested 
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that the most valid and reliable measure of lipid peroxidation is that of 
isoprostanes, specifically the F2-isoprostanes, which are breakdown products 
of polyunsaturated fat oxidation (Nikolaidis et al., 2015). While F2-
isoprostanes can be measured with immunoassay kits, more specialist 
techniques such as that of high pressure liquid gas chromatography/gas 
spectroscopy (HPLC-GS) are required to obtain the most accurate results 
(Powers et al., 2010; Nikolaidis et al., 2015). These techniques require 
specialist laboratory equipment, are expensive to run and require a great 
deal of expertise and therefore their measurement is not always possible 
(Nikolaidis et al., 2015; Powers et al., 2010).  
Another popular approach to assess oxidative stress is by estimating cellular 
modification to proteins (Powers et al., 2010). In most studies, this is 
determined by analysing systemic concentrations of protein carbonyls (PC), 
which are formed via reactions between RONS and amino acids (Powers et 
al., 2010). Although other methods are available, PC formation is considered 
to give a reliable indication of protein oxidation (Powers et al., 2010) and has 
therefore been used extensively as an indicator of exercise-induced oxidative 
stress (Bowtell et al., 2011; Fogarty et al., 2013; Goldfarb, Garten, Cho, 
Chee, & Chambers, 2011; Goldfarb, Garten, Waller, & Labban, 2014).  
It is important to highlight that although these biomarkers are widely 
measured, they have limitations in their ability to accurately quantify oxidative 
stress (Close et al., 2005; Powers et al., 2010). This largely stems from the 
fact that redox biology is very complex in vivo, especially when the influence 
of diet, age and tissue type are factored in and, therefore, irrespective of the 
biomarker measured, valid and reliable results are difficult to obtain (Fisher-
Wellman et al., 2009; Powers et al., 2010). Indeed, the extremely short half-
lives of RONS (~10-5 s) and their weak concentrations, means measuring 
oxidative stress at a specific time point in any tissue type will always be 
prone to some degree of error (Close et al., 2005; Finaud et al., 2006; 
Fisher-Wellman & Bloomer, 2009). It is also important to stress that an 
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increase in RONS after exercise is not necessarily indicative of direct oxidant 
mediated damage to a specific tissue but could merely be a consequence of 
the initial damaging stimulus, which in terms of EIMD, could be any number 
of morphological alterations (Close et al., 2005; Nikolaidis et al., 2008). 
Given the above discussion, it is clear that to truly quantify the extent of 
oxidative stress and thus, its relationship to EIMD, is extremely difficult in 
humans and, as such, results should be interpreted with a degree of caution.  
2.4.5 Measuring exercise-induced Inflammation  
Examining exercise-induced inflammation is generally performed indirectly, 
by measuring changes in limb girth due to local oedema (Warren et al., 
1999) or, directly, by measuring specific biomarkers from blood or tissue 
samples. In the last two decades, the majority of studies have favoured the 
measurement of specific biomarkers, particularly cytokines, leukocytes, and 
acute phase proteins in the blood; consequently, this section will present a 
brief discussion of the markers that fall under these categories.  
A common marker used to assess exercise-induced inflammation is C-
reactive protein (CRP); an acute phase protein secreted by hepatocytes that 
plays a central role in regulating the systemic inflammatory response (Black, 
Kushner, & Samols, 2004; Kasapis & Thompson, 2005). The main 
inflammatory functions of CRP are to stimulate the intra and extracellular 
cytokine network and activate adhesion molecules, which, in turn, help to 
facilitate phagocytosis (Black et al., 2004; Kasapis &Thompson, 2005). In 
addition to being an inducer of cytokines, the initial release of CRP is 
believed to be modulated by the cytokine network, particularly the pleiotropic 
IL-6, which is significantly elevated in response to exercise (Black et al., 
2004; Kasapis & Thompson, 2005). In addition to IL-6, CRP may also be 
regulated by IL-1β and leukocytes, both of which are key mediators of the 
acute pro-inflammatory response to exercise (Black et al., 2004). This would 
suggest that CRP release during and after exercise is likely related to the 
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activation of the hepatocyte cytokine network. Because CRP release 
appears to be sensitive to changes in exercise intensity, duration and muscle 
damage (Kasapis & Thompson, 2005), and is involved in a range of acute 
inflammatory processes, it could be considered a useful marker for 
characterising the general inflammatory response to exercise.  
Cytokines are probably the most often measured biomarkers of exercise-
induced inflammation. Of these, plasma IL-6 has been measured the most, 
which could be due to the fact that it is secreted in greater volumes than 
other cytokines, principally during, and in the immediate hours after exercise 
(Peake, Della Gatta, Suzuki, & Nieman, 2015a). Indeed, studies report 
marked but transient increases in IL-6 concentrations after resistance 
training (Calle & Fernandez, 2010; Izquierdo et al., 2009) and plyometric 
exercise (Chatzinikolaou et al., 2010) with the largest increases observed 
after high intensity, long duration endurance exercise (Bell et al., 2014; 
Brenner et al., 1999; Howatson et al., 2010).  
Other cytokines typically measured in EIMD include IL-8, IL-1β and TNF-α 
which are believed to exert mostly pro-inflammatory functions (Calle & 
Fernandez, 2010; Smith et al., 2008). Both TNF-α and IL-1β have been 
implicated in the acute inflammatory response after exercise and are thought 
to play a role in secondary muscle fibre damage (Liao, Zhou, Ji, & Zhang, 
2010; Pizza et al., 2005; Reid and Li, 2001; Smith et al., 2008) and the 
development of DOMS (Schafer, Sorkin, & Sommer 2003) providing a 
rationale for their measurement. With that said, the greatest increases in 
these cytokines are normally seen at the local level (Peake et al., 2015a) or 
after very intense exercise such as marathon running (Scherr et al., 2011; 
Shanely et al., 2013), with few studies observing increases systemically in 
the hours and days after less severe exercise (Paulsen et al., 2012; Peake et 
al., 2015a). An added layer of complexity with measuring these cytokines is 
that they also appear to be important for macrophage and fibroblast 
activation and, therefore, muscle regeneration after EIMD (Paulsen et al., 
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2012; Tidball & Villalta, 2010). Thus, while measuring cytokines may be 
useful for identifying the presence of an acute inflammatory response, their 
seemingly dual roles in the biological processes associated with EIMD 
makes it difficult to discern whether they are a cause or merely a 
consequence of muscle damage (Paulsen et al., 2012). A more in-depth 
discussion of these cytokines and others used as markers of exercise-
induced inflammation can be found in Peake et al. (2015a) and Paulsen et al. 
(2012).  
In some studies, systemic leukocytosis has been measured to assess the 
inflammatory response associated with EIMD (Malm, Lenkei, & Sjödin, 1999; 
Paulsen et al., 2005; Paulsen et al., 2005; Risoy et al., 2003; Suzuki et al., 
1999; Suzuki et al., 2003). Leukocytosis is typically measured as the total 
number of leukocytes present in a blood sample, and the proportion of which 
are neutrophils, lymphocytes or monocytes. Significant increases in 
leukocyte counts are observed very early after exercise, but are believed to 
peak 5-6 h post, largely due to the delayed neutrophilia (Malm et al., 2004; 
Paulsen et al., 2005). In contrast to the systemic response, leukocyte 
accumulation in the muscle may persist for several days’ post-exercise and 
has even been observed in the muscle up to 7 days after severe eccentric 
exercise (Paulsen et al., 2010b; Paulsen et al., 2012). Intriguingly, an 
increase in leukocyte activity, predominately neutrophils, has shown a strong 
positive correlation with post exercise losses in muscle function, and this is 
evident in both animal (Pizza et al., 2005) and human models (Paulsen et al., 
2005). This suggests that leukocytes are important mediators of secondary 
muscle damage; consequently, they might present as a useful marker of 
exercise-induced inflammation and its relationship to EIMD. 
2.5 Nutritional supplements as recovery interventions  
From the above sections, it is clear that muscle-damaging exercise can 
result in a host of deleterious consequences for both a recreational exerciser 
57 
 
 
and an athlete. Consequently, a plethora of interventions have been 
developed and tested for their ability to minimise the negative effects of 
muscle damage and enhance recovery. Some of the more popular 
interventions purported to aid recovery are cold water immersion, heat 
application, massage therapy, compression garments and nutritional or 
pharmacological therapies (Howatson & van Someren, 2008; Sousa et al., 
2013). With regards to the latter category, branch chain amino acids 
(Howatson et al., 2012; Kirby et al., 2012; Ra et al., 2013), protein and 
carbohydrates (Etheridge et al., 2008; Saunders et al., 2004), milk 
(Cockburn, Hayes, French, Stevenson, & St Clair Gibson, 2008; Cockburn, 
Robson-Ansley, Hayes, & Stevenson, 2012), NSAIDS (Paulsen et al., 2010a; 
Vella et al., 2016) and AOX supplementation (Beaton et al., 2002; Bloomer, 
2007; Thompson et al., 2001) have all been tested for their efficacy as 
recovery aids following EIMD, with varying degrees of success. It is not in the 
scope of this thesis to review all of the nutritional interventions purported to 
enhance recovery; rather, the aim of following sections is to briefly discuss 
the main findings from studies that are most relevant to this thesis: AOX and 
anti-inflammatory supplements. For an all-encompassing review of the 
recovery strategies used to manage EIMD, or just nutrition based strategies, 
the reader is referred to Howaston and van Someren, (2008) and Sousa et 
al. (2013), respectively.  
2.5.1 AOX and anti-inflammatory supplementation 
The potential benefits of consuming AOX and/or anti-inflammatory 
supplements is cellular protection against exercise-induced increases in 
inflammation and RONS, which, as described in the above sections, has the 
potential to cause secondary muscle damage (Paulsen et al., 2014b; Peake 
& Suzuki, 2004). To test whether this holds true, the vast majority of studies 
have administered either high doses of nutritional AOXs, such as vitamin C 
and/or E (Close et al., 2006; Jakeman & Maxwell, 1993; Paulsen et al., 
2014b) and N-acetylcysteine (NAC) (Cobley, McGlory, Morton, & Close, 
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2011) or anti-inflammatory medications, such as NSAIDS (Lanier, 2003; 
Paulsen et al., 2010a). Despite the high interest in these supplements, and 
their widespread use amongst athletic populations (Tscholl, Vaso, Weber, & 
Dvorak, 2015; Warden, 2010), evidence to support their effectiveness in 
protecting against muscle damage is equivocal. While some studies have 
reported beneficial effects with these supplements, including lowered muscle 
soreness with NSAIDS (Paulsen et al., 2010a) and a faster recovery of 
muscle function with NAC (Cobley et al., 2011) and vitamin C (Jakeman & 
Maxwell, 1993), the majority report no benefits (Bailey, Williams, Betts, 
Thompson, & Hurst, 2011; Beaton et al., 2002; Paulsen et al., 2014b; 
Theodorou et al., 2011).  
Interestingly, some studies have actually reported negative effects with these 
supplements, particularly with regard to exercise-induced adaptations 
(Bjørnsen et al., 2015; Child, Jacobs, Kaminski, Halliwell, & Leeuwenburgh, 
2001; Close et al., 2006). Indeed, there is a growing concern that dampening 
exercise-induced oxidative stress and/or inflammation could actually mitigate 
or at least lessen some of the physiological adaptations evoked by training 
(Gross & Baum, 2015). This is due to the evidence that RONS function as 
cell-signalling molecules, and their production is required for stimulating 
molecular pathways necessary for improved aerobic capacity (i.e., 
peroxisome proliferator-activated receptor-γ coactivator; PCG1-α) and 
hypertrophy and strength (i.e., mitogen-activated protein kinases; MAPK) 
(Gross & Baum, 2015; Paulsen et al., 2014a). This has led many to posit that 
instead of positively influencing exercise performance, as originally proposed, 
AOXs and anti-inflammatory supplements negatively affect performance, a 
consequence of suppressing RONS-induced adaptive cellular pathways 
(Gomez-Caberra et al., 2015; Paulsen et al., 2014a). Nonetheless, this is not 
a view supported by other research groups (Higashida, Kim, Higuchi, 
Holloszy, & Han, 2011).  
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As this topic continues to be hotly debated in the literature and formed the 
basis of the rationale behind Chapter 6, it was felt that a discussion of the 
main issues should be presented. However, because of the plethora of 
studies addressing this phenomenon, both in animals and humans, and with 
a variety of different supplements and doses, a full review of this topic was 
beyond the scope of this thesis. For a more in depth discussion on this topic 
the reader is referred to the reviews by Peake et al. (2015b), Gomez et al. 
(2015) and Hyldahl, Chen, & Nosaka, 2017). Instead, this section will only 
focus on the main findings and current knowledge regarding the effects of 
vitamin C and E and NSAIDS in humans only, with reference to their effects 
on the RBE, endurance performance, strength and hypertrophy. 
2.5.2 Effects of AOX and anti-inflammatory supplements on the 
repeated bout effect 
The acute adaptive response to muscle-damaging exercise is classically 
illustrated by the RBE, in which the magnitude of damage (i.e., strength loss, 
muscle soreness) evoked by the same or a similar exercise stimulus is 
lessened in a subsequent bout performed up to 6 months later (Hubal et al., 
2008; McHugh, 2003; Nosaka & Clarkson, 1995; Pizza et al. 2001). The 
precise mechanisms to explain the RBE have still not been fully elucidated, 
but it is generally assumed that they are related to adjustments in neural, 
mechanical and/or cellular pathways (McHugh, 2003; Nosaka & Aoki, 2011; 
Hyldahl et al., 2017). 
In terms of cellular pathways, exercise-induced inflammation, including 
RONS production, has been proposed as one of the mechanisms driving the 
adaptations reflected by the RBE (Nosaka & Aoki, 2011). The premise is that 
the transient increase in inflammation and RONS act as cell signals for 
transcription factors such as NF-kB, which directly transcribes most gene 
targets associated with an inflammatory response, including cytokines, 
chemokines, apoptotic and phagocytic cells (Hubal et al., 2008; Pizza et al., 
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2002; Xin, Hyldahl, Chipkin, & Clarkson, 2013). The subsequent up-
regulation of these specific genes might reinforce host defence so that in 
future exercise bouts muscle cells are less susceptible to inflammatory-
mediated damage, in other words, secondary muscle damage, that might 
depress muscle force (Hubal et al., 2008; Pizza, Koh, McGregor, & Brooks, 
2002; Xin et al., 2013). In support of this, studies have shown that neutrophil 
invasion (Pizza et al., 2001; Pizza et al., 2002), cytokine secretion (i.e., IL-6, 
IL-8) (Smith et al., 2008), NF-kB activation (Xin et al., 2013) and oxidative 
damage to biomolecules (Nikolaidis et al., 2007) are all increased after an 
initial bout of muscle damaging exercise, but attenuated when the bout is 
repeated shortly after. This would suggest that the immune and oxidative 
stress response to EIMD adapts after just a single bout of exercise. 
Ostensibly, such adaptations might help to make skeletal muscles and the 
ECM more resistant to EIMD in future bouts (Hyldahl & Hubal, 2014).  
Based on the above evidence, it seems logical to assume that AOX and or 
anti-inflammatory supplements could supress the production of RONS and 
inflammatory mediators that help to promote a RBE. In this scenario, the 
neuromuscular adaptations typically associated with the RBE, such as 
lowered muscle soreness and faster recovery of muscle function, would be 
attenuated when consuming these supplements. At present, this possibility 
has only been tested by a few studies. In one of these, healthy but untrained 
male and female volunteers, given 400 mg∙day-1 of NSAIDs (celecoxib) for 9 
days after eccentric elbow flexor exercise, showed no signs of maladaptation 
compared to a PLA group when the same bout was performed 3 weeks later 
(Paulsen et al., 2010a). Indeed, muscle function, muscle soreness, CK efflux 
and leukocyte accumulation were similarly attenuated in bout 2 compared to 
bout 1 for both groups, indicating that an RBE had occurred, irrespective of 
supplementation. Another study investigated the effects of supplementation 
with vitamin C (1000 mg·d·-1) and E (400 I·U-1) versus a PLA on the RBE to 
downhill running (40 min at −10% grade) (He, Hockemeyer, & Sedlock, 
2015). After bout 1, supplementation showed beneficial effects, reducing 
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soreness in the quadriceps and tibialis anterior by ~45 and ~60%, 
respectively; however, the authors did not detect any adverse effects of 
supplementation on the RBE. This was indicated by the similar attenuations 
in muscle soreness and plasma CK in bout 2 compared to bout 1 for both the 
supplementation and PLA group. Based on the available data, there is 
insufficient evidence that vitamin C and E or NSAIDs interfere with the RBE 
in humans. However, further work with different exercise paradigms and 
supplements are needed to gain a more in-depth understanding of the 
potential role of AOX or anti-inflammatory containing supplements in acute 
exercise adaptation.  
2.5.3 Effects of AOX and anti-inflammatory supplements on 
endurance adaptations  
The observation that AOXs might interfere with mitochondrial biogenesis 
(Gross & Baum, 2015; Paulsen et al., 2014a) raises the possibility that these 
supplements could blunt training-induced adaptations important for 
endurance performance, like an enhanced VO2max, for example. This 
possibility has been the subject of several recent investigations (Paulsen et 
al., 2014a; Peake et al., 2015b; Yfanti at al., 2010). The vast majority of 
studies in this category have been conducted with vitamin C and E as 
opposed to NSAIDS, which are more commonly used for their analgesic 
properties after muscle-damaging exercise. Although there is evidence that 
vitamin C and E might blunt training-induced changes in aerobic capacity of 
rats (Gomez-Cabrera et al., 2008; Peake et al., 2015b), there is currently a 
lack of evidence supporting similar impairments with AOX supplements in 
humans (Yfanti et al., 2010; Paulsen et al., 2014a; Peake et al., 2015b). For 
instance, improvements in VO2max and maximal power output in response to 
12 weeks of cycling training were similar between groups administered either 
a PLA or vitamin C (500 mg∙day∙-1) and E (400 IU∙day∙-1) (Yfanti at al., 2010). 
In another study, although vitamin C and E supplementation (1000 mg∙day∙-1) 
and E (400 IU∙day∙-1) suppressed the training induced increase in PGC-1α, a 
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key marker of mitochondrial biogenesis, no changes in VO2max or endurance 
capacity were detected between the PLA and vitamin groups (Paulsen et al., 
2014a). A recent review by Peake et al. (2015b) concluded that while vitamin 
C and E appear to blunt some molecular changes induced by endurance 
type exercise, evidence that this translates to changes at the performance 
level, at least in humans, is lacking.  
2.5.4 Effects of AOX and anti-inflammatory supplements on 
strength adaptations  
The supposition that AOXs or NSAIDS might interfere with endurance 
adaptations, sparked an interest in their effects on long-term adaptations 
associated with resistance training or eccentric-heavy exercise, such as 
muscle hypertrophy and strength (Paulsen et al., 2014b). With regards to 
NSAIDS, the interest in their potential to blunt such adaptations stems from 
the fact that when taken acutely alongside eccentric-heavy exercise, as is 
commonly done in an attempt to reduce EIMD (Tscholl et al., 2015), they can 
dampen anabolic signalling (Trappe et al., 2002; Markworth, Vella, 
Figueiredo, & Cameron-Smith, 2014) and reduce satellite cell activity 
(Mikkelsen et al., 2009). Such effects are believed to be due to NSAIDS 
inhibitory effect on the pro-inflammatory cyclooxygenase (COX) pathway, 
especially the blunting of the cyclooxygenase-1 (COX-1) isoform, which is a 
key precursor enzyme for prostaglandin F2 formation (PGF2) (Mikkelsen, 
Helmark, Kjær, & Langberg, 2008; Trappe et al., 2006). Nonetheless, not all 
studies have found negative effects with NSAIDS (Paulsen et al., 2010a; 
Peake et al., 2015b; Vella et al., 2016) and, in fact, a recent study suggested 
that they might actually enhance satellite cell activity and muscle 
regeneration following a severe bout of muscle-damaging exercise (Mackey 
et al., 2016).  
Furthermore, although in some instances NSAIDS appear to blunt molecular 
signals that are believed to promote gains in hypertrophy and strength, 
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evidence demonstrating that these adaptations are inhibited in humans, is 
currently lacking (Peake et al., 2015b; Schoenfield et al., 2012; Trappe & Liu, 
2013). In fact, more recent studies suggest that NSAIDS may actually induce 
positive adaptive effects, at least in elderly populations. For instance, 
Petersen et al. (2011) administered NSAIDS or a PLA to older, osteoarthritic 
adults and measured changes in hypertrophy and strength after 12 weeks of 
strength training. No group differences in cross sectional area in the 
quadriceps were detected, but gains in isometric leg strength were greater 
for the NSAID group. These data are supported by another study, in which 
acetaminophen or ibuprofen (NSAIDS) supplementation evoked greater 
improvements in 1 repetition maximum leg strength and increases in 
quadriceps hypotrophy than a PLA following 12 weeks of leg extensor 
exercise in healthy, older adults (>60 y old) (Trappe et al., 2011). These 
effects have not been shown in younger adults however, who, in an earlier 
study (Krentz, Quest, Farthing, Quest, & Chilibeck, 2008), were shown to 
experience similar gains in hypertrophy and strength after 6 weeks of 
resistance training while taking either NSAIDS (ibuprofen) or a PLA after 
training sessions. Given the above discussion, it seems that while NSAIDS 
might blunt some acute molecular responses to eccentric-exercise, they do 
not impair long-term adaptations (or there is insufficient evidence for this at 
present) and, at least in elderly individuals, they might augment some of 
these adaptations. For a more in depth discussion on the effects of NSAIDS 
on training induced adaptations the reader is referred to the reviews by 
Peake et al. (2015b), Schoenfeld (2012) or Trappe & Liu, (2013).  
The influence of AOXs on strength training adaptations was first investigated 
by Theodorou et al. (2011), in which healthy young males were administered 
either vitamin C or E a PLA in conjunction with a 4 week resistance training 
program. Training-induced improvements in muscle torque were similar 
between the PLA and vitamin supplemented groups, as were changes in 
redox biomarkers, leading the authors to conclude that AOXs had no effects 
on muscle performance following resistance exercise. In a more recent 
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study, Paulsen et al. (2014b) tested whether vitamin C and E 
supplementation in conjunction with a 10 week resistance training program 
would prevent gains in hypertrophy and strength in healthy males. Vitamin 
supplementation had no effect on hypertrophy, or lower body muscle 
strength; however, upper body strength was lower in the AOX vs. PLA group, 
suggesting that it might have interfered with normal adaptations in these 
muscle groups. Another study from the same group provided further 
evidence that AOXs might blunt strength-training adaptations. Bjørnsen et al. 
(2015) administered daily doses of vitamin C and E to older adults (≥60 yrs) 
during a 12 week strength training program and measured changes in body 
composition and strength in comparison to a PLA group. Although there were 
no group differences in strength parameters, gains in lean mass were 
significantly lower in the vitamin C and E group vs. the PLA group (1.4 vs. 
3.9%). The authors speculated that these results could have been due to the 
effects of the AOXs on RONS-induced signalling pathways associated with 
muscle hypertrophy (i.e., MAPK) given they were shown to be down-
regulated after 11 weeks of vitamin C and E supplementation in their 
previous study (Paulsen et al., 2014b). Thus, the available evidence 
suggests that vitamin C and E may impair some of the favourable 
adaptations that accompany strength training and, therefore, individuals, 
especially athletes, should be cautious about using them chronically. 
Nevertheless, it is important to take into consideration that the doses of 
vitamin C and E used in these studies are very high (~5-10 × the 
recommended daily allowance; RDA) and provided over 10-12 week periods; 
as such, these findings cannot be interpreted as evidence that lower doses 
of these supplements, taken acutely, will have the same effects. In support of 
this notion, Paulsen et al. (2014b) found that acute recovery of muscle 
function was unaffected by vitamin C and E supplementation in the 72 h 
following 4 sets of 10 leg press and knee extension exercise. The potentially 
differing effect of acute vs. chronic AOX supplementation on exercise 
adaptations requires further research.  
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2.5.5 Hormesis 
From the above discussion, it is clear that research into the effects of AOXs 
and NSAIDS on exercise-induced adaptations is equivocal. Perhaps this is 
because in some instances, a modest increase in RONS and inflammation 
may be beneficial and, therefore, countermeasures detrimental (i.e., 
adaptation), while in other scenarios, the opposite may be true (i.e., muscle 
damage or disease). This apparent dual function of RONS and inflammation 
may be partly explained by the hormesis theory (Peake et al., 2015b; Radak, 
Chung, Koltai, Taylor, & Goto, 2008). The hormesis theory refers to Hans 
Seyle’s posit almost 70 years ago, in which he suggested that exposing a 
biological system to a low/moderate stress will elicit a beneficial effect, but 
over or excessive exposure to the same stress would have a deleterious 
effect (i.e., an inverted U-shape pattern) (Nikolaidis et al., 2012b; Peake et 
al., 2015b). Applying the hormesis theory to EIMD, it could be suggested that 
an increase in immune cells and RONS could be an important driver of acute 
and chronic molecular adaptations (see Chapter 2.5.2) but, excessive or 
chronic production could lead to cell dysfunction, additional muscle damage, 
and prolonged losses in function (Peake et al., 2015b; Slattery, Bentley, & 
Coutts, 2015).    
In view of hormesis, perhaps the usefulness of AOXs or NSAIDS for athletes, 
particularly with regards to exercise recovery, is highly context dependent. 
For instance, their chronic use throughout a competitive season could 
interfere with molecular signalling processes and possibly hinder long-term 
training adaptations, therefore being detrimental. However, the acute use of 
these supplements, when the need to minimise the adverse effects of EIMD 
(i.e., soreness and losses in muscle function) far outweigh the need for 
adaptation (i.e., tournaments, fixture congestion), these supplements could 
form part of a recovery strategy to restore optimal performance.  
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Furthermore, the hormesis theory could also be extended to explain the 
effects of the supplements themselves; at low to moderate doses AOX or 
anti-inflammatory supplements could be ergogenic, but at high doses, 
deleterious. This could explain why inhibitory effects on exercise-induced 
adaptations are more commonly reported with very high doses of vitamin C 
and E (i.e., vitamin C ≥1000 mg∙day-1) (Bjørnsen et al., 2015; Close et al, 
2006; Paulsen et al, 2014b) than moderate doses (500 mg mg∙day-1) (Yfanti 
et al., 2010; Yfanti et al., 2011). The potential for dose-response effects of 
these supplements on exercise-induced adaptations is clearly an avenue that 
needs further exploration. 
2.6 Functional foods as recovery interventions  
In recent years, perhaps because of the risk of deleterious effects with 
vitamin C and E and NSAIDS, there has been a growing interest in the 
potential benefits of other AOX or anti-inflammatory containing supplements 
to attenuate muscle damage. Of particular interest are the effects of natural 
or functional food supplements on exercise recovery (Myburgh, 2014; Sousa 
et al., 2013). This interest stems from the observation that functional foods 
contain a variety of naturally occurring phytonutrients, such as polyphenols, 
(i.e., flavonoids, anthocyanins) (Myburgh, 2014). These phytonutrients 
appear to exhibit a broad range of beneficial physiological effects that 
include, but are not limited to, AOX and anti-inflammatory (Nikolaidis et al., 
2012a; Sousa et al., 2013; Urso, 2013). Unlike studies with NSAIDS and 
vitamin C and E, more favourable effects on exercise recovery have been 
demonstrated after supplementing with functional foods. For instance, there 
are now several reports that cherry juice supplementation can attenuate 
indices of muscle damage following cycling (Bell et al., 2014; Bell et al., 
2015) running (Howatson et al., 2010) and eccentric-heavy resistance 
exercise (Bowtell et al., 2010; Connolly et al., 2006). Furthermore, a series of 
studies has also shown that pomegranate juice taken before and after 
eccentric exercise can enhance the recovery of muscle function in the 
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ensuing days (Trombold et al., 2010; Trombold et al., 2011; Machin et al., 
2014). Numerous other functional foods, including curcumin (Drobnic et al., 
2014; Tanabe et al., 2015), blueberry (McLeay et al., 2009) and green tea 
(Jówko et al., 2011) have also shown favourable effects on EIMD. Why these 
functional food sources appear to be more beneficial than NSAIDS or vitamin 
C/E for alleviating EIMD is not completely understood but some potential 
explanations are briefly discussed in Chapter 6. Regardless of the precise 
mechanisms, the current evidence suggests that functional foods 
supplements might provide a useful means of attenuating EIMD. This was 
the conclusion of a recent review by Myburgh, (2014), who suggested that 
the potential benefit of this class of nutrients on EIMD and functional 
recovery is an avenue worthy of further exploration.  
2.7 Beetroot as a recovery intervention  
The overarching aim of this thesis is to investigate the effects of a functional 
food, beetroot, on recovery from strenuous exercise. Therefore, the following 
sections of this review will focus on the physiological and biochemical effects 
of beetroot and its various constituents, and how these could be exploited to 
enhance exercise recovery.  
2.7.1 Beetroot: an introduction to its history, constituents and 
potential benefits  
In recent years, the root vegetable Beta Vulgaris L. otherwise known as 
beetroot, has attracted much attention as a health promoting functional food. 
While scientific interest in beetroot has only gained momentum in the past 
few decades, reports of its use as a natural medicine date back to Roman 
times where it was used to treat a variety of illnesses (Nikolic et al., 2012; 
Ninfali & Angelino, 2013). Intriguingly, the longstanding belief that beetroot 
has natural healing properties has made it one the most popular alternative 
treatments amongst cancer patients (Nikolic et al., 2012). Today, beetroot is 
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grown in many countries worldwide, is regularly consumed as part of the 
normal diet, and commonly used in manufacturing as a food colouring agent 
known as E162 (Georgiev et al., 2010; Pietrzkowski et al., 2010). 
The recent interest in beetroot was primarily driven by the discovery that 
foods rich in dietary nitrate may have important implications for managing 
health and disease. Indeed, recent studies have provided compelling 
evidence that consuming beetroot, typically acutely as a juice, offers a 
myriad of beneficial physiological effects (Bailey et al., 2009; Gilchrist et al., 
2014; Joris & Mensink, 2013; Kapil, Weitzberg, Lundberg, & Ahluwalia, 2014; 
Vanhatalo et al., 2010). These effects have been successfully exploited to 
favourably affect clinical outcomes for several pathologies, such as; 
hypertension, atherosclerosis, type 2 diabetes and dementia (Gilchrist et al., 
2013; Presley et al., 2011; Wootton-Beard, Brandt, Fell, Warner, & Ryan, 
2014). There is also now a growing interest in the use of nitrate donors to 
manage muscle injuries (Rigamonti et al., 2013), and possibly muscular 
dystrophy (Archer, Vargas, & Anderson, 2006; D'Angelo et al., 2012) since 
the discovery that nitrate also seems to have a regulatory influence on the 
phagocytic and regenerative phases of muscle repair (Filippin, Moreira, 
Marroni, & Xavier, 2009).  
The beneficial physiological effects of beetroot juice have been largely 
attributed to its high inorganic nitrate content (250 mg∙kg−1 of fresh weight; 
(Ormsbee, Lox, & Arciero, 2013). Nitrate itself is not considered to mediate 
any specific physiological function; rather, nitrates beneficial effects are 
attributed to its in vivo reduction to NOx, a multifarious messenger molecule 
with important vascular and metabolic functions (Hobbs, George, & 
Lovegrove, 2013). The generation of NOx via nitrate involves a series of 
sequential steps that have been well described in the literature (Lundberg, 
Carlström, Larsen, & Weitzberg, 2011; Lundberg, Weitzberg, & Gladwin, 
2008). Briefly, ingested nitrate is first absorbed through the upper part of the 
small intestine into the systemic circulation (Kapil et al., 2014; Lundberg et 
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al., 2008). It is then estimated that 25% of the circulating nitrate enters the 
entero-salivary cycle where bacterial species located at the posterior aspect 
of the tongue bioactivate or reduce salivary nitrate to nitrite (Lidder & Webb, 
2013; Lundberg et al., 2011). Because salivary bacteria facilitate the 
reduction reaction that converts nitrate to nitrite, spitting out saliva or taking 
oral anti-bacterial treatments, like dental mouthwash for example, has been 
shown to diminish nitrate-nitrite conversion (Webb et al., 2008). Under 
normal circumstances, however, salivary nitrite is re-absorbed into the 
circulation via the stomach, where it is metabolised to NOx and other 
nitrogen oxides by a variety of reductase enzymes (Hobbs, Kaffa, George, 
Methven, & Lovegrove, 2012; Lundberg et al., 2008; Webb et al., 2008).  
Nitrate is not the only constituent of beetroot proposed to have beneficial 
effects in health and disease though. Beetroot is a rich source of 
phytochemical compounds (Figure 2) that includes carotenoids, phenolic 
acids and flavonoids (Kujala, Vienola, Klika, Loponen, & Pihlaja, 2002; 
Wootton-Beard & Ryan, 2011). Beetroot is also one of only a few foods that 
contain a group of highly bioactive pigments known as betalains, which stem 
from the order Caryophyllales (Kha, 2015; Lee, Wettasinghe, Bolling, Ji, & 
Parkin, 2005; Vulic et al., 2014). Members of the betalain family are 
categorised as either betacyanin pigments, that are red-violet in colour, or 
betaxanthin pigments, that are yellow-orange in colour (Ninfali & Angelino, 
2013). A number of investigations have reported betalains to have high AOX 
and anti-inflammatory capabilities in vitro and a in vivo, albeit these findings 
are mostly derived from animal models (Pavlov, Kovatcheva, Georgiev, 
Koleva, & Ilieva, 2002; Tesoriere, Allegra, Butera, & Livrea, 2004; Vidal, 
Lopez-Nicolas, Gandia-Herrero, & Garcia-Carmona, 2014; Vulic et al., 2014; 
Zielinska-Przyjemska, Olejnik, Dobrowolska-Zachwieja, & Grajek, 2009). 
Interestingly, betalains have also been shown to have adaptogenic effects, at 
least in vitro, in which they act to reinforce the endogenous AOX and 
xenobiotic defence system by upregulating specific signalling cascades 
(Esatbeyoglu et al., 2014; Khan, 2015). These findings have sparked interest 
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in a possible role for beetroot in degenerative pathologies characterised by 
oxidative stress and chronic inflammation such as liver disease (Ninfali & 
Angelino, 2013; Vulic et al., 2014), arthritis (Pietrzkowski, 2010) and even 
cancer (Kapadia et al., 2011; Kapadia et al., 2013).  
 
 
Figure 2 - Overview of potentially bioactive compounds in beetroot (based on 
data from (Georgiev et al., 2010; Kujala et al., 2002; Ninfali & Angelino, 
2013). 
The potential benefits of beetroot are not limited to the clinical setting and 
since the turn of the decade, beetroot has gained popularity as an ergogenic 
aid for athletic performance. Indeed, a single dose of beetroot juice, taken 2-
3 hours before exercise, has been shown to improve cycling (Lansley et al., 
2011), running (Murphy, Eliot, Heuertz, & Weiss, 2012) and rowing 
performance (Hoon et al., 2014), and there are several anecdotal reports of 
its successful use in the wider sporting community (Jones, 2014b; Ormsbee 
et al., 2013). Although the precise mechanisms are still being debated, most 
researchers agree that beetroots ergogenic effects are mediated by NOx and 
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its influence on metabolic pathways related to exercise efficiency/economy 
(Jones, 2014a, 2014b; Larsen, Weitzberg, Lundberg, & Ekblom, 2007). A 
more in depth discussion of the studies investigating beetroot and athletic 
performance and the potential mechanisms involved are not within the scope 
of this thesis; for this information, the reader is referred to the following 
review articles (Jones, 2014a, 2014b).  
Given the above discussion, it is clear that beetroot contains several 
chemical compounds that might exhibit beneficial physiological effects, 
including for conditions associated with inflammation and oxidative stress. 
Therefore, its application in the exercise domain may extend beyond 
enhancement of athletic performance, to include exercise recovery. Indeed, 
Chapter 2.5, highlighted the accumulating evidence that provison of foods 
with AOX and anti-inflammatory phytonutrients attenuates some of the 
deleterious symptoms that arise in the days following strenuous exercise; 
inflammation, oxidative stress, muscle soreness and loss of muscle function 
(Bell et al., 2014; Bell et al., 2015; Howatson et al., 2010; McLeay et al., 
2012; Trombold et al., 2010; Trombold et al., 2011). Consequently, the aim 
of the following sections is to discuss the anti-inflammatory and AOX effects 
of beetroot and its constituents and, thus, aims to provide a rationale for the 
use of a beetroot supplement as a recovery intervention following muscle-
damaging exercise. 
It is important to note that this discussion is primarily limited to mechanisms 
underpinned by an AOX and/or anti-inflammatory effect of beetroot. This is 
because these are the mechanisms that initially generated the hypothesis for 
this course of investigation and, thus, were tested in some of the studies in 
this thesis. However, it is acknowledged that there are other mechanisms 
afforded by beetroot that, conceivably, could also benefit exercise recovery; 
namely, increased muscle blood flow, improved contractile function and 
enhanced satellite cell activity: all of which have been demonstrated with 
either beetroot juice or nitrate supplementation (and are discussed in 
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Chapter 10). Obviously there was not scope to investigate all of these 
possible mechanisms within this thesis; hence, the investigations throughout 
were based on the premise that the anti-inflammatory or AOX effects of 
beetroot would serve to enhance exercise recovery. Therefore, in the 
following sections, after reviewing the evidence examining the bioavailability 
of the bioactive compounds in beetroot, particularly the betalains, the aim is 
to evaluate the evidence from experimental studies on the effects of beetroot 
and its various constituents on inflammation and oxidative stress.  
2.7.2 Bioavailability  
For a food component to be considered beneficial for health it must be 
bioavailable in vivo, that is, following ingestion, the active compounds are 
absorbed through the gastro-intestinal tract and made available in the 
circulation, in sufficient quantities, to be utilized by cells (Toutain & Bousquet-
Melou, 2004; Wootton-Beard & Ryan, 2011). However, in order to reach the 
systemic circulation and exert any physiological functions, a food component 
must maintain its molecular structure through several phases of digestion 
that each present a significant metabolic challenge for the molecule and 
affect its eventual rate and extent of absorption (Rein et al., 2013; Toutain & 
Bousquet-Melou, 2004). It is therefore critically important that any alleged 
health benefit of a food source be firstly verified with well-designed 
bioavailability studies that characterise the extent of its in vivo absorption 
(Rein et al., 2013).  
In this respect, the bioavailability of both nitrate and the betalains, the major 
bioactive components of beetroot, have been considered in the literature. 
The high bioavailability of inorganic dietary nitrate is well established and 
there are reports of extremely high absorption and bioavailability following 
digestion (van Velzen, Sips, Schothorst, Lambers, & Meulenbelt, 2008). The 
extent to which betalains are absorbed and bioavailable is, however, less 
clear. Two studies have directly investigated betalain bioavailability by 
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measuring their appearance in human urine after ingesting a single bolus of 
homemade BTJ (Frank et al., 2005; Kanner, Harel, & Granit, 2001). Kanner 
et al. (2001) identified 0.5%–0.9% of the ingested betacyanins (betanin and 
isobetanin) in volunteer’s urine in the 12 h after consuming 300 mL of 
homemade BTJ. This indicates that although in small amounts, betacyanins 
can be successfully absorbed and are bioavailable in humans. They also 
showed that the peak urinary excretion rate of betacyanins (indicative of 
bioavailability), occurred 2–4 h after ingestion; however, there was a high 
level of inter-individual variability within this time period. Frank et al. (2005) 
reported similar findings while investigating betacyanin bioavailability. After 
providing six healthy participants with 500 mL of homemade BTJ, they 
identified betacyanins in urine at concentrations equivalent to ~0.3% of the 
ingested dose over a 24 h period. These studies might be interpreted to 
suggest low bioavailability; however, it is important to take into account that 
betacyanins are unlikely to be exclusively excreted via the renal pathway 
(Frank et al., 2005). Indeed, the use of urinary excretion as a sole indicator of 
bioavailability has received criticism because it does not account for the 
distribution of molecules to other tissues, thus underestimating true 
bioavailability (Khan, 2015; Rein et al., 2013). In addition, the extent to which 
betalains are metabolised and structurally transformed to secondary 
metabolites is yet to be characterized, but should be acknowledged when 
evaluating their bioavailability (Frank et al., 2005; Khan, 2015).  
Given these limitations, Tesoriere et al. (2013) employed a different 
approach to investigate the bioavailability of betalains. Tesoriere and 
colleagues developed a simulated in vitro model of the human intestinal 
epithelium using Caco-2 cell monolayers to mimic a functional intestinal 
barrier. This model allowed them to examine whether betalains can be 
absorbed through a functioning intestinal barrier and hence give an indication 
of their bioavailability. They demonstrated that two betalains; betanin and to 
a greater extent indicaxanthin were well absorbed through the simulated 
model of the intestinal lining (Caco-2 cell monolayer) and mostly in their 
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unmetabolised form via paracellular transport. The latter finding is particularly 
important, because it reveals that betalains might be absorbed into the 
systemic circulation in their unchanged form, allowing them to retain at least 
some of their molecular structure and high biological activity demonstrated in 
vitro (Ting et al., 2014). This study, along with others (Khan, 2015), also 
suggests that the betaxanthins are more bioavailable than the betacyanin 
pigments. Nonetheless, it is important to note that results from in vitro 
experiments, even when designed to mimic the biological milieu of the 
human GI tract, do not necessarily translate in vivo, given that several other 
factors (i.e., first pass metabolism, interactions with gut microflora and 
protease enzyme degradation) have a significant influence on the 
concentration of the nutrient that eventually reaches the circulation (Rein et 
al., 2013; Ting et al., 2014). 
In addition to the betalain family, other aforementioned plant derived AOXs 
have been identified in beetroot, including epicatechin, rutin, and caffeic acid 
(Georgiev et al., 2010), which, to varying degrees, appear to be well 
absorbed and bioavailable in humans (Manach, Williamson, Morand, 
Scalbert, & Remesy, 2005). Although the bioavailability of these compounds 
and other phenolic compounds from beetroot has not been individually 
determined, there are data describing the bioavailability of the total phenolic 
compounds present in beetroot (Netzel et al., 2005). Netzel et al. (2005) 
measured the urinary excretion of total phenolic substances following a 
single 500 mL bolus of BTJ. They identified ~685 mg of phenolic compounds 
in participant’s urine <24 h following beetroot juice ingestion; 97% more than 
the ~347 mg identified after consuming water (i.e., basal concentrations). 
While the relative bioavailability from the individual compounds could not be 
determined, these findings clearly show that beetroot’s phenolic constituents 
are bioavailable and are likely to make a significant contribution to beetroot’s 
in vivo AOX power. Taken together, the results of the aforementioned studies 
provide a good base of evidence that beetroot is a bioavailable source of 
bioactive compounds (particularly nitrate and phenolic compounds) in 
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humans. With that said, further work is still required to firstly; elucidate the 
bioavailability of beetroot’s individual bioactive components, especially the 
different betalains and, secondly; to establish the extent that plasma, biliary, 
and other metabolic pathways contribute to the excretion of these 
components. 
2.7.3 Effects of beetroot on oxidative stress  
There is evidence to suggest that beetroot might serve as a useful strategy 
to strengthen endogenous AOX defences and help to protect cellular 
components from oxidative damage (El Gamal et al., 2014). The beneficial 
effects of beetroot in oxidative stress are based on the fact that beetroot is 
an exceptionally rich source of biochemical compounds that display AOX 
functions (Ninfali & Angelino, 2013). The betalain pigments in particular have 
been shown by several in vitro studies to protect cellular components from 
oxidative injury (Kanner et al., 2001; Reddy, Alexander-Lindo, & Nair, 2005; 
Tesoriere, Fazzari, Angileri, Gentile, & Livrea, 2008). For example, in the 
study by Kanner et al. (2001), two betalain metabolites (betanin and 
betanidin) were shown to reduce linoleate damage induced by cytochrome C 
oxidase and lipid membrane oxidation induced by H2O2-activated 
metmyoglobin and free iron (AA-Fe). The authors also reported that betanin, 
the most abundant betalain found in beetroot (300–600 mg∙kg−1), was the 
most effective inhibitor of lipid peroxidation. Betanin’s high AOX activity 
appeared to stem from its exceptional electron donating capacity and ability 
to defuse highly reactive radicals targeting cell membranes (Kanner et al., 
2001). However, as alluded to earlier, betalains are not the only AOX 
compounds present in beetroot. Beetroot contains several highly bioactive 
phenolics, such as rutin, epicatechin and chlorogenic acid which are also 
known to be excellent AOXs (Frank et al., 2005; Georgiev et al., 2010; 
Manach et al., 2005).  
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A number of studies report that beetroot, in the form of a juice supplement, 
protects against oxidative damage to DNA, lipid and protein structures in 
vitro (Esatbeyoglu et al., 2014; Kujawska et al., 2009; Winkler, Wirleitner, 
Schroecksnadel, Schennach, & Fuchs, 2005). A study by Wootton-Beard 
and colleagues suggests that a key mechanism by which beetroot juice 
exerts its AOX effects is by directly scavenging radical species (Wootton-
Beard, Moran, & Ryan, 2011). They found that two commercially available 
beetroot juices inhibited in vitro radical formation in the 2,2-diphenyl-1-
picrylhydrazyl (DPPH•) and (3-ethylbenzothiazoline-6-sulfonicacid) ABTS• 
assays by 100% and 92%, respectively. Importantly, when these assays 
were repeated, but in conditions designed to simulate the human digestive 
process, the juices still retained ≥55% of their pre-digestion radical 
scavenging capacity. Furthermore, the AOX capacity of both drinks, as 
measured by ferric-ion reducing antioxidant power (FRAP), was higher than 
the other 22 vegetable juice drinks under investigation. In another study 
(Wootton-Beard & Ryan, 2011), they showed that the FRAP of BTJ actually 
increases following simulated digestion. This could be the consequence of 
several compounds being structurally altered to secondary metabolites that 
possess AOX functions (Wootton-Beard et al., 2011; Wootton-Beard & Ryan, 
2011). Further work from this group has shown that the AOX capacity of BTJ 
is comparable to or higher than a variety of fruit and vegetable juices (see 
Figure 3 and Figure 4) (Ryan & Prescott, 2010; Wootton-Beard et al., 2011). 
Interestingly, the AOX capacity of BTJ in both the DPPH• and FRAP assays 
was far greater than more well-known vegetable juices, such as tomato and 
carrot, and fruit juices, such as orange and pineapple, with only pomegranate 
juice displaying a higher AOX capacity in the FRAP assay. 
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Figure 3 - A comparison of the 2,2-diphenyl-1-picrylhydrazyl (DPPH•) 
inhibiting capacity (%) exhibited by 10 popular fruit and vegetable beverages 
available in the UK (values based on data from Ryan & Prescott, 2010; 
Wootton-Beard et al., 2011). 
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Figure 4 - The ferric-ion reducing antioxidant power (FRAP) of 10 
commercially available fruit and vegetable beverages post a simulated in 
vitro model of human digestion (values based on data from Ryan & Prescott, 
2010; Wootton-Beard et al., 2011).  
In addition to being a source of AOXs in vitro, a growing body of evidence 
using animal models illustrates that beetroot exhibits radical scavenging 
ability in vivo (see Table 2). In a recent study (Vulic et al., 2014), rats were 
provided with 1–3 mL∙kg∙bm−1 of a beetroot pomace extract for 7 days prior 
to being exposed to 2 mL∙kg∙bm−1 of carbon-tetrachloride (CCl4), a well-
established carcinogen and RONS generator. After CCI4 administration, liver 
homogenate was removed from rats pre-treated with the beetroot extracts 
and those acting as controls (i.e., CCl4 only). Rats treated with beetroot 
extracts expressed significantly lower levels of lipid peroxidation measured 
as TBARS. Furthermore, the beetroot extracts appeared to maintain 
endogenous AOX activity (reduced glutathione, glutathione peroxidase and 
catalase enzymes) at normal cellular concentrations following the oxidative 
insult. This led the authors to speculate that in response to in vivo cellular 
attack, beetroot may exhibit indirect AOX effects that act to up regulate AOX 
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defence mechanisms (Vulic et al., 2014). Similar AOX effects have also been 
reported with studies using BTJ. Providing rat’s BTJ (8 mL∙kg∙bm∙day−1) for 
28 days was shown to attenuate lipid peroxidation, protein oxidation and 
DNA damage following xenobiotic induced liver injury (Kujawska et al., 
2009). In a more recent study, rats were fed BTJ (8 mL∙kg∙bm∙day−1 for 28 
days) and treated with the carcinogen 7,12-dimethylbenz[a]anthracene 
(DMBA) on day 27 and 28 of the BTJ feeding period (Szaefer, Krajka-
Kuzniak, Ignatowicz, Adamska, & Baer-Dubowska, 2014). Several markers 
of liver damage and inflammation were significantly increased following the 
DMBA treatment; however, these were markedly reduced in the rats pre-
treated with BTJ compared to the control group that received water only 
(Table 2). There were no differences in DNA damage between the groups. 
Intriguingly, rats given BTJ only, as in not treated with DMBA, exhibited 
increased activity of phase II detoxifying enzymes (GST and NQO1), which 
play an important role in endogenous AOX defence. The enhanced 
endogenous AOX activity in vivo, by beetroot is a consistent finding in the 
literature (see Table 2). According to recent in vitro data, such effects might 
be related, in part, to betanin and its effect on signalling pathways that 
mediate the transcription of AOX genes. Esatbeyoglu et al. (2014) found that 
betanin (extracted from beetroot) dose dependently (5–15 μm) increased the 
activity of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), a transcription 
factor that activates a gene promoter sequence: the antioxidant response 
element (ARE), responsible for the transcription of several endogenous AOX 
enzymes (Esatbeyoglu et al., 2014; Nguyen, Nioi, & Pickett, 2009; Satoh, 
McKercher, & Lipton, 2013). Krajka-Kuźniak, Paluszczak, Szaefer, & Baer-
Dubowska, (2013) presented similar findings, showing that betanin (2, 10 
and 20 μm concentration) activates the Nrf2-ARE binding sequence in non-
tumor human hepatic cell lines. Furthermore, this led to increased activity 
and mRNA expression of several phase II detoxifying enzymes, including 
glutathione S-transferases and NAD(P)H:quinone oxidoreductase, which 
play important roles in host defence against xenobiotics. This raises the 
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possibility that beetroot’s AOX potential is not limited to just scavenging and 
suppressing RONS, but includes the ability to reinforce the endogenous AOX 
network. However, whether such effects translate in vivo, particularly in 
humans, is yet to be investigated. Given these findings, it should also be 
considered that other compounds in beetroot (and their downstream 
metabolites upon ingestion) possess similar effects to betanin on 
transcriptional activity. Thus, in vivo, these compounds and metabolites 
could work synergistically to activate the Nrf2-ARE pathway, which, in turn, 
mediates an increase in endogenous AOX activity, that is independent of 
their radical scavenging effects.  
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Table 2 - Overview of studies investigating the effects of beetroot and its derivatives on oxidative stress and inflammation.  
Authors Cohort under 
investigation 
Dosage  AOX capacity of 
treatment 
    Duration  Toxic inducing protocol   Inflammation  Oxidative stress Enzymatic 
AOX  
activity  
(Kujaws
-ka et 
al., 
2009) 
48 male 
wistar rats  
Beetroot juice  
delivered by gavage  
(8 ml∙kg∙bm∙day⎺1 ;≈1.92 
ml∙day⎺1) 
23.5 𝜇mol/L 
Trolox 
equivalents∙ml⎺1 
28 days Intraperitoneal 
injection of CCl4 
(2 ml∙kg∙bm⎺1) or 
NDEA (150 
ml∙kg∙bm⎺1) 
  
N/A TBARS↓ 
PC ↓ 
DNA damage ↓ 
SOD ↑ 
GPX ↑ 
CAT ↑ 
GR ↑ 
(Krajka-
Kuźniak 
et al., 
2013) 
80 male ICR 
mice 
Betalains from beetroot 
delivered orally  
(0, 5, 20 and 80 
mg∙kg∙bm∙day⎺1 -; ≈0 - 1.44 
mg∙day⎺1) 
N/A 30 days Exposed to cobalt-60-
γ-gamma radiation 
(6.0 Gy, 1.5 Gy min⎺1)  
N/A MDA ↓ 
  
SOD ↑    
CAT ↑ 
GSH ↑    
(Lu et 
al., 
2009)  
24 male 
wistar rats 
Beetroot juice  
delivered by gavage 
(8 ml∙kg∙bm∙day⎺1) 
N/A 28 days Intraperitoneal 
injection of NDEA  
(150 ml∙kg∙bm⎺1)  
LDH ↓ 
AST↓ 
ALT↓ 
DNA damage ↓ 
 
GST ↑ 
(Pietrzk
-owski 
et al., 
2010) 
 
10 
osteoarthritic 
patients  
Capsules made from 
beetroot extract; 
delivered orally 
(70-200 mg∙day⎺1) 
N/A 10 days N/A TNF-α ↓ 
IL-6 ↓ 
RANTES ↓ 
GRO-α ↓ 
AOPP ↓  
(Vulić et 
al., 
2014) 
48 albino 
wistar rats  
Beetroot pomace extract 
delivered intraperitoneally 
(1–3 ml∙kg∙bm∙day⎺1 ;≈ 0.2-
0.6 ml∙day⎺1) 
N/A 7 days Intraperitoneal 
injection of CCl4  
(2 ml∙kg∙bm⎺1) 
N/A MDA ↓ GSH ↑ 
GSHPx ↑ 
GR ↑  
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Authors Cohort under 
investigation 
Dosage  AOX capacity of 
treatment 
Duration  Toxic inducing protocol   Inflammation  Oxidative stress Enzymatic  
AOX 
 activity  
(Krajka-
Kuźniak 
et al., 
2012) 
24 albino 
wistar rats 
Extracts of fresh beetroot 
delivered orally  
(250 and 500 
mg∙kg∙bm∙day⎺1; ≈45 – 90 
mg∙day⎺1) 
90.1% radical 
inhibition in the 
DPPH• assay 
(500 𝜇g∙ml⎺1) 
28 days Intraperitoneal injection 
of gentamicin  
(8 mg∙kg∙bm⎺¹ for 8 
days) 
IL-6 ↓ 
TNF-α ↓ 
MPO ↓ 
NF-𝜅B ↓ 
MDA ↓ 
  
CAT ↑ 
NP-SH ↑ 
    
(Szaefer 
et al., 
2014) 
24 female 
sprague–
dawley rats  
Beetroot juice delivered by 
gavage 
(8 ml∙kg∙bm∙day⎺¹ ; ≈1.92 
ml∙day⎺1) 
N/A 28 days Intraperitoneal injection 
of DMBA  
(10 mg∙kg∙bm⎺1 for 2 
days) 
LDH ↓ 
ALT↓ 
N/A GST ↑ 
NQO1 ↑ 
NDEA, N-nitrosodiethylamine; GST, glutathione S-transferase; RANTES, regulated upon activation normal T cell growth; GRO-α, regulated 
oncogene-alpha; CCl4 carbon tetrachloride; GSH, reduced glutathione; GSHPx, glutathione peroxidase; GR, glutathione reductase; GPX, glutathione 
peroxidase; TNF-α, tumour necrosis factor-alpha; TBARS, thiobarbituric acid reactive species; PC, protein carbonyls; SOD, superoxide dismutase; 
ICR, Imprinting Control Region; MDA, Malondialdehyde; CAT, catalase; AOPP, advanced oxidation protein products; IL-6, interleukin-6. Gy, gray 
unit; LDH, lactate dehydrogenase; ALT, alanine aminotransferase; AST,aspartate aminotransferase; MPO, myeloperoxidase. NF-𝜅B, nuclear factor 
kappa B; NP-SH, non protein sulfhydryl; DMBA, 7,12-dimethylbenz[a]anthracene; NQO1, NAD(P)H dehydrogenase [quinone] 1.  
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2.7.4 Effects of beetroot on inflammation  
Betalains and beetroot extracts have emerged as potent anti-inflammatory 
agents. At least part of their anti-inflammatory effects seems to be mediated 
by interfering with pro-inflammatory signalling cascades. The most important 
of these is the NF-κB cascade, which, as discussed in a previous section, 
directly activates and transcribes most gene targets that regulate and amplify 
the inflammatory response (Baker et al., 2011). Consequently, NF-κB activity 
plays a central role in the inflammatory processes associated with chronic 
disease (Baker et al., 2011) and strenuous physical activity (Gomez-Cabrera 
et al., 2005; Xin et al., 2012). In a recent study (El Gamal et al., 2014), NF- 
κB DNA-binding activity was dose-dependently attenuated in nephrotoxic 
rats administered a beetroot extract for 28 days (250 mg or 500 mg∙kg∙bm−1). 
Furthermore, kidney homogenates from the beetroot treated rats had lower 
inflammation (TNF-α, IL-6 and MPO) and reduced signs of oxidative damage 
(MDA), which could be directly related to the blunting of the NF-κB pathway. 
These effects are likely to be mediated, at least in part, by the betalains 
present in beetroot; recent evidence shows that betanin treatment (25 and 
100 mg∙kg∙bm−1 for 5 days) significantly inhibits NF-κB DNA-binding activity 
in rats induced with acute renal damage (Tan, Wang, Bai,Yang, & Han, 
2015). Betalains have also been shown to markedly supress 
cyclooxygenase-2 (COX-2) expression in vitro, which is an important 
precursor molecule for prostaglandins (Reddy et al., 2005; Vidal et al., 2014; 
Zielińska-Przyjemska et al., 2009). Reddy et al. (2005), who found that 
betanin (IC50 value 100 μg·mL
−1) inhibited COX-2 enzyme activity by 97%, 
first illustrated this. It is interesting to note that although a slightly higher 
concentration of betanin was required, its COX-2 inhibitory effects were 
comparable or greater than several phenolic compounds (cyanidin-3-O-
glucoside, lycopene, chlorophyll, b-carotene, and bixin) and anti-
inflammatory drugs (Ibuprofen, Vioxx and Celebrex).  
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A recent study from Vidal et al. (2014) provided further support for the anti-
inflammatory effects of betalains. As well as supressing COX-2 synthesis, 
betanidin, extracted from beetroot, dose dependently inhibited (to 9% of 
control activity), lipoxygenase (LOX), a catalytic enzyme vital for the 
synthesis of pro-inflammatory leukotriene molecules (Ricciotti, & FitzGerald, 
2011). Interestingly, these inhibitory effects appeared to be mediated by a 
blocking action on membrane binding activity, indicating that betalains target 
cell signalling pathways at the molecular level, acting in a similar fashion to 
selective COX-2 inhibitor drugs (Ricciotti, & FitzGerald, 2011; Vidal et al., 
2014). 
A few recent studies have indicated that nitrate, via its reduction to NOx, 
might exhibit anti-inflammatory effects. This was demonstrated in a study by 
Jädert and colleagues (2012) that showed administering mice with sodium 
nitrate for 7 days attenuated the increase in inflammatory mediators (MPO 
and P-selectin) following small intestinal injury. The principal mechanism by 
which nitrate-induced NOx generation exerts anti-inflammatory effects is 
believed to be through suppressing phagocytosis, which has the beneficial 
effect of reducing the number of pro-inflammatory mediators that invade the 
cell and perpetuate cell dysfunction (Jädert et al., 2012; Jädert, Phillipson, 
Holm, Lundberg, & Borniquel, 2014). This role for NOx in modulating 
leukocyte activity was evidenced by findings from Rigamonti et al. (2013). 
They found that mice deficient in iNOS, a precursor for NOx in muscle, had a 
higher infiltration of phagocytic cells in the days after acute skeletal muscle 
injury compared to non-deficient controls, leading them to speculate that 
NOx must have a regulatory role in inflammation.  
A recent study linked the anti-inflammatory effect of nitrate to improved 
muscle function. Justice et al. (2015) found that sodium nitrate treatment 
reduced the expression of several inflammatory cytokines in the skeletal 
muscle of older mice, effects that were associated with improved grip 
strength and run time to exhaustion over an 8 week period (Justice et al., 
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2015). Similarly, another study suggested that augmenting NOx availability 
attenuates muscle damage leading to improved function. In this study, rats 
were given an acute dose of L-arginine, a NOx donor, or a control prior to 
downhill running. Twenty four h after the exercise bout, intracellular protein 
degradation and sarcolemma damage in the soleus muscles was attenuated 
in the L-arginine treated groups and muscle function, as measured by 
running capacity, was improved (+12% vs. control) (Lomonosova, 
Shenkman, Kalamkarov, Kostrominova, & Nemirovskaya, 2015). The authors 
suggested that these effects could have been due to a NOx mediated 
reduction in local proteolytic activity and inflammation.  
The evidence presented above suggests that exogenous NOx donors, like 
BTJ for example, could be helpful for protecting against the potentially 
harmful effects that acute inflammation could have on cell function and 
integrity. As demonstrated in the study by Lomonosova and colleagues 
(2015), this could have important implications for dampening inflammatory 
mediated muscle damage, i.e., the secondary damage response to EIMD. 
With that said, it is important to note that whether the aforementioned effects 
in animals translates to humans, or are evident with nitrate-rich food 
supplements has not yet been investigated.  
There are a limited number of studies demonstrating that beetroot 
supplements have anti-inflammatory effects in vivo. Pietrzkowski et al. (2010) 
showed that therapeutic administration of betalain-rich oral capsules made 
from beetroot extracts alleviated inflammation and pain in osteoarthritic 
patients. After 10 days of supplementation (100, 70 or 35 mg per day), the 
pro-inflammatory cytokines TNF-α and IL-6 had decreased from baseline by 
8.3%–35.0% and 22.0%–28.3%, respectively. The activity of two 
chemokines; regulated oncogene-alpha (GRO-alpha) and regulated upon 
activation normal T cell growth (RANTES) were also markedly inhibited by 
the beetroot treatment. Furthermore, the moderated inflammatory response 
coincided with a significant reduction in self-reported pain on the McGill Pain 
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Questionnaire. Krajka-Kuźniak, Szaefer, Ignatowicz, Adamska, & Baer-
Dubowska, (2012) examined the protective effect of BTJ (8 mL∙kg∙bm∙day−1 
for 28 days) on markers of liver injury and inflammation induced by the toxic 
chemical N-nitrosodiethylamine (NDEA) in rats. Compared to an untreated 
control, the BTJ conferred significant hepatic protection against a range of 
inflammatory markers induced by NDEA administration; LDH, AST, gamma 
glutamyl transferase (GGT) and ALT were all shown to be markedly 
attenuated. In a more recent study, El Gamal et al. (2014) fed rats either 
water (control) or oral doses of beetroot ethanol extract (250 or 500 
mg∙kg∙bm∙day−1) for 28 days; from day 20–28 they were treated with the 
nephrotoxic drug gentamicin (85 mg∙kg∙bm∙day−1). After 28 days, kidney 
homogenates were removed from both groups and analysed for several 
markers of renal damage. They found that the beetroot-treated rats had 
significantly lower concentrations of several pro-inflammatory mediators, 
including IL-6, TNF-α, MPO (indicating neutrophil infiltration) and the 
transcription factor NF-κB. They also found reduced oxidative stress (MDA, 
uric acid) and increased endogenous AOX activity (CAT, NP-SH) in the 
homogenates removed from the rats pre-treated with beetroot. 
The above summary provides evidence that beetroot is an excellent source 
of AOX and anti-inflammatory compounds. Although there is still a lack of 
well-conducted human trials, which precludes any definitive conclusions as 
to its potential benefits, there is enough evidence to suggest that beetroot is 
capable of protecting cellular components from inflammatory and/or oxidant-
mediated damage. This makes the expectation tenable that a beetroot 
supplement could be exploited to counter secondary muscle damage after 
strenuous exercise and, as a result, serve as an efficacious means of 
enhancing exercise recovery.  
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2.8 Conclusion 
Eccentric-heavy exercise has been shown to cause a variety of 
morphological changes, including sarcolemma rupture, z-line streaming and 
ECM disruption. These changes evoke a transient but marked inflammatory 
response that can be observed in the muscle cell, ECM, and circulation. The 
inflammatory response encompasses an array of complex biochemical and 
physiological alterations that may evoke secondary muscle damage.   
Muscle damage is typically observed as an increased appearance of 
intramuscular proteins in the blood, muscle soreness and profound deficits in 
muscle function. In an attempt to alleviate muscle damage and enhance 
recovery, athletes and exercise enthusiasts often consume nutritional 
supplements before and after training and/or competitive events. There are 
several sporting scenarios when nutrition based recovery supplements might 
be particularly beneficial for athletes, including during congested fixture and 
intensified training periods, or when immune function might be depressed or 
there is a risk of nutrient deficiency. With regards to EIMD, an emerging topic 
of interest is the potential benefits of functional food supplements because 
many are rich in AOX and anti-inflammatory phytonutrients. Indeed, the 
evidence to date seems to indicate that functional foods may be of benefit for 
exercise recovery when taken before and/or immediately post-exercise, 
ostensibly due to their ability to dampen the secondary damage response.  
Beetroot is a functional food that has received enormous attention in recent 
years for its potential benefits for both general health and athletic 
performance. Recent studies have provided evidence that beetroot and its 
constituent’s may afford beneficial effects for disorders characterized by 
inflammation, oxidative stress, and aberrant vascular function. Given the 
aetiology and progression of muscle damage, such effects could be exploited 
for enhancing exercise recovery. Despite this, no study to date has examined 
the influence of beetroot on EIMD and, thus, established whether it might be 
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useful as both a pre-exercise and post-exercise ergogenic aid. As such, the 
primary aim of this thesis is to investigate the efficacy of BTJ as a recovery 
intervention following muscle damaging exercise.  
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3 General methods 
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3.1 General methods 
The methods described below are those that were employed in the majority 
of investigations in this thesis; therefore, descriptions of measures that were 
unique to individual studies are not included but can be found in the methods 
section of the relevant Chapter. Institutional ethical approval was granted 
prior to data collection for each investigation (see Appendix 2 for an 
example), and written informed consent was sought after a verbal and written 
briefing of the study procedures (see Appendix 1 for an example of informed 
consent).  
3.2 Participant recruitment  
In all but two investigations (Chapters 7 and 8) participants were recruited 
from a pool of healthy, male University students between the ages of 18-40. 
In Chapters 4, 5, 6 and 9, participants were required to be at least 
recreationally active, which for the purpose of these investigations was 
defined as completing some form of planned exercise at least 2 days per 
week. The inclusion criteria for Chapter 7 required participants to be regularly 
playing team-sports, at least at an amateur level or University standard. In 
Chapter 8, participants were recruited from a pool of marathon runners who 
expressed an interest in taking part in the Druridge Bay marathon.  
In all studies, participants were recruited via an expression of interest email 
or, if applicable, through poster advertisements placed around the University 
campus or on the student blackboard website. All participants completed a 
health-screening questionnaire to assess eligibility prior to study entry (see 
Appendix 3 for an example). Participants were excluded if they had any 
known food allergy, routinely used anti-inflammatory medications, were 
suffering from a musculoskeletal injury, or had previous history of renal, 
gastrointestinal or cardiovascular complications or any other contraindication 
to the study procedures. The use of any treatments (i.e., massage, cold 
water therapy, compression garments), nutritional supplements (i.e., whey 
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protein, vitamin C), or anti-inflammatory drugs (NSAIDS) proposed to 
enhance recovery were prohibited for the duration of each study.  
3.3 Dietary and exercise control  
With regards to exercise, in all studies (with the exception of Chapter 4), 
participants were instructed to limit their physical activity in the 48 hours prior 
to and for the duration of the data collection period (other than study 
requirements).  
In Chapters 4, 5 and 6, participants were required to follow a low phenolic, 
betalainic and nitrate diet. This included avoiding all vegetables, cured meats, 
fruits and their juices, chocolate, wholegrain breads and grains, caffeinated 
beverages including all varieties of tea, coffee and alcohol. These dietary 
restrictions began 2 days before the main trials and continued until the end of 
data collection. Participants were also instructed to eat the same or similar 
meals throughout this period. The principal aim of these restrictions was to 
try and eliminate the potential influence consuming phytonutrients from food 
sources other than the treatment under investigation might have on the 
outcome measures. Given these were the first studies to investigate BTJ in 
this manner, it was felt that it was important, from a proof of concept point of 
view, to establish that BTJ had the potential to be used as a recovery 
intervention. These restrictions have been employed in other studies to more 
accurately establish the bioavailability of functional foods (Keane et al., 2016), 
as well as their effects on EIMD (Bell et al., 2014; Bell et al., 2015). As in 
these aforementioned studies, all participants were given food diaries (see 
Appendix 4 for an example) to record their dietary intake so that compliance 
with the imposed dietary restrictions could be checked.   
In contrast, in Chapters 7, 8 and 9, no dietary restrictions were imposed but 
participants were still required to record their dietary intake (24 h prior to and 
until the end of data collection) (see Appendix 5 for example). This change in 
design was to increase the ecological validity of the findings in this thesis, 
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and make them more applicable to real-world scenarios. In these latter 
Chapters (7-9), food diaries were analysed for macronutrient content using 
Nutritics dietary analysis software (Nutritics LTD, Dublin, Ireland). This was 
to check that the nutritional compositon of dietary intakes were similar 
between different treatment groups and therefore did not have a large impact 
on the study results. Finally, in all studies, participants were asked to avoid 
using antibacterial mouthwash throughout data collection due its potential 
interference with nitrate-nitrite conversion (Webb et al., 2008).  
3.4 Nutritional supplements 
The nutritional compositions of the supplements used in the studies in this 
thesis are detailed in Table 3. The BTJ supplement was comprised of 99% 
beet juice concentrate and 1% lemon juice, and was available commercially 
under the brand Love Beets Super Tasty Beetroot Juice (Gs Fresh Ltd, 
Cambridgeshire, UK). In Chapter 5, the supplement that contained a lower 
dose of beetroot (LBT) juice contained the same nutritional composition as 
the BTJ but provided half the dose (HBT; 125 ml). The PLA used throughout 
this thesis consisted of a low fruit (<1%) squash (Kia Ora, Coca Cola 
Enterprises, Uxbridge, UK) with negligible phytochemical and nitrate content. 
Both the PLA and L-BT were fortified with maltodextrin (Myprotein, 
Manchester, UK), flavourless protein powder (Arla Foods, Amba, Denmark) 
and water, to match the H-BT drink as closely as possible for volume and 
nutrient content. The BTJ (batch used in Chapter 4-6) was also analysed for 
AOX activity, phenolic and betalainic content. These analyses were also 
performed with the PLA; details of these results can be found in Table 3.  
Double-blinding was achieved by providing the beverages in identically 
masked bottles, only distinguished by a single letter code, which was 
assigned by an individual not directly involved in the research. Due to the 
distinct taste of BTJ, the PLA was not matched for taste and texture, only 
energy content. While others have used a nitrate depleted BTJ as a PLA so 
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that the taste is the same, this is not a true PLA because it will still contain 
many other bioactive constituents (i.e., phenolics and betalains) that, as 
outlined in the introduction, could favourably affect exercise recovery and 
performance. Thus, a nitrate depleted BTJ was not deemed suitable for the 
studies in this thesis. Although it could have been used in Chapter 9 in place 
of the SN drink, it could not be sourced from the manufacturer at the time of 
the study. Instead, other controls were in place to ensure double-blinding. 
Firstly, the independent groups design used in Chapters 5-9 ensured that 
participants only consumed 1 of the supplements provided and were 
therefore unaware of any differences between the supplements under 
investigation. Furthermore, the participants were not informed of what the 
specific drinks being investigated were or the study aims. The only 
information they received was that they were AOX-containing drinks used for 
exercise recovery. This ensured that the participants did not know the overall 
aim of the study. It was hoped that this would eliminate any bias based on 
pre-conceptions of BTJs potential ergogenic effects from performance 
studies.  
Table 3 - Energy and macronutrient content of the 3 main supplements used 
throughout this thesis.  
Treatment BTJ L-BT PLA 
Energy (Kcals) 81 79 77 
Volume (ml) 250 250 250 
Carbohydrate (g) 16.4 16.4 16.4 
Protein (g) 2.8 2.8 2.8 
Fat (g) 0.4 0.2 Trace 
Nitrate (mg) ~250 ~125 N/A 
Amounts are per bottle. BTJ = Beetroot juice (also referred to as H-BT in 
Chapter 5 and 6); L-BT = low beetroot juice; placebo = PLA.  
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3.5 Muscle damaging exercise  
The same exercise protocol was used to induce muscle damage in Chapters 
5, 6 and 9. The protocol consisted of 100 drop-jumps from a 0.6 m high steel 
box; each jump was separated by a 10 s interval and each 20 jumps by a 2 
min rest period (5 sets of 20 repetitions). Participants were instructed to drop 
off the box and land on two feet, immediately descending to a ~90º knee 
angle followed by a maximal effort vertical jump. Participants were 
demonstrated this technique on several occasions before performing the 
bout and, if required, given corrective feedback throughout. Each participant 
received strong verbal encouragement to ensure maximal effort was 
maintained. This protocol was selected because it has previously been 
demonstrated to induce significant muscle damage (i.e., increased muscle 
soreness, loss of muscle function) in the lower limbs (Howatson et al. 2009; 
Howatson et al., 2012). Details regarding the other muscle-damaging 
protocols used in this thesis can be found in the relevant Chapters.  
3.6 Muscle function  
Maximal isometric voluntary contraction (MIVC) and CMJ were used to test 
muscle function in Chapters 5-9. Reactive strength index (RSI) was used as 
an additional marker of dynamic muscle function in Chapter 7, because of its 
applicability to the participant cohort under investigation (team-sports 
players); the methods used for this measure can be found in the relevant 
chapter.  
3.6.1 Maximal isometric voluntary contraction  
MIVC was measured on the right knee extensors using a portable strain 
gauge (MIE Medical Research Ltd., Leeds, UK). Participants were seated up 
right on a purpose built chair and had a strain gauge attached to a bespoke 
perspex manipulandum, which was fitted to their right ankle, just above the 
malleoli. Participants were required to exert maximal force by extension of 
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the knee joint for 3 seconds. All efforts were performed at a joint angle 
equivalent to 90° knee flexion, as assessed by a goniometer, and were 
recorded in Newtons (N). Each participant performed 3 contractions 
separated by 60 s of passive (seated) recovery, with the peak value used for 
analysis. This procedure had been employed in several previous 
investigations to quantify MIVC (Howatson et al., 2009; Howatson et al., 
2012). A reliability trial conducted before data collection revealed that the 
inter-day coefficient of variation (CV) for this protocol was <1.5%.   
3.6.2 Counter movement jump 
CMJ performance was measured from flight time using an optical 
measurement system (Optojump next, Balzano, Italy), which is considered a 
valid and reliable tool to evaluate CMJ performance (Glatthorn et al., 2011). 
To perform the jumps, participants stood with feet shoulder width apart and, 
when prompted, rapidly descended into a squat (to a 90º knee angle) and 
jumped vertically with maximum force. Participants were instructed to land in 
the same position as take off and keep their hands on their hips for the full 
movement to minimise any influence of arm swing on performance. 
Participants performed 3 maximal efforts, interspersed by 30 seconds 
passive (standing) recovery with the mean height of the 3 jumps used for 
analysis. Inter-jump rest times were kept to 30 s because pilot testing 
revealed that this was sufficient time to allow for full recovery. The inter-day 
CV for this protocol was calculated as <2.5%. 
3.1.6 Muscle soreness  
In Chapters 5, 6, 7 and 9, muscle soreness was measured as PPT. Due to 
practical constraints, PPT could not be measured in Chapter 8; therefore, a 
VAS was used to assess muscle soreness (details can be found in the 
relevant Chapter).  
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3.6.3 Pressure pain threshold 
PPT was measured with the use of a handheld algometer (Wagner 
Instruments, Greenwich CT, US). In all studies, measurements were 
performed while the participant lay supine. A cylindrical flat-headed probe (1 
cm diameter) was used to apply pressure (at a constant rate of 10 N cm−2 
s−1) on the muscle belly until the participant verbally signified they felt pain or 
discomfort; this point was recorded as PPT in N2. Muscle sites were pre-
marked with a permanent marker pen to ensure consistency for each visit. 
Muscle sites were vastus laterialis; mid-way between the superior aspect of 
the greater trochanter and head of the tibia, rectus femoris; mid-way between 
the anterior patella and inguinal fold, and gastrocnemius; most medial aspect 
of the calf at relaxed maximum girth. The average of two values from each 
site was used for analysis, unless the difference between the two values was 
≥10 N2 apart, in which case a third recording was taken, and the average of 
the two closest values used for analysis. To increase the reliability of the 
measurement, measures were taken by the same individual across days 
(Nussbaum & Downes, 1998). The inter-day CV for this procedure was 
calculated as <8% (average CV for the 3 sites measured).  
3.7 Blood sampling and analysis 
In all studies, blood samples were obtained from a branch of the basilica vein 
at the antecubital fossa. Blood was drawn from a cannula in Chapter 4, with 
all other studies using the venepuncture technique. In Chapters 4, 5 and 6, 
samples were collected into 2 × 10 ml vacutainer tubes treated with di-
potassium ethylene diamine tetra-acetic acid (EDTA). In Chapters 7, 8 and 9, 
1 × EDTA (10 ml) and 1 × serum (10 ml) tubes were collected. All samples 
were centrifuged at 3000 g (4˚) for 10 min; EDTA tubes were centrifuged 
immediately, while serum tubes were left to clot for 30-45 min beforehand. In 
all studies, plasma and serum supernatant were aspirated into a series of 
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aliquots and stored at −80º for later analysis. In Chapter 8, an additional 4 ml 
EDTA tube was collected for haematological analysis at a local hospital.  
If a specific blood marker was measured in ≥2 Chapters, the analytical 
methods used have been described below. However, for markers exclusive 
to each Chapter a description of the analytical procedures involved can be 
found in the relevant methods section.  
3.7.1 Creatine kinase  
In Chapters 5 and 6, plasma CK concentrations were determined 
spectrophotometrically using an automated system (Roche Modular, Roche 
Diagnostics, UK). In Chapters 7-9 CK was determined from serum instead of 
plasma but the same equipment and procedure was used. Normal reference 
values for this assay in males is 10-190 I∙UL-1 and the CV for this analysis is 
typically <2%. 
3.7.2 High sensitivity C-reactive protein 
Serum concentrations of high sensitivity C-reactive protein (hs-CRP) were 
measured in Chapters 7-9. Analysis was performed with an automated 
system (Cobas 8000 c702, Roche Diagnostics, UK). The CV for hs-CRP 
analysis using this system is calculated as <5%.  
3.7.3 NOx 
NOx bioavailability was determined from nitrate and nitrite concentrations 
using a standard assay kit (R&D Systems, Minneapolis, Minnesota). Analysis 
was performed using plasma in Chapter 4 and serum in Chapter 9. 
Irrespective of the biological tissue, the assay quantifies NOx by measuring 
total nitrite after nitrate has been enzymatically reduced to nitrite via nitrate 
reductase using the griess reaction. The inter and intra assay CV for these 
analyses were <15%.  
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4 The phytochemical content and antioxidant 
capacity of beetroot juice, and the plasma 
bioavailability of nitrate and betanin  
Publication arising from this Chapter: Clifford, T., Constantinou, C. M., Keane, K. 
M., West, D. J., Howatson, G., & Stevenson, E. J. (2016). The plasma bioavailability 
of nitrate and betanin from Beta vulgaris rubra in humans. European Journal of 
Nutrition, 1-10. 
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4.1 Introduction  
In recent years there has been a growing interest in beetroot with a particular 
focus on its potential health benefits (for review, see Ninfali & Angelino, 
2013). The interest in beetroot has been largely driven by its nitrate content, 
which is proposed to be ~1,459 mg∙kg-1 DW (Lidder & Webb, 2013). Dietary 
nitrate may confer beneficial health effects via its sequential reduction to 
nitrite and NOx, a pleiotropic molecule that plays a key role in the regulation 
of vascular homeostasis, immune function and metabolism (Lundberg et al., 
2008; Weitzberg & Lundberg, 2013). There are now several reports that 
acute consumption of beetroot can stimulate endogenous NOx production 
and evoke positive changes in endothelial function, blood pressure and 
metabolism (Joris & Mensink, 2013; Siervo, Lara, Ogbonmwan, & Mathers, 
2013; Webb et al., 2008). Consequently, beetroot is currently purported as a 
health promoting food that might be useful for reducing the risk of developing 
cardiovascular diseases (i.e., hypertension, stroke) and immune disorders 
(i.e., inflammatory bowel disease) (Jädert et al., 2012; Kapil et al., 2014; 
Lidder & Webb, 2013).  
As discussed in Chapter 2.7, beetroot contains several other constituents 
other than nitrate that may have beneficial effects for health. As well as being 
a good source of dietary polyphenols, beetroot contains a group of betalaimic 
acid derivatives known as betalains (Esatbeyoglu et al., 2015). Betalains are 
water-soluble phytochemicals that have been shown to possess anti-
inflammatory, AOX and chemo-preventive activities (Esatbeyoglu et al., 
2015; Lechner et al., 2010; Ninfali & Angelino, 2013; Vidal et al., 2014). In 
recent years there has been a particular interest in the biochemical activity of 
betanin (betanidin 5-O-b-glucoside; chemical structure depicted by Figure 5), 
which is the most abundant betacyanin in beetroot (300-600 mg∙kg-1 
uncooked weight) (Esatbeyoglu et al., 2014; Esatbeyoglu et al., 2015; 
Georgiev et al., 2010; Pavlov et al., 2002). As a cationized compound, 
betanin is a highly effective scavenger of RONS (Esatbeyoglu et al., 2014; 
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Kanner et al., 2001). Betanin also possesses anti-inflammatory properties; 
betanin, and its aglycone, betanidin were shown to modulate LOX and COX 
activity in vitro, indicating that betanin might downregulate pro-inflammatory 
signalling (Vidal et al., 2014). These findings have led to interest in the role of 
beetroot in the protection against the potentially damaging effects of RONS 
and aberrant immune function (Kapadia et al., 2011; Kapadia et al., 2013).   
 
 
 
 
 
 
 
 
 
Figure 5 - Chemical structure of betanin (betanidin 5-o-b-glucoside). 
An increased awareness of beetroot’s potential physiological effects and 
health benefits, together with an increased demand for convenient health 
foods, has led to the development of a number of beetroot based juice 
products. Given the wide array of bioactive compounds present in beetroot, it 
is possible that regular (or acute) consumption of these juices could have 
favourable effects for health and wellbeing. However, in order to evaluate the 
potential usefulness of a commercially available BTJ in the promotion of 
general health or as a dietary supplement, information on both its 
phytochemical content and in vivo bioavailability in humans is required. 
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Dietary nitrate is believed to be highly bioavailable (van Velzen, Sips, 
Schothorst, Lambers, & Meulenbelt, 2008) and increases in the plasma have 
been observed following ingestion of BTJ (Joris & Mensink, 2013; Wylie et 
al., 2013). Betalains, in contrast, are thought to have much lower 
bioavailability (see section 2.7.2); however, no published studies have 
characterised the bioavailability of betalains in plasma from consuming 
commercially available BTJ.  
Consequently, before beginning to address the main aim of this thesis; 
whether a commercially available BTJ can attenuate EIMD, it was important 
to determine the phytochemical content of the BTJ to be used and also the 
bioavailability of some of its allegedly most bioactive constituents, nitrate and 
betanin. This information would help to provide a rationale for using BTJ as a 
recovery intervention for attenuating EIMD. Consequently, this study had two 
main objectives; 1) to establish the AOX capacity, polyphenol and betalain 
content of BTJ, and; 2) to determine the bioavailability of betanin, the major 
betalain in beetroot, and nitrate, a precursor for NOx activity, in human 
plasma after consuming BTJ.  
4.2 Methods  
4.2.1 Participants   
Ten healthy, non-smoking males (age 23 ± 3 yrs; height 1.82 ± 0.60 m; mass 
78.8 ± 6.7 kg) were recruited to participate in this study.  
4.2.2 Experimental design 
Participants were required to attend the laboratory on 2 occasions, separated 
by seven days. In the 48 h prior to the first trial, participants were given food 
diaries and instructed to follow a low phenolic, betalainic and nitrate diet (see 
Chapter 3.3 for details). They were instructed to replicate this diet as closely 
as possible in the 48 h before the remaining trial. For each trial, partcipants 
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attended the laboratory between the hours of 07:00 - 09:00 following a 12 h 
overnight fast and had a cannula inserted into a vein at the antecubital fossa. 
After a baseline blood sample, participants were given 1 of 2 treatments; BTJ 
(250 ml), or an isocaloric PLA (250 ml) in a randomized, crossover fashion. 
Further blood samples were drawn at 1, 2, 3, 5, and 8 h after ingesting the 
treatments to ascertain the kinetics of the compounds of interest (see Figure 
6 for schematic). Participants were not allowed to consume any food until 
testing was complete but were allowed water ad libitum; the volume of water 
consumed on the first trial was recorded and replicated in the subsequent 
trials.  
 
 
Figure 6 - Schematic outline of bioavailability study procedures. 
4.2.3 Blood sampling procedures 
For blood sampling procedures please refer to Chapter 3.7. 
4.2.4 Supplementation  
Information regarding the BTJ and PLA drinks can be found in Chapter 3.4.  
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4.2.5  AOX activity and phenolic content  
Mixtures of PLA and BTJ in the same solvent were used to determine their 
total phenolic content (TPC) and Trolox equivalent antioxidant capacity 
(TEAC). A modified 2,2-diphenyl-1-picrylhydrazyl (DPPH•) assay used for 
AOX activity measurements was adjusted for use in the present study 
(Brand-Williams, Cuvelier, & Berset, 1995). The DPPH• solution was 
prepared freshly before the analysis, by dissolving the DPPH• reagent (2.4 
mg) in 80% methanol (100 mL). Samples were further diluted in deionised 
water (1:10 or 1:100) and 10 µL of sample, 40 µL of deionised water, and 
200 µL of DPPH• solution were added into each well of the CELLSTAR 96 
well plate (Greiner Bio-One, Monroe, USA). Absorbance readings were taken 
at 515 nm, at 3 min intervals over a 30 min period at 37°C, using a BioTek 
Synergy HT Multi-Mode Microplate Reader (BioTek, Winooski, USA). A 
calibration curve using Trolox (0-500 µM, R2=0.99) was plotted. Final values 
are expressed as means of Trolox equivalents per milligram of sample ± SD 
for 6 replicants. 
TPC was measured using a modified Folin-Ciocalteu colorimetric method 
(Magalhães et al., 2009; Shahidi & Ho, 2007). Samples were diluted in 
deionised water (1:10 or 1:100) and 50 µL of the diluted extract. 50 µL of 
Folin-Ciocalteu reagent diluted in water (1:25) and 100 µL of 6% (w/v) 
sodium carbonate were then added into corresponding sample wells of a 96 
well plate. Absorbance readings were taken at 725 nm, at 5 min intervals, 
over a 30 min period at 25°C using a BioTek Synergy HT Multi-Mode 
Microplate Reader. A stock solution of gallic acid (5.9 mM) was prepared in 
aqueous methanol (80% (v/v)) and quantification was performed on the basis 
of a standard curve in the range 0-50 mg/mL (R2=0.99). The analysed 
samples were measured versus a blank sample. All values are expressed as 
means of gallic acid equivalents (GAE) per gram of sample ± SD for 6 
replicants.    
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4.2.6 Total betanin and betaxanthin content       
The content of betaxanthins and betacyanins in 1:10 juice solutions in 
aqueous McIlvaine buffer (pH 6.5) was determined at 480 nm and 550 nm 
with a UV–Vis spectrometer (Ultraspec 2000UV/Vis spectrophotometer, 
Pharmacia Biotech, Sweden), respectively according to the methods of Cai, 
Sun, & Corke, (1999) and Moßhammer, Stintzing, & Carle, (2005). Total 
betalains were quantified using the following equation:  betalains [mg/L] = (A 
× DF × MW × 1000)/(εx1), where A is the absorption value at the absorption 
maximum, DF the dilution factor, MW the molecular weights and 1 the path 
length (1 cm) of the cuvette. For quantification of betacyanins and 
betaxanthins, the MW and molar extinction coefficients (ε) of betanin 
(MW=550 g/mol; ε=60,000 L/mol cm; λ=538 nm) and indicaxanthin (MW=308 
g/mol; ε=48,000 L/mol cm; λ=480 nm) were applied, respectively. 
4.2.7 Betanin determination  
Betanin standard was purchased from Adooq Bioscience (California, US). 
Betanin determination of diluted BTJ samples (2.5 mg/mL in 1:1, 0.1% formic 
acid in water: 2% HCl in MeOH) was carried out on a Dionex UltiMate 3000 
RSLC HPLC System (Dionex, Camberly, UK) equipped with an UltiMate 
3000 RS pump, an UltiMate 3000 RS autosampler and a QExactive 
Quadrupole-Orbitrap Mass Spectrometer (Thermo Fisher Scientific, 
Waltham, USA). Electrospray ionization at negative ion mode was performed 
with a spray voltage of 2.00 kV and capillary temperature of 280°C. The total 
ion current (TIC) with a range of 100-1000 m/z and 70000 resolution was 
measured. The ion m/z 549 was used for quantification of betanin. Sample 
aliquots (3 µL) were injected on a Phenomenex Luna C18(2) (250 × 2.0 mm, 
5 um particle size) reverse-phase column thermostatically regulated at 40°C. 
The mobile phase consisted of water with 1% acetic acid (solvent A), and 
acetonitrile with 1% acetic acid (solvent B). After a 6-min equilibration with 
20% solvent B, the elution programme was as follows: 0-30 min, 10-100% B, 
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(0.2 mL/min) followed by a washing stage (100% B, 30-36 min, 0.2 mL/min) 
and re-equilibration at the initial conditions for 3 min. Betanin with a retention 
time of 2.56 min was quantified by external standard determination. 
4.2.8 Extraction of plasma for betanin determination  
Several attempts to extract betanin from plasma samples were performed: a) 
1 mL of plasma was mixed with 4 mL oxalic Acid (10 nM) and 0.1 mL HCl 
(12.6 M) in 15 mL falcon tubes and centrifuged at 826 × g for 5 min. The 
supernatant was absorbed on to a primed solid phase extraction cartridge 
(Waters Sep-Pak c17 plus short cartridge, 360 mg sorbent per cartridge, 55-
105 µm), washed with methanol + 0.2% trifluoroacetic acid (TFA) followed by 
2 × 5 mL of water.  The sample was eluted with 3 mL of MeOH + 0.2% TFA, 
dried under N2 at 45°C. Samples were then reconstituted in 400 µl of solvent 
F: 0.1% formic acid in water: 2% HCl in methanol and filtered through a 0.2 
µm polytetrafluoroethylene filter prior to HPLC and LC-MS analyses; b) 1 mL 
of plasma was extracted with 4 mL 1:1 acetonitrile:water for 10 min and 
centrifuged for 10 min at 3000 rpm. The supernatant was collected, 
evaporated to dryness, reconstituted in 1:1 acetonitrile: water and filtered in 
auto sampler vials. The above two methods analysed various samples at 
different time points using HPLC/UV/Vis/FLD and liquid chromatography and 
mass spectroscopy (LCMS) methodologies.   
4.2.9 Analysis of plasma NOx 
Plasma NOx bioavailability was determined from plasma nitrate and nitrite 
concentrations. Please refer to Chapter 3.7.3 for further details.   
4.2.10 Data analysis 
All data are presented as mean ± standard deviation (SD). A two-way, 
repeated measures analyses of variance (ANOVA) was used to test for 
between trial differences in plasma NOx concentrations; 2 trials (BTJ vs. 
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PLA) by 6 time points (baseline, 1, 2, 3, 5 and 8 h post ingestion). In the 
event of a significant interaction effect (trial*time) Fisher LSD post hoc 
analysis was performed to locate pair-wise differences. Statistical 
significance was set at P < 0.05 prior to analyses. All analysis was performed 
with IBM SPSS Statistics 20 for Windows (Surrey, UK). 
4.3 Results   
Inspection of food diaries indicated that participants complied with the 
imposed dietary restrictions and that their intakes did not significantly differ 
between trials. No adverse events were reported with any of the 
supplements.  
4.3.1 Betanin content and bioavailability  
Betanin was identified in the BTJ with LCMS analysis (Figure 7). Total 
betanin content for the BTJ is presented in Table 4. Based on these 
analyses, each bottle of BTJ (250 ml) contained ~194 mg of betanin, No 
betanin was detected in the PLA used in this study. Betanin could also not be 
detected in the plasma samples obtained after BTJ and PLA consumption 
(data not shown).  
4.3.2 Antioxidant capacity, phenolic and betalain content  
Antioxidant capacity, phenolic content, total betacyanin and total betaxanthin 
content is presented in Table 4. According to these data, each serving of BTJ  
(250 ml) had a TEAC of ~3 mmol/L and contained ~405 mg GAE equivalents 
of phenolic compounds, ~17 mg of betacyanins and ~10 mg of betaxanthins. 
The PLA (250 ml) contained a small number of phenolic compounds (~43 
mg); however, betalains could not be detected and the TEAC was low (<0.5 
mmol/L).
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AOX capacity, phenolic content, total betalain and total betaxanthin content 
for the BTJ and PLA are presented in Error! Reference source not found.. 
According to this data, each serving of beetroot juice (250 ml) had a TEAC of 
~3 mmol/l and contained ~405 mg GAE equivalents of phenolic compounds, 
~17 mg of betacyanins and ~10 mg of betaxanthins. The PLA contained a 
small number of phenolic  
 
 
  
  
Figure 7- A (1) liquid chromatography mass spectroscopy (LCMS) 
chromatograms of betanin standard (retention time; RT = 2.57 min) (2) 
Mass spectroscopy (MS) output of betanin standard (base peak m/z 
548.5 – 549.5) B (1) betanin in beetroot juice (BTJ) (RT = 2.55) (2) MS 
output for BTJ (base peak m/z 548.5 – 549.5).  
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Table 4 - TEAC, TPC, betanin, betacyanin and betaxanthin content of BTJ and PLA 
Treatment TEAC (mmol/L) 
TPC 
(mg/GAE/ L) 
Betanin 
(mg/L) 
Total betaxanthins 
(mg indicaxanthin 
equivalents/ L) 
Total betacyanins 
(mg betanin 
equivalents/ L) 
BTJ 
PLA 
11.4 ± 0.2 
0.25 ± 0.02 
1606.9 ± 151 
172.3 ± 13.3 
777.9 ± 41.3 
ND 
41.7 ± 0.7 
ND 
68.2 ± 0.4 
ND 
Values are mean ± SD. GAE, gallic acid equivalent; TEAC, Trolox equivalent antioxidant capacity; TPC, total polyphenol content. 
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4.3.3 Plasma NOx concentrations  
Data are presented in Figure 8. At baseline (0 h), concentrations of plasma 
NOx were similar between trials (P > 0.05). In the PLA trial, there was no 
change in plasma NOx concentrations at any time point (P > 0.05); however, 
after ingestion of BTJ there was an increase in plasma NOx compared to 
baseline (time effects; F (5, 45) = 18.84; P < 0.001) and PLA (drink*time 
interaction; F (10, 90) = 5.35; P < 0.001). Plasma NOx reached peak 
concentrations 2 h post-ingestion in the BTJ group (P < 0.001; 163.7 ± 46.9 
μmol/L) and was still elevated above baseline values at 8 h post (P < 0.001).  
 
Figure 8 - Plasma nitric oxide (NOx) concentrations after beetroot juice (BTJ) 
and placebo (PLA) ingestion. Data are means ± SD; *BTJ higher than PLA at 
all-time points post-baseline (P < 0.05). 
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4.4 Discussion   
The present study aimed to determine the phytonutrient content of a 
commercially available BTJ and the plasma bioavailability of nitrate and 
betanin in the 8 h after it had been consumed. BTJ was found to be rich in 
betalains, particularly betanin; however, betanin could not be detected in 
plasma following consumption. Conversely, and in line with other research 
(Joris & Menesik, 2013), ingestion of BTJ evoked marked elevations in 
plasma NOx levels compared to a PLA. BTJ was found to contain significant 
amounts of polyphenols and AOX compounds. The present findings provide 
new information regarding the bioavailability and phytochemical content of a 
commercially available BTJ drink.  
The AOX capacity of the BTJ and PLA was measured using the TEAC 
assay. The TEAC assay estimates AOX capacity by comparing the 
intervention’s scavenging ability to the Trolox standard (van den Berg, 
Haenen, van den Berg, & Bast, 1999), and is commonly used to provide an 
index of a food or beverages AOX potential (van den Berg et al., 1999; 
Pellegrini et al., 2003). The analysis revealed the TEAC for BTJ (~11.4 
mmol/L) to be higher than values reported for iced tea, green tea, apple 
juice, cranberry juice and orange juice (4-10 mmol/L), but lower than acai 
juice, black cherry juice, blueberry juice and pomegranate juice (12-40 
mmol/L) (Seeram et al., 2008). These data indicate that this particular BTJ 
possesses a good level AOX capacity in comparison to other fruit and 
vegetable drinks and, therefore, could be a useful supplement for boosting 
AOX defences and protecting against oxidative damage and inflammation.  
The AOX activity of the BTJ can probably be ascribed to the high 
concentration of polyphenols and betalains it was demonstrated to contain 
(see Table 4) and also to any synergistic interactions that might occur with 
these compounds, as suggested previously (Georgiev et al., 2010). As our 
main focus was on betanin, quantifying individual polyphenols in the BTJ was 
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beyond the scope of this study. However, according to data from previous 
investigations, the main polyphenols in beetroot (including other types of 
BTJ) are phenolic acids (ferulic acid, chlorogenic acid, caffeic acid) and 
flavonoids (epicatechin, rutin, betagarin) (Georgiev et al., 2010; Kujala, 
Loponen, Klika, & Pihlaja, 2002; Wootton-Beard et al., 2014), many of which 
possess high AOX potential (Gülçin, 2012; Velioglu, Mazza, Gao, & Oomah, 
1998). Furthermore, the polyphenols in beetroot appear to be well absorbed 
in humans. Netzel et al. (2005) reported that 51% of the total phenolics 
(about 338 mg) ingested from a homemade BTJ were detectable in the 
participant’s urine, indicating that several of the polyphenols present in 
beetroot may be absorbed and made available in the circulation for 
physiological effects. BTJ was rich in betalain compounds. In accordance 
with studies on fresh beetroot extracts, the betaxanthin content of BTJ was 
much lower than the betaycanin content (Stintzing & Carle, 2007). 
Betacyanin’s appear to be stronger AOXs than betaxanthins (Esatbeyoglu et 
al., 2015; Stintzing & Carle, 2007) and were likely major contributors to the 
AOX activity demonstrated by the BTJ. This could be because the AOX 
potential of betanin is believed to be higher than other betalains present in 
beetroot (Esatbeyoglu et al., 2014; 2015; Kanner et al., 2001).   
This is the first study that has characterised the bioavailability of betanin in 
human plasma following BTJ consumption. Despite the relatively high 
amount of betanin present in the BTJ, it could not be identified in the plasma 
at any time point after consumption (1-8 h). These findings conflict with those 
of a previous study, in which betanin was identified in plasma at relatively 
high concentrations (~0.2 µmol/l) 2 h after consuming 500 g of fresh cactus 
pear fruit containing 16 mg of betanin (Tesoriare et al., 2012). However, the 
discrepant findings between this study and the present investigation could be 
related to differences in the foods analysed (i.e., cactus pear fruit versus 
beetroot). This supposition is supported by recent work from Tesoriare and 
colleagues (2012), which compared the absorption rates of betanin from 
cactus pear fruit and red beetroot in a simulated in vitro model of the 
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intestinal wall. They showed that epithelial transport was much lower when 
betanin was derived from red beetroot, speculating that the rate of absorption 
was inhibited by beetroot’s food matrix. This suggests that the bioavailability 
of betanin may be lower after beetroot consumption compared to other 
sources of betanin.  
Nevertheless, the inability to identify betanin in the plasma in this study 
suggests that it may be lost or degraded during digestive processes. 
Previous studies investigating the renal elimination of betalains have 
indicated that betanin may instead be absorbed as downstream metabolites 
(Kanner et al., 2001). Kanner and Colleagues (2001) found that after 
consuming a betanin rich BTJ, isobetanin, but not betanin, could be detected 
in urine. The authors suggested that betanin undergoes isomerization to 
isobetanin in the intestinal milieu and may therefore be the major metabolite 
absorbed after betanin ingestion. In addition to isomerization, there are 
several other metabolic processes that could degrade betanin and limit its 
systemic bioavailability, including glycosidase enzyme activity from cellulase 
(Kanner et al., 2001) or the presence of the pancreatic enzyme amylase 
(Tesoriere et al., 2008). Such data supports the possibility that betanin is 
largely metabolized to secondary compounds prior to entering the circulation, 
which would provide a potential explanation as to why it could not be 
detected in its intact form in the present study. This raises doubts as to 
whether the wide array of biological effects displayed by betanin in vitro can 
be extrapolated to in vivo conditions. Instead, the in vivo biological activity 
displayed by betanin in some studies (Han, Ma, Zhang, Yang, & Tan, 2015; 
Tan, Wang, Bai, Yang, & Han, 2015; Tesoriere, Butera, Pintaudi, Allegra, & 
Livrea, 2004) could be mostly due to the biological effects of secondary 
betanin metabolites, although this remains to be elucidated. At present, data 
on the bioavailability of these metabolites or their potential biological activity 
is not yet available. Unfortunately, it was not possible to unequivocally 
identify any metabolites of betanin in this study due to appropriate standards 
for HPLC/LCMS detection not being available. Thus, whether metabolites of 
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betanin reached the circulation in the present study is purely speculative until 
clarified with future research. The development of new methodologies, 
analytical techniques and suitable standards will be required to establish the 
presence of these compounds. Nonetheless, the fact that betanin does not 
appear to very bioavailable in BTJ would suggest that perhaps the majority of 
BTJs AOX effects, at least under in vivo conditions, stems from the phenolic 
compounds present, given their allegedly high bioavailability (Netzel et al., 
2005).  
Plasma NOx activity was significantly augmented after consumption of BTJ 
compared to the PLA (Figure 8). These findings agree with a previous study 
that reported a rapid rise in NOx activity 1-3 h after BTJ ingestion (Joris & 
Menesik, 2013). These data are important, because an increase in the 
endogenous NOx pool is associated with a range of physiological effects that 
might be beneficial to health, such as improved endothelial function, 
enhanced mitochondrial efficiency, improved metabolic function and immune 
function (Weitzberg & Lundberg, 2013). Furthermore, as alluded to in section 
2.7.4, increased NOx bioavailability might also help to reduce symptoms of 
EIMD. Thus, these findings support the idea that a commercially available 
BTJ supplement might help to promote recovery after strenuous exercise. 
It is acknowledged that a potential limitation of this study is the absence of 
urinary measures. Therefore, it cannot be ruled out that betanin would have 
been detectable in urine voids had these samples been collected after BTJ 
consumption. Because the urinary excretion of betanin had been described 
before (Kanner et al., 2001; Netzel et al., 2005), the focus of this 
investigation was specifically on plasma bioavailability, which had not been 
characterised after BTJ consumption. It is also acknowledged that restricting 
the analysis to 8 h post-consumption is also a possible limitation because 
betanin might have appeared in the plasma at later time points. However, it 
was felt that this was improbable given that previous work in cactus pear fruit 
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showed plasma betanin concentration peaked at 3 h post consumption and 
was undetectable at 8 h post (Tesoriere et al., 2004a).  
Despite the aforementioned limitations, the data presented in this study 
provides new information on the bioavailability and phytochemical content of 
commercially available BTJ, which is of use to practitioners interested in the 
potential health benefits of these products. Future research on the 
bioavailability of betanin metabolites and their potential for biological activity 
is required to further exude the potential benefits of BTJ for supplemental 
use.  
4.5 Perspectives 
The overall aim of this thesis is to determine the efficacy of BTJ 
supplementation on recovery following muscle-damaging exercise. However, 
before testing the efficacy of BTJ as a recovery aid, it was important to 
establish that it contained the compounds shown to exert beneficial biological 
effects, especially those that could attenuate EIMD. This study succeeded in 
showing that BTJ contained a number of active compounds in amounts 
comparable to other functional foods, and perhaps most importantly, to those 
that have been shown to favourably affect recovery and oxidative stress after 
exercise such as cherry juice (Howatson et al., 2010), pomegranate juice 
(Trombold et al., 2010; 2011) and green tea (Jówko et al., 2011).  
In line with our hypothesis, the nitrate in BTJ was found to be highly 
bioavailable in plasma. The large increases in plasma NOx after BTJ 
suggests that nitrate could afford some beneficial biological effects in vivo. In 
contrast, the poor bioavailability of betanin suggests that the beneficial 
effects of betalain or BTJ ingestion on inflammation or other biological 
actions demonstrated in vivo might not be attributable to betanin per se, as 
often alleged. Rather, these findings could be due to the biological actions of 
other compounds in BTJ, such as betaxanthins, polyphenols and nitrate, or 
metabolites of betanin. It is also important to recognise that the relative 
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contribution of each compound to the biological actions of BTJ is likely to be 
very complex under in vivo conditions and that additive and synergistic 
effects between these compounds are probable. Nonetheless, this 
investigation supports the hypothesis that BTJ has a favourable phytonutrient 
composition and, thus, like other functional food based supplements, might 
be of benefit for recovery following strenuous exercise. Thus, the aim of the 
following Chapter is to investigate whether BTJ can accelerate recovery after 
eccentric exercise.  
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5 The effects of beetroot juice 
supplementation on indices of muscle 
damage following eccentric exercise 
Publication arising from this Chapter: Clifford, T., Bell, O., West, D. J., Howatson, 
G., & Stevenson, E. J. (2016). The effects of beetroot juice supplementation on 
indices of muscle damage following eccentric exercise. European Journal of Applied 
Physiology, 116(2), 353-362. 
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5.1 Introduction  
The previous Chapter demonstrated that BTJ is rich in a number of 
phytonutrients shown to exhibit potent AOX and anti-inflammatory effects. 
Importantly, these findings help provide a rationale for the main aim of this 
thesis: to investigate the efficacy of BTJ as a recovery intervention. 
Accordingly, this Chapter examined the effects of acute BTJ supplementation 
on indices of muscle damage following eccentric-heavy exercise. As alluded 
to in Chapter 2.3, EIMD is often accompanied by an acute phase 
inflammatory response that might prolong muscular dysfunction (Pizza et al., 
2005; Zerba et al., 1990). Briefly, phagocytic immune cells such as 
leukocytes, and signalling molecules such as growth factors and cytokines, 
accumulate at the damaged site in order to repair the tissue; however, the 
phagocytic phase of the regenerative process may exacerbate cytoskeletal 
degradation via the release of cytotoxic RONS and other proteolytic 
molecules (Pizza et al., 2005; Toumi & Best, 2003). This inflammatory 
response might cause additional physical damage to myofibrils (Lapointe et 
al., 2002; Pizza et al., 2005; Zerba et al., 1990), and is proposed, at least in 
part, to contribute to the muscle soreness, and prolonged loss of muscle 
function typically observed 24–96 h after muscle damaging exercise 
(Howatson and van Someren, 2008; Toumi & Best, 2003).  
Consequently, attempts to attenuate the deleterious effects of muscle 
damage have focused on nutritional supplements that target the 
inflammatory response, thereby reducing the potential for any secondary 
further muscle damage (Bowtell et al., 2011; Bell et al., 2014; Howatson et 
al., 2010; Trombold et al., 2010). The previous Chapter demonstrated that 
BTJ is rich in several anti-inflammatory and AOX containing compounds, 
indicating that it might be of use in attenuating any potential secondary 
muscle damage. Of these compounds, betacyanins have generated 
particular interest because of their purported AOX, anti-carcinogenic and 
anti-inflammatory functions both in vitro (Esatbeyoglu et al. 2014; Lechner et 
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al. 2010; Vidal et al. 2014) and in vivo (El Gamal et al. 2014; Szaefer et al. 
2014) and these have been discussed in detail in Chapter 2.7. While Chapter 
4 raised questions as to whether betanin, at least in its intact form, exhibits 
these effects in humans, secondary metabolites of betanin, or other 
phytonutrients (i.e., phenolic compounds) in beetroot could exert similar 
effects. This possibility is supported by previous studies, in which betalain 
supplementation demonstrated AOX anti-inflammatory effects in humans 
(Pietrzkowski et al. 2010; Pietrzkowski et al. 2014).   
In addition, the nitrate in BTJ may also be beneficial for attenuating EIMD. A 
number of studies have demonstrated that nitrate supplementation, via its 
sequential reduction to NOx, can reduce leukocyte and cytokine activity; 
effects that, conceivably, might help to dampen an inflammatory response 
(Jädert et al., 2012; Justice et al., 2015). These data, coupled with the known 
AOX and inflammatory effects of betalains, make the expectation tenable 
that BTJ could be used to attenuate EIMD and, potentially holds promise as 
a beneficial recovery beverage following exercise. Therefore, the main 
purpose of this Chapter was to establish whether an acute dose of BTJ 
would help aid recovery following a strenuous bout of eccentric-heavy 
exercise in the form of 100 drop jumps. Also, given that this was the first 
study to investigate BTJ in this manner, it seemed prudent to evaluate the 
potential for dose-response effects with acute supplementation. This data 
would enable more cognizant decisions regarding the optimal dose required 
to elicit effects for future investigations in this thesis. Thus, the effects of BTJ 
when administered in both a high (H-BT) and low dose (L-BT) was examined 
compared to a PLA. It was hypothesized that given its high nitrate, phenolic, 
and betalain content, BTJ would, in a dose dependent manner, help to 
protect against the potentially harmful effects of acute exercise-induced 
inflammation, thereby facilitating a faster recovery of muscle function. 
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5.2 Methods 
5.2.1 Participants  
A power calculation was conducted to determine an adequate sample size 
for this investigation. Using the findings of previous studies that examined 
group differences in isometric strength (Bell et al., 2015; Howatson et al., 
2010), it was estimated that a ≥10% group difference (SD: 7.5%, based on % 
change from baseline data) in one of the primary outcome variables (MIVC), 
would be required to detect significant changes. Thus, with a power of 0.80 
and two tailed α level of 0.05, the estimated number of participants required 
was n = 9 per group. Consequently, 30 healthy, recreationally active males 
met the inclusion criteria (see Chapter 3.2) and were recruited to participate 
in the study (characteristics presented in Table 5). None of the participants 
had previously completed the protocol used to induce muscle damage in this 
study. 
Table 5 - Descriptive data for the three supplement groups; high beetroot (H-
BT), low beetroot (L-BT) and placebo (PLA).  
Group  Baseline 
MIVC (N) 
Age 
(Years) 
Height 
(m) 
Weight 
(kg) 
H-BT 602 ± 144 22 ± 6 1.80 ± 0.57 74 ± 6 
L-BT 596 ± 112 21 ± 3 1.75 ± 0.87 76 ± 8 
PLA 602 ± 133 21 ± 3 1.79 ± 0.84 77 ± 11 
Values are mean ± SD (n = 10 per group). No significant differences were detected 
between groups for any variable (P > 0.05).  
5.2.2 Experimental design  
This study employed a double blind, independent groups design with three 
experimental treatment arms; participants were allocated to receive a HBT, a 
L-BT drink or a PLA for 3 days after a bout of muscle-damaging exercise. 
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Treatment groups were matched according to MIVC scores recorded at 
familiarisation. One week after familiarisation participants were required to 
attend the laboratory for 4 consecutive days. Each visit was at the same time 
of day and was preceded by an overnight fast. On their first visit, dependent 
measures were taken pre and immediately post muscle-damaging exercise 
in the following order: muscle soreness (PPT), venous blood draw, CMJ and 
MIVC. The muscle-damaging bout consisted of 100-drop jumps. Following 
the post-exercise measures, participants were given one serving of their 
assigned supplement and a standardized breakfast meal, followed by a 
further blood draw 90 min post ingestion. The breakfast meal consisted of 2 
slices of toasted bread with butter, providing 246 kcal, 32.8 g carbohydrate, 
5.6 g protein and 10.3 g fat. During the 90 min rest period, participants were 
allowed to consume water ad libitum but were required to avoid consuming 
any other foods until the final blood draw. On the following 3 days (24, 48 
and 72 h post muscle-damaging exercise) participants returned to the 
laboratory to repeat the dependent measures and to consume their allocated 
supplements (24 and 48 h post only). On each visit participants performed a 
5 min warm up on a treadmill at a self-selected pace that corresponded to 12 
on the rate of perceived exertion (RPE) scale (Borg, 1982).  
5.2.3 Supplementation and dietary control  
The macronutrient compositions of the supplements used in this investigation 
are presented in Chapter 3.4. Participants consumed 3 servings (250 ml per 
serving) of their assigned beverage on the day after exercise (H-BT, L-BT or 
PLA); one 30 min post-exercise alongside a breakfast meal, one 90 min 
later, and a third with their evening meal. Participants consumed 2 more 
servings at 24 and 48 h post (one within 30 min of leaving the laboratory and 
another with their evening meal). The rationale for providing 2 daily servings 
of each supplement (one in the morning and one in the evening) was based 
on previous studies with cherry and pomegranate juice that showed such a 
strategy was effective in the prevention of some aspects of EIMD (Bell et al., 
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2014; 2015; Howatson et al., 2010; Trombold et al., 2010). The rationale for 
providing an additional serving on day 1 (2 h post-exercise) was based on 
observations that inflammation is more pronounced ≤24 h after an 
eccentrically-damaging bout of exercise (Pizza et al., 2001; Chatzinkolaou et 
al., 2010) and thus it was speculated there may be an amplified requirement 
for exogenous phytochemicals at this time. Please refer to Chapter 3.4 for 
details regarding the double-blind procedure. Participants were also required 
to avoid foods with a high phytochemical, nitrate or nitrite content 48 h prior 
to and during data collection (see Chapter 3.3 for further details and 
appendix 4 for an example food record diary).  
5.2.4 Muscle damaging exercise  
The muscle-damaging bout of exercise consisted of 100 drop jumps from a 
0.6 m high box. Please refer to Chapter 3.5 for further details.  
5.2.5 Muscle soreness 
Muscle specific soreness was assessed as PPT. See Chapter 3.6.3 for 
further information.  
5.2.6 Maximal isometric voluntary contraction  
Please refer to general methods Chapter 3.6.1 for details on MIVC 
measurement. 
5.2.7 Counter movement jump 
Please refer to general methods Chapter 3.6.2 for details on CMJ 
measurement. 
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5.2.8 Blood sampling and analysis  
See Chapter 3.7 for blood sampling procedures. Determination of plasma CK 
is described in section 3.7.1. Plasma IL-6, IL-8, IL-1β and TNF-α were 
analysed on a multiplex plate using an electrochemiluminescence sandwich 
immunoassay (Meso Scale Discovery, Sector Imager 2400, Rockville, USA).  
IL-1β concentrations could only be detected in <5% of samples and were 
therefore excluded from analysis. Intra assay CV’s were <12%, <4% and 
<6% for IL-6, IL-8 and TNF-α, respectively; samples for individual 
participants were analysed on the same plate to avoid inter plate variation. 
5.2.9 Data analysis  
All data are expressed as mean ± SD and were analysed using IBM SPSS 
Statistics 21 for Windows (Surrey, UK). To test for differences between 
participant group characteristics, one-way independent analyses of variance 
(ANOVA) were performed. As is typical in most studies examining the effects 
of an intervention on EIMD (Bowtell et al.,2011; Howatson et al., 2009; 
Howatson et al., 2009; Kirby et al., 2012; Trombold et al., 2010; 2011) data 
analysis for functional (also primary) outcome measures (MIVC, CMJ and 
PPT) was conducted on data corrected to percentage change from baseline. 
This was to account for the large inter-participant variability typically seen 
with these markers in response to muscle-damaging exercise (Sayers & 
Clarkson, 2002). For consistency, this same method for data analysis was 
used throughout this thesis; however, where relevant, absolute values have 
been provided alongside data corrected to percentage change from baseline 
for illustrative purposes. All dependent variables were measured using a 
mixed model ANOVA; 3 group levels (H-BT vs. L-BT vs. PLA) by 5 time 
levels (pre-exercise, post-exercise, 24, 48 and 72 h post-exercise). In the 
event of a significant interaction effect (treatment*time) Fisher LSD post hoc 
analysis was performed to locate where the significant differences occurred. 
Were relevant, Cohen’s d effect sizes (ES) were calculated with the 
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magnitude of effects considered small (0.2-0.49), medium (0.5-0.79) and 
large (≥0.8). Statistical significance was set at P < 0.05 prior to analyses. 
5.3 Results 
There were no significant differences in physical characteristics (height, 
weight, age), and baseline MIVC values between treatment groups (P > 
0.05, see Table 5). Close inspection of the food diaries revealed that all 
participants complied with the imposed dietary restrictions. All muscle 
function (CMJ, MIVC) and soreness (PPT) measures showed time effects (P 
< 0.05) indicating that the exercise protocol was effective at inducing muscle 
damage.  
5.3.1 Muscle function  
Immediately following the muscle-damaging bout, CMJ height (relative to 
baseline) declined to a similar extent in all 3 groups (H-BT: 17 ± 9.7% vs. L-
BT: 17.5 ± 7.5% vs. PLA: 15.4 ± 6.5%). There was however, a 
treatment*time interaction effect (F (2,27) = 2.87; P = 0.031) with post hoc 
analysis revealing that CMJ height recovered faster with H-BT vs. PLA at 48 
(P = 0.009; ES = 1.00) and 72 h post exercise (P = 0.046; ES = 1.25). In the 
H-BT group, CMJ height was 91.7 ± 12.4 and 93.4 ± 7.6% of baseline values 
at 48 and 72 h respectively, while at the same in the PLA group, CMJ height 
was 75.3 ± 17.3 and 86.1 ± 5.9%, respectively (Figure 9). There were no 
group or interaction effects for MIVC (P > 0.05) (Table 6).   
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Figure 9 - Percentage changes in counter movement jump (CMJ) height 
before and after muscle damaging exercise. *Represents between group 
difference (high beetroot juice; H-BT vs. placebo; PLA, P < 0.05). Values are 
means ± SD (n = 10 per group). 
5.3.2 Muscle soreness  
Muscle soreness, as measured by PPT (sum of all 3 muscle sites), showed 
interaction effects (F (7, 308) = 7.83; P < 0.001); post hoc analysis revealed a 
reduction in PPT in the PLA group vs. both the H-BT and L-BT groups at 24, 
48 and 72 h post exercise (P < 0.001; Figure 10). At 72 h post exercise, PPT 
had returned to baseline values in the H-BT and L-BT groups (103.5% and 
103% of initial values, respectively) but remained significantly reduced in the 
PLA group (80% of initial value; P < 0.001).  
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Figure 10 - Percentage changes in pressure pain threshold (PPT) before and 
after muscle damaging exercise. Values presented are average of the three 
sites measured (calf, CF; rectus femoris, RF; vastus laterialis, VL). *Indicates 
between group difference for high beetroot juice (H-BT) and low beetroot 
juice (L-BT) vs. placebo (PLA); P < 0.001. Values are means ± SD (n = 10 
per group). 
5.3.3 Blood markers  
Plasma CK demonstrated main effects for time (F (2, 52) = 9.99; P < 0.001), 
peaking at 24 h post exercise in all groups; however, no group or interaction 
effects were detected (P > 0.05; Table 6). Main effects for time were also 
observed for IL-6 (F (2, 47) = 6.47; P = 0.003), which was elevated immediately 
and 2 h post exercise but returned to baseline values by 24 h post; no group 
or interaction effects were detected (P > 0.05; Table 6). TNF-α did not 
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demonstrate a main effect for time (F (3, 58) = 1.04; P = 0.374); a time*group 
interaction effect was found (F (5, 58) = 2.55; P = 0.035), but no significant 
group differences were detected with post hoc analysis. IL-8 was not 
significantly altered by the exercise protocol, showing no time, group or 
interaction effects (P > 0.05). 
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Table 6 - MIVC, CK, IL-6, IL-8 and TNF-α values pre and post muscle damaging exercise.   
Values are mean ± SD (n = 10 per group). *Denotes time effect; P < 0.05. #Values in brackets represent % change from baseline 
data.  MIVC, maximal isometric voluntary contraction; CK, creatine kinase; IL-6, interleukin-6; IL-8, interleukin-8; TNF-α, tumor 
necrosis factor-alpha. 
Variable  Pre exercise Post exercise 2 h post exercise 24 h post exercise 48 h post exercise 72 h post exercise 
MIVC (N)*# 
   H-BT 
   L-BT 
   PLA 
 
594(100) ± 134(0) 
555(100) ± 102 (0) 
601(100) ± 152(0) 
 
489(81) ± 162(13) 
   460(83) ± 102(7) 
463(79) ± 126(12) 
  
510(84) ± 183(15) 
   462(85) ± 93(10) 
482(82) ± 141(15) 
 
533(89) ± 202(19) 
499(92) ± 100 (8) 
491(83) ± 138(16) 
 
551(93) ± 174(15) 
   525(96) ± 120(9) 
528(89) ± 138(16) 
CK (IU∙
-1
)* 
   H-BT 
   L-BT 
   PLA 
 
183 ± 102 
263 ± 152 
295 ± 248 
 
218 ± 110 
297 ±165 
350 ± 28 
 
320 ± 158 
370 ± 156 
437 ± 424 
 
572 ± 442 
597 ± 400 
679 ± 512 
 
431 ± 260 
335 ± 222 
533 ± 384  
 
319 ± 217 
236 ± 101 
543 ± 443 
IL-6 (pg∙ml
-1
)* 
   H-BT 
   L-BT 
   PLA 
 
0.46 ± 0.26 
0.52 ± 0.20 
0.38 ± 0.18 
 
0.87 ± 0.55 
0.75 ± 0.35 
0.56 ± 0.18 
 
0.79 ± 0.53 
0.65 ± 0.31 
1.19 ± 0.97 
 
0.45 ± 0.23 
0.53 ± 0.21 
0.55 ± 0.30 
 
0.27 ± 0.29 
0.50 ± 0.22 
0.59 ± 0.50 
 
0.25 ± 0.24 
0.45 ± 0.26 
0.66 ± 0.32 
IL-8 (pg∙ml
-1
) 
   H-BT 
   L-BT 
   PLA 
 
4.01 ± 2.53 
3.42 ± 1.50 
2.80 ± 0.62 
 
4.62 ± 1.87 
3.72 ±1.54 
3.15 ± 0.81 
 
3.63 ± 1.65 
3.47 ± 1.09 
2.91 ± 0.57 
 
4.09 ± 2.51 
3.63 ± 1.42 
2.99 ± 0.76 
 
3.59 ± 1.57 
3.26 ± 1.30 
3.09 ± 1.35 
 
3.53 ± 2.29 
3.00 ± 1.25 
3.58 ± 1.99 
TNF-α (pg∙ml
-1
) 
   H-BT 
   L-BT 
   PLA 
 
2.98 ± 1.08 
2.39 ± 0.39 
2.45 ± 0.72 
 
2.90 ± 1.31 
2.30 ± 0.49 
2.29 ± 0.56 
 
2.77 ± 1.03 
2.26 ± 0.44 
2.46 ± 0.70 
 
2.97 ± 1.13 
2.26 ± 0.44 
2.57 ± 0.67 
 
2.76 ± 0.98 
2.34 ± 0.49 
2.76 ± 1.09 
 
2.24 ± 1.01 
2.23 ± 0.48 
2.79 ± 1.16 
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5.4 Discussion 
The main findings of the present study were that; 1) three days of 
supplementation with H-BT facilitated a more rapid recovery of CMJ 
performance 48 and 72 h following exercise, and; 2) consuming both a lower 
dose (125 ml) and higher dose (250 ml) of BTJ reduced muscle soreness 
24–72 h post-exercise. Other markers of functional recovery, muscle 
damage, and inflammation were unaffected by BTJ.  
Although a group difference in MIVC was not detected, CMJ performance 
recovered quicker in H-BT vs. PLA at 48 and 72 h post exercise, suggesting 
that BTJ conferred a protective benefit against the acute loss in 
neuromuscular function. Group differences (vs. PLA), at least stastically, 
were only evident with H-BT, suggesting that a higher dose (250 ml) might 
be more beneficial for attenuating acute losses in muscle function. This may 
be explained by the higher quantity of AOX and anti-inflammatory 
compounds presumably within H-BT; however, further research is required to 
clarify the precise mechanisms involved. It is important to note however, that 
although the differences in CMJ performance between L-BT and PLA was 
not statistically different at these time points post-exercise, there was still a 
trend towards a large improvement with L-BT (Figure 9), and perhaps with 
greater statisctical power significant differences would have also been 
detected with this dose. It therefore cannot be ruled out that similar benefits 
might be afforded by the L-BT dose as well. Studies that specifically assess 
the minimal effective dose of BTJ on recovery are needed in the future to 
help inform practical use of this supplement. Nevertheless, this is the first 
study to report that an acute BTJ intervention can enhance the recovery of 
CMJ performance following a damaging bout of eccentric exercise. While 
several studies have reported improved recovery of isometric strength after 
consuming fruit containing beverages, such as cherry (Bell et al., 2015; 
Bowtell et al., 2011; Howatson et al., 2010), pomegranate (Trombold et al., 
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2010; Trombold et al., 2011) and blueberry juice (McLeay et al., 2012), these 
studies did not include measures of CMJ.  
Unlike the aforementioned studies that reported improved recovery of 
isometric strength, the present study did not detect any group differences for 
MIVC. This was a somewhat surprising finding and difficult to explain given 
the improved recovery observed for CMJ performance. This finding doesn’t 
appear to be related to differences in reliability between these measures as 
both were calculated to have similar CV values ~2% (see section 3.6.2). It is 
conceivable however, that the disparity is an artefact of the mechanical 
differences between these variables. In accordance with the principle of 
specificity, tests of muscle function are more sensitive to detect performance 
changes if they closely simulate the movement patterns associated with the 
exercise task in question (Baker, Wilson, & Carlyon, 1994; Gathercole et al., 
2015). In this study, the drop jump protocol used to elicit damage required 
participants to perform a countermovement (descend to a 90° knee angle) 
prior to each jump, and therefore the kinematic characteristics (i.e., angular 
velocity, involved muscles, speed of contraction) closely resembled that of 
the CMJ. In comparison, the movement patterns and mode of contraction 
required to perform a MIVC are less analogous to the drop jumps; MIVC 
measures force production when muscle length is unchanged and requires 
no dynamic movement (Byrne & Eston, 2002). Thus, given that the 
movements for drop jumps and counter movement jumps are similar, the 
latter might have been a more sensitive and specific test for detecting subtle 
performance changes than MIVCs in the present study. It would be useful for 
future studies to include measures of both dynamic and isometric 
performance in response to EIMD to shed more light on the potential 
differences between these two measures.  
Although the maintenance of CMJ performance by BTJ points towards a 
potential blunting of the secondary damage response, large between group 
changes in indices of inflammation were not observed. However, perhaps 
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this is not unsurprising given that the alteration in inflammatory indices was 
small; there was a modest increase in IL-6 immediately and 2 h post 
exercise, but TNF-α and IL-8 were not elevated above baseline values at any 
time points or in any of the groups. This would suggest that either the 
exercise protocol was not sufficiently damaging to induce an inflammatory 
response (or one large enough to be detected systemically) or that these 
markers are not representative of the inflammatory response to eccentric 
exercise. With regards to the first point, it was anticipated that the drop jump 
protocol would induce a systemic inflammatory response, given that 
analogous bouts of plyometric exercise has evoked marked inflammatory 
responses in previous studies (Chatzinkolaou et al., 2010; Dousset et al., 
2007), including significant elevations in leukocyte numbers and IL-6 up to 24 
h post-exercise (Chatzinkolaou et al., 2010). The discrepancy in findings 
between these studies and the present study could therefore be due to 
differences between participant cohorts and/or analytical methods used. With 
regards to the second point, it was recently proposed that exercise induced 
changes in TNF-α and IL-8 concentrations are much greater in the muscle 
and interstitial cells than the circulation (Paulsen et al., 2012; Peake et al., 
2015a). As a result, the systemic concentrations of these markers might not 
have adequately reflected the inflammatory response elicited by the exercise 
protocol, and therefore the ability to detect an anti-inflammatory effect with 
BTJ was limited. Notwithstanding, there was a strong rationale for examining 
these cytokines, since the only previous study measuring the anti-
inflammatory effects of beetroot in humans found a marked reduction in 
plasma TNF-α and IL-6 concentrations after taking a beetroot based 
supplement (Pietrzkowski et al., 2010); thus, it was felt they might represent 
a potential mechanism by which beetroot mediates anti-inflammatory effects. 
Furthermore, several previous studies examining the influence of AOX rich 
foods on exercise-induced inflammation detected changes in these markers 
(Bell et al., 2015; Howatson et al., 2010). Perhaps measuring the level of 
inflammation in the exercised muscles through biopsies, or with a wider array 
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of systemic inflammatory markers would have provided a greater insight into 
the exercise-induced inflammatory response in this study.  
There was a substantial reduction in PPT in the 72 h period post exercise, 
indicating that the drop jumps effectively induced muscle pain. These 
findings are in accordance with previous research that also noted a decrease 
in PPT following a single bout of strenuous eccentric exercise (Bowtell et al., 
2011; Connolly et al., 2006). In this study, PPT recovered to baseline values 
more rapidly with H-BT and L-BT compared to PLA. Furthermore, the 
recovery of PPT did not differ between H-BT and L-BT groups, indicating that 
the lower dose was equally as effective in reducing muscle pain. These 
findings concur with two recent studies that showed a betalain-rich 
supplement derived from whole beetroots dampens joint pain from chronic 
knee discomfort (Pietrzkowski et al., 2014) and osteoarthritis (Pietrzkowski et 
al., 2010). Although the precise events leading to muscle pain still remain to 
be fully elucidated, the most recent evidence indicates that intramuscular 
generation of noxious stimuli such as nerve growth factor (NGF), bradykinin, 
and prostaglandin E2 (PGE2), are likely to play important roles (Hyldahl & 
Hubal 2014; Mizumura & Taguchi, 2015; Murase et al., 2010). These 
substances can be synthesized by immune cells and act to excite and 
sensitize local muscle nociceptors. This can result in feelings of soreness 
and pain in the muscle belly and connective tissues (Hyldahl & Hubal 2014; 
Mizumura & Taguchi, 2015; Murase et al., 2010). Unfortunately, it was not 
possible to determine the presence of these substances (i.e., PGE2 or NGF) 
or the local inflammatory responses in this study, and thus whether changes 
in these indices contributed to the findings of the present study is unclear 
and needs to be clarified in future research.  
In the present study, there were no group differences in plasma CK after 
exercise, which is consistent with previous studies that report CK 
concentrations were unaffected by cherry juice (Bell et al. 2015; Howatson et 
al. 2010) and pomegranate juice (Trombold et al., 2010). This suggests that 
132 
 
 
BTJ and AOX rich foods in general might not be beneficial for attenuating 
damage to the cell membrane resulting from eccentric exercise. However, a 
large inter-individual variability in CK efflux could have limited our ability to 
detect any group differences (Paulsen et al., 2012). 
It is important to acknowledge the limitations in this study that might affect 
the ecological validity of these findings. Firstly, the participants in the present 
study were recreationally active exercisers, which potentially limit the 
application of these findings to well-trained athletic populations. Multiple 
sprint sport athletes, for example, are likely to be more accustomed to high 
force eccentric contractions and therefore less susceptible to muscle 
damage and changes in neuromuscular function. Secondly, it is 
acknowledged that instructing the participants to follow a diet low in AOX, 
phenolic, and nitrate containing foods throughout the study could have 
influenced the results. Therefore, future studies are needed to establish 
whether the present results can be replicated when participants consume 
their habitual diet.   
In summary, the present study demonstrated that supplementing with BTJ for 
3 days following a damaging bout of eccentric exercise improved certain 
aspects of exercise recovery, specifically, muscle soreness and the 
decrement in CMJ performance. These findings suggest that BTJ 
supplementation might serve to protect against the negative effects of EIMD, 
which might be of particular benefit to individuals required to perform several 
bouts of potentially damaging exercise in a short time frame.  
5.5 Perspectives  
The overall aim of this thesis is to test the efficacy of BTJ as a recovery aid 
following strenuous exercise. This study addressed the second question 
posed in the introduction of this thesis: does acute BTJ supplementation 
attenuate indices of muscle damage and enhance recovery from eccentric-
heavy exercise, and are these effects dose-dependent. Findings show that 
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BTJ provided relief from muscle pain in the days after exercise and helped to 
maintain some aspects of muscle function.  
While muscle pain was attenuated with both the lower and higher dose of 
BTJ, muscle function, as measured by CMJ height, was only improved with 
the higher dose. Therefore, this study indicated that a larger serving (1 full 
250 ml bottle) of BTJ was a more effective strategy for attenuating EIMD, 
and provides rationale for its use in future investigations in this thesis.  
 
Because a systemic inflammatory response, as measured by changes in 
cytokines, was largely absent after exercise, the beneficial effects of BTJ 
could have been due to mechanisms at the local level. Alternatively, it could 
be that these markers did not provide an adequate reflection of the 
inflammatory response in this model. Therefore, other markers may be more 
appropriate for future investigations in this thesis. Notwithstanding, it is 
important to consider these findings in view of the potential negative effects 
of AOX containing supplements on exercise-induced adaption. Although to 
date, there are no reports of a functional food supplement interfering with 
exercise adaptation, this could be because such a possibility is yet to be 
adequately investigated. Consequently, the following Chapter will examine 
the effects of BTJ on the RBE, in an attempt to help elucidate whether the 
dose of BTJ used in this study negatively affects the acute adaptive 
response to eccentric-heavy exercise.  
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6 Effects of beetroot juice supplementation 
on acute adaptation following eccentric 
exercise 
Publication arising from this Chapter: Clifford, T., Bell, O., West, D. J., Howatson, 
G., & Stevenson, E. J. (2016). AOX-rich beetroot juice does not adversely affect 
acute neuromuscular adaptation following eccentric exercise. Journal of Sports 
Sciences, 1-8. 
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6.1 Introduction 
In the previous Chapter, the fact that some aspects of EIMD were attenuated 
with BTJ suggests that it possibly had some influence on the degradative 
and regenerative processes in the muscle (i.e., inflammation, oxidative 
stress, proteolysis, and myogenesis) after an acute bout of strenuous 
exercise. Given the weight of evidence suggesting that interfering with these 
processes might impact on subsequent adaptation (see Chapter 2.5), this 
Chapter addresses whether BTJ could negatively affect the acute adaptive 
response to eccentric exercise.  
AOX supplementation is purported as a strategy to attenuate the signs and 
symptoms of muscle damage (i.e., soreness, loss of muscle function, 
inflammation) that result from exercise involving strenuous exercise, 
particularly that has a heavy eccentric component (Bloomer, 2007; Peake & 
Suzuki, 2004). However, while an excess production of RONS and the 
associated inflammatory events might initially harm the muscle cell, they are 
also fundamental to the regenerative process, and are now widely 
considered to be a necessary stimulus for both acute and chronic cellular 
adaptations to exercise (Close et al., 2006; Michailidis et al., 2013; Paulsen 
et al., 2014b). With regards to acute adaptations, RONS and other immune 
cells that transiently increase after a bout of eccentric exercise have been 
proposed to act as signalling molecules for molecular changes that reinforce 
cell defences in the muscle and ECM (Hubal et al., 2008; Hyldahl et al., 
2015; McHugh, 2003; Pizza et al., 2002; Xin et al., 2014). Such adaptations 
could make cells more resistant to damage during similar exercise bouts in 
the future. This acute adaptive response to eccentric, muscle-damaging 
exercise is classically illustrated by the RBE, in which the magnitude of 
muscle damage (i.e., force deficits) evoked by a single exercise damaging 
stimulus is attenuated in a subsequent bout performed many weeks later 
(McHugh, 2003; Nosaka & Clarkson, 1995).  
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Evidence that post-exercise inflammation and RONS production might afford 
beneficial effects for physiological and functional adaptation has sparked 
some debate within the literature (Gomez-Cabrera, Ristow and Viña, 2012; 
Higashida et al., 2011). Specifically, the question arises whether use of AOX-
rich supplements to blunt oxidative stress and inflammation could have 
detrimental effects on the regeneration and adaptive responses that might 
translate to muscle function and performance enhancement (Close et al., 
2006; Gomez-Cabrera et al., 2012; Paulsen et al., 2014b). However, very 
little attention has been given as to the effect of AOXs or any nutritional 
recovery intervention on the acute adaptive effects associated with eccentric 
exercise. The fact that the adaptive response from a just single bout of 
eccentric exercise results from (at least in part) cellular changes, it would be 
anticipated that AOX supplementation might attenuate the magnitude of the 
RBE. To date, this possibility has only been addressed by one recent study, 
which showed that 2 weeks of supplementation with a very high AOX dose of 
vitamin C (1000 mg·d·¯1) and E (400 I·U¯1) did not blunt the RBE in response 
to a bout of downhill running (He et al., 2015). However, these findings are 
limited by the absence of any measures of muscle function, which are widely 
considered the best indicators of skeletal muscle damage (Paulsen et al., 
2012; Warren et al., 1999). 
In the previous Chapter, consuming AOX-rich BTJ attenuated some indices 
of muscle damage after a bout of eccentric exercise, suggesting that BTJ 
may hold promise as a recovery aid. However, given the above discussion, 
whether such a strategy would have deleterious effects for acute cellular 
adaptations is unknown. Consequently, as a follow up to the previous 
Chapter, a sub-set of the participants repeated the same bout of eccentric 
exercise 3 weeks later, without supplementation. The aim of this study was 
to examine the effects of BTJ supplementation on the acute adaptive 
response (represented by the RBE) after muscle damaging exercise. It is 
important to make the distinction that this study specifically tested whether 
BTJ would adversely affect the adaptive response to a single bout of 
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exercise, not a series of exercise bouts, and therefore the primary outcomes 
were the acute functional adaptations typically seen after a single bout of 
exercise (i.e., improved muscle recovery, lowered muscle soreness), as 
opposed to more chronic adaptations (increased hypertrophy and strength).  
A secondary aim of this investigation was to establish whether a higher or 
lower dose of BTJ would differentially affect the RBE, given that previous 
reports have suggested that although higher AOX doses might be harmful 
(i.e., vitamin C ≥1000 mg∙day-1) (Close et al., 2006; Paulsen et al., 2014b), 
more moderate doses are not (500 mg mg∙day-1) (Yfanti et al., 2010; 2011). 
It was hypothesised that participants who consumed BTJ after the initial bout 
would have a blunted RBE compared to those who consumed a PLA 
beverage, and the magnitude of these responses might be exacerbated after 
a higher dose of BTJ. 
6.2 Methods 
6.2.1 Participants  
Twenty-nine participants completed all study procedures. All participants 
were recreationally active (see Chapter 3.2 for definition), healthy males (age 
21 ± 3 years; height 1.77 ± 0.80 m; body mass 75.6 ± 8.8 kg) who had no 
prior experience with the bout of muscle-damaging exercise.  
6.2.2 Experimental overview   
The study employed a randomised, double blind, PLA controlled, 
independent groups design. Excluding familiarisation, participants were 
required to attend the laboratory on 8 occasions. After familiarisation, 
participants were stratified into three supplement groups according to their 
baseline MIVC scores: H-BT; n = 10, L-BT; n = 9 or a PLA; n = 10. 
Supplements were consumed immediately, 2 h post-exercise, and at set 
times 24 and 48 h following a first bout of muscle damaging exercise (see 
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Chapter 5.2.3 for details). Muscle function, muscle soreness and CK were 
measured pre, post, 24, 48 and 72 h post-exercise. Fourteen to twenty-one 
days after the first bout of exercise (bout 1), participants returned to the lab 
to repeat an identical bout of exercise (bout 2) but no supplements were 
provided on this occasion. All testing was conducted in the morning following 
an overnight fast at the same time of day (within participants). Participants 
were familiarised with all equipment and study procedures prior to testing.  
6.2.3 Muscle damaging exercise  
The muscle-damaging bout of exercise consisted of 100 drop jumps from a 
0.6 m high steel box. See Chapter 3.5 for further details.  
6.2.4 Supplementation and dietary control 
Participants were provided with the same H-BT and L-BT drinks outlined in 
the previous Chapter; the nutritional content of both drinks can be found in 
Chapter 3.4. For information regarding the timing of supplement intake and 
blinding procedures please refer to Chapters 5.2.3 and 3.4, respectively. 
Details of the imposed dietary restrictions can be found in Chapter 3.3.  
6.2.5 Maximal isometric voluntary contraction  
Please refer to general methods Chapter 3.6.1 for details on MIVC 
measurement. 
6.2.6 Counter movement jump 
Please refer to general methods Chapter 3.6.2 for details on CMJ 
measurement. 
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6.2.7 Muscle soreness 
Muscle specific soreness was assessed as PPT with a handheld algometer. 
See Chapter 3.6.3 for further information.  
6.2.8 Blood sample collection and analysis  
Blood samples were collected according to the methods outlined in Chapter 
3.7. For details of CK analysis refer to Chapter 3.7.1.  
6.2.9 Data analysis 
Data were analysed using IBM SPSS statistics version 21 and expressed as 
mean ± SD. A mixed model ANOVA with 3 treatment levels (H-BT vs. L-BT 
vs. PLA) × 2 bouts (bout 1 vs. bout 2), × 5 time points (pre, post, 24, 48 and 
72 h post-exercise) was used to test for significant differences between the 
dependent variables. Group differences in height, weight, age, and baseline 
MIVC scores were analysed using one-way independent group ANOVAs. If 
significant group and interaction effects were observed, Fisher LSD post hoc 
tests were performed to locate where the differences occurred. Significance 
was set at P < 0.05 prior to analyses. 
6.3 Results  
There were no differences in participant characteristics (age, height, mass) 
and baseline MIVC between groups (P > 0.05). Data relating to group 
differences after bout 1 can be found in Chapter 5.3. Main effects for time 
were observed for all dependent variables (CMJ, MIVC, CK and PPT; P < 
0.05) following bout 1, indicating that the drop jumps effectively induced 
muscle damage. The decrement in MIVC was less in bout 2 compared to 
bout 1 (F (1, 26) = 4.49; P = 0.04; Figure 11), providing evidence of an RBE. 
The percentage decrease in MIVC in bout 1 (average across groups) was 
16.1%, 12.2% and 17.3% at 24, 48 and 72 h post exercise, respectively, 
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whereas after bout 2, decrements were attenuated to 9.5%, 6.2%, and 2.3% 
at 24, 48 and 72 h post-exercise, respectively. There were no bout*group 
interactions (F (2, 26) = 0.20; P = 0.815), indicating that strength loss was 
similarly attenuated in all groups. At 72 h post bout 2, MIVC had recovered to 
98.0 ± 9.0, 97.8 ± 6.0 and 97.1 ± 7.0% of baseline values in the H-BT, L-BT 
and PLA groups, respectively.  
 
 
Figure 11 - Changes (% of baseline) in maximal isometric voluntary 
contraction (MIVC) pre and up to 72 h after exercise bout 1 and bout 2 in all 
3 groups; high beetroot juice (H-BT), low beetroot juice (LBT) and placebo 
(PLA). *Attenuation of muscle force in bout 2 compared to bout 1(P = 0.040); 
n = 29. 
The decrease in CMJ height was also attenuated in bout 2 compared to bout 
1 (bout effect; F (1, 26) = 25.43; P <0.001) and there were no differences 
between the groups (bout *group interaction; F (2, 26) = 0.71; P = 0.501). 
Seventy two h post bout 1 CMJ height recovered in the H-BT, L-BT, and PLA 
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groups to 91.7 ± 9.7, 93.2 ± 7.1 and 87.4 ± 7.3% of baseline values, 
respectively, whereas 72 h following bout 2, CMJ height recovered to 101.4 ± 
5.9, 96.9 ± 7.4 and 96.9 ± 4.8% of baseline values, respectively (Figure 12).  
Figure 12 - Changes (% of baseline) in counter movement jump (CMJ) height 
pre and up to 72 h after exercise bout 1 and bout 2 in all 3 groups; high 
beetroot juice (H-BT), low beetroot juice (LBT) and placebo (PLA). 
*Attenuation of jump height in bout 2 compared to bout 1(P = 0.001); n = 29. 
A main effect for bout showed that plasma CK was lower in bout 2 compared 
to bout 1 (F (1, 24) = 15.20; P = 0.001; Figure 13); there were no differences 
between the 3 groups (bout*group interaction; F (2, 21) = 2.42; P = 0.113). 
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Figure 13 - Plasma creatine kinase (CK) concentrations pre and up to 72 h 
after exercise bout 1 and bout 2 in all 3 groups; high beetroot juice (H-BT), 
low beetroot juice (LBT) and placebo (PLA). *Decrease in CK efflux in bout 2 
compared to bout 1(P = 0.001); n = 29. 
PPT did not show an overall bout effect (F (1, 84) = 1.68; P = 0.198); but a 
bout*group interaction was observed (F (2, 84) = 4.00; P = 0.022), with post 
hoc analysis revealing that PPT was improved in bout 1 compared to bout 2 
in PLA only (Table 7; P = 0.001). 
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Table 7 - Percentage change from baseline in PPT for the 3 supplement 
groups. 
                                 Time Post exercise 
 Pre Post  24 h 48 h  72 h 
     
PPT HBT 1 100 ± 0 84.7 ± 14.9 88.1 ± 20.5 91.1 ± 22.0 103.5 ± 23.2 
 2 100 ± 0 90.6 ± 11.3 86.0 ± 16.8 93.2 ± 16.1 95.7 ± 12.9 
L-BT 1 100 ± 0 93.2 ± 21.4 87.1 ± 19.7 92.4 ± 24.0 104.5 ± 20.1 
 2 100 ± 0 90.3 ± 10.7 86.6 ± 12.5 91.2 ± 13.7 99.8 ± 12.4 
PLA* 1 100 ± 0 85.01 ± 18.8 67.4 ± 20.8 61.7 ± 20.8 80.0 ± 28.9 
 2 100 ± 0 87.5 ± 14.4 79.5 ± 15.1 81.5 ± 14.9 90.5 ± 17.9 
*Different from bout 1; P < 0.05, n = 29.  
6.4 Discussion  
The aim of the current study was to examine whether the beneficial effects 
demonstrated by BTJ in the previous Chapter would negatively impact the 
RBE, as illustrated by an attenuation of functional recovery in a subsequent 
exercise bout. The principal finding of the current study was that 3 days of 
BTJ supplementation, at either a higher or lower dosage, did not interfere 
with the RBE to a single bout of eccentric exercise. 
There were significant reductions in MIVC and CMJ height in all three groups 
after bout 1; however, consistent with a RBE, these reductions were 
significantly attenuated in bout 2, irrespective of supplementation and dose. 
These findings are in agreement with a previous study that observed similar 
attenuations in strength loss when a series of drop jumps were repeated 14-
21 days after an initial bout (Howatson et al., 2009). CK activity was also 
significantly lower following bout 2 than bout 1, an effect typical of the RBE, 
and which has been observed in previous investigations using repeated 
bouts of eccentric exercise (Paulsen et al., 2010a; Stupka et al., 2001). The 
fact that there were no group differences in MIVC, CMJ or CK activity after 
bout 2, would imply, albeit indirectly, that BTJ supplementation did not 
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interfere with the cellular mechanisms postulated to underpin the RBE to a 
single bout of exercise.  
While the precise cellular mechanisms that contribute to the RBE are not 
clear, they are postulated to include an increased expression of inflammatory 
related genes in muscle (Hubal et al., 2008; Xin et al., 2013), a blunted 
inflammatory and oxidative stress response (Hirose et al., 2004; Nikolaidis et 
al., 2007; Pizza, Baylies and Mitchell, 2001; Pizza et al., 2002) that, together, 
drive extensive cytoskeletal and ECM remodelling (Hubal et al., 2008; 
Hyldahl et al., 2015) to protect the muscle from damage when exposed to a 
similar stimulus in the future (McHugh, 2003). Although the aforementioned 
mechanisms were not directly measured in the present study, it is highly 
likely that they are at least partly responsible for the RBE we observed (i.e., 
faster resolution of force deficits, reduced CK efflux). Therefore, the 
magnitude of the RBE would have intuitively been altered if this cascade of 
events had been negatively affected by BTJ. Furthermore, the similar 
responses to bout 2 in both the L-BT and H-BT groups suggest that no dose-
response effects were evident in terms of the magnitude of the RBE 
experienced. Notwithstanding these findings, it is important to acknowledge 
that the effects of BTJ (and at different doses) on longer term adaptive 
responses remains to be elucidated. 
In contrast, only in the PLA group was the decrement in PPT, used as a 
measure of muscle soreness, attenuated in bout 2 versus bout 1. However, 
PPT did not differ between the PLA and BTJ groups in the 72 h period 
following bout 2. Therefore, this discrepancy is likely explained by the fact 
that PPT was significantly improved with BTJ supplementation after bout 1 
(Table 7), but not PLA.  Thus, after bout 2, while no further improvements in 
PPT were evident in the BTJ groups (probably because no BTJ was provided 
on this occasion), there was a significant improvement (or attenuation in 
muscle soreness) in the PLA group, as normally expected with an RBE.  
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The most pertinent new question posed in this study is the examination of 
exercise-induced adaptation after supplementation with an AOX-rich food 
(BTJ), whereas previous studies have predominately focused on the 
potential effects of high dose AOXs vitamin C and E (He et al., 2015; 
Nikolaidis et al., 2012a; Sousa et al., 2013). Furthermore, studies examining 
the effects of AOXs on adaptation to a single bout of eccentrically biased 
exercise, where muscle damage is principally induced via mechanical stress, 
are scarce. Nevertheless, these findings are in agreement with those of a 
recent study, in which 2 weeks of vitamin C and E supplementation did not 
have any adverse effects on adaptation to repeated bouts of downhill running 
(He et al., 2015). Furthermore, they also concur with the study of Theodorou 
et al. (2011) who although not measuring the RBE per se, reported that 11 
weeks of supplementation with vitamin C and E had no effect (positive or 
negative) on the recovery of muscle function following an acute exercise bout 
performed after 4 weeks of resistance training. Nevertheless, a few studies 
have suggested that functional measures of exercise-induced adaptations 
might be blunted by AOX supplementation and these cannot be ignored. For 
instance, Close et al., (2006) reported that vitamin C supplementation (1000 
mg∙day-1) for 14 days following a bout of 30 min of downhill running impaired 
the acute regeneration (within 2 weeks) of isokinetic muscle strength 
compared to a PLA. Deleterious effects with AOX supplementation were also 
demonstrated in a long term trial, where combined ingestion of vitamin C 
(1000 mg∙day-1) and E (235 mg∙day-1) for 12 weeks impaired resistance 
training-induced gains in muscle strength and lean muscle (Bjørnsen et al., 
2015).  
The fact that the aforementioned studies showing negative effects were not 
designed to specifically assess the RBE precludes any direct comparisons to 
the current study. Nevertheless, it is important to highlight that unlike 
previous work, the present study investigated acute adaptive responses after 
consuming a phytochemical rich food in BTJ, not highly concentrated doses 
of vitamin C or E AOXs. It has been proposed that AOX molecules derived 
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from plant sources, such as polyphenols, are likely to elicit distinct 
physiological effects to nutritional AOX supplements, which are typically 
formulated in highly concentrated doses (Nikolaidis et al., 2012a). This is 
possibly due to the fact that 1) AOX-rich functional foods are less likely to 
provide isolated molecules in supra-physiological doses (Sousa et al., 2013), 
which is perhaps due to differences in absorption, bioavailability and 
biotransformation, and; 2) many contain a diverse range of molecules, each 
of which might possess additional biochemical effects beyond just AOX 
(Nikolaidis et al., 2012a). For instance, the BTJ used in the present study 
contains a range of bioactive molecules, such as nitrate, phenolics and 
betalains, which, in addition to being AOXs, have demonstrated anti-
inflammatory, anti-proliferative, chemo-preventive (El Gamal et al., 2014; 
Jädert et al., 2012; Justice et al., 2015; Lechner et al., 2010) and 
hormetic/adaptogenic effects on the endogenous AOX network (Esatbeyoglu 
et al., 2014). This data would suggest that BTJ might possess distinct 
biochemical effects to concentrated AOX sources such as vitamin C and E, 
and this may result in different physiological outcomes in terms of functional 
recovery and the RBE. Further research is needed to clarify the potential 
differing effects of these two supplements on acute adaptive responses to 
eccentric exercise.  
The main limitation of this study is the inability to ascertain the inflammatory 
and oxidative stress response to both bouts of exercise. Thus, it cannot be 
ruled out that the present findings are due to the fact that BTJ had little, if 
any, influence on the level of inflammation and oxidative stress following bout 
1, and that other mechanisms were responsible for the enhanced functional 
recovery observed with BTJ in Chapter 5. With that said, because the 
potential implications of AOX supplementation on exercise performance are 
of most concern for athletes and practitioners, this study purposely limited its 
outcomes to the acute changes in functional recovery markers. Nonetheless, 
it is stressed that based on the present data alone, it cannot be conclusively 
ruled out that BTJ does not influence the RBE at the cellular level or would 
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not influence more long term adaptations to eccentric-heavy exercise 
training.   
Despite these limitations, this is the first study to suggest that acute 
supplementation with an AOX-rich BTJ does not adversely affect the RBE to 
a single bout of exercise. These preliminary findings suggest that athletes 
seeking strategies to increase their AOX intake might favour the use of BTJ 
or other AOX-rich functional foods over high doses of vitamin C and E 
supplements that might interfere with exercise-induced adaptations. 
Nonetheless, future work with higher participant numbers is needed to not 
only corroborate these conclusions, but to examine the chronic use of BTJ in 
the adaptive process to elucidate its influence in longer-term adaptive 
training responses. 
6.5 Perspectives 
This study addressed the 3rd aim of this thesis, which was to investigate the 
effects of acute BTJ supplementation on the RBE to eccentric-heavy 
exercise. There were no differences in the recovery of several indices of 
muscle damage between the BTJ and PLA groups when the exercise bout 
was repeated, which would indicate that BTJ did not negatively affect acute 
adaptation, as reflected by the RBE.  
The results from Chapter 5 suggested that BTJ might serve as a useful 
strategy to alleviate muscle damage after a single bout of exercise. However, 
because of studies proposing that supplements with AOX or anti-
inflammatory functions might adversely affect exercise-induced adaptations 
(Pasulsen et al. 2014a; Paulsen et al. 2014b), it was important to establish, 
albeit acutely, if such effects were evident with BTJ. The fact that no adverse 
effects were demonstrated after BTJ supplementation suggests that athletes 
and recreational exercises might favour its use over high doses of vitamin C 
and E or NSAID supplements.  
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It is important to note however, that the finding in this Chapter should not be 
interpreted to reflect the potential long-term consequences of BTJ 
supplementation on exercise-adaptations. As the aim of this thesis is to focus 
on the short-term provision of BTJ, it is beyond the scope of this thesis to 
determine the long-term effects chronic use might have on exercise-
adaptation.  
Given the findings of Chapter 5, in which BTJ enhanced some indices of 
exercise recovery in recreationally active individuals, and this Chapter, 
showing that BTJ did not adversely affect acute adaption, the next Chapter 
will examine whether acute BTJ intake could aid short-term recovery in a 
more athletic population. In addition to a range of recovery indices, this study 
will also consider whether BTJ can influence subsequent performance.  
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7 Effects of beetroot juice on recovery of 
muscle function and performance between 
bouts of repeated sprint exercise 
Publication arising from this Chapter: Clifford, T., Berntzen, B., Davsion, W. G., 
West, D. J., Howatson, G., & Stevenson, E. J. (2016). Effects of beetroot juice on 
recovery of muscle function and performance between bouts of repeated sprint 
exercise. Nutrients, 8(8), 506 – 523.  
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7.1 Introduction  
Chapter 5 demonstrated that BTJ can minimise some aspects of EIMD and 
help to accelerate exercise recovery after eccentric-heavy exercise. 
However, this study was performed with recreationally active participants, 
which limits the applicability of the findings to more athletic populations, for 
whom the need to optimise recovery is undoubtedly more important. Team-
sport athletes for example, are often required to complete multiple training 
sessions and, in some instances, competitive matches in a weekly cycle. In 
these circumstances, recovery time is likely to be insufficient and subsequent 
performance could be impaired. Thus, identifying recovery strategies that 
could help to minimise the magnitude of EIMD is of great interest in this 
group of athletes. In view of this, this study aimed to address the 4th aim of 
this thesis, which was to investigate the effects of BTJ on muscle damage 
and recovery in team-sport athletes between bouts of repeated sprint 
exercise.  
Repeated sprint exercise (RSE), in which a number of short-duration 
maximal effort sprints (2-6 s) are completed intermittently with brief recovery 
periods (≤60 sec), places a great deal of stress on the physiological and 
musculoskeletal systems (Girard, Mendez-Villanueva, & Bishop, 2011). The 
high energy turnover during RSE induces significant metabolic stress, 
triggering rapid perturbations in the nervous, immune, and endocrine 
systems (Girard et al., 2011), as well as an increased formation of RONS 
(Bogdanis et al., 2013; Jówko, Długołęcka, Makaruk, & Cieśliński, 2014). In 
addition, the high-force eccentric muscle contractions required to accelerate 
and decelerate during RSE places a great deal of mechanical stress on the 
musculoskeletal system, particularly the quadriceps and hamstring muscle 
groups (Howatson & Milak, 2009). It is therefore not surprising that team-
sport players, who routinely engage in RSE in training sessions and 
matches, often display symptoms of muscle damage (i.e., muscle soreness 
and reduced muscle function) that can persist for several days (Duffield et 
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al., 2010; Howatson & Milak, 2009). Because the typical time between 
training sessions and or matches is often not sufficient for full recovery, 
athletes and coaches are continually seeking strategies that could help 
minimise the negative effects of muscle damage, particularly the decrements 
in muscle function (Barnett, 2006; Nédélec et al., 2013).  
The exact mechanisms to explain the causes of muscle damage after RSE 
are not fully understood, but a host of factors such as muscle membrane 
damage, sarcomere disorganization, EC coupling dysfunction, contractile 
protein damage, and inflammation, are all likely to play a role (Hyldahl & 
Hubal, 2014). Furthermore, as alluded to in Chapter 2.3, it has been 
suggested that the generation of RONS in the day’s post-exercise, likely a 
consequence of inflammatory mediated repair processes, might exacerbate 
the existing muscle damage by degrading components of the cytosol that are 
integral to force production (Pizza et al., 2005; Toumi & Best, 2003). A 
number of studies have provided evidence of oxidative stress in the hours 
and days following RSE (Bogdanis et al., 2013; Jówko et al., 2015), 
suggesting that the endogenous AOX system is unable to cope with excess 
RONS production under these conditions. Thus, it would be reasonable to 
assume that the prolonged decrement in muscle function might be, at least in 
part, attributable to excessive oxidant production. This also makes the 
expectation tenable that interventions attempting to combat the excess 
production of RONS and control oxidative stress, such as AOXs, could help 
accelerate the rate of muscle recovery following RSE.  
While the nutritional AOXs vitamin C and E have proven largely ineffective at 
attenuating muscle damage (Nikolaidis et al., 2012a), there is growing 
support for the use of AOX-rich fruit and vegetable beverages as recovery 
aids (see Myburgh et al., 2014; Sousa et al., 2013 and discussion in Chapter 
2.6). Moreover, in Chapter 5, it was demonstrated that BTJ was able to 
protect against some of the symptoms of EIMD, effects that could have been 
mediated by a dampening of oxidative stress. At present however, the effects 
152 
 
 
of BTJ (or any AOX-rich food) on muscle damage, recovery and oxidative 
stress after activity incorporating RSE has not been investigated. 
Additionally, the effectiveness of such an intervention on subsequent 
performance has not been considered. Therefore, the main aim of this study 
was to examine whether BTJ can attenuate losses in muscle function and 
performance between two repeated sprint tests (RST) performed 72 h apart. 
We also examined the effects of BTJ on biochemical markers associated 
with muscle damage, specifically oxidative stress. Based on the findings from 
Chapter 5, it was hypothesized that; 1) BTJ would attenuate muscle function 
deficits and oxidative stress between and after the two repeated sprint tests, 
and; 2) that performance during the second RST would be preserved with 
BTJ compared to a PLA.  
7.2 Methods 
7.2.1 Participants 
A power calculation was conducted to determine an adequate sample size 
for this study. Based on the findings from Chapter 5, with a power of 0.80 
and two tailed α level set at 0.05, the minimum number of participants 
required to detect an 8% (ES = 1.25) difference in CMJ performance 
between groups (SD: 6%) was estimated as n = 10 per group. As such, 
twenty male participants were recruited and gave written informed consent 
for participation in this study (characteristics presented in Table 8). All 
participants were University standard or amateur level team-sports players, 
competing in either soccer (n = 10), rugby (n = 5), basketball (n = 2) hockey 
(n = 2) or handball (n = 1); all testing was performed at the end of the 
competitive season.   
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Table 8 - Descriptive data for participants in the BTJ and PLA groups.  
Group 
Age 
(Years) 
Height 
(m) 
Mass 
(kg) 
BTJ 23 ± 3 1.83 ± 0.90 76.8 ± 9.5 
PLA 21 ± 2 1.77 ± 0.51 73.4 ± 12.4 
Values are mean ± SD (n = 10 per group). No significant differences were detected 
between groups for any variable (P > 0.05). 
7.2.2 Experimental design  
This study employed a double-blind, PLA controlled, independent groups 
design. Participants were required to attend the laboratory for 6 visits over a 
2-week period. The first visit was to familiarise the participants with the study 
procedures and allocate them to either a BTJ or an isocaloric PLA group. As 
in previous Chapters, their baseline MIVC scores were used to match the 
groups. The next 5 visits were performed on consecutive days in the same 
laboratory, at the same time of day, and preceded by an overnight fast. For 
the main trials, participants performed two repeated sprint tests separated by 
72 h (visit 2 = RST1 and visit 5 = RST2) (see Figure 14 for schematic 
outline). A range of dependent variables were taken pre, immediately post, 
24, 48 and 72 h after RST1, and immediately post and 24 h after RST2 to 
monitor recovery. On each occasion, dependent variables were performed in 
the following order: PPT, venous blood draw, CMJ, RSI and MIVC. After 
completing the post-exercise measures participants consumed 1 serving of 
their allocated treatment, and returned to the lab 2.5 h post-ingestion for a 
further blood sample.  
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Figure 14 - Schematic outline of study procedures. 
7.2.3 Repeated sprint test  
The RST consisted of 20 maximal-effort 30 m sprints, interspersed by 30 
seconds of passive recovery. A 10 m deceleration zone was marked out at 
the end of each 30 m sprint, in which participants were required to stop 
within; the 30 second rest period commenced when participants had come to 
a halt. The RST was adapted from previous studies that showed repeated 
sprints with forced decelerations induce substantial muscle damage and 
fatigue in team-sport trained participants (Howatson & Milak, 2009; Keane, 
Salicki, Goodall, Thomas, & Howatson, 2015). Furthermore, the muscle 
damage induced by a similar RST (Howatson & Milak, 2009), seems to 
cause reductions in muscle function comparable to those observed after 
intermittent sport simulations, such as the Loughborough Intermittent Shuttle 
Test (LIST) (Thompson et al., 2001) and competitive matches (Andersson et 
al., 2008). Before performing each RST, participants undertook a 
standardized warm up as per previously described methods (Howatson & 
Milak, 2009). Briefly, participants completed 400 m of self-selected jogging, a 
series of dynamic stretches, and sprints at 60 and 80% of maximal effort. 
Participants were then given a further 5 min to complete their own stretching. 
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Timing gates (Brower Timing Systems, Draper, UT, US) were positioned at 0 
and 30 m to record sprint times. Participants were instructed to give maximal 
effort for each sprint and provided with strong verbal encouragement 
throughout. All testing took place in an air conditioned sprint track in similar 
environmental conditions.  
7.2.4 Maximal isometric voluntary contractions  
Please refer to general methods Chapter 3.6.1 for details on MIVC 
measurement. 
7.2.5 Counter movement jump 
Please refer to general methods Chapter 3.6.2 for details on CMJ 
measurement. 
7.2.6 Reactive strength index  
Reactive strength index (RSI) was used to measure the impact of muscle 
damaging exercise on participant’s ability to utilize the stretch shortening 
cycle and perform explosive actions. In a similar fashion to previous studies 
(Cockburn, Stevenson, Hayes, Robson-Ansley, & Howatson, 2010; 
Cockburn et al. 2012), participants performed a drop jump from a 30 cm box 
and, upon landing, immediately jumped vertically, with instructions to 
minimise ground contact time while maximising jump height. RSI was 
calculated as jump height divided by ground contact time (cm/ms) recorded 
from an optical measurement system (Optojump next, Bolzano, Italy). 
Participants performed 3 maximal efforts separated by 30 seconds of 
passive (standing recovery) with the mean height of the 3 jumps used for 
analysis. The CV for this protocol was calculated as <2%.  
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7.2.7 Treatments and dietary control  
Participants consumed 2 bottles (250 ml per bottle) of their assigned 
treatment (BTJ or PLA) immediately post, 24, and 48 h after RST1 and 
immediately post RST2, equating to 8 servings in total. One bottle was 
consumed immediately after each trial, and one with an evening meal. 
Macronutrient and phytochemical information for these treatments can be 
found in Chapter 3.4. Participants were provided with food dairies to record 
their intake 24 h prior to RST1 up until data collection was complete (24 h 
post RST2; 5 days in total) (see Chapter 3.3 for further details). Average 
energy and macronutrient intake for each group is presented in Table 9. 
Table 9 - Average intake and macro nutrient composition of participant’s 
diets (average of 5 days).  
 Mean dietary intake (5 days) 
 BTJ PLA 
Energy (Kcal) 2554 ± 682 2448 ± 390 
Carbohydrates (%) 41 ± 5 43 ± 6 
Protein (%) 21 ± 3 24 ± 7 
Fat (%) 38 ± 7 33 ± 9 
Values are mean ± SD (n = 10 per group). No significant differences were detected 
between groups for any variable (P > 0.05).  
7.2.8 Muscle soreness 
Site specific muscle soreness was assessed as PPT with a handheld 
algometer (see Chapter 3.6.3 for details).  
7.2.9 Blood sampling  
Venous blood was obtained as described in Chapter in 3.7.  
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7.2.10 Biochemical analysis 
Determination of serum CK and serum hs-CRP is described in section 3.7.1 
and 3.7.2, respectively. Plasma PC was measured according to the 
manufactures instructions with a commercially available assay kit (Cayman 
Chemical, Ann Arbor, Michigan, USA). Samples were analysed in duplicate, 
with inter and intra assays CVs calculated as <5% and <8%, respectively. 
Lipid hydroperoxides (LOOH) were measured in serum using the ferrous 
iron/xylenol orange (FOX) assay (Wolff, 1994). The FOX assay determines 
the susceptibility to iron-induced LOOH formation in blood. Absorbance was 
read at 560 nm using a spectrophotometer (U-2001, Hitachi, England) (range 
0–5 μmol.L−1). Samples were analysed in duplicate, with inter and intra 
assays CVs calculated as <6% and <4%, respectively. Ascorbyl free radical 
(A•−) determination was quantified at room temperature using a Bruker EMX 
series X-band EPR spectrometer (Bruker, Karlsruhe, Germany). One ml of 
plasma was mixed thoroughly with 1 ml of dimethyl sulfoxide (DMSO) and 
slowly flushed into an aqua X multiple bore cavity cell. The EMX parameter 
settings were frequency, 9.785 GHz; microwave power, 20 mW; modulation 
frequency, 100 kHz and modulation amplitude, 1.194 G. All EPR spectra 
were subjected to 3 scans, identically filtered, and analysed using WinEPR 
software (Version 3.2, Bruker WinEPR). The average spectral peak-to-trough 
line amplitude was used to determine free radical concentration. The intra 
assay CV for this analysis was <5%.  
7.2.11 Data analysis  
All data are expressed as mean ± SD and were analysed using IBM SPSS 
Statistics 22 for Windows (Surrey, UK). Please refer to Chapter 3.3 for 
details on the analysis of participant food diaries. Differences between 
participant group characteristics were analysed with an independent samples 
t-test. CMJ, RI, MIVC and PPT were measured (after being corrected for % 
change from baseline) using a mixed model ANOVA; 2 group levels (BTJ vs. 
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PLA) by 7 time levels (pre, post, 24, 48, 72, 73 and 96 h post RST1). The 
same ANOVA was used to analyse all blood indices but with 2 additional 
time levels (2.5 h post RST1 and 2.5 h post RST2). A separate ANOVA was 
used to measure for differences between RST1 and RST2; 2 group levels 
(BTJ vs. PLA) by 2 time levels (pre and post). In the event of a significant 
interaction effect (group*time) Fisher LSD post hoc analysis was performed 
to locate where the significant differences occurred. Statistical significance 
was set at P < 0.05 prior to analyses. To estimate the magnitude of the 
supplements effects, Cohen’s d ES were calculated with the magnitude of 
effects considered either small (0.20-0.49), medium (0.50-0.79) and large 
(>0.80).  
7.3 Results  
There were no between group differences in age, height or mass (Table 8; P 
> 0.05), indicating that the groups were well matched prior to testing. 
Furthermore, there were no differences in participant’s energy and 
macronutrient intake 24 h prior to and throughout the duration of the study 
(Table 9; P > 0.05).  
7.3.1 Repeated sprints  
RPE showed no bout (P = 0.925) or interaction effects (P = 0.584) between 
RST1 and RST2, indicating that perceived exertion was similar for both bouts 
(Table 10). This was reflected in the sprint data, as fastest sprint time and 
fatigue index were also similar between repeated sprint bouts, showing no 
main effects of time, bout, or bout*group interactions (P > 0.05).  
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Table 10 - Sprint and RPE data for the BTJ and PLA groups in the first and 
second repeated sprint test (RST1 and RST2, respectively).  
Group 
Average sprint 
time (s) 
Fastest sprint 
time (s) 
Fatigue index 
(%) 
RPE 
BTJ 
   RST1 
   RST2 
 
4.65±0.25 
4.66±0.24 
 
4.41±0.23 
4.38±0.17 
 
5.60±2.13 
6.48±2.66 
 
15±1 
15±1 
PLA 
   RST1 
   RST2 
 
4.70±0.15 
4.77±0.20 
 
4.48±0.14 
4.53±0.15 
 
4.91±1.51 
5.19±3.21 
 
14±2 
14±2 
 
7.3.2 Functional measures 
All tests of neuromuscular function (CMJ, MIVC, RSI), and PPT, showed 
main effects for time (P < 0.05), indicating that the RST induced muscle 
damage. Immediately post RST1, CMJ height was reduced by 11.8 ± 8.9% 
and 9.6 ± 4.8% (of baseline values) in the BTJ and PLA groups, respectively. 
A group effect showed that CMJ height appeared to recover quicker in BTJ 
vs. PLA throughout the remainder of the testing period (P = 0.048; Figure 
15). Although no group*time interaction effects were present (P = 0.176), 
there was a large ES (1.86) at 72 h post RST1, whereby CMJ height in the 
BTJ group was 7.6% higher than in the PLA group. A group effect for RSI (P 
= 0.030) showed that the maintenance of RSI performance was also greater 
in BTJ vs. PLA throughout the trial (Figure 16). As with CMJ, a large ES 
(1.43) was evident at 72 h post RST1 where RSI had returned to 95.8 ± 9.5% 
of baseline values in BTJ compared to 82.0 ± 9.5% in PLA. There were no 
group effects for PPT (P = 0.368); however, an interaction effect was 
observed (P = 0.013). Post-hoc analysis revealed a group difference at 96 h 
post RST1 (P = 0.012; ES = 0.57); in the BTJ group, PPT had recovered to 
104.7 ± 12.5% of baseline values, while in the PLA group, PPT was 94.3 ± 
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18.0% of baseline values (Figure 17). There were no significant group or 
interaction effects for MIVC (P > 0.05).  
 
Figure 15 - Percentage changes in counter movement jump (CMJ) height 
between repeated sprint tests (RST1 and RST2). *Represents group 
difference (beetroot juice (BTJ) vs. placebo (PLA); P < 0.05). Values are 
mean ± SD (n = 10 per group). 
 
 
 
 
 
161 
 
 
 
Figure 16 - Percentage changes in reactive strength index (RSI) between 
repeated sprint tests (RST1 and RST2). *Represents group difference 
(beetroot juice (BTJ) vs. placebo (PLA); P < 0.05). *Values are mean ± SD (n 
= 10 per group). 
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Figure 17 - Percentage changes in pressure pain threshold (PPT) between 
repeated sprint tests (RST1 and RST2). Values presented are average of the 
three sites measured (calf, CF; rectus femoris, RF; vastus laterialis, VL). 
*Indicates interaction effect beetroot juice (BTJ) vs. placebo (PLA), P < 0.05. 
Values are mean ± SD (n = 10 per group).  
7.3.3 Biochemical indices  
Serum concentrations of hs-CRP remained close to baseline values 
throughout the trial, showing no time, group or interaction effects (P > 0.05). 
Serum CK showed main effects for time (P < 0.001), with the greatest 
increases observed 2.5 and 24 h post RST1 and RST2 in both groups (P > 
0.05; Table 11). However, no group of interaction effects were observed (P > 
0.05). A main effect for time was observed for serum LOOH (P < 0.001); 
LOOH was elevated immediately and at 2.5 h post-RST1 in both groups 
before returning to baseline 24 h post. A transient increase in LOOH was 
also evident at 75.5 h (2.5 h post RST2) but by 96 h had recovered to pre-
exercise values. No group or interaction effects were present for LOOH (P > 
0.05). PC remained largely unchanged after both sprint bouts and showed no 
group or interaction effects (P > 0.05). Likewise, A•−, as measured by EPR, 
showed no time, group or interaction effects throughout the trial (P > 0.05).  
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Table 11 - MIVC, hs-CRP, CK, LOOH, PC and A•− for the BTJ and PLA group’s pre (0 h) - 96 h post RST1.  
 0 h 1 h 2.5 h 24 h 48 h  72 h  73 h 75.5 h  96 h 
MIVC (N)* 
   BTJ 
   PLA 
 
601(100)±89(0) 
590(100)±123(0) 
 
 
554(92)±75(6) 
541(92)±128(7) 
  
545(91)±92(10) 
535(91)±120(6) 
 
 
558(93)±94(10) 
543(92)±130(5) 
 
 
579(96)±121(9) 
544(92)±132(6) 
 
 
516(85)±101(8) 
511(86)±128(6) 
 
  
558(93)±75(8) 
536(91)±121(6) 
 
Hs-CRP (mg∙L
-1
) 
   BTJ 
   PLA 
 
 
0.60±0.72 
0.44±0.39 
 
0.61±0.75 
0.46±0.45 
 
0.57±0.69 
0.44±0.42 
 
0.64±0.56 
0.52±0.52 
 
0.64±0.58 
0.4±0.25 
 
0.52±0.52 
0.34±0.21 
 
0.52±0.49 
0.35±0.21 
 
0.46±0.50 
0.38±0.22 
 
0.48±0.50 
0.38±0.24 
CK (IU∙L
-1
)* 
   BTJ 
   PLA 
 
188±62 
318±145 
 
219±68 
362±154 
 
383±197 
518±274 
 
542±461 
592±321 
 
406±252 
435±255 
 
310±145 
387±273 
 
349±163 
433±290 
 
474±246 
623±423 
 
516±210 
749±423 
LOOH(mmol∙mL
-1
)* 
   BTJ 
   PLA 
 
1.49±0.25 
1.53±0.14 
 
1.68±0.23 
1.79±0.23 
 
1.69±0.37 
1.77±0.40 
 
1.33±0.36 
1.54±0.16 
 
1.46±0.19 
1.57±0.14 
 
1.47±0.17 
1.53±0.12 
 
1.53±0.40 
1.69±0.23 
 
1.74±0.31 
1.94±0.75 
 
1.44±0.21 
1.44±0.14 
PC (μmol∙L
-1
) 
   BTJ 
   PLA 
 
14±6 
16±8 
 
16±0 
19±6 
 
15±6 
14±6 
 
17±5 
13±5 
 
18±7 
14±5 
 
14±5 
18±9 
 
16±5 
16±7 
 
17±10 
15±5 
 
15±6 
15±4 
  A
•-
 (AU) 
   BTJ 
   PLA 
 
5567±1898 
6372±1454 
 
6111±2145 
6730±1337 
 
5883±2044 
6559±2027 
 
6247±1846 
5674±1716 
 
6202±1911 
5225±1088 
 
5809±2238 
6013±671 
 
5752±1854 
5433±1521 
 
5422±2002 
6354±1315 
 
5862±1802 
5819±975 
AU = Arbitrary units. *Denotes time effect (P < 0.05). MIVC, maximal isometric voluntary contraction; hs-CRP, high sensitivity C-reactive protein; CK, creatine kinase; 
LOOH, lipid hydroperoxides; PC, protein carbonyls; A•-, ascorbyl radical.  
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7.4 Discussion  
The main finding of the present study was that BTJ, when compared to a 
PLA, was able to accelerate the recovery of CMJ and RSI performance and 
reduce muscle pain after a muscle-damaging RST, but had no influence on 
sprint performance. Markers of systemic oxidative stress or other 
biochemical indices associated with muscle damage were unaffected by BTJ 
supplementation.  
In both the BTJ and PLA groups CMJ and RSI significantly decreased after 
RST1, indicating the presence of muscle damage; however, both CMJ and 
RSI recovered quicker with BTJ (vs. PLA) during the following +96 h. This 
was most evident at 72 h after the first sprint bout (RST1), whereby CMJ and 
RSI were still significantly lower than baseline values, but restored close to 
pre-exercise values in BTJ group. These findings are consistent with Chapter 
5, in which 3 days of BTJ supplementation enhanced the recovery of CMJ 
performance 72 h after high intensity plyometric activity.   
Interestingly, although BTJ appeared to enhance the recovery of dynamic 
muscle function (CMJ and RSI), isometric strength (MIVC) was unaffected by 
BTJ supplementation. As suggested in Chapter 5, perhaps this discrepancy 
can be explained by the different movement patterns (static vs. dynamic 
function), specific abilities each test measures (power vs. isometric strength) 
and primary mode of contraction (eccentric vs. concentric). Both CMJ and 
RSI are arguably more ecologically valid tests of functional recovery than 
MIVC, particularly for team-sports players as their movement patterns more 
closely reflect the activity required for performance (Gathercole et al., 2015). 
Thus, it would be reasonable to assume that CMJ and RSI are likely to be 
more sensitive tests for detecting decrements in muscle function after RSE in 
team-sports players.  
It was initially hypothesized that sprint performance would be reduced in 
RST2 compared to RST1; a consequence of muscle damage, and that this 
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reduction would be attenuated with BTJ supplementation. However, contrary 
to this hypothesis, aside from a non-significant decrease in average sprint 
time, sprint performance was largely unaffected in RST2 compared to RST1 
(Table 10). The reductions in muscle function were similar ≤24 h after both 
sprints tests though, suggesting that the participants did not become 
accustomed to the sprint test after the first bout. Additionally, BTJ had no 
influence on any aspect of sprint performance, although perhaps our ability 
to detect any differences between groups was limited by the lack of change 
in performance between the two sprint tests. Nonetheless, the fact that sprint 
performance was unchanged seems to contrast with other studies, which 
reported sprint times to still be slower than pre-exercise values up to 72 h 
after an RST similar to the present study (Brown, Howatson, Keane, & 
Stevenson, 2015; Keane et al., 2015; Woolley, Jakeman, & Faulkner, 2015). 
Because the muscle-damaging RST was similar between these studies (in 
fact, the one in the present study was designed to be more challenging), 
perhaps the divergent findings between these studies and the present one is 
due, in large part, to the different training status of the participants. The 
participants in the present study were experienced team-sports players who 
regularly perform RSE as part of training and matches and, thus, may have 
been less vulnerable to prolonged decrements in sprint performance than 
recreationally active participants tested in some of the other studies (Brown 
et al., 2015; Wooley et al., 2014).  
In addition, the fact that CMJ and RI were still significantly depressed at 72 h 
post-RST1, but sprint performance was not, suggests that there is 
dissociation between jump based tests and repeated sprint tests. Indeed, 
previous literature appears to be equivocal on how well sprint and jump tests 
correlate. Some studies demonstrate that the time course of recovery for 
CMJ and sprint performance are similar after muscle-damaging RSE (Brown 
et al., 2015; Wooley et al., 2014), while others agree with the present study 
(Gathercole et al., 2015; Semark, Noakes, Gibson, Lambert, 1999), and have 
found that reductions in CMJ are more prolonged than sprint decrements. A 
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recent study attempted to address this issue by comparing CMJ, drop jumps 
(DJ) and a 20 m sprint test after intermittent exercise and concluded that 
sprint performance seemed to recover more rapidly than both CMJ and DJ 
performance, both of which were still below pre-exercise values 72 h post-
exercise (Gathercole et al., 2015). This led the authors to suggest that CMJ 
and DJ are more sensitive tests of changes in neuromuscular function, which 
could provide an explanation for the dissociation between the jump and 
sprint tests in the present study.  
Due to the fact that oxidative stress has been associated with muscle 
damage after eccentric-heavy exercise (Zerba et al., 1990), and that beetroot 
and its constituents have been shown to act as AOXs (El Gamal et al., 2014; 
Esatbeyoglu et al., 2014; Tesoriere et al., 2004b), it was hypothesized that 
BTJ could attenuate muscle damage by protecting cells against oxidative 
stress. However, the findings of this study do not support this contention. 
There was no evidence that BTJ attenuated oxidative stress as both indirect 
markers (LOOH and PC) and a direct marker of free radical production (A•−) 
were similar between the BTJ and PLA groups at all-time points (Table 11). 
These data are in contrast to a number of previous studies that found AOX-
rich food supplements reduced oxidative stress after high intensity sprint 
exercise (Bell et al., 2014; Jówko et al., 2015). However, unlike these 
studies, there was no evidence of oxidative stress throughout the trial, apart 
from a small increase in LOOH immediately and 2.5 h after both sprint tests 
(Table 11). The modest increase in these markers was unexpected, as 
previous studies reported large systemic elevations in oxidative stress up to 
48 h after high intensity intermittent cycling exercise (Bogdanis et al., 2013; 
Jówko et al., 2015), an activity which, in comparison to running, typically 
results in less oxidative stress because of the absence of an extensive 
eccentric component (Nikolaidis et al., 2008). The divergent findings in 
oxidative stress response between the present and aforementioned studies 
could, therefore, be explained by the different biochemical markers examined 
and/or analytical techniques used. Jówko et al. (2014) for instance, noted 
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systemic increases in total AOX capacity (TAC), superoxide dismutase, and 
glutathione peroxidase (GPX) 24 h after exercise and Bogdanis et al. (2013) 
noted increases in TAC, PC, and GPX; thus, neither study measured LOOH 
or A•− formation, as in the present study. Although this study and Bogdanis et 
al. (2013) both measured PC, different analytical methods were used, which 
could account for the discrepant results. Nonetheless, EPR spectroscopy is a 
very sensitive method for detecting excessive free radical production 
(Buettner & Jurkiewicz, 1993; Pietri, Seguin, Darbigny, & Culcasi, 1994) and 
the fact that there was no evidence of an increase with this marker in the 
present study perhaps draws into question the reliability of the biomarkers in 
other studies using a similar protocol.  
The fact that muscle damage was clearly evident in the days after both RST 
tests but oxidative stress was not, suggests that muscle damage occurred 
independent of any systemic changes in oxidative stress. This would 
perhaps suggest that RONS have a limited role in the muscle damage 
process post-exercise. However, it cannot be ruled out that oxidative stress 
occurred, but was confined predominately to muscle cells and surrounding 
tissues. Unfortunately, muscle samples could not be obtained in this study, 
and as such, this supposition is speculative. A recent review however, 
concluded that skeletal muscle is a prime producer of RONS following 
exercise; so, intuitively, oxidative stress would perhaps be expected to be 
greater in muscle than the circulation (Jackson et al., 2016). Alternatively, the 
muscle damage observed could have been unrelated to oxidative stress. 
Instead, the muscle damage could have been caused by other biochemical 
changes within muscle, such as increased inflammation and calpain activity 
(Belcastro, Shewchuk, & Raj, 1998; Paulsen et al., 2005) or damage to 
components involved in the EC coupling pathway, as previously suggested 
(Warren et al., 2002). 
Serum CK concentrations, incorporated as a surrogate marker of 
sarcolemma damage, were raised to a similar extent in both groups after 
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exercise (Table 11). The increase in CK after the RST was similar to 
previous reports (Howatson & Milak, 2009; Wooley et al., 2015), as was the 
lack of a suppressive effect with an AOX-rich food beverage (Bell et al., 
2014; Howatson et al., 2010). These data suggest that improved 
sarcolemma integrity cannot explain the enhanced rate of recovery by BTJ in 
this study.  
Because there were no changes in oxidative stress between groups, the 
beneficial effects of BTJ on the recovery of CMJ and RSI cannot be 
attributed to an AOX effect of the juice. This suggests that mechanisms other 
than AOX effects were possibly involved. It was beyond the scope of this 
study to examine the role of other mechanisms by which BTJ could attenuate 
muscle damage, but owing to the seemingly pleotropic nature of the 
chemical compounds in BTJ (NOx, phenolics and betalains) there are a 
number of possible candidates. For instance, other effects associated with 
phenolic compounds and NOx donors akin to BTJ are anti-inflammatory (El 
Gamal et al., 2014; Jädert et al., 2012) and regenerative, insofar as they 
appear to have a regulatory role in phagocytosis and promote satellite cell 
proliferation in skeletal muscle (Kruger & Smith, 2012; Rigamonti et al., 2013; 
Sakurai et al., 2013). Increasing in vivo NOx availability has also 
demonstrated additional biochemical and physiological effects that, 
conceivably, could contribute to improved functional recovery after exercise, 
such as reduced calpain activity (Lomonosova et al., 2014), increased 
muscle blood flow (Ferguson et al., 2012) and enhanced muscle power 
potential, possibly via improved Ca2+ handling (Coggan et al., 2014; 
Hernández et al., 2012; Hoon, Fornusek, Chapman, & Johnson, 2015). Thus, 
there are a number of potential physiological mechanisms that could explain 
why BTJ supplementation was able to enhance the recovery of muscle 
function, independent of AOX effects. However, since none of these 
mechanisms were measured per se, it can only be speculated on what role, 
if any, they might have had in the present study’s findings (and those of 
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Chapter 5). Clearly, the potential role of these additional mechanisms and 
their relative contributory effects are worthy of further exploration.  
Participants in the BTJ group reported a significantly higher PPT than the 
PLA group 24 h after the second sprint test (Figure 17). Reduced muscle 
soreness when other AOX-rich food supplements are taken after muscle-
damaging exercise has been reported previously (Connolly et al., 2006; 
Drobic et al., 2014). Chapter 5 also found evidence of improved PPT with 
BTJ after muscle-damaging exercise. The mechanism(s) by which BTJ might 
attenuate muscle pain is unclear, however. Previous reports suggest that the 
betalains in beetroot are responsible for its analgesic effects, most likely via 
an anti-inflammatory related mechanism (Pietrzkowski et al., 2010). The 
possibility that an anti-inflammatory mechanism would be involved is 
supported by data that suggests muscle pain after exercise may stem from 
the release of inflammatory and noxious stimuli (i.e., bradykin and NGF) due 
to tears at the ECM (Crameri et al., 2007; Murase et al., 2010). Perhaps BTJ 
acts to dampen these responses or desensitize pain receptors, as has been 
suggested with curcumin supplements (Drobnic et al., 2014); however, 
whatever the precise mechanisms, they are likely to occur at the skeletal 
muscle level, and thus could not be tested in the present study.  
It is also unclear why BTJ only improved PPT 24 h after RST2 in the present 
study and not at earlier time points, as was shown in Chapter 5. A previous 
study did observe greater reductions in pain scores after participants took 
betalain-rich beetroot supplements for 5-10 days compared to 1 day 
(Pietrzkowski et al., 2010), which, coupled with our data, suggests that the 
analgesic effects of BTJ might be augmented with longer-term dosage 
regimens. Such a possibility needs to be investigated in future studies.  
In conclusion, this study demonstrates that consuming BTJ for 4 days after a 
muscle damaging RST attenuated muscle pain (96 h later) and decrements 
in dynamic muscle function, as measured by CMJ and RSI. These effects did 
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not translate to improved recovery of isometric strength or sprint 
performance however. These data suggest BTJ could be applied as a post-
exercise recovery strategy to help restore some aspects of dynamic muscle 
function in team-sports players between bouts of RSE. However, because 
actual sprint performance was unchanged, which is arguably more 
meaningful to team-sports players, how transferable these findings are to 
real-world team-sport competition is unclear. Future studies are needed to 
clarify the underlying cellular mechanisms, as the beneficial effects of BTJ 
were shown to be unrelated to systemic changes in oxidative stress or other 
biochemical markers of muscle damage. 
7.5 Perspectives 
This study addressed the 4th aim of this thesis, which was to examine the 
effects of BTJ on muscle damage following RSE in team-sports players. 
Findings show that the rate of recovery for some markers of functional 
performance (CMJ and RSI) was improved with BTJ but others (isometric 
strength and subsequent sprint performance) were unaffected. BTJ also 
showed signs of attenuating muscle pain, consistent with the findings of 
Chapter 5.   
The RST proved to be a good model to investigate muscle damage in team-
sport players, given the large decrements in functional performance in the 
ensuing days. However, sprint performance had largely recovered by 72 h 
after the RST, which could explain why markers such as CMJ and RSI that 
were still depressed at this time point were positively influenced by BTJ 
supplementation, but sprint performance was not. This finding also suggests 
that 72 h was sufficient to allow full restoration of repeated sprint 
performance in this cohort of athletes. Perhaps limiting recovery to 48 h 
between repeated sprint tests would have shed more light the potential 
effects of BTJ on the recovery of sprint performance.  
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Another important finding of this study was that oxidative stress, as 
measured by systemic changes in PC and the A-•, was largely absent after 
exercise. There was an increase in LOOH immediately and at 2.5 h post-
exercise but BTJ did not attenuate this rise compared to a PLA, suggesting 
that BTJ did not exhibit any AOX effects in this study. This would suggest 
that any beneficial effect of BTJ on recovery might be unrelated to its AOX 
potential but instead due to other mechanisms. Irrespective of the precise 
mechanisms, this study indicates that BTJ could be a useful strategy for 
mitigating some of the negative symptoms associated with RSE in team-
sports players, notably muscle pain and loss of power generating capacity. 
Coupled with the findings of Chapter 5, the present findings raise the 
possibility that BTJ could be an effective recovery aid after other types of 
muscle-damaging exercise.  
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8 The influence of beetroot juice on muscle 
damage and inflammation following a 
marathon race  
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8.1 Introduction  
In Chapters 5 and 7, BTJ was demonstrated to attenuate some of the 
negative symptoms associated with EIMD, which would indicate that it has 
the potential to be an effective recovery aid following muscle-damaging 
exercise. However, in both these studies, the exercise protocols were 
performed under well-controlled laboratory conditions, which potentially limit 
the applicability of the findings to real-world athletic performance. 
Furthermore, the exercise protocols used to inflict muscle damage in these 
studies (drop jumps and repeated sprints) were relatively short duration (<20 
min) and, thus, may not reflect the muscle damage resulting from more 
prolonged strenuous activities known to precipitate muscle damage, such as 
long-distance running. Thus, in an attempt to widen the applicability of the 
findings from Chapters 5 and 7 to other sporting scenarios, the present 
Chapter sought to investigate the effects of BTJ on muscle damage following 
a marathon running race.  
It has long been established that running a marathon can cause marked and 
prolonged damage to skeletal muscle fibres and the surrounding connective 
structures (Hikida, Staron, Hagerman, Sherman, & Costill, 1983; Warhol et 
al., 1985). From a functional perspective, the ultrastructural damage often 
manifests as a loss in muscle force generating capacity and feelings of 
muscle pain and tenderness in the lower limbs (Areces et al., 2014; 
Howatson et al., 2010; Hill et al., 2014). Typically, these symptoms, 
particularly muscle soreness, become more apparent in the days after the 
marathon (Hill et al., 2014; Howatson et al., 2010); hence, soreness is 
usually referred to as DOMS (Smith, 1992). Such prolonged impairments in 
functional capacity can hinder an individual’s ability to perform exercise and 
even daily activities that incorporate the affected muscle groups. 
Furthermore, muscle soreness, coupled with a restricted range of movement, 
and attenuated muscle function, might increase the propensity for injury 
(Smith, 1992). It is therefore of great interest to identify recovery strategies 
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that could minimise the muscle damage associated with running a marathon. 
Based on the findings in Chapter 5 and 7, BTJ supplementation might offer 
an effective and practical modality for alleviating the deleterious symptoms 
that accompany marathon running. 
A marathon can also evoke a profound inflammatory response, which, as 
alluded to in Chapter 2.2.3, is proposed to be a key driver of secondary 
muscle damage. Evidence for the marked perturbations in immune function 
after marathon running is provided by a number of studies, in which large 
systemic increases in cytokine and leukocyte activity in the hours and days 
were observed following a race (Howatson et al., 2010; Laupheimer, Perry, 
Benton, Malliaras, & Maffulli, 2014; Scherr et al., 2011; Suzuki et a., 2003). 
Consequently, the marathon also serves as useful model to study the acute 
inflammatory response and its relationship with muscle-damaging exercise. 
Additionally, because the increase in inflammation is generally greater than 
after other exercise paradigms, it is perhaps one of the most appropriate 
models for studying the anti-inflammatory potential of an intervention. Thus, 
this study also provided an opportunity to gain a deeper understanding of the 
anti-inflammatory potential of BTJ; an aspect that has received limited 
attention in this thesis so far (see Chapter 5). To test this, a comprehensive 
array of inflammatory makers proposed to play a role in the secondary 
muscle damage process were measured alongside the primary outcome 
measures (muscle function), in the hope that it would shed some light on the 
potential mechanism(s) by which BTJ might alleviate muscle damage and 
facilitate recovery. It was hypothesized that BTJ would be more effective 
than a PLA for attenuating muscle damage and the systemic inflammatory 
response in the 48 h after the marathon. 
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8.2 Methods  
8.2.1 Participants  
Participants were recruited from a pool of runners taking part in the 2016 
Druridge Bay Marathon, Northumberland, UK, which took place on April the 
17th 2016. Based on a previous study that examined recovery after a 
marathon race (Howatson et al., 2010), it was estimated that at 0.80 power 
and 0.05 significance level, the minimum number of participants required to 
detect a ≥10% group difference (SD: 7.5%) in one of our primary outcomes, 
MIVC, would be n = 10 per group. We surpassed this target, with 36 runners 
initially volunteering to participate in this investigation. Two runners dropped 
out during the race after sustaining injuries unrelated to the study 
procedures, thus, thirty-four runners completed all study requirements. A 
summary of their characteristics is presented in Table 12. Female 
participants completed a menstrual cycle questionnaire in order to determine 
menstrual cycle phase. Of those still menstruating, testing fell during the 
early/mid luteal phase. Information regarding eligibility criteria can be found 
in Chapter 3.1.  
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Table 12 - Participant characteristics and training history for the BTJ and 
PLA groups.  
 BTJ (n=17) PLA (n=17) 
Age (yrs) 
Sex (M/F) 
Height (m) 
Mass (kg) 
Yrs running 
Average weekly mileage 
Longest training run (miles) 
Previous marathons 
Predicted finish time 
Actual finish time 
Pre-post change in body mass (kg) 
Pre-post change in plasma volume (%) 
42±10 
10/7 
1.71±0.09 
69.7±10.4 
13±11 
34±11 
20±2 
12±14 
04:04:06 
04:05:39 
1.3±0.9 
0.5 ± 5.3 
39±12 
11/6 
1.72±0.08 
71.0±11.3 
7±6 
32±10 
21±2 
19±38 
04:09:24 
04:28:29 
1.3±0.8 
−1.9 ± 5.7 
Values are mean ± SD. There were no differences between groups for any variable 
(P> 0.05). 
8.3 Study design 
This study employed a double blind, placebo-controlled, independent group 
design with two experimental arms. Participants were allocated to receive 
either BTJ; n = 17 or a PLA; n = 17 for 3 days after a marathon race, with the 
first supplement taken immediately after a series of post-race marathon tests 
had been completed. All participants recorded their dietary intake throughout 
the trial (24 h prior to until 48 h after the marathon) (See Chapter 3.3 for 
further details). The groups were matched according to predicted marathon 
finish times and contained a similar number of females and males (Table 12). 
Participants attended the lab on 3 occasions in total: the first was in the week 
leading up to the marathon to collect baseline measures, and the other two 
on consecutive days after the marathon. Pre-marathon (baseline), 
immediately post-marathon, and on two days after the marathon (day 1 and 
day 2) participants had a blood sample taken, rated their muscle soreness, 
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and completed a CMJ and MIVC test. Participants were fully familiarised with 
these procedures on their baseline visit.  
8.3.1 Supplementation  
Please refer to general methods Chapter 3.4 for further details on the 
supplements used in this study. With regards to timings, in the present study, 
participants consumed 3 bottles (250 ml each) of their assigned supplement 
on the day of the marathon (immediately post-marathon, 3 h later and at 
20:00); another 3 bottles on day 1 post (upon waking, with lunch and at 
20:00) and 1 bottle (upon waking) on day 2 post. The rationale for providing 
3 daily servings after the marathon was based on the findings from Chapter 5 
that showed 3, 250 ml servings taken after muscle-damaging exercise 
attenuated muscle pain and muscle function deficits in the ensuing days. 
Furthermore, because it has been shown that systemic inflammation is still 
significantly elevated in the days after a marathon, 3 servings were also 
provided on day 1 post-marathon in an attempt to counteract this stress (Hill 
et al., 2015; Scherr et al., 2011).  Participants were given written instructions 
on when to consume their supplements. They were also asked to complete a 
checklist, which was to be returned to the principle investigator at the 
conclusion of the study to ensure compliance.  
8.3.2 Marathon race 
The race consisted of 4 laps of the Druridge Bay Country Park situated on 
the Northumberland coast (Morpeth, UK). The course is mostly flat and 
across a mix of grassy or concrete terrain; however, approximately 1 mile of 
each lap was on soft sand (see Figure 18 for race route). At 09:00, when the 
race started, the air temperature was 3.8˚C, humidity 82%, barometric 
pressure 1013 hpa and wind speed 9 km∙h-1. Towards the end of the race 
(13:00-14:00) there was an increase in air temperature (8.5°C) and wind 
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speed (14 km∙h-1) with the humidity dropping (62%). It remained dry and 
mostly overcast for the duration of the race with intermittent sunny spells.  
 
 
Figure 18 - Marathon race route.  
 
START/FINISH 
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8.3.3 Maximal voluntary isometric contraction 
Please refer to general methods Chapter 3.6.1 for details on MIVC 
measurement. 
8.3.4 Countermovement jump  
Please refer to general methods Chapter 3.6.2 for details on CMJ 
measurement.  
8.3.5 Muscle soreness 
Muscle soreness was measured as per previously described methods 
(Howatson et al., 2009). After performing a squat (at ~90˚ knee flexion), 
participants rated their perceived level of muscle soreness (lower limbs only) 
by drawing a vertical line on a VAS, in which 0 represented ‘no soreness’ 
and 200 mm represented ‘unbearably painful’. The line placement was 
measured with a ruler and recorded in mm.  
8.3.6 Blood sampling and biochemical analysis  
For details of blood sampling procedures please refer to general methods, 
Chapter 3.7. Haemoglobin, haematocrit, and leukocytes were measured in 
whole blood using an automated haematology system (Sysmex XE-2100, 
Illinois, US). According to data provided by the laboratory, the CV’s for this 
procedure are typically <10%. Haemoglobin and haematocrit were used to 
calculate pre-post marathon changes in plasma volume according to the 
methods of Dill & Costill (1974). Serum concentrations of cytokines and 
growth factors were measured according to the manufacturer’s instructions 
using a multiplex sandwich chemiluminescent immunoassay kit (Evidence 
Investigator, Randox Laboratories, Northern Ireland, UK). Inter and intra 
assay CV’s were below 5%.  
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CK, hs-CRP and AST were measured in serum using an automated system 
based on an electrochemiluminescence method (Roche Modular, Roche 
Diagnostics, UK). According to data provided by the laboratory, the typical 
CV for these measures with this procedure is <5%.  
8.3.7 Data Analysis 
All data are expressed as mean ± SD and statistical significance was set at P 
< 0.05 prior to analyses. Please refer to Chapter 3.2 for details on the 
analysis of participant food diaries. Differences in participant group 
characteristics were analysed with multiple student t-test’s. All blood 
variables were adjusted for plasma volume changes prior to analyses. 
Dependent variables (MIVC, CMJ, VAS and all blood indices) were analysed 
using a mixed model ANOVA with 2 independent group levels (BTJ vs. PLA) 
and 4 repeated measures time points (pre, post, day 1 and day 2 post). If the 
ANOVA indicated a significant interaction effect (drink*time) Fisher LSD post 
hoc analysis was performed to locate where the significant differences 
occurred. Homogeneity of variance was checked with Mauchly’s test of 
sphericity and in the event of a significant result, Greenhouse-Geisser 
adjustments were used. All data were analysed using IBM SPSS Statistics 
22 for Windows (Surrey, UK). 
8.4 Results 
There were no between group differences for training history and personal 
characteristics suggesting that the groups were well matched before the 
marathon (Table 12). Mass decreased to a similar extent in both groups after 
the marathon. Changes in plasma volume from pre-post marathon were 
modest and did not differ between groups (P > 0.05).  
Average energy intake did not differ between groups (BTJ, 2488 ± 607 vs. 
PLA, 2308 ± 480 kcal), nor did the proportion consumed from carbohydrates 
(BTJ, 49.88 ± 0.07 vs. PLA, 46.76 ± 0.05%) and protein (BTJ, 16.38 ± 0.02 
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vs. PLA, 14.71 ± 0.04%) (P > 0.05). The proportion of calories from fat was 
slightly higher in the PLA vs. BTJ group (P = 0.032; 36.12 ± 0.04 and 32.06 ± 
0.06%, respectively).  
8.4.1 Muscle function and muscle soreness 
All muscle function tests (CMJ and MIVC) and muscle soreness showed a 
main effect of time (P < 0.001), indicating the presence of muscle damage 
after the marathon (Figure 19 and Figure 20). Relative to baseline values, 
CMJ decreased to a similar extent in the BTJ and PLA groups immediately 
post-marathon (71.4 ± 18.5 vs. 69.2 ± 20.5%, respectively) and remained 
similarly depressed at day 2 (94.5 ± 8.86 vs. 95.3 ± 5.9%, respectively). No 
group or interaction effects were present at any time point (P > 0.05). MIVC 
was less affected by the marathon than CMJ and had recovered to pre-
marathon values by day 2 (BTJ: 100.6 ± 13.5 vs. PLA: 99.1 ± 10.6% of 
baseline). MIVC recovery was independent of treatment with no group or 
interaction effect observed (P > 0.05). Muscle soreness was greatest 
immediately after the marathon and was largely absent at day 2 (Figure 20). 
No group or interaction effects were present (P > 0.05).  
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Figure 19 - (A) Percentage change from baseline in counter movement jump 
(CMJ) height before and after the marathon (beetroot juice; BTJ, placebo; 
PLA). (B) Percentage change from baseline in maximal isometric voluntary 
contractions (MIVC) before and after the marathon. *Represents time effect 
(P < 0.05). Values are mean ± SD (n = 17 per group).  
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Figure 20 - (A) Serum creatine kinase (CK) concentrations before and after 
the marathon (beetroot juice; BTJ, placebo; PLA). (B) Muscle soreness 
(VAS) before and after the marathon. *Represents time effect (P < 0.05). 
Values are mean ± SD (n = 17 per group). 
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8.4.2 Leukocytosis, inflammation and liver function  
Total blood leukocyte counts demonstrated main effects for time (F (3, 90) = 
200.16; P < 0.001) increasing 1.7 fold (average across groups) immediately 
after the race. Leukocytes were still raised above pre-marathon levels on day 
1 (P < 0.001) and day 2 post-marathon (P < 0.05); however, no group or 
interaction effects were present (P > 0.05; Table 13). Neutrophils and 
monocytes followed the same pattern, peaking immediately after the 
marathon and not returning to baseline by day 2 post-marathon in both 
groups (P < 0.05). No group or interaction effects were present at any time 
point for these measures (P > 0.05).  
Serum CK and AST demonstrated main effects for time (P < 0.001) but no 
group or interaction effects were present (P > 0.05). In both groups CK and 
AST increased immediately after the marathon, peaked day 1 post, and 
although were attenuated on day 2, still remained higher than pre-marathon 
values (Figure 20 and Table 13, respectively). Serum hs-CRP also 
demonstrated main effects for time (F (3, 87) = 45.30; P < 0.001) and was 
elevated on day 1 and day 2 post-marathon (Table 13). There were no group 
or interaction effects for hs-CRP (P > 0.05). 
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Table 13 - Serum inflammation and liver function response before and after 
the marathon in the BTJ and PLA groups.  
Values are mean ± SD, n = 17 per group. *Elevated above baseline values (P < 0.05). hs-
CRP, high sensitivity-C-reactive protein; AST, aspartate aminotransferase, CK, creatine 
kinase.  
8.4.3 Cytokines, growth factors and chemokines 
Changes in cytokine, growth factor, and chemokine activity pre to post 
marathon are displayed in Table 14. Immediately post-race, the serum 
cytokines IL-6, IL-8, IL-10 and TNF-α all increased (time effect; P < 0.001). 
IL-6 was the only cytokine still significantly elevated on day 2 (~0.9 fold 
change in BTJ and ~0.5 fold in PLA) but no significant group or interaction 
effects were present (P > 0.05). Other cytokines measured (IL-ra, IL-2, IL-4 
and IFN-γ) did not rise appreciably at any time point after the marathon in 
either group (P > 0.05). VEGF was unchanged after the marathon but EGF 
Biomarker 
 
Pre race Post race Day 1 post Day 2 post 
Leukocytes  
(10*
9 
cells
∙
L
-1
) 
   BTJ 
   PLA 
Neutrophils 
(10*
9 
cells
∙
L
-1
) 
   BTJ 
   PLA 
Monocytes 
(10*
9 
cells
∙
L
-1
) 
   BTJ 
   PLA 
Hs-CRP  
(mg∙L
-1
) 
   BTJ 
   PLA 
AST  
(IU∙L
-1
) 
   BTJ 
   PLA 
 
 
6.26 ± 1.11 
5.25 ± 1.5 
 
 
3.55 ± 1.01 
2.67 ± 1.07 
 
 
0.51 ± 0.11 
0.50 ± 0.17 
 
 
0.88 ± 1.16 
0.70 ± 0.82 
 
 
21.66 ± 7.43 
23.25 ± 12.47 
 
 
15.24 ± 2.90
*
 
15.22 ± 3.60
*
 
 
 
12.55 ± 2.55
*
 
12.52 ± 3.49
*
 
 
 
1.00 ± 0.38
*
 
1.06 ± 0.27
*
 
 
 
0.62 ± 0.62 
0.57 ± 0.71 
 
 
30.68 ± 9.25
*
 
31.24 ± 7.36
*
 
 
 
7.46 ± 2.02
*
 
7.10 ± 1.44
*
 
 
 
4.21 ± 1.23
*
 
3.88 ± 1.13
*
 
 
 
0.65 ± 0.21
*
 
0.61 ± 0.13
*
 
 
 
12.22 ± 9.03
*
 
11.37 ± 10.10
*
 
 
 
49.97 ± 29.44
*
 
60.28 ± 48.80
*
 
 
 
7.28 ± 1.94
*
 
6.47 ± 1.47
*
 
 
 
4.04 ± 1.13
*
 
3.38 ± 0.89
*
 
 
 
0.68 ± 0.16
*
 
0.62 ± 0.20
*
 
 
 
7.18 ± 4.49
*
 
6.10 ± 4.90
*
 
 
 
41.16 ± 23.5
*
 
48.94 ± 31.79
*
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showed main effects for time (F (3, 90) = 23.47; P < 0.001), initially decreasing 
after the marathon before increasing at day 1 and day 2; however, no group 
or interaction effects were observed (P > 0.05). The chemokine, MCP-1, 
demonstrated a main effect for time (F (3, 90) = 151.88; P < 0.001) increasing 
in BTJ (~2 fold-change) and PLA (~1.9 fold change) immediately after the 
marathon. MCP-1 was still elevated on day 2 post marathon but to a similar 
extent in both groups with no group or interaction effects present (P > 0.05). 
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Table 14 - Serum cytokine, growth factor, and chemokine response before 
and after the marathon in the BTJ and PLA groups.  
Values are mean ± SD, n = 17 per group. *Elevated above baseline values (P < 
0.05); #Decreased below baseline levels (P > 0.05). IL-1-ra, interleukin 1-receptor 
agonist; IL-1β, interleukin-1beta; IL-2, interluekin-2; IL-4, interleukin-4; IL-6, 
interleukin-6; IL-8, interleukin-8; IL-10, interleukin-10; TNF-α, tumor necrosis factor-
alpha; VEGF, vascular endothelial growth factor; EGF, epidermal growth factor; 
INF-γ, interferon-gamma; MCP-1, monocyte chemoattractant protein 1.  
 
 
 
 
Biomarker 
(pg/ml) 
Pre race Post race Day 1 post Day 2 post 
IL-1ra 
   BTJ 
   PLA 
IL-1β 
   BTJ 
   PLA 
IL-2 
   BTJ 
   PLA 
IL-4 
   BTJ 
   PLA 
IL-6 
   BTJ 
   PLA 
IL-8 
   BTJ 
   PLA 
IL-10 
   BTJ 
   PLA 
TNF-α 
   BTJ 
   PLA 
VEGF 
   BTJ 
   PLA 
INF-γ 
   BTJ 
   PLA 
EGF 
   BTJ 
   PLA 
MCP-1 
   BTJ 
   PLA 
 
0.38 ± 0.27 
0.39 ± 0.27 
 
1.44 ± 0.72 
1.79 ± 1.03 
 
2.89 ± 3.32 
4.19 ± 3.00 
 
2.15 ± 0.61 
2.52 ± 0.78 
 
1.15 ± 0.48 
1.02 ± 0.51 
 
7.60 ± 3.57 
8.38 ± 5.83 
 
0.94 ± 0.35 
1.62 ± 1.01 
 
2.98 ± 1.13 
2.81 ± 0.70 
 
127.41 ± 86.69 
100.66 ± 77.58 
 
0.52 ± 0.51 
0.42 ± 0.32 
 
22.55 ± 20.36 
27.68 ± 34.97 
 
178.49 ± 85.24 
172.75 ± 52.12 
 
0.31 ± 0.12 
0.37 ± 0.24 
 
3.09 ± 1.41* 
2.29 ± 1.21* 
 
4.96 ± 8.72 
3.84 ± 2.97 
 
2.13 ± 0.41 
2.32 ± 0.73 
 
31.12 ± 15.93* 
31.42 ± 25.12* 
 
19.34 ± 8.95* 
19.22 ± 10.91* 
 
17.55 ± 16.42* 
16.58 ± 19.01* 
 
3.61 ± 1.34* 
3.17 ± 0.77* 
 
131.57 ± 112.48 
97.24 ± 102.34 
 
0.51 ± 0.65 
0.34 ± 0.24 
 
17.68 ± 13.25
#
 
10.37 ± 10.15
#
 
 
537.22 ± 107.60* 
486.49 ± 190.83* 
 
0.29 ± 0.09 
0.38 ± 0.22 
 
1.76 ± 0.60 
2.26 ± 1.70 
 
2.85 ± 2.57 
4.34 ± 3.16 
 
2.25 ± 0.45 
2.36 ± 0.68 
 
2.26 ± 1.89* 
1.53 ± 0.58* 
 
7.00 ± 3.06 
6.94 ± 4.93 
 
0.90 ± 0.18 
1.36 ± 0.72 
 
2.94 ± 0.84 
2.70 ± 0.58 
 
144.87 ± 101.78 
121.54 ± 99.59 
 
0.43 ± 0.61 
0.43 ± 0.31 
 
59.24 ± 47.00* 
50.94 ± 37.99* 
 
235.82 ± 60.80* 
222.19 ± 78.08* 
 
0.30 ± 0.09 
0.37 ± 0.31 
 
1.63 ± 0.77 
2.45 ± 2.31 
 
2.87 ± 2.52 
6.75 ± 10.03 
 
2.56 ± 0.81 
2.38 ± 0.78 
 
1.64 ± 0.73 
1.05 ± 0.47 
 
7.78 ± 4.03 
6.83 ± 6.40 
 
1.34 ± 1.74 
1.50 ± 1.02 
 
3.17 ± 1.15 
2.95 ± 1.01 
 
144.74 ± 94.74 
120.5 ± 100.09 
 
0.61 ± 0.77 
0.66 ± 0.86 
 
72.21 ± 45.06* 
58.35 ± 43.95* 
 
225.92 ± 76.46* 
198.28 ± 69.59* 
188 
 
 
8.5 Discussion 
It was hypothesized that BTJ would enhance the recovery of muscle function 
and attenuate muscle soreness after a marathon race, possibly by reducing 
the acute inflammatory response shown to accompany long-distance 
running. However, contrary to this hypothesis, BTJ did not favourably affect 
the recovery of muscle function or attenuate muscle soreness in the 2 days 
after the marathon. In addition, biochemical markers of inflammation or 
muscle damage measured before and up to 2 days after the race did not 
differ between the BTJ and PLA groups, suggesting that BTJ was ineffective 
for attenuating the acute inflammatory response after marathon running.   
The findings in the present study are in contrast to a previous study that 
examined the effects of a phytonutrient rich drink (cherry juice) on EIMD after 
a marathon (Howatson et al., 2009). In this study, cherry juice 
supplementation was shown to attenuate biomarkers of inflammation (IL-6) 
and oxidative stress (TBARS) in the 48 h following the marathon; effects that 
were associated with an accelerated recovery of MIVC (Howatson et al., 
2010). There are, however, some differences in study design that could 
account for these discrepant findings. Apart from the obvious difference in 
that cherry juice was used as opposed to BTJ and, therefore, the biological 
activities of the phytonutrients in each drink likely differ, Howatson and 
colleagues (2010) also provided supplements in the 5 days leading up to the 
marathon, as well as the 3 days after. By contrast, in the present study, 
supplementation only began after the marathon race; thus, the discrepancy 
in findings between these two studies could be due, at least in part, to the 
different dosage strategies used. Speculatively, a more long-term 
prophylactic dosage strategy could have been required to mediate similar 
recovery benefits with BTJ after the marathon.  
The lack of benefit with BTJ in the current study is also in direct contrast to 
the findings in previous Chapters, in which BTJ was shown to enhance the 
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recovery of CMJ performance and PPT in the days following strenuous 
plyometric exercise (Chapter 5) and RSE (Chapter 7). The differences in 
exercise protocol (marathon race), participant cohort (experienced marathon 
runners) and techniques used to assess EIMD (VAS vs. PPT) between the 
present and previous studies are all factors that could provide a potential 
explanation for these disparate results. Another possible explanation is 
related to the magnitude of the muscle damage response, which, in the 
present study, was markedly lower, and largely absent by 2 days post. 
Additionally, in contrast to the previous studies (Chapter 5 and 7), there was 
no further loss in muscle function in the post-exercise period. It is therefore 
possible that the small magnitude of muscle damage in this study might have 
limited our ability to detect any subtle differences between groups. Indeed, it 
would be reasonable to assume that any recovery benefits associated with 
BTJ or any recovery intervention would only be evident when muscle 
damage is still present. The present data suggests that the marathon runners 
in this study might have already been sufficiently well protected from marked 
and prolonged symptoms of muscle damage and, thus, BTJ conferred no 
benefits for recovery.  
After strenuous exercise, leukocytes, mostly neutrophils and monocytes, 
migrate from the circulation into damaged muscle in order to degrade 
structural components and, thus, are thought to play a major role in 
secondary muscle damage after exercise (Butterfield et al., 2006; Pizza et 
al., 2005). As alluded to in earlier Chapters (2.7.4), several of the phenolic 
compounds and pigments in BTJ have been shown to exhibit ant-
inflammatory activity (El Gamal et al., 2014; Vulic et al., 2014), and there is 
also evidence that NOx, which can be endogenously generated from the 
nitrate in BTJ (Chapter 4; Wylie et al., 2012), is a critical regulator of 
inflammation (Waltz, Escobar, Botero, & Zuckerbraun, 2015; Weitzberg & 
Lundberg, 2013). As such, it was hypothesized that BTJ might inhibit 
leukocytosis, which, in turn, might reflect a preservation of muscle cell 
integrity and functional strength. However, contrary to this hypothesis, 
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leukocyte accumulation in the circulation was unaffected by BTJ 
supplementation. As shown in Table 13, while the marathon provoked a 
large inflammatory response, with total leukocyte counts, neutrophils and 
monocytes still elevated above pre-marathon values 2 days’ post, the 
magnitude of change was not different in the PLA and BTJ groups. These 
results suggest that BTJ, at least at this dose and in marathon runners, did 
not modulate the systemic leukocyte response after exercise. Based on 
these data, perhaps it is unsurprising this study did not find any beneficial 
effect of BTJ on muscle soreness and muscle function.  
BTJ also had no effect on AST, hs-CRP or a host of cytokines in the days 
after the marathon race. Several cytokines were increased immediately after 
the marathon race (IL-6, IL-8 and TNF-α), which is in agreement with 
previous studies that examined the early cytokine response after long 
distance running events (Howatson et al., 2010; Nieman et al., 2002; 
Shanely et al., 2013; Scherr et al., 2011). However, some of the cytokines 
measured did not change at all after the marathon (IL-1β, IL-1ra, IL-2, IL-4, 
IFN-y) and only IL-6 was elevated above pre-exercise values in the days 
after the marathon. These findings are in contrast to a previous study that 
found experienced runners still exhibited elevated levels of TNF-α and IL-10 
>1 day after a marathon race (Scherr et al., 2011). This study did contain a 
larger cohort of participants than the present study however (n = 105), so 
perhaps this study was underpowered to detect such small changes in these 
markers. Nonetheless, the present findings suggest that cytokines, at least at 
the systemic level, might not play a significant role in the secondary muscle 
damage process in the days after the marathon. Instead, their activity might 
be primarily limited to the muscle and surrounding tissues, as previously 
suggested after other types of exercise (Peake et al., 2015a). It is possible 
that had blood samples been taken at additional time points however, 
specifically between the end of the marathon and day 1, several of these 
cytokines would have still been elevated. This might have been a better time 
in the post-exercise period for detecting potential differences between the 
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groups. Likewise, if supplements had been consumed in the days before the 
marathon, as in the study by Howatson et al. (2010), group differences might 
have been apparent at the post-marathon time point, or have at least been 
easier to detect, given the majority of biomarkers were significantly elevated 
at this point (Table 13 and Table 14).  
In contrast to many of the cytokines, the chemokine, MCP-1, and the growth 
factor, EGF, were still significantly elevated at 2 days’ post-marathon, 
suggesting that they have more prominent roles in muscle damage after 
exercise. Indeed, MCP-1, also known as CCL2, is thought to play a 
particularly important role in resolving muscle damage after exercise, via its 
effects on facilitating macrophage infiltration and activating resident satellite 
cells (Hubal et al., 2008; Urso et al., 2013; Warren et al., 2004). Nonetheless, 
as with the other inflammatory markers measured in this study, MCP-1 was 
unaffected by BTJ supplementation.  
As seen in previous marathon studies, serum CK activity was markedly 
increased, peaking 1 day after the race (Howatson et al., 2010; Hill et al., 
2015). The magnitude of CK release did not differ between the groups 
however, which is consistent with previous Chapters (5 and 7) and the work 
of others who report no benefit of functional foods akin to BTJ on CK efflux 
after muscle damaging exercise (Bell et al., 2014; Howatson et al., 2010; 
Trombold et al., 2010).  
In conclusion, this study reports that consuming BTJ for 3 days after a 
marathon does not attenuate muscle soreness, enhance the recovery of 
muscle function or attenuate biochemical markers of inflammation and 
muscle damage in experienced marathon runners. Because muscle fucntion 
recovery was largely complete, and muscle soreness absent by 2 days after 
the marathon, the experienced runners in this study might have already been 
sufficiently well-trained to protect against high levels of muscle damage; 
thus, BTJ provided no additional benefit. Notwithstanding, future studies 
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might benefit from including a loading phase in the days leading up to the 
marathon.  
8.6 Perspectives  
The overall aim of this thesis is to determine whether BTJ is more effective 
than a PLA for attenuating muscle damage and enhancing recovery following 
strenuous exercise. In previous Chapters (5 and 7), BTJ was associated with 
an improved recovery of muscle function and reduced feelings of muscle 
pain after high volume plyometric exercise and high-intensity RSE. It was 
therefore anticipated that BTJ might also help to protect against muscle 
damage following a marathon, which involves a high volume of eccentric 
muscle contractions and, thus, typically results in a prolonged muscle 
damage response. However, the results presented in this Chapter suggest 
that BTJ is not an effective recovery aid following marathon running. Muscle 
function, as measured by MIVC and CMJ performance, and muscle 
soreness, as measured with a VAS, did not differ in the BTJ and PLA groups 
in the 2 days after the marathon. Furthermore, a host of inflammatory 
markers were unaffected by BTJ supplementation.  
There are several factors that could explain the discrepant results between 
this study and the previous studies in this thesis. These include but are not 
limited to differences in exercise model, participant training status, timing of 
measures and measurement tools used. Perhaps the biggest difference in 
the present study is that the magnitude of muscle damage was much lower 
than that reported in the two previous studies. This could be because the 
marathon runners in the present study were experienced (16 previous 
marathons completed on average per group) and, therefore, possibly 
sufficiently well accustomed to protect against muscle soreness and 
prolonged deficits in muscle function. Irrespective of the exact reasoning, this 
study does not support the use of BTJ to alleviate muscle damage and 
193 
 
 
accelerate recovery in athletes already accustomed to the EIMD associated 
with long distance running events.  
Furthermore, although the original hypothesis was that BTJ might enhance 
recovery by reducing post-exercise inflammation, there was no evidence of 
this in the present study. Perhaps this could explain why BTJ was ineffective 
at enhancing functional recovery. Nonetheless, the fact that inflammation did 
not differ between the groups would suggest that any benefits of BTJ on 
exercise recovery could be unrelated to an anti-inflammatory effect per se. In 
order to gain a deeper understanding of the potential mechanisms by which 
BTJ has benefitted exercise recovery, it would be useful to know which 
compounds in BTJ are most likely to exert positive effects for recovery. Thus, 
the final Chapter in this thesis attempted to isolate the effects of the nitrate in 
BTJ from the other phytonutrients (i.e., phenolic and betalainic compounds) 
on EIMD.  
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9 Comparison of the effects of beetroot juice 
and sodium nitrate on exercise-induced 
muscle damage  
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9.1 Introduction  
The data presented in this thesis so far has demonstrated that BTJ might be 
beneficial for attenuating indices of EIMD after some (plyometric exercise 
and RSE; Chapters 5 and 7, respectively) but not all (marathon running; 
Chapter 8) forms of exercise. Notwithstanding these equivocal findings, an 
intriguing question that still remains is what are the compounds in BTJ 
primarily responsible for exerting some of these positive effects? Indeed, it is 
unclear whether some of the beneficial effects of BTJ seen in previous 
Chapters is attributable to the phenolic and betalainic compounds in BTJ, as 
is proposed for other functional foods (Bell et al., 2014; Bell et al., 2015; 
Bowtell et al., 2011; Howatson et al., 2010; Trombold et al., 2010; Trombold 
et al., 2011), or, the nitrate in BTJ, as has been suggested by other work 
(Lomonosova et al., 2014; Rigamonti et al., 2013). Thus, the aim of the final 
investigation in this thesis was to gain a more in-depth understanding of the 
role the nitrate component of BTJ has in exerting protection against EIMD.  
As demonstrated in Chapter 4, BTJ is rich in a variety of phenolic and 
betalainic compounds. Many of these compounds are endowed with 
interesting biological activities that include, but also extend beyond anti-
inflammatory and AOX and, thus, at least theoretically, they could be of 
benefit for exercise recovery (see Chapter 2.6). In support, several studies 
have demonstrated that EIMD is attenuated after consuming functional food 
supplements rich in AOX phenolic compounds (Bell et al., 2014; Bell et al., 
2015; Bowtell et al., 2011; McLeay et al., 2012; Howatson et al., 2010; 
Trombold et al., 2010; Trombold et al., 2011), evidencing that this class of 
nutrients appears to have a positive role in recovery after exercise. 
Consequently, it would be reasonable to assume that any beneficial effects 
of BTJ on exercise recovery would be mediated, in large part, by the high 
number of phenolic and betalainic compounds it contains.  
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However, unlike other functional foods shown to attenuate EIMD, BTJ is 
unique in that it also contains high amounts of nitrate, a precursor for 
endogenous NOx production (Lundberg et al., 2008; Kapil et al., 2014). It has 
become apparent that NOx has a regulatory influence on several of the 
biological processes often impaired (microvascular blood flow, Ca2+ 
handling) (Ferguson et al., 2013; Ferguson et al., 2014; Hernandez et al., 
2013; Hoon et al., 2015) or upregulated (phagocytosis, calpain activity and 
myogenesis) (Jädert et al., 2012; Lomonosova et al., 2014; Rigamonti et al., 
2013) after muscle-damaging exercise. Due to the potential involvement of 
NOx in the damage and repair processes in skeletal muscle, it has been 
suggested that NOx donors, such as nitrate for example, could offer a 
therapeutic approach to enhance recovery after muscle injury (Lomonosova 
et al., 2014; Rigamonti et al., 2013). However, the effects of nitrate on 
muscle recovery have not been tested in humans. A greater understanding 
of the role of nitrate in EIMD could help to elucidate the mechanisms behind 
some of the benefits seen with BTJ on recovery in this thesis so far. It would 
also help to answer the question of whether these effects are exclusive to 
BTJ and its somewhat unique mixture of phytonutrients, or whether similar 
effects could be expected with foods that are just simply rich in nitrate. Thus, 
the aim of this study was to investigate the effects of BTJ versus a nitrate 
only containing drink (SN) on muscle damage following a bout of eccentric-
heavy exercise. It was hypothesized that BTJ and SN would be similarly 
effective for attenuating indices of muscle damage compared to a PLA.   
9.2 Methods  
9.2.1 Participants  
According to the findings from Chapter 5, a sample size of n = 10 per group 
was sufficient to detect an 8% (ES = 1.25) between group difference (SD: 
6%) in CMJ at a power of 0.80 and α level of 0.05. Consequently, 30 healthy 
male participants were recruited to participate in this study 
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Table 15). All participants were recreationally active but none had completed 
intense plyometric exercise for ≥12 months.  
Table 15 - Physical characteristics, nitrate content of the supplements, and 
macronutrient content of participant’s dietary intake throughout the study.  
 
 
Characteristic 
 Group  
BTJ SN PLA 
Age (years) 23±3 22±3 21±1 
Mass (kg) 76.7±12.1 76.0±7.5 72.8±10.8 
Height (cm) 178.9±7.5 179.2±6.9 176.1±5.0 
Daily energy intake (kcal) 2460±494 2491±706 2108±387 
CHO (%) 42 44 43 
PRO (%) 18 22 20 
FAT (%) 40 34 37 
Nitrate (mg per serving) ~210 ~210 N/A 
Values are means ± SD; n=10 per group. Groups did not differ for any variable (P > 
0.05).  
9.2.2 Experimental design  
The study employed a double blind, randomized, independent groups 
design. Prior to data collection, participants were required to attend a 
familiarisation session in which height, mass and MIVC were established. 
Using MIVC scores as a blocking factor, participants were then randomized 
to 1 of 3 experimental treatment groups: SN; n =10, BTJ; n =10 or PLA; n 
=10. At least 1 week after familiarisation participants attended the laboratory 
on 4 consecutive mornings. As in Chapter 5, on day 1, participants 
performed a strenuous plyometric exercise protocol to induce muscle 
damage. A venous blood draw, muscle soreness and measures of muscle 
function were taken pre and immediately post muscle-damaging exercise on 
day 1 and on the following 3 mornings (24, 48 and 72 h post-exercise). After 
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the muscle-damaging exercise on day 1, participants consumed 1 serving of 
their allocated supplement alongside a standardized breakfast meal. 
Breakfast consisted of cereal (Rice Krispies, Kellogs, UK) and milk (semi-
skimmed, Tesco Ltd, UK) and provided 10% of daily energy requirements 
calculated from age and body mass (kg) (Schofield, 1984). Following a 2.5 h 
absorption period a final blood draw was taken. Participants could consume 
water ad libitum during the absorption period but were required to avoid 
consuming any other foods until the final blood draw.  
9.2.3 Muscle-damaging protocol 
The muscle damaging protocol consisted of 100 drop jumps from a 0.6 m 
high box. See Chapter 3.5 for further information. 
9.2.4 Muscle soreness 
Muscle specific soreness was assessed as PPT with a handheld algometer. 
See Chapter 3.6.3 for further information.  
9.2.5 Maximal isometric voluntary contraction  
Please refer to Chapter 3.6.1 for details on MIVC measurement. 
9.2.6 Counter movement jump 
Please refer to Chapter 3.6.2 for details on CMJ measurement. 
9.2.7 Blood sampling and analysis  
See Chapter 3.7. for blood sampling procedures. CK, hs-CRP and NOx were 
measured according to the methods described in section 3.7.1, 3.7.2 and 
3.7.3, respectively.   
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9.2.8 Supplementation  
Participants received BTJ, SN or an isocaloric PLA for 3 days’ post muscle-
damaging exercise. Similar to a previous study in this thesis (Chapter 5), 
supplements were consumed on three occasions on day 1; one 30 min post-
exercise alongside a breakfast meal, one 2.5 h post after an additional blood 
sample, and a third with their evening meal. Participants consumed 2 more 
servings at 24 and 48 h post (the first within 30 min of completing all 
dependent variables and the second with their evening meal). Details of the 
BTJ and PLA treatments used in this study are provided in Chapter 3.4. SN 
was purchased in powder form (BASF, Ludwigshafen, Germany) and mixed 
with water into bottles for participants to consume as a drink. Both 
maltodextrin (Myprotein, Manchester, UK) and flavourless protein powder 
(Arla Foods, Amba, Denmark) were added to each serving of SN to match 
the BTJ for macronutrient composition. The SN and BTJ were matched as 
closely as possible for nitrate content. The nitrate content of this particular 
batch of BTJ was approximately 210 mg (~3.4 mmol/L; see Table 15) per 
250 ml serving (data from the manufacturer). This amount of nitrate was 
equivalent to 287 mg of SN after adjusting for differences in molecular 
weight; thus, 287 mg (~3.4 mmol/L) of SN powder was weighed and added 
to each 250 ml serving.  
9.2.9 Dietary control 
Participants were asked to record their dietary intake throughout the trial (see 
Chapter 3.2 for further information and Appendix 5 for a food diary example). 
In addition, prior to each study visit, participants were provided with a meal 
(Beef Lasagne, 450 g; Tesco Ltd, UK) and a snack bar (Honey and Oat 
Cunch Bar, 42 g; Natures Valley, UK) to consume as a replacement for their 
usual evening meal. Participants were instructed to consume both the foods 
together at least 12 h prior to their study visit the following morning and to 
avoid consuming any other food or drink (other than water) until all measures 
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had been completed that day. The meal and snack bar provided 836 kcal, of 
which 34.6% was carbohydrates, 18.9% protein and 43.7% fat.  
9.2.10 Data analysis  
All data were analysed using IBM SPSS Statistics 22 for Windows (Surrey, 
UK) and are presented as mean ± SD. Multiple one-way ANOVA’s were 
used to test for group differences between participant’s physical 
characteristics and dietary intake. CMJ, MIVC and PPT were measured 
using a mixed design ANOVA; 3 group levels (BTJ vs. SN vs. PLA) by 5 time 
levels (pre-exercise, post-exercise, 24, 48 and 72 h post-exercise). 
Biochemical markers were analysed with a 3 (group) × 6 (time; pre-exercise, 
post-exercise, 2.5 h post-breakfast, 24, 48 and 72 h post-exercise) mixed 
design ANOVA. Significance was read from the Greenhouse-Geisser 
adjustment if Mauchly’s test of Sphericity had been violated. In the event of a 
significant interaction effect (drink*time) Fisher LSD post hoc analysis was 
performed to locate where the differences occurred. Where relevant, 
Cohen’s d ES were calculated with the magnitude of effects considered small 
(0.2-0.49), medium (0.5-0.79) and large (≥0.8). Statistical significance was 
set at P < 0.05 prior to analyses.  
9.3 Results  
There were no significant differences between groups for their physical 
characteristics or macronutrient intake throughout the testing period (Table 
15; P > 0.05). PPT showed a main effect for both time (F (3, 249) = 26.89; P = 
0.001) and group (F (2, 87) = 3.25; P = 0.043) whereby PPT was reduced in all 
groups as a result of exercise but consistently higher in BTJ compared to the 
SN and PLA in the 72 h post-exercise period (Figure 21). PPT had recovered 
to baseline values in the BTJ group by 72 h (104.3 ± 25.9%) but remained 
depressed in both the SN (94.1 ± 16.0%) and PLA groups (91.2 ± 19.0%) 
(ES = 0.69 vs PLA and 0.53 vs. SN).  
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Figure 21 - Pressure pain threshold (PPT) before and 72 h after exercise (% 
of baseline). Values presented are average of the three sites measured (calf, 
CF; rectus femoris, RF; vastus laterialis, VL). *Denotes group effect; P < 
0.05, beetroot juice (BTJ) higher than sodium nitrate (SN) and placebo 
(PLA). Values are mean ± SD; n = 10 per group.  
 
Serum NOx concentrations showed group (F (2, 25) 6.11; P = 0.007) and 
group*time interaction effects (F (7, 83) = 3.38; P = 0.004), increasing after BTJ 
and SN but not PLA. As shown in Figure 22, 2 h after consuming BTJ and 
SN serum NOx was markedly higher (P < 0.001; 135.5 ± 78.7 and 189.2 ± 
78.8 μmol/L, respectively) than baseline and PLA concentrations. Serum 
NOx remained elevated above baseline for the rest of the trial in the BTJ and 
SN groups (P < 0.05).  
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Figure 22 - Serum nitric oxide (NOx) concentrations before and 72 h after 
exercise. *Interaction effect; beetroot juice (BTJ) and sodium nitrate (SN) 
higher than placebo (PLA); P < 0.05. Data are mean ± SD, n = 10 per group.  
 
There was an immediate decline in MIVC and CMJ following the exercise 
bout (time effect; P < 0.05) with neither variable recovering to baseline by 72 
h post-exercise (Table 16). There were no differences between the three 
groups at any time point for MIVC and CMJ (P > 0.05). Plasma CK increased 
in response to the exercise bout (time effect; F (1, 31) = 6.43; P = 0.011), 
peaking at 24 h post in all groups (Table 16); however, no group or 
interaction effects were present (P > 0.05). hs-CRP was unaltered following 
exercise and showed no time, group or interaction effects (P > 0.05). 
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Table 16 - MIVC, CMJ, CK and hs-CRP values pre and post muscle damaging exercise.  
#Values in brackets represents data normalised to percentage change from baseline. *Time effect; P < 0.05. MIVC, maximal isometric 
voluntary contraction; CMJ, counter movement jump; CK, creatine kinase; hs-CRP, high sensitivity C-reactive protein.  
Variable Pre exercise Post exercise 
2.5 h post 
exercise 
24 h post 
exercise 
48 h post 
exercise 
72 h post 
exercise 
MIVC (N)*# 
BTJ 
SN 
PLA 
 
602(100) ± 109(0) 
577(100) ± 100(0) 
597(100) ± 117(0) 
 
 479(80) ± 144(16) 
 503(87) ± 136(9) 
 504(84) ± 111(8) 
 
 
 487(81) ± 159(19) 
 510(88) ± 126(10) 
 505(84) ± 153(15) 
 
510(87) ± 162(10) 
501(85) ± 151(19) 
521(87) ± 136(13) 
 
 556(95) ± 164(8) 
 546(92) ± 149(17) 
 536(89) ± 131(10) 
CMJ (cm)*# 
BTJ 
SN 
PLA 
 
31.8(100) ± 7.0(0) 
33.9(100) ± 6.2(0) 
36.5(100) ± 4.8(0) 
 
29.1(90) ± 8.8(11) 
30.1(88) ± 7.0(9) 
32.0(90) ± 5.2(11) 
 
 
29.2(91) ± 8.4(15) 
30.5(90) ± 5.5(7) 
32.1(87) ± 6.7(14) 
 
29.4(91) ± 8.9(15) 
29.7(89) ± 5.2(11) 
31.6(86) ± 6.9(15) 
 
30.9(97) ± 8.0(10) 
32.8(96) ± 5.3(7) 
33.7(92) ± 5.6(10) 
CK (IU∙-1)* 
BTJ 
SN 
PLA 
 
     224 ± 104 
          198 ± 108 
          224 ± 88 
 
 242 ± 129 
 229 ± 121 
        266 ± 97 
 
 358 ± 142 
        264 ± 98 
 298 ± 122 
 
714 ± 638 
312 ± 122 
395 ± 245 
 
 564 ± 615 
        192 ± 43 
 274 ± 194 
 
 351 ± 396 
        148 ± 31 
 261 ± 126 
hs-CRP (mg∙L-1) 
BTJ 
SN 
PLA 
 
    0.41 ± 0.28 
    0.42 ± 0.30 
    0.44 ± 0.32 
 
0.43 ± 0.33 
0.45 ± 0.30 
0.48 ± 0.34 
 
0.40 ± 0.29 
0.42 ± 0.27 
0.42 ± 0.31 
 
0.35 ± 0.14 
0.50 ± 0.28 
0.42 ± 0.29 
 
0.44 ± 0.12 
0.46 ± 0.26 
0.34 ± 0.34 
 
0.58 ± 0.82 
0.39 ± 0.18 
0.32 ± 0.13 
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9.4 Discussion  
The aim of this study was to compare the effects of a nitrate matched BTJ 
and SN drink on muscle force loss and muscle pain after eccentric exercise, 
in an attempt to gain a better understanding of the potential effects of nitrate 
on EIMD. While ingestion of BTJ and SN increased serum NOx levels, 
neither drink protected against muscle force deficits (MIVC and CMJ) in the 
72 h after the exercise bout. However, BTJ was more efficacious for 
attenuating muscle pain than SN and a PLA. A biochemical marker of muscle 
damage (CK) and a general marker of inflammation (hs-CRP) did not differ 
between supplement groups at any time point.   
As expected, provision of BTJ and SN after muscle-damaging exercise 
evoked large increases in serum NOx concentrations compared to PLA 
(Figure 22). These results are in agreement with the findings of Chapter 4, 
and others who report large increases in NOx bioavailability after SN and 
BTJ ingestion (Cristensen, Nyberg, & Bangsbo, 2012; Joris & Menesik, 
2013). Importantly, the rise in serum NOx was similar between SN and BTJ, 
indicating that the drinks were well-matched for nitrate content.  
Recent data have shown that NOx is integral for normal muscle 
regeneration, and that administering NOx donors enhances the recovery of 
strength after eccentric exercise (Lomonsova et al., 2014; Rigamonti et al., 
2013). Nevertheless, the present findings are in contrast to the above data, 
instead suggesting that SN supplementation is ineffective for attenuating 
force loss or any other parameter of EIMD after an eccentric-heavy exercise 
bout. The most obvious explanation for the discrepant findings between the 
present and aforementioned studies is the species difference; the present 
study was in humans, whereas most previous studies suggesting a role for 
NOx in EIMD were in animals (Corona & Ingalls, 2013; Lomonsova et al., 
2014; Rigamonti et al., 2013; Sakurai et al., 2013). However, it is also 
possible that other methodological differences, such as exercise model, NOx 
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donor and dosage contributed to the discrepancies. Notwithstanding, the fact 
that SN had no influence on any of the indices of muscle damage measured 
in this study, would seem to indicate that nitrate, at least at this dose, might 
not exert any favourable effects on exercise recovery. These findings also 
suggest that nitrate might not be the main constituent in BTJ responsible for 
attenuating losses in muscle function, as seen in Chapters 5 and 7.  
The inability of BTJ to attenuate the post-exercise loss in CMJ height is in 
direct contrast to a previous investigation in this thesis (Chapter 5), in which 
48 and 72 h after the same bout of plyometric exercise, BTJ was found to 
attenuate the deficit in CMJ. Because in both studies muscle damage was 
induced with an identical protocol, and the participants were similar in terms 
of training status, this discrepancy is difficult to account for. With that said, it 
is important to not overlook the fact that the magnitude of EIMD in response 
to the same exercise stimulus, even amongst individuals of similar training 
status, can vary widely (Hubal, Rubenstein, & Scott, 2007; Sayers & 
Clarkson, 2001). Intuitively, this could also impact how an individual might 
respond to a recovery intervention. Thus, the inherent heterogeneity in 
susceptibility to EIMD makes it difficult to compare the findings between any 
two studies, irrespective of protocol and participant similarity.  
With that said, there are subtle differences between these two studies that 
could account for the different effects of BTJ on CMJ recovery. One potential 
difference between these studies (and all the studies in this thesis) that could 
provide at least a partial explanation for these equivocal findings is the 
different batch of BTJ supplements used. It was not possible to elucidate the 
AOX and phenolic content of each batch of BTJ used in the studies in this 
thesis; however, it is reasonable to assume that the phytochemical content of 
each batch varied slightly due to seasonal variations in crop production. 
Speculatively, the batch of BTJ used in the present study could have 
contained less phenolic/betalainic compounds and had a lower AOX capacity 
than the batch used in Chapter 5. In this scenario, it would be reasonable to 
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assume that the BTJ with a higher AOX and phytochemical content would be 
more beneficial for enhancing CMJ recovery than one with a lower content 
(as suggested by Chapter 5). However, without data to compare the 
phytonutrient content of the two batches of BTJ used in these studies, this 
remains a very speculative attempt to explain these discrepant findings. A 
more plausible explanation could be related to the differences in dietary 
control between the two investigations. In the previous study (Chapter 5), a 
strict low-phytonutrient diet was imposed 48 h prior to and throughout the 
course of the trial (5 days in total) (see Chapter 3.3 for details and Appendix 
4 for an example), whereas in the present study, participants were 
encouraged to not deviate from their usual eating patterns. This change in 
design was to ensure the findings of the present study were more 
ecologically valid and applicable to real-world scenarios, in which individuals, 
particularly athletes, do not restrict their phytonutrient intake. Nonetheless, it 
has been demonstrated that restricting the intake of AOX and phytonutrient 
rich foods in the diet can leave individuals more vulnerable to oxidative 
stress (Watson et al., 2005) and inflammation (Plunkett, Callister, Watson & 
Garg, 2009) after stressful exercise. This could have important implications 
for secondary muscle damage after strenuous exercise, and overall muscle 
function (Paschalis et al., 2016), and makes the expectation tenable that 
dietary intake of AOX and/or phytonutrient rich foods could influence an 
individual’s susceptibility to EIMD, and their ability to recover from muscle-
damaging exercise. Interestingly, the CMJ loss in response to the drop jumps 
in Chapter 5 was clearly greater than in the present study, which would lend 
some support to the idea that a low phytonutrient intake might impact an 
individual’s rate of recovery. Indeed, the recovery of CMJ performance was 
more prolonged in the 72 h following the drop jumps in that study, and there 
was a clear secondary loss in muscle function without BTJ supplementation 
in the 24-72 h after exercise (see Figure 9), which was also less pronounced 
in the present study. These results provide tentative support for the idea that 
restricting phytonutrients through the diet might leave an individual more 
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vulnerable to muscle damage, at least after eccentric-heavy exercise, in 
which secondary damage is presumed to be of a higher magnitude and more 
prolonged (Howatson & van Someren, 2008). If this is the case, it would be 
reasonable to assume that BTJ would be more beneficial for functional 
recovery and performance in individuals with lower AOX intakes, as has 
been recently suggested with vitamin C supplementation (Paschalis et al., 
2016). This might help to explain, at least in part, why BTJ attenuated the 
loss in CMJ in Chapter 5, when phytonutrient intake was restricted (and 
participants might have been more susceptible to EIMD) but not in present 
study, when phytonutrient intake was unrestricted (thus participants were 
possibly less vulnerable to EIMD). Clearly, without measuring phytonutrient 
intake and inflammation/oxidative stress (and other aspects that might 
influence secondary muscle damage) in these studies the above postulate is 
speculative, and needs to be clarified in future work.  
As in Chapters 5, 6, 7 and 8, serum CK efflux increased after exercise, 
irrespective of supplementation. These data support the conclusions of 
others who have also found that functional foods do not seem to reduce CK 
efflux to a greater extent than a PLA (Bell et al., 2014; Bell et al., 2015; 
Goldfarb et al., 2011; Howatson et al., 2010; Peschek, Pritchett, Bergman, & 
Pritchett, 2013). It is important to note that CK is not considered a valid 
enough measure for assessing the extent of EIMD (Paulsen et al., 2012; 
Warren et al., 1999) and, thus, it might not be a sensitive enough marker to 
detect changes associated with an intervention. Hence, throughout this 
thesis, the primary outcome measures were changes in muscle function, 
which are proposed at the most sensitive and valid markers of EIMD (see 
Chapter 2.4.1). 
Unlike the muscle function measures, muscle pain, as measured by changes 
in PPT, was alleviated by BTJ supplementation (Figure 21). This pattern for 
improved recovery of PPT is consistent with those from Chapter 5 and 7, 
where PPT recovered quicker with BTJ versus a PLA after eccentric-heavy 
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plyometric exercise and RSE, respectively. An explanation as to how BTJ 
might reduce muscle pain is still unclear. Part of the difficulty in determining 
the potential mechanisms involved stems from the fact that the precise 
causes of exercise-induced muscle pain are still uncertain (Yu, Liu, Carlsson, 
Thornell, & Stål, 2013). Nonetheless, as described in Chapters 5 and 7, a 
possibility is that BTJ might suppress the release of stimuli thought to 
sensitize nociceptive neurons in the muscle and ECM (Murase et al., 2013), 
the latter of which, to the best of the current knowledge, is proposed as the 
main site where muscle pain originates (Crameri et al., 2007; Malm et al., 
2004). However, because muscle tissue samples could not be obtained as 
part of this thesis, this posit is somewhat speculative until confirmed by future 
studies.   
Perhaps the most pertinent new finding of this study is that muscle pain was 
attenuated with BTJ but not SN. These results suggest that phytonutrients 
other than nitrate, such as betalains and phenolics, or interactions between 
them (or with nitrate), are likely responsible for its analgesic effects. Although 
there have been no previous attempts to directly compare the effects of 
nitrate and BTJ on muscle pain, reports that nitrate free but betalain-rich 
treatments can alleviate muscle pain appear to support this concept. In two 
studies (Pietrzkowski et al., 2010 & Pietrzkowski et al., 2014) muscle and 
joint pain, as measured with the McGill pain questionnaire, was significantly 
lower after 10 days of taking specially formulated betalain capsules derived 
from beetroot extracts. The supplements used in these studies did not 
contain any of the nitrate or phenolic compounds inherently found in BTJ, 
therefore suggesting that betalains, independent of any interactions with 
other biological compounds, were responsible for alleviating muscle and joint 
pain. Based on these findings, the improved PPT seen in the present study 
with BTJ might have been due to the high amount of betalains it contains 
(see Chapter 4). However, because the BTJ used in this study contained 
many other potentially bioactive compounds (see Chapter 4) it cannot be 
ruled out that these compounds worked synergistically and this had additive 
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effects. Regardless of the underpinning mechanisms, the present findings, 
coupled with the previous findings in this thesis, suggests there is scope for 
further research to examine the potential role of BTJ in muscle pain, perhaps 
not just in relation to EIMD but also in clinical settings.  
In conclusion, this study found that acute supplementation with BTJ and SN 
did not influence the recovery of muscle function or attenuate CK efflux or 
hs-CRP after exercise. BTJ was more beneficial than SN for attenuating PPT 
though, advocating the use of BTJ over nitrate only containing drinks for 
attenuating exercise-induced muscle pain. These findings also suggest that 
the phenolics and betalains could be the compounds in BTJ most likely to 
exhibit analgesic effects after exercise.  
9.5 Perspectives  
The overall aim of this thesis was to establish whether BTJ could be an 
effective recovery aid after muscle-damaging exercise. The present 
investigation addressed the final aim of this thesis, which was to gain a 
deeper understanding of the phytonutrients in BTJ that might exert beneficial 
effects for recovery; specifically, the contributory effects of nitrate. The main 
finding from this study was that BTJ was more effective than SN for 
attenuating muscle pain after exercise and, therefore, suggests that the 
analgesic effects afforded by BTJ are likely due to phytonutrients in BTJ 
other than nitrate, such as the betalains and/or phenolics, or interactions 
between them.  
The reduction in muscle pain with BTJ compared to a PLA is consistent with 
the findings from Chapters 5 and 7, and provides further evidence that BTJ 
could be a useful analgesic therapy. The beneficial effects of BTJ on 
reducing muscle pain might have important implications for athletes in a 
variety of sports, especially as many athletes frequently report suffering from 
muscle pain after exercise. These findings also raise the possibility that BTJ 
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would be of use for clinical populations who suffer from disorders associated 
with chronic muscle pain (i.e., fibromyalgia and osteoarthritis).  
Interestingly, in contrast to the findings of Chapter 5, BTJ supplementation 
was not associated with an improved recovery of CMJ after eccentric-heavy 
exercise. The reason for the divergent findings between these two studies is 
not overtly clear, but it could be related to the fact that the magnitude of 
muscle damage in the present study was smaller, irrespective of supplement. 
Speculatively, muscle damage might have been lower in this study because 
dietary intake of phytonutrients was not restricted as in Chapter 5. 
Alternatively, the lower muscle damage response could just be an artefact of 
the inherently large variability in individual recovery rates after strenuous 
exercise. Notwithstanding, because neither SN nor BTJ were able to 
influence the recovery of muscle function, the independent effects of nitrate 
on this parameter remains elusive.  
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10 General discussion  
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10.1 Aims and summary  
Recent years have seen a growing interest in the potential for plant based 
food supplements to attenuate EIMD and enhance exercise recovery. The 
interest in these foods stems from the fact that they contain large amounts of 
bioactive compounds. In turn, these compounds that might confer protection 
against cellular and physiological processes associated with muscle 
damage, most notably, inflammation and oxidative stress. Several of the 
compounds in the root vegetable, beetroot, demonstrate interesting 
biological effects that fall into this category. This led to the hypothesis that 
consuming a BTJ drink after exercise might attenuate some of the 
deleterious symptoms that can impair functional performance after muscle- 
damaging exercise, such as muscle soreness and deficits in force generating 
capacity. Consequently, the purpose of this thesis was, firstly, to establish 
whether a BTJ drink had the potential to be an effective recovery aid, based 
on its phytochemical profile; and, secondly, whether BTJ would be beneficial 
for attenuating muscle damage, principally the decrements in functional 
performance indices after strenuous exercise. 
The series of investigations in this thesis have led to a number of new 
contributions to the body of knowledge. The opening investigation (Chapter 
4) was the first to study the bioavailability of betanin in a commercially 
available BTJ. It was also the first to demonstrate that this BTJ is a rich 
source of phytonutrients (specifically, phenolic and betalainic compounds) 
and possesses a good level AOX capacity and, therefore, seemed to hold 
potential as a recovery aid following exercise. In further investigations, there 
was some evidence that consuming BTJ after strenuous exercise 
accelerated the recovery of dynamic muscle function and reduced muscle 
pain. These findings were not consistent across all studies; however, a 
pattern seemed to emerge, in which BTJ was only beneficial (at least in 
terms of muscle function recovery) when the magnitude of force loss was 
more pronounced and/or there was clear evidence of a secondary drop in 
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muscle function. Intriguingly, there was no benefit of BTJ on circulatory 
markers of inflammation, oxidative stress or muscle damage (CK) in any of 
the investigations in this thesis. Collectively, the results presented in this 
thesis add to the current body of literature by suggesting that application of 
BTJ in the exercise domain may extend beyond just enhancement of acute 
athletic performance to include exercise recovery.  
10.2 Effects of beetroot juice on exercise-induced muscle pain 
The most consistent finding in this thesis was that BTJ reduced muscle pain. 
Other than Chapter 8, which suggested that BTJ did not attenuate muscle 
soreness after a marathon race, all other Chapters found some evidence that 
BTJ reduced muscle pain more effectively than a PLA. In line with these 
findings, supplementation with other antioxidant rich foods, such as cherries 
(Connolly et al., 2006), curcumin (Drobnic et al., 2014) and ginger (Black, 
Herring, Hurley, & O'Connor, 2010; Wilson, Fitzgerald, Rhodes, Lundstrom, 
& Ingraham, 2015) have also been shown to attenuate exercise-induced 
muscle pain. As alluded to in Chapter 8, an explanation as to why BTJ 
attenuated muscle pain in Chapters 5, 6 and 9, but not Chapter 8, could be 
due to a number of factors, including differences in exercise protocol, training 
status of the participants, and methods used to measure muscle 
soreness/pain between these studies (PPT vs. VAS). With regards to the 
latter, a previous study reported inconsistent responses to PPT and VAS 
measures of muscle soreness following muscle-damaging exercise, 
suggesting that they might not correlate (Connolly et al., 2006). Nonetheless, 
another explanation for these equivocal findings could be entirely unrelated 
to the different methods used, and design of the studies, but instead due to 
the fact that muscle soreness after the marathon was modest, particularly in 
comparison to the muscle soreness after the drop jumps and the RST in 
Chapters 5, 9 and 7, respectively. Thus, the lack of an analgesic effect of 
BTJ in Chapter 8 could be mostly due to the fact that the magnitude of 
muscle soreness was not severe enough to warrant an intervention. This 
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seems the most plausible explanation, as unlike in all the other studies 
assessing BTJ as a recovery intervention in this thesis, none of the indices of 
EIMD were modulated by BTJ in this study.  
It was beyond the scope of this thesis to examine, at least in great detail, the 
mechanisms by which BTJ might reduce muscle pain, largely because 
muscle tissue samples could not be obtained. Although the exact causes of 
muscle pain are still not fully understood, the most up to date understanding 
is that it stems from the sensitization of muscle fibre afferents in the muscle 
and ECM (Mizmuara & Murase, 2015; Mizumura & Tauchi, 2015). It was 
therefore felt that without obtaining muscle tissue, it would be almost 
impossible to identify, at least with any degree of certainty, the potential 
mechanisms involved.  
While a mechanistic explanation as to how BTJ reduced muscle pain 
remains elusive, this thesis did shed some light on the constituents in BTJ 
that might be exerting pain-relieving effects. Indeed, Chapter 9 showed that 
BTJ was more effective than a nitrate-matched SN drink for attenuating 
muscle pain after exercise, which would suggest that the betalainic and/or 
phenolic compounds in BTJ contributed to the analgesic effects observed in 
this thesis. These results concur with others, who reported that muscle and 
knee joint pain was reduced by betalain-rich but nitrate free oral beetroot 
supplements (Pietrzkowski et al., 2010; Pietrzkowski et al., 2014).  Based on 
these findings, and knowledge of betalains biological effects from previous 
work (Reddy et al., 2005; Vidal et al., 2014), a potential explanation for how 
BTJ might attenuate muscle pain can be offered. As alluded to in section 
2.6.4, betalains can blunt the in vitro activation of COX-2, an enzyme that 
helps to orchestrate the transient inflammatory response in EIMD via the 
formation of prostanoids (Warden, 2010; Weinheimer et al., 2007; Vella et al., 
2016). In relation to muscle pain, COX-2 has been shown to upregulate 
neurotrophins that sensitize muscle afferents, particularly glial cell-line 
derived neurotrophic factor (GDNF) (Mizumura & Taguchi, 2015; Murase et 
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al., 2013). Thus, one mechanism by which BTJ could have exerted pain-
reliving effects is by suppressing COX-2, thus acting in a similar fashion to 
pharmacological COX-2 inhibitor drugs designed for pain-relief, i.e., NSAIDS. 
A similar mechanism of action has also been proposed as a partial 
explanation for ginger’s analgesic effects in EIMD (Black et al., 2010; Wilson, 
2015). One potential flaw with this theory however, is that reducing muscle 
pain via this pathway was shown to be more beneficial when NSAID 
treatment was given prophylactically (Murase et al., 2013), which was not the 
case in the studies in this thesis. However, this might only be specific to 
selective COX-2 inhibitor NSAIDS and not other chemical compounds. 
Another possibility is that the constituents in beetroot reduced local 
concentrations of pro-inflammatory cytokines, such as TNF-α, that are known 
activators of other neurotropic factors associated with muscle pain, such as 
NGF (Schafers, Sorkin, & Sommers, 2003). As described in section 2.6.4, 
BTJ and betalain compounds have been shown attenuate local inflammatory 
responses in several animal studies, which lends some support to this 
suggestion (El Gamal et al., 2014; Krajka-Kuźniak et al., 2012; Lu et al., 
2009). It is important to stress that the mechanisms described above are 
merely speculative attempts to explain how BTJ might, at least in theory, 
reduce exercise-induced muscle pain. Obtaining and analysing muscle 
samples in future studies will be integral for establishing how BTJ exerted 
analgesic effects. Nonetheless, the findings in this thesis suggest that BTJ 
might help to relieve muscle pain, and could be more beneficial than 
pharmacological pain treatments such as NSAIDS, which might adversely 
affect anabolic signalling (Markworth et al., 2014) and/or cause gastro-
intestinal issues (Jädert et al., 2012).   
10.3 Effects of beetroot juice on muscle function recovery  
There was some evidence that BTJ might enhance the rate of recovery for 
measures of dynamic but not isometric muscle function after muscle-
damaging exercise. This was first demonstrated in Chapter 5, in which the 
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recovery of CMJ performance was significantly accelerated with BTJ versus 
a PLA at 48 and 72 h following a bout of high intensity plyometric exercise 
(100 drop jumps). A similar pattern was noted in Chapter 7, as BTJ was 
shown to be more effective than a PLA for enhancing the recovery of CMJ 
and RSI performance following high intensity RSE in team-sports players. 
The findings in these two studies agree with others who have observed a 
similar pattern of recovery with functional food supplementation after single 
bouts of muscle damaging exercise (Bell et al., 2015; Bowtell et al., 2011; 
Howatson et al., 2010; Trombold et al., 2010; Trombold et al., 2011). In 
contrast to these studies, however, in Chapter 8 BTJ was no more effective 
than a PLA for attenuating CMJ or other markers of muscle function in the 
days after a marathon race, and, in Chapter 9, BTJ was not associated with 
improved functional recovery following the drop jump protocol used in 
Chapter 5. The reason for the equivocal findings between the studies in this 
thesis could be attributable to several factors, including the differences in 
exercise models used to initiate EIMD (excluding Chapter 5 & 9), training 
status of the participants, and, as discussed in Chapter 9, differences in 
dietary control throughout the testing periods. Nonetheless, perhaps the 
most convincing explanation is related to the variation in the magnitude of 
EIMD in each study. With regards to Chapter 8, in which BTJ did not 
enhance dynamic muscle function after a marathon, the magnitude of muscle 
damage was much smaller, and the rate of recovery much quicker than in 
the studies where BTJ did enhance the recovery of function (Chapter 5 and 
7). In addition, a secondary loss in muscle function was observed in these 
studies; as shown in Figures 9 (Chapter 5), and 15 and 16 (Chapter 7), 
muscle function actually deteriorated in the 24-72 h period post-exercise 
without BTJ supplementation, where as in Chapter 8, when BTJ was 
ineffective, muscle function steadily recovered from 24 h onwards (Figure 
19). The variation in muscle damage and rate of recovery could also help to 
explain, at least in part, why BTJ enhanced the recovery of CMJ in Chapter 5 
but not in Chapter 9, despite the almost identical design of the studies. As 
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explained in section 9.4, the overall loss in dynamic muscle function was far 
less in Chapter 9 than in Chapter 5, and this could have rendered BTJ less 
effective for accelerating the recovery of this parameter. In view of these 
findings, it could be speculated that BTJ was ineffective in the 
aforementioned studies because either; 1) the muscle function loss was 
smaller and, thus, group differences were more difficult to detect, and/or; 2) 
there was no further loss in muscle function and, therefore, the secondary 
muscle damage response was minimal and not of a large enough magnitude 
for BTJ to be of benefit. These findings would suggest that the magnitude of 
force loss in the days after the initiating event could be a key determinant of 
the effectiveness of BTJ as a recovery aid and subsequent research should 
consider if the exercise stimulus is sufficiently strenuous to actually warrant 
an intervention. Nonetheless, the inconsistent findings mean that a definitive 
conclusion cannot be reached as to the efficacy of BTJ for enhancing muscle 
function recovery on these studies alone.  
While it was not the primary aim to elucidate the potential mechanism(s) by 
which BTJ might attenuate decrements in force loss after exercise, where 
possible, markers of inflammation and oxidative stress were measured. As 
suggested with other functional foods, it was initially hypothesized that BTJ 
would attenuate EIMD by dampening the inflammatory and/or oxidative 
stress response associated with muscle-damaging exercise; however, 
contrary to this hypothesis, biomarkers of inflammation and oxidative stress 
were not different after BTJ or a PLA in any of the studies in this thesis. It is 
important to note however, that these markers were all taken systemically 
and, thus, it is possible that BTJ mitigated oxidative stress and or 
inflammation at the local level, but was not detectable in blood. Others have 
also reported that functional foods improved recovery of muscle function 
after exercise in the absence of any changes in systemic levels of 
inflammation and oxidative stress (Bowtell et al., 2011; Trombold et al., 
2010).  
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Nonetheless, the lack of systemic changes in these markers with BTJ raises 
the possibility that mechanisms other than AOX and anti-inflammatory could 
have been responsible for the improved muscle function recovery in 
Chapters 5 and 7 with BTJ. In support of this notion, nitrate (via its 
conversion to NOx) and phenolic compounds, might influence other 
biological processes that could reduce the secondary muscle damage 
response and accelerate recovery, such as increasing satellite cell activity 
(Kruger & Smith, 2012; Rigamonti et al., 2013; Skaurai et al., 2013) and 
inhibiting proteolysis (Lambert et al., 2014; Louis et al., 2014). NOx, in 
particular, is involved in several of these processes, and, unlike most 
phytonutrients, is known to be highly bioavailable (see Chapter 4). An 
attractive mechanism by which NOx might help attenuate muscle damage is 
by blunting the activation of calpain isoforms that are known to promote the 
secondary degradation of cytoskeletal proteins after eccentric-heavy 
exercise (Koh & Tidball, 2000; Lomonosova et al., 2014). Although evidence 
for such effects has not been investigated in humans, increasing in vivo NOx 
availability has been shown to simultaneously inhibit calpain activation, 
reduce EIMD, and preserve muscle function in rats (Lomonosova et al., 
2014), which lends some support to this notion. Alternatively, the enhanced 
dynamic function (CMJ and RSI) in these studies might not be entirely 
related to a dampening of the biochemical processes thought to provoke 
secondary cell damage. Instead, they could merely be an artefact of NOx 
mediated improvements in muscle contractile function, as demonstrated by 
animal (Hernandez et al., 2012) and some recent human studies (Coggan et 
al., 2014; Hoon et al., 2015; Flanagan et al., 2016). Although most studies 
have not found BTJ to improve voluntary isometric strength compared to a 
depleted nitrate control (Haider & Folland et al., 2014; Hoon et al., 2015), 
Coggan et al. (2014) reported that muscle strength and power at higher 
angular velocities were enhanced with an acute pre-exercise dose of BTJ. 
Thus, another possible mechanism by which BTJ could have enhanced 
dynamic function after exercise (independent of AOX or anti-inflammatory 
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effects) is related to NOx-mediated increases in muscle power potential. 
Such effects would be possible if NOx availability was significantly increased 
in the muscle when function was assessed; unfortunately, this was not 
measured in Chapters 5 and 7 to endorse this speculation.  
Nonetheless, it is clear from the above discussion that there are a number of 
potential mechanisms that could explain why BTJ was able to enhance the 
recovery of muscle function in Chapters 5 and 7. As such, it is also important 
to consider that these effects are unlikely to be explained by just one 
biochemical mechanism; rather, several might converge to produce these 
effects. In other words, BTJ might act to decrease inflammation, oxidative 
stress (in muscle tissue only) and proteolysis, but also simultaneously 
increase satellite cell activity and contractile function. However, if these 
effects are involved, they are likely to be largely dependent on the extent of 
muscle damage present, as highlighted above. The possible role of these 
mechanisms and their relative contributory effects requires further 
exploration. 
When discussing the potential mechanisms by which BTJ might have 
enhanced recovery of both muscle function and PPT in these studies, it is 
important to not rule out the influence of psychosocial factors that are 
unrelated to the content of BTJ and its potential for biochemical effects, i.e., 
the placebo effect. Although the studies in this thesis were placebo-
controlled, insofar as an isocaloric drink with negligible nitrate and phenolic 
content was examined alongside BTJ, the two drinks could not be matched 
for taste and texture. As outlined in Chapter 3.4, taste matching was not 
possible for several reasons and therefore additional controls were relied 
upon to try and limit the psychological influence that knowingly consuming 
different tasting drinks might have on the results. Specifically, in each 
experimental study: 1) double blinding was employed, 2) the PLA was made 
with a fruit squash to give it the appearance of an AOX-rich fruit drink, 3) 
participants were split into independent groups (so participants were 
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unaware of the other treatment(s) being tested) and, 4) the studies specific 
aim was concealed (to ensure participants were unaware if the supplement 
they had was actually the treatment under investigation). Notwithstanding 
these controls, it is conceivable that at least some of the participants were 
aware of BTJs proposed ergogenic effects from performance studies and, 
irrespective of the other supplement(s) under investigation, this was enough 
to fill them with the expectation that it would also be of benefit for recovery. 
This is based on the notion that the placebo effect is dependent on an 
individual’s pre-conceived belief about how beneficial an intervention might 
be in a given situation or for a specific ailment and, ultimately, this conclusion 
dictates the expectation of a positive or negative effect (Beedie & Foad, 
2009; McClung & Collins, 2007; Pollo, Carlino, & Benedetti, 2008). This 
makes the expectation tenable that perhaps just believing BTJ can positively 
influence recovery is enough to alter an individual’s perception of muscle 
pain and/or an individual’s sense of muscle fatigue. Such effects were 
recently suggested with a sham water immersion intervention (Broatch, 
Peterson, & Bishop 2014).  
The potential for a beneficial effect of BTJ, independent of any actual 
physiological or biochemical effects stemming from its contents, is an 
intriguing idea and is lent some credence by the fact that none of the 
biochemical markers associated with improved functional recovery (i.e., 
inflammation and oxidative stress) was influenced by BTJ in this thesis. 
Thus, a potential role for the placebo effect to, at least partially, explain the 
findings in this thesis warrants further attention. Future studies could 
consider adding a no-placebo arm to intervention trials with BTJ (or indeed 
any recovery intervention) to try and help elucidate the influence, if any, the 
placebo effect might be having on the outcome measures (Beedie & Foad, 
2009). A brief questionnaire asking participants whether they believed they 
were on an experimental treatment or placebo could also serve as an added 
layer of control to rule out the potential of influence of a placebo effect.  
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10.4 Beetroot juice and acute adaptation   
Given that many of the cellular processes BTJ aims to blunt after muscle 
damaging exercise (i.e., oxidative stress and inflammation), are, 
paradoxically, critical mediators of the acute and chronic adaptive response 
to exercise (Gomez et al., 2015), it could be argued that BTJ 
supplementation might interfere with the normal adaptations to eccentric-
heavy exercise and actually have negative effects. Indeed, it has been 
mooted that attempts to diminish these responses might supress cell 
signalling responses that promote physiological adaptations following a bout 
of exercise (Gomez et al., 2015).  
It was not within the scope of this thesis to investigate the long term 
implications of BTJ supplementation on exercise adaptations; however, 
Chapter 6 did address the issue of short-term BTJ provision on the acute 
adaptive response to muscle damaging exercise, typically referred to as the 
RBE. In this study there was no evidence that BTJ negatively affected the 
RBE, despite attenuating the magnitude of EIMD after the first bout of 
exercise (Chapter 5). Although there are no similar studies with BTJ, these 
findings are consistent with those of He et al. (2015) who found that vitamin 
C and E did not affect the RBE between two bouts of downhill running. 
Interestingly, this study, and the findings from Chapter 6, are in contrast to 
the findings from two longer-term studies, whereby vitamin C and E blunted 
strength gains following 12 weeks of resistance training (Bjørnsen et al., 
2015; Paulsen et al., 2014b). In view of the disparate findings in the acute 
and longer-term studies, it could be speculated that vitamin C and E (or other 
AOX supplements) might only supress exercise-induced adaptive responses 
when taken over an extended period. Nonetheless, it is also important to 
stress that the dose of vitamin C and E used in the above studies is ≥10 × 
the RDA and, therefore, with such high doses perhaps these deleterious 
effects should be unsurprising. The effects of lower doses of AOX 
compounds over shorter periods of time (as in this thesis) might be more 
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appropriate. Similarly, this recommendation might also be extended to 
include other recovery strategies that attempt to limit post-exercise oxidative 
stress and inflammation, such as cold water immersion, which was recently 
shown to blunt strength adaptations after long-term exposure (12 weeks) 
(Roberts et al., 2015).   
It is also noteworthy that in later Chapters’ oxidative stress and inflammation 
were unaffected by BTJ, so perhaps it is unsurprising that BTJ did not 
appear to interfere with the acute adaptive response. As discussed above, 
the mechanisms by which BTJ might attenuate EIMD could differ to vitamin 
C and E AOXs and, thus, the influence of each supplement on exercise-
induced adaptations might differ. Nonetheless, until the implications of more 
chronic BTJ doses have been examined, it would seem prudent to not 
recommend BTJ as a long-term recovery strategy. Rather, in scenarios 
where BTJ has shown some promise as a recovery aid, such as after high 
intensity plyometric exercise and RSE, BTJ could serve as a useful short 
term strategy to provide relief from EIMD, particularly muscle pain. For 
example, BTJ could be of benefit after training or events/matches when the 
need to minimise the deleterious effects of EIMD and optimise recovery is of 
far greater importance than physiological adaptation. From an applied 
perspective, there are several examples when such situations might arise in 
sport, including during tournament scenarios, congested fixture schedules 
and in preparation for important events/matches, such as cup finals and 
Olympic qualifying.   
10.5 Limitations and future research directions 
While the series of investigations in this thesis have produced a number of 
novel and interesting findings, they have also raised several questions for 
future research. In addition, it is important to acknowledge that there are 
several limitations in the interpretation of the findings presented in this thesis. 
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As such, the following section will discuss both potential future research 
directions and the limitations of the findings in this thesis.  
A pertinent question raised by the first study in this thesis (Chapter 4), is 
what is the fate of betanin after ingesting BTJ and, therefore, its potential for 
biological effects associated with EIMD in vivo? Interestingly, in previous 
studies, betanin ingestion has decreased inflammation and oxidative stress, 
which, in contrast to the findings in Chapter 4, would suggest, albeit 
indirectly, that betanin is bioavailable in humans (Pietrzkowski et al., 2010; 
Pietrzkowski et al., 2014; Tesoriere et al., 2004b). One potential explanation 
for these seemingly contrasting findings is related to the fact that the plasma 
bioavailability of betanin is not necessarily reflective of total bioavailability, as 
betanin might have been present in urine or faeces (Frank et al., 2005). It is 
also possible that betanin was bioavailable in this study but just not 
detectable in the circulation at the specific time points measured due to being 
rapidly distributed to cells. Thus, an important limitation of this work is that 
betanin bioavailability was possibly underestimated by failing to measure 
additional time points and other excretory pathways. Nonetheless, the 
findings from the aforementioned studies and Chapter 4 could also be 
interpreted to suggest that it is not betanin per se that exerts biological 
activity in vivo, but perhaps secondary metabolites of betanin that are 
produced from biochemical interactions in the large intestine. The argument 
has been made by others (Frank et al., 2005; Netzel et al., 2005) and was 
acknowledged in Chapter 4, but the chemical standards for unambiguously 
identifying betanin metabolites were not commercially available and, thus, 
they could not be measured in this study. As such, in the series of 
investigations that followed, it was unclear as to what extent betanin and its 
metabolites contributed to some of the beneficial effects on recovery. 
Additionally, other betalains proposed to exert biological effects such as 
indicaxanthin (Allegra et al., 2005; Tesoriere et al., 2008), or individual 
phenolic compounds were not measured in Chapter 4 and, thus, the precise 
role they might have in the muscle damage process can only be speculated.  
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Given the above discussion, the results of this study are clearly limited in that 
the bioavailability of other potentially bioactive compounds in BTJ were not 
considered. Consequently, there is a need for future research to characterise 
the bioavailability of betalain compounds and their metabolites before the 
biological significance of these compounds in vivo can be firmly established 
and subsequently their role, if any, in EIMD. This has become particularly 
relevant in light of the findings of Chapter 9 that suggest the betalain and 
phenolic compounds are the main compounds in BTJ with analgesic 
potential after muscle-damaging exercise.   
Another important question for future studies is what are the mechanisms by 
which BTJ might attenuate muscle-damage and enhance recovery? An 
acknowledged limitation of this work is the inability to obtain muscle tissue 
samples to investigate the underpinning mechanisms in detail. Intuitively, in 
order to truly understand the effect of any intervention on EIMD, at least from 
a mechanistic perspective, the affected muscle tissue needs to be analysed. 
Nonetheless, the fact BTJ did not attenuate systemic markers of 
inflammation or oxidative stress after exercise in any of the studies in this 
thesis, provides rationale for future studies to instead focus on changes in 
these biomarkers at the local level, or look to investigate some of the other 
potential mechanisms suggested in section 10.3 above, including the 
potential influence of a placebo effect.  
Future research examining the effects of BTJ as a recovery aid should also 
aim to focus on; 1) its application in real world sporting settings i.e., after 
races or actual training sessions, and; 2) in higher calibre athletes. With 
regards to the former, apart from Chapter 8 (marathon race), muscle damage 
was assessed after exercise bouts performed in well controlled laboratory 
conditions and, in Chapters 5 and 9, bouts that did not reflect the 
physiological demands or movement patterns of a real world sporting activity. 
It could therefore be argued that the findings from these studies lack 
ecological validity and as such their generalizability to real-world settings is 
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limited. Although the RST in Chapter 7 did attempt to reproduce some of the 
mechanical (i.e., acceleration and deceleration) and metabolic (i.e., high 
intensity sprints) stress imposed by team-sport activity, the protocol could not 
account for the other factors that likely contribute to EIMD in competitive 
settings, such as clashes with opponents, kicking/hitting, multi directional 
changes and jumping actions. As such, this test cannot be considered a valid 
representation of an actual team sports match and, therefore, the beneficial 
recovery effects of BTJ might not be directly transferable to real-world 
scenarios. Given these limitations, an important direction for future research 
will be to investigate whether BTJ is a useful recovery intervention in real 
world sporting situations, specifically after competitive matches or high 
intensity resistance or plyometric training sessions.  
In line with the above suggestion, it is critically important for future studies to 
examine the effects of BTJ in better trained athletic populations, especially if 
BTJ is to gain any recognition as a recovery intervention in elite sporting 
settings. Indeed, participants in Chapters 5 and 9 were only recreationally 
active and unfamiliar with the exercise task. Given that better trained 
populations are more likely to be accustomed to bouts of high volume 
eccentric exercise, the muscle damage and pattern of recovery observed in 
these studies is probably not reflective of that observed in higher calibre 
athletes, especially those at the elite level (Barnett, 2006). Thus, a key 
limitation of these findings is that they cannot be readily applied to more elite 
athlete populations. Another limitation of this work is the lack of 
investigations in female participants. Indeed, apart from Chapter 8, in which 
a mixed gender cohort was recruited, all studies were performed with males. 
Given the suggestion that males and females might recover at different rates 
after EIMD (Minahan, Joyce, Bulmer, Cronin, & Sabapathy, 2015; Sayers & 
Clarkson, 2001), and even respond differently to functional food supplements 
(Rankin, Stevenson, Cockburn, 2015), future research should also look to 
compare the effects of BTJ on recovery in male and female athletes.  
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Another important direction for future research is to establish the most 
effective supplementation strategy of BTJ for minimising EIMD and 
enhancing recovery. It was beyond the scope of this thesis to address this 
question in detail, but Chapter 5 showed that several servings of a 250 ml 
dose of BTJ was more effective than the equivalent number of servings with 
a 125 ml dose for enhancing the recovery of CMJ. Intuitively, the 250 ml 
serving was more beneficial because it supplied a higher dose of 
phytonutrients than the 125 ml serving; however, this needs to be clarified 
with further research, especially as muscle pain was attenuated to a similar 
extent with the 125 and 250 ml dose of BTJ. This latter finding suggests that 
perhaps the dose of BTJ needed to attenuate decrements in muscle function 
might be greater than the dose needed to attenuate muscle pain. In view of 
this, future studies might benefit from providing higher doses of BTJ when 
attempting to accelerate the recovery of muscle function after strenuous 
exercise.   
Other important aspects relating to dosage strategy that require further 
investigation are the frequency and timing of BTJ ingestion after exercise.  
Because this thesis was the first to investigate BTJ supplementation in terms 
of its effects of muscle damage and recovery, there was no previous 
literature on which to base a dosage strategy on. As such, the dose, 
frequency and timing of supplementation in each study was based on 
knowledge regarding; 1) the time course of secondary muscle damage and 
likely pattern of recovery (i.e., post-exercise); 2) other food supplements 
demonstrating favourable effects on EIMD, and; 3) what would be most 
easily applied to a real-world scenario. Notwithstanding this rationale, it is 
unclear whether this approach was the most effective with BTJ and, 
therefore, future studies should look to compare this strategy to more acute 
or chronic strategies, including the pre-load strategy used by others (Bell et 
al., 2014; Bell et al., 2015; Howatson et al., 2010; Trombold et al., 2010; 
Trombold et al., 2011). Moreover, in developing an appropriate dosing 
strategy for BTJ, the practical feasibility from an athlete’s perspective needs 
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to be factored in. Therefore, elements such as taste preferences, cost, 
availability and safety/risks associated with BTJ supplementation all need to 
be carefully considered.  
10.6 Practical recommendations 
Based on the findings from the studies in this thesis, some practical 
recommendations for BTJs use as an acute recovery intervention following 
muscle-damaging exercise can be offered:  
1 – In general, BTJ might be of more benefit after novel or unaccustomed 
bouts of eccentric-heavy exercise and/or in situations when fruit and 
vegetable intake might be compromised. With regards to the first point, the 
potential recovery benefits of BTJ might become more apperant after 
exercise that typically results in moderate to severe EIMD (defined as muscle 
pain and/or pronounced losses in muscle function lasting for >48 h; Paulsen 
et al., 2012), and which might cause further deterioration in muscle function 
before recovering. Thus, the beginning of a new exercise regime/training 
technique, returning to exercise after injury, or pre-season training, are all 
situations in which BTJ might help to provide short term relief from EIMD 
symptoms. Improved functional capacity could be beneficial for mitigating 
injury risk in the days after muscle-damaging exercise and for improving 
adherence at the outset of a new exercise regimen. With regards to the 
second point, BTJ might be a more effective recovery aid while traveling and 
competing in foreign countries, where access to phytochemical rich foods 
(i.e., fruits and vegetables) might be more limited. 
2 – BTJ might help to preserve dynamic muscle power after exercise that 
incorporates high intensity repeated sprints, enabling athletes to perform 
closer to their optimum in the ensuing days. Thus, from an applied 
perspective, team-sport players (at least at the amateur level) might benefit 
from consuming BTJ during congested fixture periods, tournaments, or in 
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other scenarios where recovery time might be insufficient such as intensified 
training periods.  
3 – In terms of dosage strategy, for muscle function recovery, a 250 ml 
serving of BTJ seems more efficacious; however, for relief from muscle pain, 
a 125 ml serving might be equally as effective. Two to three servings should 
be taken at intervals throughout the day (AM and PM) for 3 days after the 
exercise bout or until symptoms subside.  
In conclusion, the series of investigations in this thesis have provided the first 
evidence that a commercially available BTJ is rich in phytonutrients and has 
potential as a recovery intervention, at least after exercise that results in 
marked and prolonged symptoms of EIMD. With that said, it is critically 
important that future work corroborates these findings in real world sporting 
scenarios, and in better trained athletes. If some of the findings in this thesis 
can be replicated in this population, BTJ could serve as an easy to 
implement and efficacious intervention for attenuating the some of the 
undesirable effects of EIMD and, thus, might help to facilitate functional 
recovery.  
 
 
 
 
 
 
 
229 
 
 
11 Reference List  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
230 
 
 
Allegra, M., Furtmüller, P. G., Jantschko, W., Zederbauer, M., Tesoriere, L., 
Livrea, M. A., & Obinger, C. (2005). Mechanism of interaction of betanin and 
indicaxanthin with human myeloperoxidase and hypochlorous acid. 
Biochemical and Biophysical Research Communications, 332(3), 837-844. 
Allen, D. G. (2001). Eccentric muscle damage: mechanisms of early 
reduction of force. Acta Physiologica Scandinavica, 171(3), 311-319.  
Andersson, H. M., Raastad, T., Nilsson, J., Paulsen, G., Garthe, I., & Kadi, F. 
(2008). Neuromuscular fatigue and recovery in elite female soccer: effects of 
active recovery. Medicine & Science in Sports & Exercise, 40(2), 372-380. 
Andersson, H., Bøhn, S. K., Raastad, T., Paulsen, G., Blomhoff, R., & Kadi, 
F. (2010a). Differences in the inflammatory plasma cytokine response 
following two elite female soccer games separated by a 72‐h recovery. 
Scandinavian Journal of Medicine & Science in sports, 20(5), 740-747. 
Andersson, H., Karlsen, A., Blomhoff, R., Raastad, T., & Kadi, F. (2010b). 
Plasma antioxidant responses and oxidative stress following a soccer game 
in elite female players. Scandinavian Journal of Medicine & Science in 
Sports, 20(4), 600-608. 
Archer, J. D., Vargas, C. C., & Anderson, J. E. (2006). Persistent and 
improved functional gain in mdx dystrophic mice after treatment with L-
arginine and deflazacort. Faseb Journal, 20(2), 738-+.  
Areces, F., Salinero, J. J., Abian-Vicen, J., Gonzalez-Millan, C., Ruiz-
Vicente, D., Lara, B., . . . Del Coso, J. (2015). The Use of Compression 
Stockings During a Marathon Competition to Reduce Exercise-Induced 
Muscle Damage: Are They Really Useful? Journal of Orthopaedic & Sports 
Physical Therapy, 45(6), 462-470.  
Armstrong, R. B., Warren, G. L., & Warren, J. A. (1991). Mechanisms of 
exercise-induced muscle fibre injury. Sports Medicine, 12(3), 184-207. 
231 
 
 
Armstrong, R. B., Warren, G. L., & Warren, J. A. (1991). Mechanisms of 
exercise-induced muscle fibre injury. Sports Medicine, 12(3), 184-207.  
Bailey, D. M., Williams, C., Betts, J. A., Thompson, D., & Hurst, T. L. (2011). 
Oxidative stress, inflammation and recovery of muscle function after 
damaging exercise: effect of 6-week mixed antioxidant supplementation. 
European Journal of Applied Physiology, 111(6), 925-936. 
Bailey, S. J., Winyard, P., Vanhatalo, A., Blackwell, J. R., DiMenna, F. J., 
Wilkerson, D. P., . . . Jones, A. M. (2009). Dietary nitrate supplementation 
reduces the O2 cost of low-intensity exercise and enhances tolerance to 
high-intensity exercise in humans. Journal of Applied Physiology,107(4), 
1144-1155.  
Baird, M. F., Graham, S. M., Baker, J. S., & Bickerstaff, G. F. (2012). 
Creatine-kinase- and exercise-related muscle damage implications for 
muscle performance and recovery. Journal of Nutrition and Metabolism, 
2012.  
Baker, D., Wilson, G., & Carlyon, B. (1994). Generality versus specificity: a 
comparison of dynamic and isometric measures of strength and speed-
strength. European Journal of Applied Physiology And Occupational 
Physiology, 68(4), 350-355. http://dx.doi.org/10.1007/bf00571456 
Baker, R. G., Hayden, M. S., & Ghosh, S. (2011). NF-κB, inflammation, and 
metabolic disease. Cell metabolism, 13(1), 11-22. 
Barnett, A. (2006). Using recovery Modalities between training sessions in 
elite athletes. Sports Medicine, 36(9), 781–796.  
Beaton, L. J., Tarnopolsky, M. A., & Phillips, S. M. (2002). Contraction-
induced muscle damage in humans following calcium channel blocker 
administration. Journal of Physiology, 544(Pt 3), 849-859.  
232 
 
 
Beedie, C. J., & Foad, A. J. (2009). The placebo effect in sports 
performance. Sports Medicine, 39(4), 313-329. 
Belcastro, A., Shewchuk, L., & Raj, D. (1998). Exercise-induced muscle 
injury: A calpain hypothesis. Molecular and Cellular Biochemistry, 179, 135–
45.  
Bell, P. G., Walshe, I. H., Davison, G. W., Stevenson, E. J., & Howatson, G. 
(2015). Recovery facilitation with Montmorency cherries following high-
intensity, metabolically challenging exercise. Applied Physiology, Nutrition 
and Metabolism, 40(4), 414-423.  
Bell, P. G., Walshe, I. H., Davison, G. W., Stevenson, E., & Howatson, G. 
(2014). Montmorency cherries reduce the oxidative stress and inflammatory 
responses to repeated days high-intensity stochastic cycling. Nutrients, 6(2), 
829-843.  
Best, T. M., Fiebig, R., Corr, D. T., Brickson, S., & Ji, L. (1999). Free radical 
activity, antioxidant enzyme, and glutathione changes with muscle stretch 
injury in rabbits. Journal of Applied Physiology, 87(1), 74-82.  
Bjørnsen, T., Salvesen, S., Berntsen, S., Hetlelid, K. J., Stea, T. H., Lohne‐
Seiler, H., ... & Haugeberg, G. (2015). Vitamin C and E supplementation 
blunts increases in total lean body mass in elderly men after strength 
training. Scandinavian Journal of Medicine & Science in Sports, 6(7), 755–
63. 
Black, S., Kushner, I., & Samols, D. (2004). C-reactive protein. Journal of 
Biological Chemistry, 279(47), 48487-48490. 
Black, C. D., Herring, M. P., Hurley, D. J., & O'Connor, P. J. (2010). Ginger 
(Zingiber officinale) reduces muscle pain caused by eccentric exercise. The 
Journal of Pain, 11(9), 894-903. 
233 
 
 
Bloomer, R. J. (2007). The role of nutritional supplements in the prevention 
and treatment of resistance exercise-induced skeletal muscle injury. Sports 
Medicine, 37(6), 519-532.  
Bogdanis, G. C., Stavrinou, P., Fatouros, I. G., Philippou, A., Chatzinikolaou, 
A., Draganidis, D., … Maridaki, M. (2013). Short-term high-intensity interval 
exercise training attenuates oxidative stress responses and improves 
antioxidant status in healthy humans. Food and Chemical 
Toxicology, 61,171–177.  
Borg, G. A. (1982). Psychophysical bases of perceived exertion. Medicine 
and Science in Sports Exercise, 14(5), 377-381. 
Borsa, P. A., Kaiser, K. L., & Martin, J. S. (2013). Oral consumption of 
electrokinetically modified water attenuates muscle damage and improves 
post exercise recovery. Journal of Applied Physiology, 114(12), 1736-1742. 
Bowtell, J. L., Sumners, D. P., Dyer, A., Fox, P., & Mileva, K. N. (2011). 
Montmorency cherry juice reduces muscle damage caused by intensive 
strength exercise. Medicine and Science in Sports and Exercise, 43(8), 
1544-1551.  
Brand-Williams, W., Cuvelier, M. E., & Berset, C. L. W. T. (1995). Use of a 
free radical method to evaluate antioxidant activity. Food science and 
Technology, 28(1), 25-30. 
Brenner, I. K. M., Natale, V. M., Vasiliou, P., Moldoveanu, A. I., Shek, P. N., 
& Shephard, R. J. (1999). Impact of three different types of exercise on 
components of the inflammatory response. European Journal of Applied 
Physiology and Occupational Physiology, 80(5), 452-460. 
Brickson, S., Ji, L. L., Schell, K., Olabisi, R., St Pierre Schneider, B., & Best, 
T. M. (2003). M1/70 attenuates blood-borne neutrophil oxidants, activation, 
234 
 
 
and myofiber damage following stretch injury. Journal of Applied Physiology, 
95(3), 969-976.  
Broatch, J. R., Petersen, A., & Bishop, D. J. (2014). Postexercise cold-water 
immersion benefits are not greater than the placebo effect. Medicine and 
Science in Sports and Exercise, 46(11), 2139-47. 
Buettner, G. R., & Jurkiewicz, B. A. (1993). Ascorbate free radical as a 
marker of oxidative stress: an EPR study. Free Radical Biology and 
Medicine, 14(1), 49-55. 
Butterfield, T. A., Best, T. M., & Merrick, M. A. (2006). The dual roles of 
neutrophils and macrophages in inflammation: a critical balance between 
tissue damage and repair. Journal of Athletic Training, 41(4), 457-465.  
Byrne, C., & Eston, R. (2002). The effect of exercise-induced muscle 
damage on isometric and dynamic knee extensor strength and vertical jump 
performance. Journal of Sports Science, 20(5), 417-425.  
Byrne, C., Twist, C., & Eston, R. (2004). Neuromuscular function after 
exercise-induced muscle damage: theoretical and applied implications. 
Sports Medicine, 34(1), 49-69.  
Calle, M. C., & Fernandez, M. L. (2010). Effects of resistance training on the 
inflammatory response. Nutrition Research and Practice, 4(4), 259-269. 
Cannon, J. G., & St Pierre, B. A. (1998). Cytokines in exertion-induced 
skeletal muscle injury. Molecular and Cellular Biochemistry, 179(1-2), 159-
167.   
Ceci, R., Duranti, G., Sgro, P., Sansone, M., Guidetti, L., Baldari, C., . . . Di 
Luigi, L. (2015). Effects of tadalafil administration on plasma markers of 
exercise-induced muscle damage, IL6 and antioxidant status capacity. 
European Journal of Applied Physiology, 115(3), 531-539.  
235 
 
 
Chan, V., Duffield, R., & Watsford, M. (2016). The effects of compression 
garments on performance of prolonged manual-labour exercise and 
recovery. Applied Physiology, Nutrition and Metabolism, 41(2), 125-132. 
doi:10.1139/apnm-2015-0335.  
Chatzinikolaou, A., Fatouros, I. G., Gourgoulis, V., Avloniti, A., Jamurtas, A. 
Z., Nikolaidis, M. G., ... & Tofas, T. (2010). Time course of changes in 
performance and inflammatory responses after acute plyometric exercise. 
The Journal of Strength & Conditioning Research, 24(5), 1389-1398. 
Chazaud, B. (2016). Inflammation during skeletal muscle regeneration and 
tissue remodeling: application to exercise-induced muscle damage 
management. Immunology & Cell Biology, 94(2), 140-145.  
Child, R., Brown, S., Day, S., Donnelly, A., Roper, H., & Saxton, J. (1999). 
Changes in indices of antioxidant status, lipid peroxidation and inflammation 
in human skeletal muscle after eccentric muscle actions. Clinical Science, 
96(1), 105-115. 
Childs, A., Jacobs, C., Kaminski, T., Halliwell, B., & Leeuwenburgh, C. 
(2001). Supplementation with vitamin C and N-acetyl-cysteine increases 
oxidative stress in humans after an acute muscle injury induced by eccentric 
exercise. Free Radical Biology and Medicine, 31(6), 745-753. 
Christensen, P., Nyberg, M., & Bangsbo, J. (2012). Influence of nitrate 
supplementation on VO 2 kinetics and endurance of elite cyclists. 
Scandinavian Journal of Medicine and Science in Sports, 23(1), e21-e31.  
http://dx.doi.org/10.1111/sms.12005.  
Clarkson, P. M., & Hubal, M. J. (2002). Exercise-induced muscle damage in 
humans. American Journal of Physical Medicine and Rehabilitation, 81(11), 
52-69.  
236 
 
 
Close, G. L., Ashton, T., Cable, T., Doran, D., & MacLaren, D. P. (2004). 
Eccentric exercise, isokinetic muscle torque and delayed onset muscle 
soreness: the role of reactive oxygen species. European Journal of Applied 
Physiology, 91(5-6), 615-621.  
Close, G. L., Ashton, T., Cable, T., Doran, D., Holloway, C., McArdle, F., & 
MacLaren, D. P. (2006). Ascorbic acid supplementation does not attenuate 
post-exercise muscle soreness following muscle-damaging exercise but may 
delay the recovery process. British Journal of Nutrition, 95(5), 976-981.  
Close, G. L., Ashton, T., McArdle, A., & Maclaren, D. P. (2005). The 
emerging role of free radicals in delayed onset muscle soreness and 
contraction-induced muscle injury. Comparative Biochemistry and Physiology 
- Part A: Molecular & Integrative Physiology, 142(3), 257-266.  
Cobley, J., McGlory, C., Morton, J., & Close, G. (2011). N-Acetylcysteine’s 
attenuation of fatigue after repeated bouts of intermittent exercise: Practical 
implications for tournament situations. International Journal of Sport Nutrition 
and Exercise Metabolism, 21(6), 451–61.  
Cockburn, E., Hayes, P. R., French, D. N., Stevenson, E., & St Clair Gibson, 
A. (2008). Acute milk-based protein-CHO supplementation attenuates 
exercise-induced muscle damage. Applied physiology, Nutrition, and 
Metabolism, 33(4), 775-783. 
Cockburn, E., Robson-Ansley, P., Hayes, P. R., & Stevenson, E. (2012). 
Effect of volume of milk consumed on the attenuation of exercise-induced 
muscle damage. European Journal of Applied Physiology, 112(9), 3187-
3194. 
Cockburn, E., Stevenson, E., Hayes, P. R., Robson-Ansley, P., & Howatson, 
G. (2010). Effect of milk-based carbohydrate-protein supplement timing on 
the attenuation of exercise-induced muscle damage. Applied Physiology, 
Nutrition, and Metabolism, 35(3), 270–277.  
237 
 
 
Coggan, A. R., Leibowitz, J. L., Kadkhodayan, A., Thomas, D. P., 
Ramamurthy, S., Spearie, C. A., ... & Peterson, L. R. (2015). Effect of acute 
dietary nitrate intake on maximal knee extensor speed and power in healthy 
men and women. Nitric Oxide, 48, 16-21. 
Connolly, D. A., McHugh, M. P., Padilla-Zakour, O. I., Carlson, L., & Sayers, 
S. P. (2006). Efficacy of a tart cherry juice blend in preventing the symptoms 
of muscle damage. British Journal of Sports Medicine, 40(8), 679-683. 
Crameri, R. M., Aagaard, P., Qvortrup, K., Langberg, H., Olesen, J., & Kjaer, 
M. (2007). Myofibre damage in human skeletal muscle: effects of electrical 
stimulation versus voluntary contraction. Journal of Physiology, 583(Pt 1), 
365-380.  
D'Angelo, M. G., Gandossini, S., Boneschi, F. M., Sciorati, C., Bonato, S., 
Brighina, E., . . . Clementi, E. (2012). Nitric oxide donor and non steroidal 
anti inflammatory drugs as a therapy for muscular dystrophies: Evidence 
from a safety study with pilot efficacy measures in adult dystrophic patients. 
Pharmacological Research, 65(4), 472-479.  
Dill, D. B., & Costill, D. L. (1974). Calculation of percentage changes in 
volumes of blood, plasma, and red cells in dehydration. Journal of Applied 
Physiology, 37(2), 247-248. 
Dousset, E., Avela, J., Ishikawa, M., Kallio, J., Kuitunen, S., Kyrolainen, H., . 
. . Komi, P. V. (2007). Bimodal recovery pattern in human skeletal muscle 
induced by exhaustive stretch-shortening cycle exercise. Medicine and 
Science in Sports and Exercise, 39(3), 453-460.  
Drobnic, F., Riera, J., Appendino, G., Togni, S., Franceschi, F., Valle, X., ... 
& Tur, J. (2014). Reduction of delayed onset muscle soreness by a novel 
curcumin delivery system (Meriva®): a randomised, placebo-controlled trial. 
Journal of the International Society of Sports Nutrition, 11(1), 1. 
238 
 
 
Duffield, R., Cannon, J., & King, M. (2010). The effects of compression 
garments on recovery of muscle performance following high-intensity sprint 
and plyometric exercise. Journal of Science and Medicine in Sport, 13(1), 
136-140.  
Duffield, R., Edge, J., Merrells, R., Hawke, E., Barnes, M., Simcock, D., & 
Gill, N. (2008). The effects of compression garments on intermittent exercise 
performance and recovery on consecutive days. International Journal of 
Sports Physiology and Performance, 3(4), 454-468.  
Ebbeling, C. B., & Clarkson, P. M. (1989). Exercise-induced muscle damage 
and adaptation. Sports Medicine, 7(4), 207-234. 
El Gamal, A. A., AlSaid, M. S., Raish, M., Al-Sohaibani, M., Al-Massarani, S. 
M., Ahmad, A., ... & Rafatullah, S. (2014). Beetroot (Beta vulgaris L.) extract 
ameliorates gentamicin-induced nephrotoxicity associated oxidative stress, 
inflammation, and apoptosis in rodent model. Mediators of inflammation, 
2014.  
Esatbeyoglu, T., Wagner, A. E., Motafakkerazad, R., Nakajima, Y., Matsugo, 
S., & Rimbach, G. (2014). Free radical scavenging and antioxidant activity of 
betanin: electron spin resonance spectroscopy studies and studies in 
cultured cells. Food and Chemicl Toxicolology, 73, 119-126.  
Esatbeyoglu, T., Wagner, A. E., Schini-Kerth, V. B., & Rimbach, G. (2015). 
Betanin-A food colorant with biological activity. Molecular Nutrition and Food 
Research, 59(1), 36-47.  
Etheridge, T., Philp, A., & Watt, P. W. (2008). A single protein meal 
increases recovery of muscle function following an acute eccentric exercise 
bout. Applied Physiology, Nutrition and Metabolism, 33(3), 483-488.  
239 
 
 
Faulkner, J. A., Brooks, S. V., & Opiteck, J. A. (1993). Injury to skeletal 
muscle fibers during contractions: conditions of occurrence and prevention. 
Physical Therapy, 73(12), 911-921.  
Ferguson, S. K., Hirai, D. M., Copp, S. W., Holdsworth, C. T., Allen, J. D., 
Jones, A. M., … Poole, D. C. (2012). Impact of dietary nitrate 
supplementation via beetroot juice on exercising muscle vascular control in 
rats. The Journal of Physiology, 591(2), 547–557.  
Filippin, L. I., Moreira, A. J., Marroni, N. P., & Xavier, R. M. (2009). Nitric 
oxide and repair of skeletal muscle injury. Nitric Oxide, 21(3), 157-163. 
Finaud, J., Lac, G., & Filaire, E. (2006). Oxidative stress. Sports Medicine, 
36(4), 327-358 
Fisher-Wellman, K., & Bloomer, R. J. (2009). Acute exercise and oxidative 
stress: a 30 year history. Dynamic Medicine, 8, 1.  
Flanagan, S. D., Looney, D. P., Miller, M. J., DuPont, W. H., Pryor, L., 
Creighton, B. C., ... & Volek, J. S. (2016). The Effects of Nitrate-Rich 
Supplementation on Neuromuscular Efficiency during Heavy Resistance 
Exercise. Journal of the American College of Nutrition, 35(2), 100-107. 
Fletcher, B. D., Twist, C., Haigh, J. D., Brewer, C., Morton, J. P., & Close, G. 
L. (2016). Season-long increases in perceived muscle soreness in 
professional rugby league players: role of player position, match 
characteristics and playing surface. Journal of Sports Sciences, 34(11), 
1067-1072.  
Fogarty, M. C., Hughes, C. M., Burke, G., Brown, J. C., & Davison, G. W. 
(2013). Acute and chronic watercress supplementation attenuates exercise-
induced peripheral mononuclear cell DNA damage and lipid peroxidation. 
British Journal of Nutrition, 109(02), 293-301. 
240 
 
 
Frank, T., Stintzing, F. C., Carle, R., Bitsch, I., Quaas, D., Strass, G., . . . 
Netzel, M. (2005). Urinary pharmacokinetics of betalains following 
consumption of red beet juice in healthy humans. Pharmacology Research, 
52(4), 290-297.  
Friden, J., & Lieber, R. L. (2001). Eccentric exercise-induced injuries to 
contractile and cytoskeletal muscle fibre components. Acta Physiologica 
Scandinavia, 171(3), 321-326.  
Friden, J., Sjostrom, M., & Ekblom, B. (1981). A morphological study of 
delayed muscle soreness. Experientia, 37(5), 506-507.  
Friden, J., Sjostrom, M., & Ekblom, B. (1983). Myofibrillar damage following 
intense eccentric exercise in man. International Journal of Sports Medicine, 
4(3), 170-176.  
Georgiev, V. G., Weber, J., Kneschke, E. M., Denev, P. N., Bley, T., & 
Pavlov, A. I. (2010). Antioxidant activity and phenolic content of betalain 
extracts from intact plants and hairy root cultures of the red beetroot Beta 
vulgaris cv. Detroit dark red. Plant Foods in Human  Nutrition, 65(2), 105-
111.  
Gilchrist, M., Winyard, P. G., Aizawa, K., Anning, C., Shore, A., & Benjamin, 
N. (2013). Effect of dietary nitrate on blood pressure, endothelial function, 
and insulin sensitivity in type 2 diabetes. Free Radical Biology and Medicine, 
60, 89-97.  
Gilchrist, M., Winyard, P. G., Fulford, J., Anning, C., Shore, A. C., & 
Benjamin, N. (2014). Dietary nitrate supplementation improves reaction time 
in type 2 diabetes: development and application of a novel nitrate-depleted 
beetroot juice placebo. Nitric Oxide, 40, 67-74.  
Girard, O., Mendez-Villanueva, A., & Bishop, D. (2011). Repeated-sprint 
ability – part I. Sports Medicine, 41(8), 673–694.  
241 
 
 
Gissel, H., & Clausen, T. (2001). Excitation-induced Ca2+ influx and skeletal 
muscle cell damage. Acta Physiologica Scandinavia, 171(3), 327-334.  
Glatthorn, J. F., Gouge, S., Nussbaumer, S., Stauffacher, S., Impellizzeri, F. 
M., & Maffiuletti, N. A. (2011). Validity and reliability of Optojump 
photoelectric cells for estimating vertical jump height. The Journal of Strength 
& Conditioning Research, 25(2), 556-560. 
Goldfarb, A. H., Garten, R. S., Cho, C., Chee, P. D., & Chambers, L. A. 
(2011). Effects of a fruit/berry/vegetable supplement on muscle function and 
oxidative stress. Medicine and Science in Sports and Exercise, 43(3), 501-
508. 
Goldfarb, A. H., Garten, R. S., Waller, J., & Labban, J. D. (2014). Day to day 
variability and reliability of blood oxidative stress markers within a four-week 
period in healthy young men. Journal of Biomarkers, 2014. 
Goll, D. E., Thompson, V. F., Li, H., Wei, W. E. I., & Cong, J. (2003). The 
calpain system. Physiological Reviews, 83(3), 731-801. 
Gomez-Cabrera, M. C., Martínez, A., Santangelo, G., Pallardó, F. V., Sastre, 
J., & Vina, J. (2006). Oxidative stress in marathon runners: interest of 
antioxidant supplementation. British Journal of Nutrition, 96(S1), S31-S33. 
Gomez-Cabrera, M. C., Salvador-Pascual, A., Cabo, H., Ferrando, B., & 
Viña, J. (2015). Redox modulation of mitochondriogenesis in exercise. Does 
antioxidant supplementation blunt the benefits of exercise training? Free 
Radical Biology and Medicine, 86, 37-46. 
Gomez-Cabrera, M., Domenech, E., Romagnoli, M., Arduini, A., Borras, C., 
Pallardo, F., … Viña, J. (2008). Oral administration of vitamin C decreases 
muscle mitochondrial biogenesis and hampers training-induced adaptations 
in endurance performance. The American Journal of Clinical Nutrition, 87(1), 
142–9. 
242 
 
 
Gomez-Cabrera, M., Ristow, M., & Vina, J. (2012). Antioxidant supplements 
in exercise: worse than useless? AJP: Endocrinology And Metabolism, 
302(4), 476-477.  
Grielberger, J, F., Greilberger, M., & Djukic, R. (2015). Biomarkers part I: 
Biomarkers to estimate bioefficacy of dietary/supplemental antioxidants in 
sport. In Antioxidants in sport nutrition (pp. 247-260). United States: CRC 
press 
Gross, M., & Baum, O. (2015). Supplemental antioxidants and adaptation to 
physical training. In Antioxidants in sport nutrition (pp. 111-122). United 
States: CRC press 
Haider, G., & Folland, J. P. (2014). Nitrate supplementation enhances the 
contractile properties of human skeletal muscle. Medicine and Science in 
Sports and Exercise, 46(12), 2234-2243. 
Han, J., Ma, D., Zhang, M., Yang, X., & Tan, D. (2015). Natural Antioxidant 
Betanin protects rats from paraquat-induced acute lung injury interstitial 
pneumonia. BioMed Research International, 2015, 1–9.  
He, F., Hockemeyer, J. A. K., & Sedlock, D. (2015). Does combined 
antioxidant vitamin supplementation blunt repeated bout effect? International 
Journal of Sports Medicine, 36(05), 407-413. 
Hernández, A., Schiffer, T. A., Ivarsson, N., Cheng, A. J., Bruton, J. D., 
Lundberg, J. O., … Westerblad, H. (2012). Dietary nitrate increases tetanic 
[Ca 2+] i and contractile force in mouse fast-twitch muscle. The Journal of 
Physiology, 590(15), 3575–3583.  
Higashida, K., Kim, S., Higuchi, M., Holloszy, J., & Han, D. (2011). Normal 
adaptations to exercise despite protection against oxidative stress. American 
Journal of Physiology-  Endocrinology and Metabolism, 301(5), 779-784.  
243 
 
 
Hikida, R., Staron, R., Hagerman, F., Sherman, W., & Costill, D. (1983). 
Muscle fiber necrosis associated with human marathon runners. Journal of 
the Neurological Sciences, 59(2), 185–203.  
Hill, J. A., Howatson, G., Van Someren, K. A., Walshe, I., & Pedlar, C. R. 
(2014). Influence of compression garments on recovery after marathon 
running. The Journal of Strength & Conditioning Research, 28(8), 2228-
2235. 
Hirose, L., Nosaka, K., Newton, M., Laveder, A., Kano, M., Peake, J., & 
Suzuki, K. (2004). Changes in inflammatory mediators following eccentric 
exercise of the elbow flexors. Exercise Immunology Review, 10, 75-90.  
Hobbs, D. A., George, T. W., & Lovegrove, J. A. (2013). The effects of 
dietary nitrate on blood pressure and endothelial function: a review of human 
intervention studies. Nutrition Research Reviews, 26(02), 210-222.  
Hobbs, D. A., Kaffa, N., George, T. W., Methven, L., & Lovegrove, J. A. 
(2012). Blood pressure-lowering effects of beetroot juice and novel beetroot-
enriched bread products in normotensive male subjects. British Journal of 
Nutrition, 108(11), 2066-2074.  
Hoon, M. W., Fornusek, C., Chapman, P. G., & Johnson, N. A. (2015). The 
effect of nitrate supplementation on muscle contraction in healthy 
adults. European Journal of Sport Science, 15(8), 712–719.  
Hoon, M. W., Jones, A. M., Johnson, N. A., Blackwell, J. R., Broad, E. M., 
Lundy, B., . . . Burke, L. M. (2014). The effect of variable doses of inorganic 
nitrate-rich beetroot juice on simulated 2,000-m rowing performance in 
trained athletes. International Journal of Sports Physiology and Performance, 
9(4), 615-620. 
Hoppeler, H. (1986). Exercise-induced ultrastructural changes in skeletal 
muscle. International Journal of Sports Medicine, 7(4), 187-204.  
244 
 
 
Howatson, G., & van Someren, K. A. (2008). The prevention and treatment 
of exercise-induced muscle damage. Sports Medicine, 38(6), 483-503.  
Howatson, G., Goodall, S., & van Someren, K. A. (2009). The influence of 
cold water immersions on adaptation following a single bout of damaging 
exercise. European Journal of Applied Physiology, 105(4), 615-621.  
Howatson, G., Hoad, M., Goodall, S., Tallent, J., Bell, P. G., & French, D. N. 
(2012). Exercise-induced muscle damage is reduced in resistance-trained 
males by branched chain amino acids: a randomized, double-blind, placebo 
controlled study. Journal of the International Society of Sports Nutrition, 9, 
20. doi:10.1186/1550-2783-9-20.  
Howatson, G., Hoad, M., Goodall, S., Tallent, J., Bell, P. G., & French, D. N. 
(2012). Exercise-induced muscle damage is reduced in resistance-trained 
males by branched chain amino acids: a randomized, double-blind, placebo 
controlled study. Journal of the International Society of Sports Nutrition, 9(1), 
1. 
Howatson, G., McHugh, M. P., Hill, J. A., Brouner, J., Jewell, A. P., van 
Someren, K. A., . . . Howatson, S. A. (2010). Influence of tart cherry juice on 
indices of recovery following marathon running. Scandinavian Journal of 
Medicine and Science in Sports and Exercise, 20(6), 843-852.  
Hubal, M. J., Rubinstein, S. R., & Clarkson, P. M. (2007). Mechanisms of 
variability in strength loss after muscle-lengthening actions. Medicine and 
Science in Sports and Exercise, 39(3), 461-468. 
Hubal, M. J., Chen, T. C., Thompson, P. D., & Clarkson, P. M. (2008). 
Inflammatory gene changes associated with the repeated-bout effect. 
American Journal of Physiology-Regulatory, Integrative and Comparative 
Physiology, 294(5), 1628-1637. 
245 
 
 
Hyldahl, R. D., & Hubal, M. J. (2014). Lengthening our perspective: 
morphological, cellular, and molecular responses to eccentric exercise. 
Muscle Nerve, 49(2), 155-170.  
Hyldahl, R. D., Nelson, B., Xin, L., Welling, T., Groscost, L., Hubal, M. J., … 
Parcell, A. C. (2015). Extracellular matrix remodeling and its contribution to 
protective adaptation following lengthening contractions in human 
muscle. The FASEB Journal, 29(7), 2894–2904.  
Hyldahl, R. D., Chen, T. C., & Nosaka, K. (2017). Mechanisms and 
Mediators of the Skeletal Muscle Repeated Bout Effect. Exercise and Sport 
Sciences Reviews, 45(1), 24-33. 
Izquierdo, M., Ibañez, J., Calbet, J. A., Navarro-Amezqueta, I., González-
Izal, M., Idoate, F., ... & Gorostiaga, E. M. (2009). Cytokine and hormone 
responses to resistance training. European Journal of Applied Physiology, 
107(4), 397-409. 
Jackson, M. J. (1999). An overview of methods for assessment of free 
radical activity in biology. Proceedings of the Nutrition Society, 58(04), 1001-
1006. 
Jackson, M. J., Vasilaki, A., & McArdle, A. (2016). Cellular mechanisms 
underlying oxidative stress in human exercise. Free Radical Biology and 
Medicine. doi:10.1016/j.freeradbiomed.2016.02.023 
Jädert, C., Petersson, J., Massena, S., Ahl, D., Grapensparr, L., Holm, L., ... 
& Phillipson, M. (2012). Decreased leukocyte recruitment by inorganic nitrate 
and nitrite in microvascular inflammation and NSAID-induced intestinal injury. 
Free Radical Biology and Medicine, 52(3), 683-692. 
Jädert, C., Phillipson, M., Holm, L., Lundberg, J. O., & Borniquel, S. (2014). 
Preventive and therapeutic effects of nitrite supplementation in experimental 
inflammatory bowel disease. Redox biology, 2, 73-81. 
246 
 
 
Jakeman, P., & Maxwell, S. (1993). Effect of antioxidant vitamin 
supplementation on muscle function after eccentric exercise. European 
Journal of Applied Physiology and Occupational Physiology, 67(5), 426-430. 
Jones, A. M. (2014a). Dietary nitrate supplementation and exercise 
performance. Sports Medicine, 44 Suppl 1, 35-45.  
Jones, A. M. (2014b). Influence of dietary nitrate on the physiological 
determinants of exercise performance: a critical review. Applied Physiology, 
Nutrition and Metabolism, 39(9), 1019-1028.  
Joris, P. J., & Mensink, R. P. (2013). Beetroot juice improves in overweight 
and slightly obese men postprandial endothelial function after consumption 
of a mixed meal. Atherosclerosis, 231(1), 78-83.  
Jówko, E., Długołęcka, B., Makaruk, B., & Cieśliński, I. (2014). The effect of 
green tea extract supplementation on exercise-induced oxidative stress 
parameters in male sprinters. European Journal of Nutrition, 54(5), 783–791.  
Jówko, E., Sacharuk, J., Balasińska, B., Ostaszewski, P., Charmas, M., & 
Charmas, R. (2011). Green tea extract supplementation gives protection 
against exercise-induced oxidative damage in healthy men. Nutrition 
Research, 31(11), 813-821. 
Justice, J. N., Gioscia-Ryan, R. A., Johnson, L. C., Battson, M. L., de 
Picciotto, N. E., Beck, H. J., ... & Seals, D. R. (2015). Sodium nitrite 
supplementation improves motor function and skeletal muscle inflammatory 
profile in old male mice. Journal of Applied Physiology, 118(2), 163-169. 
Kannan, K., & Jain, S. K. (2000). Oxidative stress and apoptosis. 
Pathophysiology, 7(3), 153-163.  
Kanner, J., Harel, S., & Granit, R. (2001). Betalains--a new class of dietary 
cationized antioxidants. Journal of Agriculture and Food Chemistry, 49(11), 
5178-5185.  
247 
 
 
Kapadia, G. J., Azuine, M. A., Rao, G. S., Arai, T., Iida, A., & Tokuda, H. 
(2011). Cytotoxic effect of the red beetroot (Beta vulgaris L.) extract 
compared to doxorubicin (Adriamycin) in the human prostate (PC-3) and 
breast (MCF-7) cancer cell lines. Anti-cancer Agents Medicinal Chemistry, 
11(3), 280-284.  
Kapadia, G. J., Rao, G. S., Ramachandran, C., Iida, A., Suzuki, N., & 
Tokuda, H. (2013). Synergistic cytotoxicity of red beetroot (Beta vulgaris L.) 
extract with doxorubicin in human pancreatic, breast and prostate cancer cell 
lines. Journal of Complementary and Integrative Medicine, 10.  doi: 
10.1515/jcim-2013-0007 
Kapil, V., Weitzberg, E., Lundberg, J., & Ahluwalia, A. (2014). Clinical 
evidence demonstrating the utility of inorganic nitrate in cardiovascular 
health. Nitric Oxide, 38, 45-57.  
Kasapis, C., & Thompson, P. D. (2005). The effects of physical activity on 
serum C-reactive protein and inflammatory markers: a systematic review. 
Journal of the American College of Cardiology, 45(10), 1563-1569. 
Keane, K. M., Salicki, R., Goodall, S., Thomas, K., & Howatson, G. (2015). 
Muscle damage response in female collegiate athletes after repeated sprint 
activity. Journal of Strength and Conditioning Research, 29(10), 2802–2807.  
Keane, K. M., Bell, P. G., Lodge, J. K., Constantinou, C. L., Jenkinson, S. E., 
Bass, R., & Howatson, G. (2016). Phytochemical uptake following human 
consumption of montmorency tart cherry (L. Prunus cerasus) and influence 
of phenolic acids on vascular smooth muscle cells in vitro. European Journal 
of Nutrition, 4(55), 1695-1705. 
Kharraz, Y., Guerra, J., Mann, C. J., Serrano, A. L., & Munoz-Canoves, P. 
(2013). Macrophage plasticity and the role of inflammation in skeletal muscle 
repair. Mediators of Inflammation, 2013, 491-497.  
248 
 
 
King, M., & Duffield, R. (2009). The effects of recovery interventions on 
consecutive days of intermittent sprint exercise. Journal of Strength and 
Conditioning Research, 23(6), 1795-1802.  
Kinser, A. M., Sands, W. A., & Stone, M. H. (2009). Reliability and validity of 
a pressure algometer. The Journal of Strength & Conditioning Research, 
23(1), 312-314. 
Kirby, T. J., Triplett, N. T., Haines, T. L., Skinner, J. W., Fairbrother, K. R., & 
McBride, J. M. (2012). Effect of leucine supplementation on indices of 
muscle damage following drop jumps and resistance exercise. Amino Acids, 
42(5), 1987-1996. 
Koh, T. J., & Tidball, J. G. (2000). Nitric oxide inhibits calpain-mediated 
proteolysis of talin in skeletal muscle cells. American Journal of Physiology-
Cell Physiology, 279(3), 806-812. 
Kohen, R., & Nyska, A. (2002). Oxidation of biological systems: oxidative 
stress phenomena, antioxidants, redox reactions, and methods for their 
quantification. Toxicology and Pathology, 30(6), 620-650.  
Krajka-Kuźniak, V., Paluszczak, J., Szaefer, H., & Baer-Dubowska, W. 
(2013). Betanin, a beetroot component, induces nuclear factor erythroid-2-
related factor 2-mediated expression of detoxifying/antioxidant enzymes in 
human liver cell lines. British Journal of Nutrition, 110(12), 2138-2149. 
Krajka-Kuźniak, V., Szaefer, H., Ignatowicz, E., Adamska, T., & Baer-
Dubowska, W. (2012). Beetroot juice protects against N-nitrosodiethylamine-
induced liver injury in rats. Food and Chemical Toxicology, 50(6), 2027-2033. 
Kruger, M. J., & Smith, C. (2012). Postcontusion polyphenol treatment alters 
inflammation and muscle regeneration. Medicine and Science in Sports and 
Exercise, 44(5), 872-880. 
249 
 
 
Kujala, T. S., Vienola, M. S., Klika, K. D., Loponen, J. M., & Pihlaja, K. 
(2002). Betalain and phenolic compositions of four beetroot (Beta vulgaris) 
cultivars. European Food Research and Technology, 214(6), 505-510.  
Kujawska, M., Ignatowicz, E., Murias, M., Ewertowska, M., Mikolajczyk, K., & 
Jodynis-Liebert, J. (2009). Protective effect of red beetroot against carbon 
tetrachloride- and N-nitrosodiethylamine-induced oxidative stress in rats. 
Journal of Agriculture and Food Chemistry, 57(6), 2570-2575.  
Lambert, K., Coisy-Quivy, M., Bisbal, C., Sirvent, P., Hugon, G., Mercier, J., 
... & Sultan, A. (2015). Grape polyphenols supplementation reduces muscle 
atrophy in a mouse model of chronic inflammation. Nutrition, 31(10), 1275-
1283. 
Lanier, A. B. (2003). Use of nonsteroidal anti-inflammatory drugs following 
exercise-induced muscle injury. Sports Medicine, 33(3), 177-186. 
Lansley, K. E., Winyard, P. G., Bailey, S. J., Vanhatalo, A., Wilkerson, D. P., 
Blackwell, J. R., . . . Jones, A. M. (2011). Acute dietary nitrate 
supplementation improves cycling time trial performance. Medicine and 
Science in Sports and Exercise, 43(6), 1125-1131.  
Lapointe, B. M., Frenette, J., & Cote, C. H. (2002). Lengthening contraction-
induced inflammation is linked to secondary damage but devoid of neutrophil 
invasion. Journal of Applied Physiology, 92(5), 1995-2004.  
Larsen, F. J., Weitzberg, E., Lundberg, J. O., & Ekblom, B. (2007). Effects of 
dietary nitrate on oxygen cost during exercise. Acta Physiologica, 191(1), 59-
66.  
Laupheimer, M., Perry, M., Benton, S., Malliaras, P., & Maffulli, N. (2014). 
Resveratrol exerts no effect on inflammatory response and delayed onset 
muscle soreness after a marathon in male athletes.: A randomised, double-
250 
 
 
blind, placebo-controlled pilot feasibility study. Translational Medicine, 10, 
38–42.  
Lechner, J. F., Wang, L. S., Rocha, C. M., Larue, B., Henry, C., McIntyre, C. 
M., . . . Stoner, G. D. (2010). Drinking water with red beetroot food color 
antagonizes esophageal carcinogenesis in N-nitrosomethylbenzylamine-
treated rats. Journal of Med Food, 13(3), 733-739.  
Lee, C. S., Wettasinghe, M., Bolling, B. W., Ji, L. L., & Parkin, K. L. (2005). 
Betalains, phase II enzyme-inducing components from red beetroot (Beta 
vulgaris L.) extracts. Nutrition and Cancer-an International Journal, 53(1), 91-
103.  
Liao, P., Zhou, J., Ji, L. L., & Zhang, Y. (2010). Eccentric contraction induces 
inflammatory responses in rat skeletal muscle: role of tumor necrosis factor-
α. American Journal of Physiology-Regulatory, Integrative and Comparative 
Physiology, 298(3), 599-607. 
Lidder, S., & Webb, A. J. (2013). Vascular effects of dietary nitrate (as found 
in green leafy vegetables and beetroot) via the nitrate‐nitrite‐nitric oxide 
pathway. British Journal of Clinical Pharmacology, 75(3), 677-696.  
Lomonosova, Y. N., Shenkman, B. S., Kalamkarov, G. R., Kostrominova, T. 
Y., & Nemirovskaya, T. L. (2014). L-arginine supplementation protects 
exercise performance and structural integrity of muscle fibres after a single 
bout of eccentric exercise in rats. PloS one, 9(4), 944-948. 
Louis, X. L., Thandapilly, S. J., Kalt, W., Vinqvist-Tymchuk, M., Aloud, B. M., 
Raj, P., ... & Netticadan, T. (2014). Blueberry polyphenols prevent 
cardiomyocyte death by preventing calpain activation and oxidative stress. 
Food & function, 5(8), 1785-1794.  
251 
 
 
Lu, X., Wang, Y., & Zhang, Z. (2009). Radioprotective activity of betalains 
from red beets in mice exposed to gamma irradiation. European Journal of 
Pharmacology, 615(1), 223-227. 
Lundberg, J. O., Carlström, M., Larsen, F. J., & Weitzberg, E. (2011). Roles 
of dietary inorganic nitrate in cardiovascular health and disease. 
Cardiovascular Research, 89(3), 525-532.  
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008). The nitrate–nitrite–
nitric oxide pathway in physiology and therapeutics. Nature Reviews Drug 
Discovery, 7(2), 156-167.  
Machin, D. R., Christmas, K. M., Chou, T. H., Hill, S. C., Van Pelt, D. W., 
Trombold, J. R., & Coyle, E. F. (2014). Effects of differing dosages of 
pomegranate juice supplementation after eccentric exercise. Physiology 
Journal, 2014. 
MacIntyre, D. L., Reid, W. D., & McKenzie, D. C. (1995). Delayed muscle 
soreness. Sports Medicine, 20(1), 24-40. 
Madamanchi, N. R., Vendrov, A., & Runge, M. S. (2005). Oxidative stress 
and vascular disease. Arteriosclerosis, Thrombosis, and Vascular Biology, 
25(1), 29-38.  
Magalhães, P., Vieira, J., Gonçalves, L., Pacheco, J., Guido, L., & Barros, A. 
(2009). Isolation of phenolic compounds from hop extracts using 
polyvinylpolypyrrolidone: Characterization by high-performance liquid 
chromatography-diode array detection electrospray tandem mass 
spectrometry. Journal of Chromatography, 1217(19), 3258–68.   
Malm, C., Lenkei, R., & Sjödin, B. (1999). Effects of eccentric exercise on the 
immune system in men. Journal of Applied Physiology, 86(2), 461-468. 
Malm, C., Sjodin, T. L., Sjoberg, B., Lenkei, R., Renstrom, P., Lundberg, I. 
E., & Ekblom, B. (2004). Leukocytes, cytokines, growth factors and 
252 
 
 
hormones in human skeletal muscle and blood after uphill or downhill 
running. Journal of Physiology, 556(Pt 3), 983-1000.  
Manach, C., Williamson, G., Morand, C., Scalbert, A., & Remesy, C. (2005). 
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 
bioavailability studies. American Journal of Clinical Nutrition, 81(1), 230-242.  
Margaritelis, N. V., Veskoukis, A. S., Paschalis, V., Vrabas, I. S., Dipla, K., 
Zafeiridis, A., . . . Nikolaidis, M. G. (2015). Blood reflects tissue oxidative 
stress: a systematic review. Biomarkers, 20(2), 97-108.  
Markworth, J. F., Vella, L. D., Figueiredo, V. C., & Cameron-Smith, D. 
(2014). Ibuprofen treatment blunts early translational signaling responses in 
human skeletal muscle following resistance exercise. Journal of Applied 
Physiology, 117(1), 20-28. 
McArdle, A., van der Meulen, J. H., Catapano, M., Symons, M. C., Faulkner, 
J. A., & Jackson, M. J. (1999). Free radical activity following contraction-
induced injury to the extensor digitorum longus muscles of rats. Free Radical 
Biology and Medicine, 26(9-10), 1085-1091.  
McHugh, M. P. (2003). Recent advances in the understanding of the 
repeated bout effect: the protective effect against muscle damage from a 
single bout of eccentric exercise. Scandinavian Journal of Medicine & 
Science in Sports, 13(2), 88-97. 
McLeay, Y., Barnes, M. J., Mundel, T., Hurst, S. M., Hurst, R. D., & 
Stannard, S. R. (2012). Effect of New Zealand blueberry consumption on 
recovery from eccentric exercise-induced muscle damage. Journal of 
International Society of Sports Nutrition, 9(1), 19.  
McClung, M., & Collins, D. (2007). “Because I know it will!”: Placebo effects 
of an ergogenic aid on athletic performance. Journal of Sport & Exercise 
Psychology, 29(3), 382–94.  
253 
 
 
Michailidis, Y., Karagounis, L., Terzis, G., Jamurtas, A., Spengos, K., & 
Tsoukas, D. et al. (2013). Thiol-based antioxidant supplementation alters 
human skeletal muscle signaling and attenuates its inflammatory response 
and recovery after intense eccentric exercise. American Journal of Clinical 
Nutrition, 98(1), 233-245. http://dx.doi.org/10.3945/ajcn.112.049163 
Minahan, C., Joyce, S., Bulmer, A. C., Cronin, N., & Sabapathy, S. (2015). 
The influence of estradiol on muscle damage and leg strength after intense 
eccentric exercise. European Journal of Applied Physiology, 115(7), 1493-
1500. 
Mohr, M., Draganidis, D., Chatzinikolaou, A., Barbero-Álvarez, J. C., 
Castagna, C., Douroudos, I., ... & Jamurtas, A. Z. (2016). Muscle damage, 
inflammatory, immune and performance responses to three football games in 
1 week in competitive male players. European Journal of Applied Physiology, 
116(1), 179-193 
Montgomery, P. G., Pyne, D. B., Cox, A. J., Hopkins, W. G., Minahan, C. L., 
& Hunt, P. H. (2008). Muscle damage, inflammation, and recovery 
interventions during a 3-day basketball tournament. European Journal of 
Sport Science, 8(5), 241-250. 
Morgan, D. (1990). Modeling of lengthening muscle: the role of inter-
sarcomere dynamics. In Multiple Muscle Systems (pp. 46-56). Springer New 
York. 
Morgan, D. L., & Allen, D. G. (1999). Early events in stretch-induced muscle 
damage. Journal of Applied Physiology, 87(6), 2007-2015.  
Morgan, D. L., & Proske, U. (2004). Popping sarcomere hypothesis explains 
stretch-induced muscle damage. Clinical and Experimental Pharmacology 
and Physiology, 31(8), 541-545. doi:10.1111/j.1440-1681.2004.04029.x 
254 
 
 
Morillas-Ruiz, J., Zafrilla, P., Almar, M., Cuevas, M. J., Lopez, F. J., Abellan, 
P., . . . Gonzalez-Gallego, J. (2005). The effects of an antioxidant-
supplemented beverage on exercise-induced oxidative stress: results from a 
placebo-controlled double-blind study in cyclists. European Journal of 
Applied Physiology, 95(5-6), 543-549.  
Murase, S., Terazawa, E., Queme, F., Ota, H., Matsuda, T., & Hirate, K. et 
al. (2010). Bradykinin and nerve growth factor play pivotal roles in muscular 
mechanical hyperalgesia after exercise (Delayed-Onset Muscle Soreness). 
Journal of Neuroscience, 30(10), 3752-3761.  
Murphy, M., Eliot, K., Heuertz, R. M., & Weiss, E. (2012). Whole beetroot 
consumption acutely improves running performance. Journal of the Academy 
of Nutrition and Dietetics, 112(4), 548-552.  
Musarò, A. (2014). The basis of muscle regeneration. Advances in Biology, 
2014. 
Myburgh, K. H. (2014). Polyphenol supplementation: benefits for exercise 
performance or oxidative stress? Sports Medicine, 44(1), 57-70. 
Nédélec, M., McCall, A., Carling, C., Legall, F., Berthoin, S., & Dupont, G. 
(2013). Recovery in Soccer: Part IIRecovery Strategies. Sports 
Medicine, 43(1), 9-22. 
Netzel, M., Stintzing, F. C., Quaas, D., Strass, G., Carle, R., Bitsch, R., . . . 
Frank, T. (2005). Renal excretion of antioxidative constituents from red beet 
in humans. Food Research International, 38(8-9), 1051-1058.  
Nguyen, H. X., Lusis, A. J., & Tidball, J. G. (2005). Null mutation of 
myeloperoxidase in mice prevents mechanical activation of neutrophil lysis of 
muscle cell membranes in vitro and in vivo. Journal of Physiology, 565(Pt 2), 
403-413.  
255 
 
 
Nguyen, T., Nioi, P., & Pickett, C. B. (2009). The Nrf2-Antioxidant Response 
Element Signaling Pathway and Its Activation by Oxidative Stress. Journal of 
Biological Chemistry, 284(20), 13291-13295.  
Nieman, D. C., Gillitt, N. D., Knab, A. M., Shanely, R. A., Pappan, K. L., Jin, 
F., & Lila, M. A. (2013). Influence of a polyphenol-enriched protein powder on 
exercise-induced inflammation and oxidative stress in athletes: a randomized 
trial using a metabolomics approach. PLoS One, 8(8), 722-715.  
Nieman, D. C., Henson, D. A., McAnulty, S. R., McAnulty, L., Swick, N. S., 
Utter, A. C., … Morrow, J. D. (2002). Influence of vitamin C supplementation 
on oxidative and immune changes after an ultramarathon. Journal of Applied 
Physiology, 92(5), 1970–1977.  
Nikolaidis, M. G., Jamurtas, A. Z., Paschalis, V., Fatouros, I. G., Koutedakis, 
Y., & Kouretas, D. (2008). The effect of muscle-damaging exercise on blood 
and skeletal muscle oxidative stress: magnitude and time-course 
considerations. Sports Medicine, 38(7), 579-606.  
Nikolaidis, M. G., Kyparos, A., Spanou, C., Paschalis, V., Theodorou, A. A., 
& Vrabas, I. S. (2012b). Redox biology of exercise: an integrative and 
comparative consideration of some overlooked issues. Journal of 
Experimental Biology, 215(Pt 10), 1615-1625.  
Nikolaidis, M. G., Margaritelis, N. V., Paschalis, V., Theodorou, A. A., 
Kyparos, A., & Vrabas, I. S. (2015). Common questions and tentative 
answers on how to assess oxidative stress after antioxidant supplementation 
and exercise. In Antioxidants in sport nutrition (pp. 221-246). United States: 
CRC press. 
Nikolaidis, M. G., Paschalis, V., Giakas, G., Fatouros, I. G., Koutedakis, Y. I. 
A. N. N. I. S., Kouretas, D., & Jamurtas, A. Z. (2007). Decreased blood 
oxidative stress after repeated muscle-damaging exercise. Medicine and 
Science in Sports and Exercise, 39(7), 1080-1089. 
256 
 
 
Nikolaidis, M., Kerksick, C., Lamprecht, M., & McAnulty, S. (2012a). Does 
vitamin C and E supplementation impair the favourable adaptations of 
regular exercise? Oxidative Medicine and Cellular Longevity, 2012. 
Nikolic, I., Smiljenic, D., Kukic, B., Bogdanovic, B., Petrovic, T., Ivkovic-
Kapicl, T., . . . Djan, I. (2012). Application of alternative medicine in 
gastrointestinal cancer patients. Vojnosanitetski Pregled, 69(11), 947-950.  
Ninfali, P., & Angelino, D. (2013). Nutritional and functional potential of Beta 
vulgaris cicla and rubra. Fitoterapia, 89, 188-199.  
Nosaka, K., & Aoki, M. S. (2011). Repeated bout effect: research update and 
future perspective. Brazilian Journal of Biomotricity, 5(1), 5-15. 
Nosaka, K., & Clarkson, P. M. (1995). Muscle damage following repeated 
bouts of high force eccentric exercise. Medicine and Science in Sports and 
Exercise, 27(9), 1263-1269. 
Nosaka, K., Newton, M., & Sacco, P. (2002). Delayed-onset muscle 
soreness does not reflect the magnitude of eccentric exercise-induced 
muscle damage. Scandinavian Journal of Medicine and Science in Sports 
and Exercise, 12(6), 337-346.  
Nussbaum, E. L., & Downes, L. (1998). Reliability of clinical pressure-pain 
algometric measurements obtained on consecutive days. Physical therapy, 
78(2), 160-169. 
Ormsbee, M. J., Lox, J., & Arciero, P. (2013). Beetroot juice and exercise 
performance. Journal of the International Society of Sports Nutrition, 5, 27-
35.  
Paschalis, V., Theodorou, A., Kyparos, A., Dipla, K., Zafeiridis, A., & 
Panayiotou, G. et al. (2014). Low vitamin C values are linked with decreased 
physical performance and increased oxidative stress: reversal by vitamin C 
supplementation. European Journal of Nutrition, 55(1), 45-53. 
257 
 
 
Paulsen, G., Benestad, H. B., Strom-Gundersen, I., Morkrid, L., Lappegard, 
K. T., & Raastad, T. (2005). Delayed leukocytosis and cytokine response to 
high-force eccentric exercise. Medicine and Science in Sports and Exercise, 
37(11), 1877-1883. 
Paulsen, G., Crameri, R., Benestad, H. B., Fjeld, J. G., Morkrid, L., Hallen, J., 
& Raastad, T. (2010b). Time course of leukocyte accumulation in human 
muscle after eccentric exercise. Medicine and Science in Sports and 
Exercise, 42(1), 75-85. 
Paulsen, G., Cumming, K. T., Holden, G., Hallen, J., Ronnestad, B. R., 
Sveen, O., . . . Raastad, T. (2014a). Vitamin C and E supplementation 
hampers cellular adaptation to endurance training in humans: a double-blind, 
randomised, controlled trial. Journal of Physiology, 592(Pt 8), 1887-1901.  
Paulsen, G., Egner, I. M., Drange, M., Langberg, H., Benestad, H. B., Fjeld, 
J. G., . . . Raastad, T. (2010a). A COX-2 inhibitor reduces muscle soreness, 
but does not influence recovery and adaptation after eccentric exercise. 
Scandinavian Journal of Medicine and Science in Sports and Exercise, 
20(1), 195-207.  
Paulsen, G., Hamarsland, H., Cumming, K. T., Johansen, R. E., Hulmi, J. J., 
Børsheim, E., ... & Raastad, T. (2014b). Vitamin C and E supplementation 
alters protein signalling after a strength training session, but not muscle 
growth during 10 weeks of training. The Journal of Physiology, 592(24), 
5391-5408. 
Paulsen, G., Mikkelsen, U. R., Raastad, T., & Peake, J. M. (2012). 
Leucocytes, cytokines and satellite cells: what role do they play in muscle 
damage and regeneration following eccentric exercise? Exercise 
Immunology Review, 18, 42-97.  
Pavlov, A., Kovatcheva, P., Georgiev, V., Koleva, I., & Ilieva, M. (2002). 
Biosynthesis and radical scavenging activity of betalains during the 
258 
 
 
cultivation of red beet (Beta vulgaris) hairy root cultures. Z Naturforsch C, 
57(7-8), 640-644.  
Peake, J. M., Markworth, J. F., Nosaka, K., Raastad, T., Wadley, G. D., & 
Coffey, V. G. (2015b). Modulating exercise-induced hormesis: does less 
equal more? Journal of Applied Physiology, 119(3), 172-189. 
Peake, J., & Suzuki, K. (2004). Neutrophil activation, antioxidant 
supplements and exercise-induced oxidative stress. Exercise Immunology 
Review, 10, 129-141.  
Peake, J., Della Gatta, P., Suzuki, K., & Nieman, D. (2015). Cytokine 
expression and secretion by skeletal muscle cells: regulatory mechanisms 
and exercise effects. Exercise Immunology Review, 21, 8-25. 
Peschek, K., Pritchett, R., Bergman, E., & Pritchett, K. (2013). The effects of 
acute post exercise consumption of two cocoa-based beverages with varying 
flavanol content on indices of muscle recovery following downhill treadmill 
running. Nutrients, 6(1), 50-62.  
Petersen, S. G., Beyer, N., Hansen, M., Holm, L., Aagaard, P., Mackey, A. 
L., & Kjaer, M. (2011). Nonsteroidal anti-inflammatory drug or glucosamine 
reduced pain and improved muscle strength with resistance training in a 
randomized controlled trial of knee osteoarthritis patients. Archives of 
Physical Medicine and Rehabilitation, 92(8), 1185-1193. 
Pietri, S., Séguin, J. R., d'Arbigny, P., & Culcasi, M. (1994). Ascorbyl free 
radical: a noninvasive marker of oxidative stress in human open-heart 
surgery. Free Radical Biology and Medicine, 16(4), 523-528.  
Pietrzkowski Z., N. B., Spórna, A., Stalica, P., Tresher, W., Keller, R., 
Jimenez, R., Michałowski, T., & Wybraniec, S. (2010). Influence of betalain-
rich extract on reduction of discomfort associated with osteoarthritis New 
Medicine, 1, 12-17.  
259 
 
 
Pizza, F. X., Baylies, H., & Mitchell, J. B. (2001). Adaptation to eccentric 
exercise: Neutrophils and E-selectin during early recovery. Canadian Journal 
of Applied Physiology, 26(3), 245–253.  
Pizza, F. X., Koh, T. J., McGregor, S. J., & Brooks, S. V. (2002). Muscle 
inflammatory cells after passive stretches, isometric contractions, and 
lengthening contractions. Journal of Applied Physiology, 92(5), 1873-1878. 
Pizza, F. X., Peterson, J. M., Baas, J. H., & Koh, T. J. (2005). Neutrophils 
contribute to muscle injury and impair its resolution after lengthening 
contractions in mice. Journal of Physiology, 562(Pt 3), 899-913.  
Grielberger, J, F., Greilberger, M., & Djukic, R. (2015). Biomarkers part I: 
Biomarkers to estimate bioefficacy of dietary/supplemental antioxidants in 
sport. In Antioxidants in sport nutrition (pp. 247-260). United States: CRC 
press 
Pizza, F. X. (2008). Neutrophils and macrophages in muscle damage and 
repair. In Skeletal Muscle Damage and Repair (pp. 49-57). United States: 
Human Kinetics.  
Plunkett, B. A., Callister, R., Watson, T. A., & Garg, M. L. (2010). Dietary 
antioxidant restriction affects the inflammatory response in athletes. British 
Journal of Nutrition, 103(08), 1179-1184. 
Pollo, A., Carlino, E., & Benedetti, F. (2008). The top‐down influence of 
ergogenic placebos on muscle work and fatigue. European Journal of 
Neuroscience, 28(2), 379-388. 
Powers, S. K., & Jackson, M. J. (2008). Exercise-induced oxidative stress: 
cellular mechanisms and impact on muscle force production. Physiological 
Reviews, 88(4), 1243-1276.  
260 
 
 
Powers, S. K., Nelson, W. B., & Hudson, M. B. (2011). Exercise-induced 
oxidative stress in humans: cause and consequences. Free Radical Biology 
and Medicine, 51(5), 942-950.  
Powers, S. K., Smuder, A. J., Kavazis, A. N., & Hudson, M. B. (2010). 
Experimental guidelines for studies designed to investigate the impact of 
antioxidant supplementation on exercise performance. International Journal 
of Sports Nutrition and Exercise Metabolism, 20(1), 2-14.  
Presley, T. D., Morgan, A. R., Bechtold, E., Clodfelter, W., Dove, R. W., 
Jennings, J. M., . . . Miller, G. D. (2011). Acute effect of a high nitrate diet on 
brain perfusion in older adults. Nitric Oxide, 24(1), 34-42.  
Proske, U., & Morgan, D. L. (2001). Muscle damage from eccentric exercise: 
mechanism, mechanical signs, adaptation and clinical applications. Journal 
of Physiology, 537(Pt 2), 333-345.  
Ra, S. G., Miyazaki, T., Ishikura, K., Nagayama, H., Komine, S., Nakata, Y., 
... & Ohmori, H. (2013). Combined effect of branched-chain amino acids and 
taurine supplementation on delayed onset muscle soreness and muscle 
damage in high-intensity eccentric exercise. Journal of the International 
Society of Sports Nutrition, 10(1), 1. 
Raastad, T., Owe, S. G., Paulsen, G., Enns, D., Overgaard, K., Crameri, R., 
... & Hallén, J. (2010). Changes in calpain activity, muscle structure, and 
function after eccentric exercise. Medicine and Science in Sports and 
Exercise, 42(1), 86-95. 
Radak, Z., Chung, H. Y., Koltai, E., Taylor, A. W., & Goto, S. (2008). 
Exercise, oxidative stress and hormesis. Ageing Research Reviews, 7(1), 
34-42. 
261 
 
 
Rankin, P., Stevenson, E., & Cockburn, E. (2015). The effect of milk on the 
attenuation of exercise-induced muscle damage in males and females. 
European Journal of Applied Physiology, 115(6), 1245-1261. 
Reddy, M. K., Alexander-Lindo, R. L., & Nair, M. G. (2005). Relative 
inhibition of lipid peroxidation, cyclooxygenase enzymes, and human tumor 
cell proliferation by natural food colors. Journal of Agriculture and Food 
Chemistry, 53(23), 9268-9273. 
Reid, M. B., & Li, Y. P. (2001). Tumor necrosis factor-α and muscle wasting: 
a cellular perspective. Respiratory Research, 2(5), 1. 
Rein, M. J., Renouf, M., Cruz-Hernandez, C., Actis-Goretta, L., Thakkar, S. 
K., & da Silva Pinto, M. (2013). Bioavailability of bioactive food compounds: a 
challenging journey to bioefficacy. British Journal of Clinical Pharmacology, 
75(3), 588-602.  
Reuter, S., Gupta, S. C., Chaturvedi, M. M., & Aggarwal, B. B. (2010). 
Oxidative stress, inflammation, and cancer: how are they linked? Free 
Radical Biology and Medicine, 49(11), 1603-1616.  
Ricciotti, E., & FitzGerald, G. A. (2011). Prostaglandins and inflammation. 
Arteriosclerosis, Thrombosis, and Vascular Biology, 31(5), 986-1000. 
Rigamonti, E., Touvier, T., Clementi, E., Manfredi, A. A., Brunelli, S., & 
Rovere-Querini, P. (2013). Requirement of inducible nitric oxide synthase for 
skeletal muscle regeneration after acute damage. The Journal of 
Immunology, 190(4), 1767-1777. 
Risøy, B. A., Raastad, T., Hallén, J., Lappegård, K. T., Bæverfjord, K., 
Kravdal, A., ... & Benestad, H. B. (2003). Delayed leukocytosis after hard 
strength and endurance exercise: Aspects of regulatory mechanisms. BMC 
Physiology, 3(1), 1. 
262 
 
 
Roberts, L. A., Raastad, T., Markworth, J. F., Figueiredo, V. C., Egner, I. M., 
Shield, A., ... & Peake, J. M. (2015). Post‐exercise cold water immersion 
attenuates acute anabolic signalling and long‐term adaptations in muscle to 
strength training. The Journal of physiology, 593(18), 4285-4301. 
Ronglan, L. T., Raastad, T., & Borgesen, A. (2006). Neuromuscular fatigue 
and recovery in elite female handball players. Scandinavian Journal of 
Medicine and Science in Sports and Exercise, 16(4), 267-273.  
Ryan, L., & Prescott, S. L. (2010). Stability of the antioxidant capacity of 
twenty-five commercially available fruit juices subjected to an in vitro 
digestion. International Journal of Food Science and Technology, 45(6), 
1191-1197.  
Sakurai, T., Kashimura, O., Kano, Y., Ohno, H., Ji, L. L., Izawa, T., & Best, T. 
M. (2013). Role of nitric oxide in muscle regeneration following eccentric 
muscle contractions in rat skeletal muscle. The Journal of Physiological 
Sciences, 63(4), 263–270.  
Sands, W. A., McNeal, J. R., Murray, S. R., & Stone, M. H. (2015). Dynamic 
compression enhances pressure-to-pain threshold in elite athlete recovery: 
exploratory study. The Journal of Strength & Conditioning Research, 29(5), 
1263-1272. 
Satoh, T., McKercher, S. R., & Lipton, S. A. (2013). Nrf2/ARE-mediated 
antioxidant actions of pro-electrophilic drugs. Free Radical Biology and 
Medicine, 65, 645-657.  
Saunders, M. J., Kane, M. D., & Todd, M. K. (2004). Effects of a 
carbohydrate-protein beverage on cycling endurance and muscle damage. 
Medicine and Science in Sports and Exercise, 36(7), 1233-1238.  
263 
 
 
Sayers, S. P., & Clarkson, P. M. (2001). Force recovery after eccentric 
exercise in males and females. European Journal of Applied 
Physiology, 84(1-2), 122-126. 
Schäfers, M., Sorkin, L. S., & Sommer, C. (2003). Intramuscular injection of 
tumor necrosis factor-alpha induces muscle hyperalgesia in rats. Pain, 
104(3), 579-588. 
Scherr, J., Braun, S., Schuster, T., Hartmann, C., Moehlenkamp, S., 
Wolfarth, B., ... & Halle, M. (2011). 72-h kinetics of high-sensitive troponin T 
and inflammatory markers after marathon. Medicine and Science in Sports 
and Exercise, 43(10), 1819-1827. 
Schoenfeld, B. J. (2012). The Use of Nonsteroidal anti-inflammatory drugs 
for exercise-induced muscle damage. Sports Medicine, 42(12), 1017-1028. 
Schofield, W. N. (1984). Predicting basal metabolic rate, new standards and 
review of previous work. Human nutrition. Clinical nutrition, 39, 5-41. 
Semark, A., Noakes, T. D., Gibson, A. S. C., & Lambert, M. I. (1999). The 
effect of a prophylactic dose of flurbiprofen on muscle soreness and sprinting 
performance in trained subjects. Journal of Sports Sciences, 17(3), 197-203. 
Shahidi, F., & Ho, C. T. (Eds.). (2007). Antioxidant measurement and 
applications. American Chemical Society- symposium series, 956, 2-7. 
Shanely, R. A., Nieman, D. C., Zwetsloot, K. A., Knab, A. M., Imagita, H., 
Luo, B., ... & Zubeldia, J. M. (2014). Evaluation of Rhodiola rosea 
supplementation on skeletal muscle damage and inflammation in runners 
following a competitive marathon. Brain, Behavior, and Immunity, 39, 204-
210. 
Siervo, M., Lara, J., Ogbonmwan, I., & Mathers, J. C. (2013). Inorganic 
nitrate and beetroot juice supplementation reduces blood pressure in adults: 
a systematic review and meta-analysis. Journal of Nutrition, 143(6), 818-826.  
264 
 
 
Slattery, K., Bentley, D., & Coutts, A. J. (2015). The role of oxidative, 
inflammatory and neuroendocrinological systems during exercise stress in 
athletes: implications of antioxidant supplementation on physiological 
adaptation during intensified physical training. Sports Medicine, 45(4), 453-
471. 
Smith, C., Kruger, M. J., Smith, R. M., & Myburgh, K. H. (2008). The 
inflammatory response to skeletal muscle injury: illuminating complexities. 
Sports Medicine, 38(11), 947-969.  
Smith, L. L. (1992). Causes of Delayed Onset Muscle Soreness and the 
Impact on Athletic Performance: A Review. The Journal of Strength & 
Conditioning Research, 6(3), 135-141. 
Sousa, M., Teixeira, V. H., & Soares, J. (2014). Dietary strategies to recover 
from exercise-induced muscle damage. International Journal of Food 
Sciences and Nutrition, 65(2), 151-163. 
Stintzing, F. C., & Carle, R. (2007). Betalains – emerging prospects for food 
scientists. Trends in Food Science & Technology, 18(10), 514–525.  
Stupka, N., Tarnopolsky, M. A., Yardley, N. J., & Phillips, S. M. (2001). 
Cellular adaptation to repeated eccentric exercise-induced muscle damage. 
Journal of Applied Physiology, 91(4), 1669-1678.  
Suzuki, K., Nakaji, S., Yamada, M., Liu, Q., Kurakake, S., Okamura, N., ... & 
Sugawara, K. (2003). Impact of a competitive marathon race on systemic 
cytokine and neutrophil responses. Medicine and Science in Sports and 
Exercise, 35(2), 348-355. 
Suzuki, K., Totsuka, M., Nakaji, S., Yamada, M., Kudoh, S., Liu, Q., ... & 
Sato, K. (1999). Endurance exercise causes interaction among stress 
hormones, cytokines, neutrophil dynamics, and muscle damage. Journal of 
Applied Physiology, 87(4), 1360-1367. 
265 
 
 
Szaefer, H., Krajka-Kuzniak, V., Ignatowicz, E., Adamska, T., & Baer-
Dubowska, W. (2014). Evaluation of the effect of beetroot juice on DMBA-
induced damage in liver and mammary gland of female Sprague-Dawley 
rats. Phytotherapy Research, 28(1), 55-61.  
Tan, D., Wang, Y., Bai, B., Yang, X., & Han, J. (2015). Betanin attenuates 
oxidative stress and inflammatory reaction in kidney of paraquat-treated rat. 
Food and Chemical Toxicology, 78, 141-146. 
Tan, D., Wang, Y., Bai, B., Yang, X., & Han, J. (2015). Betanin attenuates 
oxidative stress and inflammatory reaction in kidney of paraquat-treated 
rat. Food and Chemical Toxicology, 78, 141–146.  
Tanabe, Y., Maeda, S., Akazawa, N., Zempo-Miyaki, A., Choi, Y., Ra, S. G., 
... & Nosaka, K. (2015). Attenuation of indirect markers of eccentric exercise-
induced muscle damage by curcumin. European Journal of Applied 
Physiology, 115(9), 1949-1957. 
Tee, J. C., Bosch, A. N., & Lambert, M. I. (2007). Metabolic consequences of 
exercise-induced muscle damage. Sports Medicine, 37(10), 827-836.  
Tesoriere, L., Allegra, M., Butera, D., & Livrea, M. A. (2004). Absorption, 
excretion, and distribution of dietary antioxidant betalains in LDLs: potential 
health effects of betalains in humans. American Journal of Clinical Nutrition, 
80(4), 941-945.  
Tesoriere, L., Butera, D., Pintaudi, A., Allegra, M., & Livrea, M. (2004b). 
Supplementation with cactus pear (Opuntia ficus-indica) fruit decreases 
oxidative stress in healthy humans: A comparative study with vitamin C. The 
American journal of Clinical Nutrition, 80(2), 391–5.  
Tesoriere, L., Fazzari, M., Angileri, F., Gentile, C., & Livrea, M. A. (2008). In 
vitro digestion of betalainic foods. Stability and bioaccessibility of 
betaxanthins and betacyanins and antioxidative potential of food digesta. 
266 
 
 
Journal of Agriculture and Food Chemistry, 56(22), 10487-10492. 
doi:10.1021/jf8017172 
Tesoriere, L., Gentile, C., Angileri, F., Attanzio, A., Tutone, M., Allegra, M., & 
Livrea, M. A. (2013). Trans-epithelial transport of the betalain pigments 
indicaxanthin and betanin across Caco-2 cell monolayers and influence of 
food matrix. European Journal of Nutrition, 52(3), 1077-1087. 
Theodorou, A. A., Nikolaidis, M. G., Paschalis, V., Koutsias, S., Panayiotou, 
G., Fatouros, I. G., ... & Jamurtas, A. Z. (2011). No effect of antioxidant 
supplementation on muscle performance and blood redox status adaptations 
to eccentric training. The American journal of Clinical Nutrition, 93(6), 1373-
1383. 
Thompson, D., Williams, C., Kingsley, M., Nicholas, C. W., Lakomy, H. K. A., 
McArdle, F., & Jackson, M. J. (2001). Muscle soreness and damage 
parameters after prolonged intermittent shuttle-running following acute 
vitamin C supplementation. International Journal of Sports Medicine, 22(01), 
68-75. 
Tidball, J. G. (2005). Inflammatory processes in muscle injury and repair. 
American Journal of Physiology- Regulatory, Integrative Comparative 
Physiology, 288(2), 345-353.  
Tidball, J. G., & Villalta, S. A. (2010). Regulatory interactions between 
muscle and the immune system during muscle regeneration. American 
Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 
298(5), R1173-R1187. 
Ting, Y. W., Jiang, Y., Ho, C. T., & Huang, Q. R. (2014). Common delivery 
systems for enhancing in vivo bioavailability and biological efficacy of 
nutraceuticals. Journal of Functional Foods, 7, 112-128.  
267 
 
 
Toumi, H., & Best, T. M. (2003). The inflammatory response: friend or enemy 
for muscle injury? British Journal of Sports Medicine, 37(4), 284-286.  
Toumi, H., F'Guyer, S., & Best, T. M. (2006). The role of neutrophils in injury 
and repair following muscle stretch. Journal of Anatomy, 208(4), 459-470.  
Toutain, P. L., & Bousquet-Melou, A. (2004). Bioavailability and its 
assessment. Journal of Veterinary Pharmacology and Therapeutics, 27(6), 
455-466.  
Trappe, T. A., Carroll, C. C., Dickinson, J. M., LeMoine, J. K., Haus, J. M., 
Sullivan, B. E., ... & Hollon, C. J. (2011). Influence of acetaminophen and 
ibuprofen on skeletal muscle adaptations to resistance exercise in older 
adults. American Journal of Physiology-Regulatory, Integrative and 
Comparative Physiology, 300(3), R655-R662 
Trappe, T., Raue, U., Williams, R., Carrithers, J., & Hickner, R. (2006). 
Effects of age and resistance exercise on skeletal muscle interstitial 
prostaglandin F 2α. Prostaglandins, Leukotrienes and Essential fatty acids, 
74(3), 175-181. 
Trappe, T. A., & Liu, S. Z. (2013). Effects of prostaglandins and COX-
inhibiting drugs on skeletal muscle adaptations to exercise. Journal of 
Applied Physiology, 115(6), 909-919. 
Trombold, J. R., Barnes, J. N., Critchley, L., & Coyle, E. F. (2010). 
Ellagitannin consumption improves strength recovery 2-3 d after eccentric 
exercise. Medicine and Science in Sports and Exercise, 42(3), 493-498.  
Trombold, J. R., Reinfeld, A. S., Casler, J. R., & Coyle, E. F. (2011). The 
effect of pomegranate juice supplementation on strength and soreness after 
eccentric exercise. Journal of Strength and Conditioning Research, 25(7), 
1782-1788.  
268 
 
 
Tscholl, P. M., Vaso, M., Weber, A., & Dvorak, J. (2015). High prevalence of 
medication use in professional football tournaments including the World 
Cups between 2002 and 2014: a narrative review with a focus on NSAIDs. 
British Journal of Sports Medicine, 49(9), 580-582.  
Twist, C., & Highton, J. (2013). Monitoring fatigue and recovery in rugby 
league players. International Journal of Sports Physiology and 
Performance, 8(5), 467-474. 
Urso, M. L. (2013). Anti-inflammatory interventions and skeletal muscle 
injury: Benefit or detriment? Journal of Applied Physiology, 115(6), 920–928.  
van Velzen, A. G., Sips, A. J., Schothorst, R. C., Lambers, A. C., & 
Meulenbelt, J. (2008). The oral bioavailability of nitrate from nitrate-rich 
vegetables in humans. Toxicology Letters, 181(3), 177-181.  
Vanhatalo, A., Bailey, S. J., Blackwell, J. R., DiMenna, F. J., Pavey, T. G., 
Wilkerson, D. P., . . . Jones, A. M. (2010). Acute and chronic effects of 
dietary nitrate supplementation on blood pressure and the physiological 
responses to moderate-intensity and incremental exercise. American Journal 
of Physiology- Regulatory, Integrative, Comparative Physiology, 299(4), 
R1121-1131.  
Vassalle, C., Pingitore, A., De Giuseppe, R., Vigna, L., & Bamonti, F. (2015). 
Biomarkers Part II: Biomarkers to estimate bioefficacy of 
dietary/supplemental antioxidants in sport. In Antioxidants in sport nutrition 
(pp. 247-260). United States: CRC press.  
Vella, L., Markworth, J. F., Paulsen, G., Raastad, T., Peake, J. M., Snow, R. 
J., ... & Russell, A. P. (2016). Ibuprofen ingestion does not affect markers of 
post-exercise muscle inflammation. Frontiers in Physiology, 7. doi:  
10.3389/fphys.2016.00086.  
269 
 
 
Vidal, P. J., Lopez-Nicolas, J. M., Gandia-Herrero, F., & Garcia-Carmona, F. 
(2014). Inactivation of lipoxygenase and cyclooxygenase by natural betalains 
and semi-synthetic analogues. Food Chemistry, 154, 246-254.  
Vulic, J. J., Cebovic, T. N., Canadanovic-Brunet, J. M., Cetkovic, G. S., 
Canadanovic, V. M., Djilas, S. M., & Saponjac, V. T. T. (2014). In vivo and in 
vitro antioxidant effects of beetroot pomace extracts. Journal of Functional 
Foods, 6, 168-175.  
Waltz, P., Escobar, D., Botero, A. M., & Zuckerbraun, B. S. (2015). 
Nitrate/nitrite as critical mediators to limit oxidative injury and inflammation. 
Antioxidants & Redox Signalling, 23(4), 328-339. 
Warden, S. J. (2010). Prophylactic use of NSAIDs by athletes: a risk/benefit 
assessment. The Physician and Sportsmedicine, 38(1), 132-138.  
Warhol, M. J., Siegel, A. J., Evans, W. J., & Silverman, L. M. (1985). Skeletal 
muscle injury and repair in marathon runners after competition. The 
American Journal of Pathology, 118(2), 331. 
Warren, G. L., Ingalls, C. P., Lowe, D. A., & Armstrong, R. B. (2002). What 
mechanisms contribute to the strength loss that occurs during and in the 
recovery from skeletal muscle injury? Journal of Orthopaedic & Sports 
Physical Therapy, 32(2), 58-64.  
Warren, G. L., Lowe, D. A., & Armstrong, R. B. (1999). Measurement tools 
used in the study of eccentric contraction-induced injury. Sports Medicine, 
27(1), 43-59.  
Warren, G. L., Lowe, D. A., Hayes, D. A., Karwoski, C. J., Prior, B. M., & 
Armstrong, R. B. (1993). Excitation failure in eccentric contraction‐induced 
injury of mouse soleus muscle. The Journal of Physiology, 468(1), 487-499. 
Warren, G., O’Farrell, L., Summan, M., Hulderman, T., Mishra, D., Luster, 
M., … Simeonova, P. (2004). Role of CC chemokines in skeletal muscle 
270 
 
 
functional restoration after injury. American journal of physiology. Cell 
Physiology, 286(5).  
Warren, G. L., Call, J. A., Farthing, A. K., & Baadom-Piaro, B. (2016). 
Minimal Evidence for a Secondary Loss of Strength After an Acute Muscle 
Injury: A Systematic Review and Meta-Analysis. Sports Medicine, 1-19. 
Watson, T. A., Callister, R.., Taylor, R. D., Sibbritt, D. W., MacDonald-Wicks, 
L. K., & Garg, M. L. (2005). Antioxidant restriction and oxidative stress in 
short-duration exhaustive exercise. Medicine and Science in Sports and 
Exercise, 37(1), 63-71. 
Webb, A. J., Patel, N., Loukogeorgakis, S., Okorie, M., Aboud, Z., Misra, S., . 
. . Benjamin, N. (2008). Acute blood pressure lowering, vasoprotective, and 
antiplatelet properties of dietary nitrate via bioconversion to nitrite. 
Hypertension, 51(3), 784-790.  
Weitzberg, E., & Lundberg, J. O. (2013). Novel aspects of dietary nitrate and 
human health. Annual Review of Nutrition, 33, 129-159.  
Wilson, G. J., & Murphy, A. J. (1996). The use of isometric tests of muscular 
function in athletic assessment. Sports Medicine, 22(1), 19-37. 
Wilson, P. B., Fitzgerald, J. S., Rhodes, G. S., Lundstrom, C. J., & Ingraham, 
S. J. (2015). Effectiveness of Ginger Root (Zingiber officinale) on Running-
Induced Muscle Soreness and Function: A Pilot Study. International Journal 
of Athletic Therapy & Training, 20(6). 
Wilson, P. B. (2015). Ginger (Zingiber officinale) as an analgesic and 
ergogenic aid in sport: a systemic review. The Journal of Strength & 
Conditioning Research, 29(10), 2980-2995. 
Wink, D. A., Hines, H. B., Cheng, R. Y. S., Switzer, C. H., Flores-Santana, 
W., Vitek, M. P., . . . Colton, C. A. (2011). Nitric oxide and redox mechanisms 
in the immune response. Journal of Leukocyte Biology, 89(6), 873-891.  
271 
 
 
Winkler, C., Wirleitner, B., Schroecksnadel, K., Schennach, H., & Fuchs, D. 
(2005). In vitro effects of beet root juice on stimulated and unstimulated 
peripheral blood mononuclear cells. American Journal of Biochemistry and 
Biotechnology, 1, 180-185. 
Wolff, S. P. (1994). [18] Ferrous ion oxidation in presence of ferric ion 
indicator xylenol orange for measurement of hydroperoxides. Methods in 
Enzymology, 233, 182-189. 
Woolley BP, Jakeman JR, Faulkner JA. Multiple Sprint Exercise with a Short 
Deceleration Induces Muscle Damage and Performance Impairment in 
Young, Physically Active Males. Journal of Athletic Enhancement, 2014:7:2.  
Wootton-Beard, P. C., & Ryan, L. (2011). A beetroot juice shot is a significant 
and convenient source of bioaccessible antioxidants. Journal of Functional 
Foods, 3(4), 329-334.  
Wootton-Beard, P. C., Brandt, K., Fell, D., Warner, S., & Ryan, L. (2014). 
Effects of a beetroot juice with high neobetanin content on the early-phase 
insulin response in healthy volunteers. Journal of Nutrition Science 3, 9.  
Wootton-Beard, P. C., Moran, A., & Ryan, L. (2011). Stability of the total 
antioxidant capacity and total polyphenol content of 23 commercially 
available vegetable juices before and after in vitro digestion measured by 
FRAP, DPPH, ABTS and Folin-Ciocalteu methods. Food Research 
International, 44(1), 217-224.  
Wylie, L. J., Kelly, J., Bailey, S. J., Blackwell, J. R., Skiba, P. F., Winyard, P. 
G., … Jones, A. M. (2013). Beetroot juice and exercise: Pharmacodynamic 
and dose-response relationships. Journal of Applied Physiology, 115(3), 
325–336.  
Xin, L., Hyldahl, R. D., Chipkin, S. R., & Clarkson, P. M. (2014). A 
contralateral repeated bout effect attenuates induction of NF-κB DNA binding 
272 
 
 
following eccentric exercise. Journal of Applied Physiology, 116(11), 1473-
1480. 
Yfanti, C., Akerström, T., Nielsen, S., Nielsen, A. R., Mounier, R., Mortensen, 
O. H., ... & Pedersen, B. K. (2010). Antioxidant supplementation does not 
alter endurance training adaptation. Medicine and Science in Sports and 
Exercise, 42(7), 1388-1395. 
Yfanti, C., Nielsen, A. R., Åkerström, T., Nielsen, S., Rose, A. J., Richter, E. 
A., ... & Pedersen, B. K. (2011). Effect of antioxidant supplementation on 
insulin sensitivity in response to endurance exercise training. American 
Journal of Physiology-Endocrinology and Metabolism, 300(5), 761-770. 
Yu, J., Liu, J., Carlsson, L., Thornell, L., & Stål, P. (2013). Re-Evaluation of 
Sarcolemma Injury and Muscle Swelling in Human Skeletal Muscles after 
Eccentric Exercise. Plos ONE, 8(4), 620-656.  
Zerba, E., Komorowski, T. E., & Faulkner, J. A. (1990). Free radical injury to 
skeletal muscles of young, adult, and old mice. American Journal of 
Physiology, 258(3 Pt 1), 429-435.  
Zielinska-Przyjemska, M., Olejnik, A., Dobrowolska-Zachwieja, A., & Grajek, 
W. (2009). In vitro effects of beetroot juice and chips on oxidative metabolism 
and apoptosis in neutrophils from obese individuals. Phytotherapy Research, 
23(1), 49-55. 
 
 
 
 
273 
 
 
12 Appendices  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
274 
 
 
12.1 Appendix 1 – Example informed consent document. 
 
 
 
           Faculty of Health & Life Sciences 
                     INFORMED CONSENT FORM 
 
 
Project title:  
 
 
               please tick or initial  
  where applicable 
I have carefully read and understood the Participant Information Sheet.  
 
I have had an opportunity to ask questions and discuss this study and I have 
received satisfactory answers. 
 
 
I understand I am free to withdraw from the study at any time, without having to 
give a reason for withdrawing, and without prejudice. 
 
 
I agree to take part in this study.  
 
I would like to receive feedback on the overall results of the study at the email 
address given below.   
 
Email address…………………………………………………………………… 
 
 
 
 
Signature of participant.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
 
 Signature of Parent / Guardian in the case of a minor  
......................................................................................... 
 
 
Signature of researcher.......................................................    Date.....……………….. 
 
(NAME IN BLOCK LETTERS)....................................................………………………. 
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INFORMED CONSENT FOR REMOVAL AND STORAGE OF TISSUE 
 
Principal Investigator: Tom Clifford  
 
I agree that the following tissue or other bodily material may be taken and used for 
the study:  
 
Tissue/Bodily material Purpose Removal Method 
Blood 
 
For analysis of oxidative 
stress and inflammation.  
Via venepuncture  
 
I understand that if the material is required for use in any other way than that 
explained to me, then my consent to this will be specifically sought. I understand 
that I will not receive specific feedback from any assessment conducted on my 
samples, but should any kind of abnormality be discovered then the investigator will 
contact me.  
 
I understand that the University may store this tissue in a Licensed Tissue 
Bank only for the duration of the study, it will then be destroyed. 
 
 
 
 
 
 
I consent to the University distributing this tissue to partners in this research 
study, outside of the University, for further testing (please tick the box if you 
agree).                                                                     
 
                                                        
Signature of participant.......................................................    Date.....……………….. 
 
Signature of Parent / Guardian in the case of a minor             
 
.........................................................................................        
Date.....……………….. 
 
Signature of researcher.......................................................    Date.....……………….. 
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12.2 Appendix 2 – Example of institutional ethical approval 
Mic Wilkinson <mic.wilkinson@northumbria.ac.uk> 
26/01/2016 
 
Hi Tom, 
 
Thanks for your responses. As they were very minor, the reviewer was happy for me to sign off once 
they had been made. The project listed below now has ethical approval. Please keep the message 
for your records. 
 
Regards, 
Mick 
 
HLSTC120116 
The influence of recovery drinks on muscle damage following a marathon race 
 
Mick Wilkinson, PhD 
Senior Lecturer 
Sport, Exercise and Rehabilitation 
Northumbria University 
Newcastle-upon-Tyne 
England 
NE1 8ST 
mic.wilkinson@northumbria.ac.uk 
Tel: 0191 243 7097 
micwilkinson.youcanbook.me 
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12.3 Appendix 3 – General health history questionnaire  
 
HEALTH HISOTRY QUESTIONNAIRE 
D.O.B:…………….. 
As you are participating in exercise within this laboratory, please can you complete 
the following questionnaire.  Your co-operation is greatly appreciated. 
All information within this questionnaire is considered confidential. 
Where appropriate please circle your selected answer. 
 
1. How would you describe your current level of activity? 
Sedentary / Moderately Active / Highly Active 
2. How would you describe your current level of fitness? 
Very Unfit / Moderately Fit / Trained / Highly Trained 
3. How would you describe your current body weight? 
Underweight / Ideal / Slightly Overweight / Very Overweight 
4. Smoking Habit: - 
Currently a non-smoker  Yes / No 
Previous smoker   Yes / No 
If previous smoker, how long since you stopped? ………Years 
Regular smoker   Yes / No of …… per day 
Occasional smoker   Yes / No of …… per day 
 
5. Alcohol Consumption: - 
Do you drink alcohol?  Yes / No 
If yes then do you -  have an occasional drink   Yes / No 
   have a drink every day?   Yes / No 
   have more than one drink per day?  Yes / No 
 
6. Have you consulted your doctor within the last 6 months? 
Yes / No 
If yes, please give details ……………………………………………………. 
7. Are you currently taking any medication (including anti-inflammatory drugs)? 
Yes / No 
If yes, please give details ……………………………………………………. 
8. Do you, or have you ever suffered from:- 
Diabetes   Yes / No 
Asthma   Yes / No 
Epilepsy   Yes / No 
Bronchitis   Yes / No 
Elevated cholesterol  Yes / No 
High Blood Pressure  Yes / No 
 
9. Do you suffer from, or have you ever suffered from any heart complaint or 
pains in your chest, either associated with exercise or otherwise? 
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Yes / No 
10. Is there a history of heart disease in your family? 
Yes / No 
11. Do you feel faint or have spells of severe dizziness when undertaking 
exercise or otherwise? 
Yes / No 
12. Do you currently have any form of muscle joint injury? 
Yes / No 
If yes, please give details …………………………………………………… 
13. Have you ever suffered from any knee joint injury or thigh injury? 
Yes / No 
If yes, please give details …………………………………………………… 
14. Do you currently take any form of nutritional supplement (e.g. creatine, whey 
and casein protein, HMB, etc)? 
Yes / No 
If yes, please give details …………………………………………………… 
15. Do you have any food allergies?  
Yes/No 
If yes, please give details …………………………………………………… 
16. Are you currently on any special diet or have dieted in the past? (e.g. weight 
loss/ high protein)    
Yes/No 
If yes, please give details 
…………………………………………………………… 
………………………………………………………………………………………
…. 
 
17. Is there anything to your knowledge that may prevent you from successfully 
completing the test that has been explained to you? 
Yes / No 
If yes, please give details ………………………………………………….. 
 
Please provide any further information concerning any condition/complaint that you 
suffer from and any medication that you may be taking by prescription or otherwise. 
…………………………………………………………………………………………………
………………………………………………………………………………………………… 
 
Signature of participant: …………………………………. Date: 
………………………….. 
Signature of test supervisor: ………………………… 
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12.4 Appendix 4 – Low phenolic diet food diary example (Chapters 
4, 5 and 6).  
CONFIDENTIAL 
Participant ID:_____________________ 
 
 
FOOD RECORD DIARY 
 
Please record everything you eat and drink for 2 days prior to your trial 
and throughout the trial (72 hours). You will then be asked to consume 
similar food and drink prior to and during the second trial.  Please avoid 
consuming the foods listed at the back of this document throughout 
the 2 days prior to and during the trial periods.  This is vitally important 
to the results of the study so please adhere to this strictly.  Instructions 
and examples are given inside. 
 
Information about your diet will be treated in confidence. 
 
If you have a problem, please contact: Tom 07508200021 
tom.clifford@northumbria.ac.uk 
 
Department of Sports, Exercise and Rehabilitation  
School of Life Sciences 
Northumbria University 
Newcastle Upon Tyne 
NE1 8ST 
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INSTRUCTIONS FOR USING THE FOOD DIARY 
 
Everything that you eat and drink over the course of the day should be 
recorded. 
 
Do not forget to record second helpings and between meal snacks. 
 
Eating Out – Most people eat foods away from home each day, please do 
not forget to record these. Take your diary with you where ever it is possible. 
If this is too inconvenient just record the type of food eaten. 
 
Names and descriptions of foods should be as detailed as possible, including 
the brand name and any other information available.  
 
e.g. Cheese – is insufficient information. 
 Cheese, cheddar (Shape reduced fat) – is sufficient information. 
 
 
Start a new page in your diary for each day, and record each item on a 
separate line. Record the time of day in the first column of each line. 
e.g. 10:30 am  McVities  Digestive Biscuits (2)  50g 
            
The space provided at the foot of each page for general comments is for you 
to give any further information about your diet and your training/activity for 
that day. 
 
e.g. Steady run, morning 1 hour. 
 Missed lunch due to stomach pains 
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DAY 1 (48 hours pre-trial 1)     
Date:        /              /  
 
Please use a separate line for each item eaten; write in weight of plate; leave a line 
between different ‘plate’ entries. 
A B C D E F  
Time Food eaten Brand name 
of each item 
(except 
fresh food) 
Full description of each item 
including: 
-whether fresh, frozen, dried, 
canned 
-cooked: boiled, grilled, fried, 
roasted. 
-what type of fat food fried in 
Weight 
Served 
Weight 
of 
Leftover
s 
Actual 
Weight 
am/p
m 
home awa
y 
 
(gms) 
 
(gms) 
 
(gms) 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
GENERAL COMMENTS and ACTIVITY UNDERTAKEN: 
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Dietary Restrictions 
 
Please see below for foods that you can/cannot eat during the period 2 days 
prior to and during each trial.  It is vitally important that you strictly follow 
these restrictions in order to make sure any changes we see in your samples 
(bloods) are directly as a result of the beverage you are provided with.  The 
foods on the ‘should NOT’ eat list are those are high in polyphenols (AOXs) 
and nitrate/nitrite, if you come across foods not listed there but you know are 
high in AOXs, please avoid these also. 
 
Foods that should NOT be eaten during the diet 
 
 Tea, coffee, drinking chocolate, alcohol (specially red wine and apple 
cider), fruit juice 
 Fruits and Vegetables 
 Chocolate and chocolate products 
 Cereals / wholemeal bread / grains 
 Spices (such as curry) and herbs 
 Cured meats (Bacon, sausages, salami, ham, chorizo and hot dogs).  
 
 Foods that you may eat 
 White bread 
 Butter, vegetable oil (avoid olive oil) 
 Pasta, rice 
 Meat, eggs, fish 
 Peeled potatoes (mash, crisps, french fries) 
 Mushrooms 
 Digestive biscuits 
 Milk and milk products (plain yogurts, cheese) 
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EXAMPLES OF DIET FOR THE STUDY 
 
Here below is an example of what you can eat during the 2 days preceding 
your visit and the 4 days of testing: 
 
Breakfast: 
 Toast (white bread) with butter (NO jam) 
 Glass of milk or plain yogurt (or Greek yogurt but without 
Honey) 
 Scrambled eggs 
 Croissant, pastries (NO jam or chocolate coated) 
 Waffles, pancakes 
 Rice Krispies with milk and sugar 
 
Lunch: 
 Sandwich (white bread, white bagels, white pitta bread, or 
panini) with any of the following fillings (NO lettuce, or 
tomatoes): 
- Chicken 
- Cheese 
- Tuna 
- Prawns 
- Butter 
- Mayonnaise 
 Pack of crisps (Ready salted) 
 Burger and chips 
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Dinner: 
 Fish and chips with salt and vinegar (NO tomato sauce) 
 Chicken with mushrooms and mash potatoes or chips (NO 
vegetable or peas) 
 Chicken and fried rice / fried noodles with eggs, and oyster 
sauce (NO peas and NO soya sauce) 
 Macaroni and cheese (cream cheese sauce) 
 Tuna, salmon, cod, with rice or pasta (NO tomato-based or 
vegetable-based sauce) 
 Steak, pork chops 
 Spaghetti carbonara (cream cheese sauce, bacon) 
 
 
Snacks: 
 Digestive biscuits (NO chocolate coated) 
 Short breads 
 Custard rice pudding 
 Crisps (Ready salted) 
 Ice cream (vanilla flavour) 
 Vanilla flavour milk-shake 
 Plain scones with butter, clotted cream 
 
You can drink water at all times. 
 
WHAT YOU MUST NOT EAT OR DRINK 
 
285 
 
 
 Coffee 
 
 Tea 
 
 Alcohol (especially red/white wine, apple cider, beer) 
 
 Fruits (especially apples, pears, apricots, prunes, plums, cherries, 
peaches, blueberries, grapes) 
 
 Vegetables (especially tomatoes, spinach, asparagus, cabbage, carrots, 
peppers, onions, broccoli, cauliflower) 
 
 Fruits juices (especially Ribena), soft drinks (coca cola, irn bru…) 
 
 Chocolate / chocolate products (biscuits, cakes, chocolate bars) / drinking 
chocolate 
 
 Wholemeal bread, granary bread, brown bread 
 
 Wholegrain cereals (such as Weetabix, bran flakes, Corn flakes, oat 
cakes, porridge, Muesli) 
 
 Wholemeal food (such as wholemeal pasta, wholemeal rice…) 
 
 Beans (such as baked beans, green beans), lentils, peas 
 
 Curry dishes, curry spice, chilli, paprika 
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 Herbs (such as basil, parsley, coriander, chives…) 
 
 Tomato sauce (such as Ketchup, ready-made pasta sauce in jar…) 
 
 Cured meats (Bacon, sausages, salami, ham, chorizo and hot dogs). 
 
 
We are aware that this may be difficult for you to follow such a diet, as it may 
be really different from your usual diet. The reason we ask you to change 
your normal diet is that the foods listed above contain similar components 
that we want to be testing in the AOX drinks. Therefore, if you do eat the 
foods above, this may interfere with the study. 
 
Thank you for your co-operation. 
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12.5 Appendix 5 – Food diary (unrestricted; Chapters 7,8 and 9).  
 
CONFIDENTIAL 
Participant ID:_____________________ 
 
 
FOOD RECORD DIARY 
 
Please record everything you eat and drink 1 day prior to the trial, the day 
of the trial, and for the remainder of the testing period. Please do not 
deviate from your usual eating patterns. Instructions and examples are 
given inside. 
 
Information about your diet will be treated in confidence. 
 
 
If you have a problem, please contact: Tom 07508200021 
tom.clifford@northumbria.ac.uk 
 
Department of Sports Science 
School of Life Sciences 
Northumbria University 
Newcastle Upon Tyne 
NE1 8ST 
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INSTRUCTIONS FOR USING THE FOOD DIARY 
 
Everything that you eat and drink over the course of the day should be 
recorded. 
 
Do not forget to record second helpings and between meal snacks. 
 
Eating Out – Most people eat foods away from home each day, please do 
not forget to record these. Take your diary with you where ever it is possible. 
If this is too inconvenient just record the type of food eaten. 
 
Names and descriptions of foods should be as detailed as possible, including 
the brand name and any other information available.  
 
e.g. Cheese – is insufficient information. 
 Cheese, cheddar (Shape reduced fat) – is sufficient information. 
 
 
Start a new page in your diary for each day, and record each item on a 
separate line. Record the time of day in the first column of each line. 
e.g. 10:30 am  McVities  Digestive Biscuits (2)  50g 
            
The space provided at the foot of each page for general comments is for you 
to give any further information about your diet and your training/activity for 
that day. 
 
e.g. Steady run, morning 1 hour. 
 Missed lunch due to stomach pains 
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DAY 1 (48 hours pre-trial 1)     
Date:        /              /  
 
Please use a separate line for each item eaten; write in weight of plate; leave a line 
between different ‘plate’ entries. 
A B C D E F  
Time Food 
eaten 
Brand 
name of 
each item 
(except 
fresh 
food) 
Full description of each 
item including: 
-whether fresh, frozen, 
dried, canned 
-cooked: boiled, grilled, 
fried, roasted. 
-what type of fat food fried 
in 
Weight 
Served 
Weight 
of 
Leftov
ers 
Actual 
Weight 
am/p
m 
hom
e 
aw
ay 
 
(gms) 
 
(gms) 
 
(gms) 
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
        
GENERAL COMMENTS and ACTIVITY UNDERTAKEN: 
 
 
 
 
